Toceranib
     RDKit          3D

 29 32  0  0  0  0  0  0  0  0999 V2000
    0.2204   -2.5366    0.0986 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1155   -1.0365    0.0325 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1465   -0.1986   -0.0231 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6611    1.1164   -0.0735 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7416    1.0405   -0.0377 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1156   -0.2433    0.0282 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5171   -0.7776    0.1002 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7129   -1.9958    0.1838 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5697    0.0385    0.1015 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9005   -0.4900    0.2206 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9290    0.6411    0.0042 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.2918    0.1460    0.2806 N   0  0  0  0  0  0  0  0  0  0  0  0
   -7.7022   -0.9362   -0.6054 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.1767   -1.1058   -0.1891 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.6176    0.3483    0.1420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.3067    1.1560   -0.0055 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6403    2.2474   -0.0613 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5775   -0.6066   -0.0249 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6126    0.2486   -0.0250 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9901   -0.1158   -0.0211 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5460   -1.3201   -0.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0296   -1.3720   -0.0132 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7460   -0.2370   -0.0058 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0660    1.0762   -0.0057 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7398    1.0755   -0.0135 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8798    2.1987   -0.0138 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.6125    1.7340   -0.0205 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6174    2.4628   -0.0199 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.6589   -2.5554   -0.0129 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
  5 17  1  0
  3 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  1  0
 27 28  2  0
 22 29  1  0
  6  2  1  0
 16 12  1  0
 19 27  1  0
 25 20  1  0
M  END
>  <BrandName>  (1) 
nan

>  <Phase>  (1) 
0.0

>  <Applicants>  (1) 
Pfizer

>  <Links>  (1) 
|http://www.chemspider.com/Chemical-Structure.4486268.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL13608|http://pubchem.ncbi.nlm.nih.gov/compound/5329106|http://zinc15.docking.org/substa
nces/ZINC000003989258|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=59L7Y
0530C|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4818

>  <LigID>  (1) 
nan

>  <pdbID>  (1) 
nan

>  <Type>  (1) 
nan

>  <RoF>  (1) 
0

>  <MW>  (1) 
396.2

>  <LogP>  (1) 
3.1

>  <TPSA>  (1) 
77.2

>  <HBA>  (1) 
3

>  <HBD>  (1) 
3

>  <NRB>  (1) 
5

>  <Indications>  (1) 
nan

>  <Targets>  (1) 
KIT

>  <Kinase families>  (1) 
KIT

>  <Canonical_Smiles>  (1) 
Cc1c([nH]c(c1C(=O)NCCN2CCCC2)C)/C=C\3/c4cc(ccc4NC3=O)F

>  <InChiKey>  (1) 
SRSGVKWWVXWSJT-ATVHPVEESA-N

>  <First_Approval>  (1) 
nan

>  <SC_Patent>  (1) 
None

>  <Chirality>  (1) 
Achiral Molecule

>  <Synonyms>  (1) 
PHA-291639 | TOCERANIB

>  <FDA_approved>  (1) 


>  <Melting points>  (1) 


$$$$
Dezapelisib
     RDKit          2D

 30 34  0  0  0  0  0  0  0  0999 V2000
    6.4901    0.2200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3958    1.2459    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5826    2.7342    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2249    3.3718    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    3.1989    2.2775    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9226    0.9636    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.1466   -0.3201    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8703   -1.6339    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.6469   -0.2899    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9232    1.0240    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6992    2.3077    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5765    1.0542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3002    2.3681    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3525   -0.2295    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8522   -0.1993    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5759    1.1146    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0755    1.1448    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5103    2.5804    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2792    3.4375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0837    2.5315    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8515   -0.1389    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1278   -1.4528    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6281   -1.4830    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.8709   -1.5735    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6288   -1.5434    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4048   -2.8270    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6811   -4.1409    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8186   -4.1711    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5946   -2.8874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5423   -5.4850    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  2  0
 10 11  1  0
 10 12  1  0
 12 13  1  1
 12 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 17 21  1  0
 21 22  2  0
 22 23  1  0
  9 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 28 30  1  0
  6  2  1  0
 11  5  2  0
 23 15  2  0
 20 16  1  0
 29 24  1  0
M  END
>  <BrandName>  (2) 
nan

>  <Phase>  (2) 
0.0

>  <Applicants>  (2) 
Incyte Corporation

>  <Links>  (2) 
|http://www.chemspider.com/Chemical-Structure.28651137.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL2216863|http://pubchem.ncbi.nlm.nih.gov/compound/58111426|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9728|http://zinc15.docking.org/substances/ZINC000095564453|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=2K59L7G59M|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50004547

>  <LigID>  (2) 
nan

>  <pdbID>  (2) 
nan

>  <Type>  (2) 
nan

>  <RoF>  (2) 
0

>  <MW>  (2) 
421.1

>  <LogP>  (2) 
3.7

>  <TPSA>  (2) 
100.9

>  <HBA>  (2) 
8

>  <HBD>  (2) 
2

>  <NRB>  (2) 
4

>  <Indications>  (2) 
nan

>  <Targets>  (2) 
nan

>  <Kinase families>  (2) 


>  <Canonical_Smiles>  (2) 
Cc1csc2n1c(=O)c(c(n2)[C@H](C)Nc3c4c([nH]cn4)ncn3)c5cccc(c5)F

>  <InChiKey>  (2) 
RSIWALKZYXPAGW-NSHDSACASA-N

>  <First_Approval>  (2) 
nan

>  <SC_Patent>  (2) 
None

>  <Chirality>  (2) 
Single Stereoisomer

>  <Synonyms>  (2) 
DEZAPELISIB | INCB040093

>  <FDA_approved>  (2) 


>  <Melting points>  (2) 


$$$$
Oclacitinib
     RDKit          2D

 23 25  0  0  0  0  0  0  0  0999 V2000
   -4.1363    2.8709    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0543    1.6845    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4859    0.2964    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8741   -0.2720    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0978    0.8648    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9175   -1.0917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4312   -1.2936    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5132   -0.1073    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0268   -0.3091    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5416   -1.6972    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3764   -2.8835    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8628   -2.6817    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0279   -1.8991    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.9459   -0.7127    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4322   -0.9146    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.3502    0.2717    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7818    1.6599    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.2955    1.8617    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3775    0.6754    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9656    1.1818    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0109    2.6812    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4509    3.1013    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.5963   -3.2872    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  2  0
  3  6  1  0
  7  6  1  1
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 10 13  1  6
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 13 23  1  0
 12  7  1  0
 19 14  1  0
 22 18  1  0
M  END
>  <BrandName>  (3) 
nan

>  <Phase>  (3) 
0.0

>  <Applicants>  (3) 
Pfizer

>  <Links>  (3) 
|http://www.chemspider.com/Chemical-Structure.28528036.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL2103874|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9696|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=99GS5XTB51|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=185700

>  <LigID>  (3) 
nan

>  <pdbID>  (3) 
nan

>  <Type>  (3) 
nan

>  <RoF>  (3) 
0

>  <MW>  (3) 
337.2

>  <LogP>  (3) 
1.5

>  <TPSA>  (3) 
91

>  <HBA>  (3) 
5

>  <HBD>  (3) 
2

>  <NRB>  (3) 
5

>  <Indications>  (3) 
nan

>  <Targets>  (3) 
JAK1; JAK2; JAK3

>  <Kinase families>  (3) 
Tyr

>  <Canonical_Smiles>  (3) 
CNS(=O)(=O)C[C@H]1CC[C@@H](CC1)N(c2ncnc3c2cc[nH]3)C

>  <InChiKey>  (3) 
HJWLJNBZVZDLAQ-HAQNSBGRSA-N

>  <First_Approval>  (3) 
nan

>  <SC_Patent>  (3) 
None

>  <Chirality>  (3) 
Single Stereoisomer

>  <Synonyms>  (3) 
JAKI | OCLACITINIB | PF-03394197

>  <FDA_approved>  (3) 


>  <Melting points>  (3) 


$$$$
Lifirafenib
     RDKit          2D

 35 41  0  0  0  0  0  0  0  0999 V2000
   -7.9046   -0.2890    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.1460    1.0050    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6460    0.9951    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9046   -0.3089    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6633   -1.6030    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.1632   -1.5930    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.9219   -2.8870    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.6805   -4.1810    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -9.2159   -2.1284    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6278   -3.6456    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4354   -0.0068    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2687    1.4839    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6349    2.1031    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9647    2.2252    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4647    2.2152    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2061    3.5192    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1950    4.6273    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.1713    4.0081    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0046    2.5173    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2122    1.6276    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5865    2.2286    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7532    3.7193    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5456    4.6090    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7942    1.3389    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.6275   -0.1518    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2531   -0.7528    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0864   -2.2435    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2940   -3.1333    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.6684   -2.5323    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8351   -1.0416    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2094   -0.4406    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4171   -1.3303    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2504   -2.8210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4580   -3.7107    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.8760   -3.4220    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  7  9  1  0
  7 10  1  0
  4 11  1  0
 11 12  1  0
 12 13  2  0
 14 12  1  6
 14 15  1  0
 15 16  1  0
 16 17  1  1
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 21 24  1  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
 33 34  2  0
 33 35  1  0
  6  1  1  0
 13  3  1  0
 16 14  1  0
 15 19  1  1
 23 18  1  0
 30 25  1  0
 35 29  1  0
M  END
>  <BrandName>  (4) 
nan

>  <Phase>  (4) 
1.0

>  <Applicants>  (4) 
BeiGene

>  <Links>  (4) 
|http://www.chemspider.com/Chemical-Structure.58145118.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL4209157|http://pubchem.ncbi.nlm.nih.gov/compound/89670174|http://www.drugbank.ca/drugs/DB14773| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=3K3|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/3K3|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8958|http://zinc15.docking.org/substances/ZINC000068764621|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=8762XZS5ZF

>  <LigID>  (4) 
'3K3'

>  <pdbID>  (4) 
4r5y

>  <Type>  (4) 
nan

>  <RoF>  (4) 
1

>  <MW>  (4) 
478.1

>  <LogP>  (4) 
5.3

>  <TPSA>  (4) 
89.1

>  <HBA>  (4) 
5

>  <HBD>  (4) 
2

>  <NRB>  (4) 
3

>  <Indications>  (4) 
nan

>  <Targets>  (4) 
nan

>  <Kinase families>  (4) 


>  <Canonical_Smiles>  (4) 
c1cc2c(cc1C(F)(F)F)[nH]c(n2)[C@H]3[C@H]4[C@@H]3Oc5c4cc(cc5)Oc6ccnc7c6CCC(=O)N7

>  <InChiKey>  (4) 
NGFFVZQXSRKHBM-FKBYEOEOSA-N

>  <First_Approval>  (4) 
nan

>  <SC_Patent>  (4) 
None

>  <Chirality>  (4) 
Single Stereoisomer

>  <Synonyms>  (4) 
BGB 283 | BGB-283 | LIFIRAFENIB

>  <FDA_approved>  (4) 


>  <Melting points>  (4) 


$$$$
Agerafenib
     RDKit          2D

 37 40  0  0  0  0  0  0  0  0999 V2000
    7.4221    0.0068    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6923   -1.3036    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9624   -2.6141    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3818   -0.5738    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2019    0.9154    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7301    1.2045    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0002   -0.1060    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.0211   -1.2051    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.0988    2.5652    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.6048    2.6989    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7420    1.4719    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.9736    4.0596    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5204    4.1933    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1517    5.5540    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6457    5.6878    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5085    4.4607    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8773    3.1000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3832    2.9663    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7401    1.8730    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1089    0.5123    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9717   -0.7147    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4657   -0.5810    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.3285   -1.8080    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6973   -3.1688    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2032   -3.3025    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3404   -2.0755    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8464   -2.2092    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9836   -0.9821    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6148    0.3786    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5601   -4.3958    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9288   -5.7565    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.8225   -1.6743    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -8.4537   -0.3136    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0027   -2.0335    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3132   -2.7633    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    8.7326   -0.7230    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    7.2729   -3.3439    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  6  9  1  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 24 30  1  0
 30 31  1  0
 23 32  1  0
 32 33  1  0
  2 34  1  0
 34 35  1  0
 34 36  1  0
 34 37  1  0
  8  4  1  0
 18 13  1  0
 29 20  2  0
 26 21  1  0
M  END
>  <BrandName>  (5) 
nan

>  <Phase>  (5) 
1.0

>  <Applicants>  (5) 
nan

>  <Links>  (5) 
|http://www.chemspider.com/Chemical-Structure.28506650.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL2029988|http://pubchem.ncbi.nlm.nih.gov/compound/56846693|http://www.drugbank.ca/drugs/DB15068|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7880|http://zinc15.docking.org/substances/ZINC000043207440|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=78I4VEX88N|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50382959

>  <LigID>  (5) 
nan

>  <pdbID>  (5) 
nan

>  <Type>  (5) 
nan

>  <RoF>  (5) 
2

>  <MW>  (5) 
517.2

>  <LogP>  (5) 
5.9

>  <TPSA>  (5) 
120.6

>  <HBA>  (5) 
8

>  <HBD>  (5) 
2

>  <NRB>  (5) 
7

>  <Indications>  (5) 
nan

>  <Targets>  (5) 
nan

>  <Kinase families>  (5) 


>  <Canonical_Smiles>  (5) 
CC(C)(c1cc(no1)NC(=O)Nc2cccc(c2)Oc3c4cc(c(cc4ncn3)OC)OC)C(F)(F)F

>  <InChiKey>  (5) 
DKNUPRMJNUQNHR-UHFFFAOYSA-N

>  <First_Approval>  (5) 
nan

>  <SC_Patent>  (5) 
None

>  <Chirality>  (5) 
Achiral Molecule

>  <Synonyms>  (5) 
AB-024 | AC-013773 | AGERAFENIB | CEP-32496 | RXDX 105 | RXDX-105

>  <FDA_approved>  (5) 


>  <Melting points>  (5) 


$$$$
Cenisertib
     RDKit          2D

 33 37  0  0  0  0  0  0  0  0999 V2000
    2.4709   -1.2306    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7372    0.2456    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5919    1.2143    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8582    2.6904    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2697    3.1979    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4150    2.2292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1487    0.7531    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2940   -0.2156    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.0277   -1.6918    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1730   -2.6605    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5845   -2.1530    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.8508   -0.6768    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7056    0.2919    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7298   -3.1217    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7129    3.6591    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6986    3.1516    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8439    4.1203    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2554    3.6128    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5217    2.1367    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3764    1.1680    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9649    1.6755    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6427   -0.3082    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0543   -0.8157    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2945    0.0280    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7870   -1.3836    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9727   -2.3024    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4734   -2.2559    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5545   -3.4416    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0683   -3.2387    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1219   -4.8301    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -7.2129   -1.4587    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.7938   -0.0185    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9332    1.6292    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 11 14  1  0
  4 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 20 22  1  0
 23 22  1  1
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  1
 28 29  2  0
 28 30  1  0
 26 31  1  6
 31 32  2  0
 19 33  1  0
  7  2  1  0
 13  8  1  0
 21 16  1  0
 27 23  1  0
 24 32  1  6
M  END
>  <BrandName>  (6) 
nan

>  <Phase>  (6) 
1.0

>  <Applicants>  (6) 
EMD Serono

>  <Links>  (6) 
|http://www.chemspider.com/Chemical-Structure.9744737.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL1614709|http://pubchem.ncbi.nlm.nih.gov/compound/11569967|http://www.drugbank.ca/drugs/DB06347|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9927|http://zinc15.docking.org/substances/ZINC000063298059|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=5277GPA358|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50389967

>  <LigID>  (6) 
nan

>  <pdbID>  (6) 
nan

>  <Type>  (6) 
nan

>  <RoF>  (6) 
0

>  <MW>  (6) 
451.2

>  <LogP>  (6) 
2.5

>  <TPSA>  (6) 
99.4

>  <HBA>  (6) 
7

>  <HBD>  (6) 
3

>  <NRB>  (6) 
6

>  <Indications>  (6) 
nan

>  <Targets>  (6) 
AURKA; AURKB; AURKC

>  <Kinase families>  (6) 
Other

>  <Canonical_Smiles>  (6) 
Cc1cc(ccc1N2CCN(CC2)C)Nc3ncc(c(n3)N[C@@H]4[C@@H]5C[C@H]([C@@H]4C(=O)N)C=C5)F

>  <InChiKey>  (6) 
KSOVGRCOLZZTPF-QMKUDKLTSA-N

>  <First_Approval>  (6) 
nan

>  <SC_Patent>  (6) 
None

>  <Chirality>  (6) 
Racemic Mixture

>  <Synonyms>  (6) 
AS-703569 | R-763

>  <FDA_approved>  (6) 


>  <Melting points>  (6) 


$$$$
Balamapimod
     RDKit          2D

 40 45  0  0  0  0  0  0  0  0999 V2000
   -6.9295   -2.6378    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.3413   -2.1310    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -9.5811   -2.9752    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.7672   -2.0570    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.2604   -0.6452    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -8.7611   -0.6909    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.8428    0.4951    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -6.3565    0.2929    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7885   -1.0954    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3022   -1.2976    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3839   -0.1116    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9519    1.2767    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4382    1.4790    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0062    2.8672    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -1.8976   -0.3138    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9793    0.8723    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5070    0.6700    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0750   -0.7183    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5614   -0.9205    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4796    0.2656    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9116    1.6539    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4253    1.8561    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8573    3.2444    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6290    3.4466    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5473    2.2606    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0336    2.4628    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5199    2.6650    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.9659    0.0633    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.5340   -1.3249    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0203   -1.5272    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9386   -0.3411    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3705    1.0472    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8842    1.2494    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4249   -0.5433    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.4621    0.5402    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8132   -0.1114    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6109   -1.5977    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1349   -1.8647    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1294   -2.3088    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.2111   -3.4948    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 11 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  1  0
 26 27  3  0
 20 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
 31 34  1  0
 34 35  1  0
 35 36  1  0
 36 37  1  0
 37 38  1  0
 19 39  1  0
 39 40  1  0
  6  2  1  0
 13  8  1  0
 25 16  2  0
 22 17  1  0
 33 28  1  0
 38 34  1  0
M  END
>  <BrandName>  (7) 
nan

>  <Phase>  (7) 
1.0

>  <Applicants>  (7) 
Wyeth

>  <Links>  (7) 
|http://www.chemspider.com/Chemical-Structure.9653509.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL2104954|http://pubchem.ncbi.nlm.nih.gov/compound/11478684|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9925|http://zinc15.docking.org/substances/ZINC000011726212|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=7Y0IV7N95Q

>  <LigID>  (7) 
nan

>  <pdbID>  (7) 
nan

>  <Type>  (7) 
nan

>  <RoF>  (7) 
2

>  <MW>  (7) 
573.2

>  <LogP>  (7) 
6.5

>  <TPSA>  (7) 
82.2

>  <HBA>  (7) 
9

>  <HBD>  (7) 
1

>  <NRB>  (7) 
7

>  <Indications>  (7) 
nan

>  <Targets>  (7) 
RAF1; MAP2K1; MAP2K2

>  <Kinase families>  (7) 
STE<br>TKL

>  <Canonical_Smiles>  (7) 
Cn1ccnc1Sc2ccc(cc2Cl)Nc3c4cc(c(cc4ncc3C#N)N5CCC(CC5)N6CCCC6)OC

>  <InChiKey>  (7) 
CVAKNHIXTWLGJO-UHFFFAOYSA-N

>  <First_Approval>  (7) 
nan

>  <SC_Patent>  (7) 
None

>  <Chirality>  (7) 
Achiral Molecule

>  <Synonyms>  (7) 
BALAMAPIMOD | MKI-833

>  <FDA_approved>  (7) 


>  <Melting points>  (7) 


$$$$
Recilisib
     RDKit          2D

 22 23  0  0  0  0  0  0  0  0999 V2000
   -3.8172   -0.8558    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0051   -1.7717    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.3923   -1.2010    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5916    0.2857    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4038    1.2017    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0166    0.6309    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8287    1.5469    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4415    0.9762    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8708    2.3634    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0123   -0.4110    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0544    0.4055    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1335    1.3214    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5207    0.7507    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7200   -0.7360    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1072   -1.3067    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2950   -0.3907    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0957    1.0960    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7085    1.6667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6822   -0.9615    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8701   -0.0455    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.8815   -2.4482    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -7.5801   -2.1170    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  8 10  2  0
  8 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 16 19  1  0
 19 20  2  0
 19 21  1  0
  3 22  1  0
  6  1  1  0
 18 13  1  0
M  END
>  <BrandName>  (8) 
Ex-RAD

>  <Phase>  (8) 
1.0

>  <Applicants>  (8) 
Onconova Therapeutics

>  <Links>  (8) 
|http://www.chemspider.com/Chemical-Structure.8059894.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL2219421|http://pubchem.ncbi.nlm.nih.gov/compound/9884220|http://zinc15.docking.org/substances/ZINC000034007613|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=F5V4K11SYV

>  <LigID>  (8) 
nan

>  <pdbID>  (8) 
nan

>  <Type>  (8) 
nan

>  <RoF>  (8) 
0

>  <MW>  (8) 
336

>  <LogP>  (8) 
3.6

>  <TPSA>  (8) 
71.4

>  <HBA>  (8) 
3

>  <HBD>  (8) 
1

>  <NRB>  (8) 
5

>  <Indications>  (8) 
nan

>  <Targets>  (8) 
nan

>  <Kinase families>  (8) 


>  <Canonical_Smiles>  (8) 
c1cc(ccc1CS(=O)(=O)/C=C/c2ccc(cc2)C(=O)O)Cl

>  <InChiKey>  (8) 
KBEKQQJUNVQLDZ-MDZDMXLPSA-N

>  <First_Approval>  (8) 
nan

>  <SC_Patent>  (8) 
None

>  <Chirality>  (8) 
Achiral Molecule

>  <Synonyms>  (8) 
EX-RAD | ON 01210 | ON 01210.NA | ON-01210 | RECILISIB

>  <FDA_approved>  (8) 


>  <Melting points>  (8) 


$$$$
Vorolanib
     RDKit          2D

 32 35  0  0  0  0  0  0  0  0999 V2000
    0.8589   -2.7586    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8114   -1.2593    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9964   -0.3396    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4879    1.0716    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0113    1.0240    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4294   -0.4165    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8406   -0.9250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1059   -2.4013    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9866    0.0429    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3977   -0.4656    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8159   -1.9061    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.3151   -1.9536    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.8236   -0.5424    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6386    0.3772    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.2641   -0.1243    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.3465   -1.1628    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -8.6223    1.3323    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  -10.0629    1.7504    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.5399    2.3708    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9310    2.2090    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4370   -0.7578    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5193    0.2807    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9957    0.0155    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7865   -1.2591    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2857   -1.2116    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9942    0.1105    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2034    1.3851    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7042    1.3376    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6657    2.4200    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.3154    1.7668    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9932    2.4753    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.0765   -2.4863    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  7  9  1  0
 10  9  1  1
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 13 15  1  0
 15 16  2  0
 15 17  1  0
 17 18  1  0
 17 19  1  0
  5 20  1  0
  3 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  1  0
 30 31  2  0
 25 32  1  0
  6  2  1  0
 14 10  1  0
 22 30  1  0
 28 23  1  0
M  END
>  <BrandName>  (9) 
nan

>  <Phase>  (9) 
1.0

>  <Applicants>  (9) 
Tyrogenex

>  <Links>  (9) 
|http://www.chemspider.com/Chemical-Structure.58827733.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL4297587|http://pubchem.ncbi.nlm.nih.gov/compound/59215954|http://www.drugbank.ca/drugs/DB15247|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=YP8G3I74EL

>  <LigID>  (9) 
nan

>  <pdbID>  (9) 
nan

>  <Type>  (9) 
nan

>  <RoF>  (9) 
0

>  <MW>  (9) 
439.2

>  <LogP>  (9) 
2.7

>  <TPSA>  (9) 
97.5

>  <HBA>  (9) 
3

>  <HBD>  (9) 
3

>  <NRB>  (9) 
3

>  <Indications>  (9) 
nan

>  <Targets>  (9) 
nan

>  <Kinase families>  (9) 


>  <Canonical_Smiles>  (9) 
Cc1c([nH]c(c1C(=O)N[C@H]2CCN(C2)C(=O)N(C)C)C)/C=C\3/c4cc(ccc4NC3=O)F

>  <InChiKey>  (9) 
KMIOJWCYOHBUJS-HAKPAVFJSA-N

>  <First_Approval>  (9) 
nan

>  <SC_Patent>  (9) 
None

>  <Chirality>  (9) 
Single Stereoisomer

>  <Synonyms>  (9) 
VOROLANIB

>  <FDA_approved>  (9) 


>  <Melting points>  (9) 


$$$$
Allitinib
     RDKit          2D

 32 35  0  0  0  0  0  0  0  0999 V2000
  -10.1922   -3.2857    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.6939   -3.2149    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.0061   -1.8819    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.8165   -0.6197    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5077   -1.8111    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8199   -0.4781    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6303    0.7841    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9425    2.1170    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4441    2.1878    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6337    0.9256    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3215   -0.4074    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1353    0.9964    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4475    2.3294    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2579    3.5916    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7563    3.5208    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3249   -0.2658    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.1735   -0.1950    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9839   -1.4572    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4823   -1.3864    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1701   -0.0534    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3597    1.2088    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8613    1.1380    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0475    2.5417    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    4.6684    0.0173    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.4789   -1.2449    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9772   -1.1741    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7877   -2.4363    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2860   -2.3655    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9739   -1.0325    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1634    0.2297    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6651    0.1589    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8513    1.5627    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 12 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 21 23  1  0
 20 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 30 32  1  0
 11  6  1  0
 15  9  1  0
 22 17  1  0
 31 26  1  0
M  END
>  <BrandName>  (10) 
nan

>  <Phase>  (10) 
1.0

>  <Applicants>  (10) 
Allist Pharmaceuticals

>  <Links>  (10) 
|http://www.chemspider.com/Chemical-Structure.25027184.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL1947204|http://pubchem.ncbi.nlm.nih.gov/compound/24739943|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9912|http://zinc15.docking.org/substances/ZINC000052509434

>  <LigID>  (10) 
nan

>  <pdbID>  (10) 
nan

>  <Type>  (10) 
nan

>  <RoF>  (10) 
1

>  <MW>  (10) 
448.1

>  <LogP>  (10) 
5.9

>  <TPSA>  (10) 
76.1

>  <HBA>  (10) 
5

>  <HBD>  (10) 
2

>  <NRB>  (10) 
7

>  <Indications>  (10) 
nan

>  <Targets>  (10) 
ERBB2; EGFR

>  <Kinase families>  (10) 
Tyr

>  <Canonical_Smiles>  (10) 
C=CC(=O)Nc1ccc2c(c1)c(ncn2)Nc3ccc(c(c3)Cl)OCc4cccc(c4)F

>  <InChiKey>  (10) 
MVZGYPSXNDCANY-UHFFFAOYSA-N

>  <First_Approval>  (10) 
nan

>  <SC_Patent>  (10) 
None

>  <Chirality>  (10) 
Single Stereoisomer

>  <Synonyms>  (10) 
ALL-3 | AST-1306

>  <FDA_approved>  (10) 


>  <Melting points>  (10) 


$$$$
Omipalisib
     RDKit          2D

 36 40  0  0  0  0  0  0  0  0999 V2000
   -4.6358   -4.0183    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4090   -4.8814    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0481   -4.2506    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9140   -2.7566    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5531   -2.1257    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6737   -2.9889    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5396   -4.4829    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8213   -5.1137    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.0346   -2.3580    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2614   -3.2211    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6222   -2.5903    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7563   -1.0963    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5296   -0.2332    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1687   -0.8640    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6637    1.2608    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0246    1.8917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2513    1.0286    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1172   -0.4654    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.4369    2.1240    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5710    3.6180    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3442    4.4811    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0167    3.8502    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1508    2.3562    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.0760    1.4931    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1408   -1.8935    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0067   -0.3995    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5127   -0.5336    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5007   -0.2654    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8726    1.0945    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5117    1.7254    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3776    3.2194    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6044    4.0825    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9653    3.4517    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0994    1.9577    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4602    1.3268    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4703    5.5765    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  6  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 15 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
  4 25  1  0
 25 26  1  0
 26 27  2  0
 26 28  2  0
 26 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 32 33  1  0
 33 34  2  0
 34 35  1  0
 32 36  1  0
  8  3  1  0
 14  9  1  0
 18 12  1  0
 24 19  1  0
 34 29  1  0
M  END
>  <BrandName>  (11) 
nan

>  <Phase>  (11) 
1.0

>  <Applicants>  (11) 
GlaxosmithKline

>  <Links>  (11) 
|http://www.chemspider.com/Chemical-Structure.25027388.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL1236962|http://pubchem.ncbi.nlm.nih.gov/compound/25167777|http://www.drugbank.ca/drugs/DB12703| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=ZIG|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/ZIG|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8974|http://zinc15.docking.org/substances/ZINC43208634|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=1X8F5A3NA0|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50145416

>  <LigID>  (11) 
'ZIG'

>  <pdbID>  (11) 
3l08

>  <Type>  (11) 
1

>  <RoF>  (11) 
1

>  <MW>  (11) 
505.1

>  <LogP>  (11) 
4.8

>  <TPSA>  (11) 
107

>  <HBA>  (11) 
7

>  <HBD>  (11) 
1

>  <NRB>  (11) 
6

>  <Indications>  (11) 
nan

>  <Targets>  (11) 
PIK3CA; MTOR

>  <Kinase families>  (11) 
Atypical

>  <Canonical_Smiles>  (11) 
COc1c(cc(cn1)c2ccc3c(c2)c(ccn3)c4ccnnc4)NS(=O)(=O)c5ccc(cc5F)F

>  <InChiKey>  (11) 
CGBJSGAELGCMKE-UHFFFAOYSA-N

>  <First_Approval>  (11) 
nan

>  <SC_Patent>  (11) 
None

>  <Chirality>  (11) 
Achiral Molecule

>  <Synonyms>  (11) 
GSK-2126458 | GSK2126458 | OMIPALISIB

>  <FDA_approved>  (11) 


>  <Melting points>  (11) 


$$$$
Pexmetinib
     RDKit          2D

 41 45  0  0  0  0  0  0  0  0999 V2000
   -7.3682    4.2931    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4826    3.0825    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9913    3.2442    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1057    2.0335    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7114    0.6612    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2026    0.4996    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.0882    1.7102    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8257   -0.5494    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3257   -0.5446    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8576   -1.9696    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0682   -2.8552    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2846   -1.9775    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0633   -4.3552    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5633   -4.3601    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5633   -4.3504    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0584   -5.8552    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4480    0.6718    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0443    0.5199    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9220    1.7363    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.6588   -0.8484    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.1511   -1.0004    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7657   -2.3687    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8880   -3.5851    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5025   -4.9534    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9948   -5.1053    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8725   -3.8889    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2580   -2.5206    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1357   -1.3042    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.5211    0.0641    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0288    0.2160    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4143    1.5844    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2920    2.8008    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7843    2.6488    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3988    1.2805    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3899    4.0211    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2719    5.0212    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.9754    4.2670    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.6031    4.8726    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4414    6.3639    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0691    6.9695    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.6248   -6.1698    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  5  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  1  0
 13 15  1  0
 13 16  1  0
  9 17  1  0
 17 18  1  0
 18 19  2  0
 18 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 32 33  1  0
 33 34  2  0
 33 35  1  0
 35 36  2  0
 36 37  1  0
 37 38  1  0
 38 39  1  0
 39 40  1  0
 24 41  1  0
  7  2  1  0
 12  8  1  0
 27 22  1  0
 34 29  1  0
 37 32  1  0
M  END
>  <BrandName>  (12) 
nan

>  <Phase>  (12) 
1.0

>  <Applicants>  (12) 
Array BioPharma

>  <Links>  (12) 
|http://www.chemspider.com/Chemical-Structure.32702049.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3991932|http://pubchem.ncbi.nlm.nih.gov/compound/24765037|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9917|http://zinc15.docking.org/substances/ZINC000041747181|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=3750D0U8B5

>  <LigID>  (12) 
nan

>  <pdbID>  (12) 
nan

>  <Type>  (12) 
nan

>  <RoF>  (12) 
2

>  <MW>  (12) 
556.3

>  <LogP>  (12) 
6.1

>  <TPSA>  (12) 
106.2

>  <HBA>  (12) 
7

>  <HBD>  (12) 
3

>  <NRB>  (12) 
8

>  <Indications>  (12) 
nan

>  <Targets>  (12) 
MAPK14; TEK

>  <Kinase families>  (12) 
Tyr<br>CMGC

>  <Canonical_Smiles>  (12) 
Cc1ccc(cc1)n2c(cc(n2)C(C)(C)C)NC(=O)NCc3cc(ccc3Oc4ccc5c(c4)cnn5CCO)F

>  <InChiKey>  (12) 
LNMRSSIMGCDUTP-UHFFFAOYSA-N

>  <First_Approval>  (12) 
nan

>  <SC_Patent>  (12) 
None

>  <Chirality>  (12) 
Single Stereoisomer

>  <Synonyms>  (12) 
nan

>  <FDA_approved>  (12) 


>  <Melting points>  (12) 


$$$$
Selatinib
     RDKit          2D

 39 43  0  0  0  0  0  0  0  0999 V2000
   -4.8068    7.6802    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8776    6.6298    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -7.3227    7.0319    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5033    5.1773    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5741    4.1268    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1998    2.6743    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -7.2706    1.6238    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.8963    0.1713    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.8514   -0.9853    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.0465   -2.2511    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5940   -1.8768    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5011   -0.3797    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4374   -2.8319    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6862   -4.3111    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5296   -5.2663    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1242   -4.7422    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8753   -3.2630    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0319   -2.3078    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4698   -2.7389    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6868   -3.6940    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.4379   -5.1732    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9676   -5.6973    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2210   -1.2597    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1845   -0.7356    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3411   -1.6907    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7466   -1.1666    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9954    0.3126    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8388    1.2677    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4333    0.7436    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0877    2.7469    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    5.4009    0.8367    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.5575   -0.1184    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9630    0.4056    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1196   -0.5495    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5250   -0.0254    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7739    1.4538    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6173    2.4089    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2118    1.8848    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8661    3.8881    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 11 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 19 23  1  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 28 30  1  0
 27 31  1  0
 31 32  1  0
 32 33  1  0
 33 34  2  0
 34 35  1  0
 35 36  2  0
 36 37  1  0
 37 38  2  0
 37 39  1  0
 12  8  1  0
 18 13  1  0
 22 16  1  0
 29 24  1  0
 38 33  1  0
M  END
>  <BrandName>  (13) 
nan

>  <Phase>  (13) 
1.0

>  <Applicants>  (13) 
Qilu Pharmaceutical

>  <Links>  (13) 
|http://www.chemspider.com/Chemical-Structure.30841488.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3040548|http://pubchem.ncbi.nlm.nih.gov/compound/51348455|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9919|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=140985

>  <LigID>  (13) 
nan

>  <pdbID>  (13) 
nan

>  <Type>  (13) 
nan

>  <RoF>  (13) 
2

>  <MW>  (13) 
564.1

>  <LogP>  (13) 
6.5

>  <TPSA>  (13) 
89.3

>  <HBA>  (13) 
7

>  <HBD>  (13) 
2

>  <NRB>  (13) 
11

>  <Indications>  (13) 
nan

>  <Targets>  (13) 
EGFR; ERBB2

>  <Kinase families>  (13) 
Tyr

>  <Canonical_Smiles>  (13) 
CS(=O)CCNCc1ccc(o1)c2ccc3c(c2)c(ncn3)Nc4ccc(c(c4)Cl)OCc5cccc(c5)F

>  <InChiKey>  (13) 
OAMVGUFHZPRXOM-UHFFFAOYSA-N

>  <First_Approval>  (13) 
nan

>  <SC_Patent>  (13) 
nan

>  <Chirality>  (13) 
nan

>  <Synonyms>  (13) 
nan

>  <FDA_approved>  (13) 


>  <Melting points>  (13) 


$$$$
Altiratinib
     RDKit          2D

 37 41  0  0  0  0  0  0  0  0999 V2000
   -5.4916    1.7164    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9257    3.1523    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8993    4.2461    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4388    3.9042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0047    2.4684    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0311    1.3745    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5969   -0.0613    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6233   -1.1552    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0838   -0.8132    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1892   -2.5910    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2723   -4.0887    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5278   -3.2678    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6998   -2.4128    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1095   -1.0338    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8008   -3.6135    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3114   -3.4353    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5876   -4.6360    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0770   -4.4578    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6673   -3.0789    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7683   -1.8781    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2789   -2.0563    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6201   -0.8556    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    4.1567   -2.9006    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.7471   -1.5217    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2364   -1.3435    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8268    0.0354    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9278    1.2362    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.4384    1.0580    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8480   -0.3210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5394    2.2587    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.1297    3.6376    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6191    3.8159    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.2307    4.8384    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8518    5.4287    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0525    6.3278    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9760   -5.6585    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3335    5.6819    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 10 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 19 23  1  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 28 30  1  0
 30 31  1  0
 31 32  2  0
 31 33  1  0
 33 34  1  0
 34 35  1  0
 18 36  1  0
  3 37  1  0
  6  1  1  0
 12 10  1  0
 21 16  1  0
 29 24  1  0
 35 33  1  0
M  END
>  <BrandName>  (14) 
nan

>  <Phase>  (14) 
1.0

>  <Applicants>  (14) 
Deciphera Pharmaceuticals

>  <Links>  (14) 
|http://www.chemspider.com/Chemical-Structure.33427355.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3545365|http://pubchem.ncbi.nlm.nih.gov/compound/54576299|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9174|http://zinc15.docking.org/substances/ZINC000113198271|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=T678746713|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50193395

>  <LigID>  (14) 
nan

>  <pdbID>  (14) 
nan

>  <Type>  (14) 
nan

>  <RoF>  (14) 
1

>  <MW>  (14) 
510.2

>  <LogP>  (14) 
5

>  <TPSA>  (14) 
109.4

>  <HBA>  (14) 
5

>  <HBD>  (14) 
3

>  <NRB>  (14) 
8

>  <Indications>  (14) 
nan

>  <Targets>  (14) 
MET; TEK; KDR; NTRK1

>  <Kinase families>  (14) 
Tyr

>  <Canonical_Smiles>  (14) 
c1cc(ccc1NC(=O)C2(CC2)C(=O)Nc3cc(c(cc3F)Oc4ccnc(c4)NC(=O)C5CC5)F)F

>  <InChiKey>  (14) 
GNNDEPIMDAZHRQ-UHFFFAOYSA-N

>  <First_Approval>  (14) 
nan

>  <SC_Patent>  (14) 
None

>  <Chirality>  (14) 
Achiral Molecule

>  <Synonyms>  (14) 
ALTIRATINIB | DCC-2701 | DP-5164

>  <FDA_approved>  (14) 


>  <Melting points>  (14) 


$$$$
Tafetinib
     RDKit          2D

 31 34  0  0  0  0  0  0  0  0999 V2000
  -10.4357    0.6696    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.0343    1.2044    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.8704    0.2582    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -8.1079   -1.2229    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.5093   -1.7577    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4690    0.7931    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3051   -0.1531    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9037    0.3817    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7398   -0.5645    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9773   -2.0456    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3384   -0.0296    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9474    1.4185    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5507    1.4942    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.0855    0.0928    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0820   -0.8490    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1498   -2.3310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5492   -2.8712    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7167   -1.9295    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4849   -0.4475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6524    0.4943    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1006    0.1032    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7790   -1.2346    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2768   -1.3160    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0961   -0.0595    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4177    1.2783    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9199    1.3597    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9782    2.5272    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.5768    1.9923    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3203    2.8117    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.9552   -2.6538    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8892    2.5861    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  3  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  1  0
 28 29  2  0
 23 30  1  0
 12 31  1  0
 15 11  1  0
 14 19  1  0
 20 28  1  0
 26 21  1  0
M  END
>  <BrandName>  (15) 
nan

>  <Phase>  (15) 
1.0

>  <Applicants>  (15) 
Nanjing Yoko Biomedical

>  <Links>  (15) 
|http://www.chemspider.com/Chemical-Structure.28664989.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL2180602|http://pubchem.ncbi.nlm.nih.gov/compound/56935577|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9921|http://zinc15.docking.org/substances/ZINC000095575309|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=H4X2M2NN5N|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50399535

>  <LigID>  (15) 
nan

>  <pdbID>  (15) 
nan

>  <Type>  (15) 
nan

>  <RoF>  (15) 
0

>  <MW>  (15) 
424.2

>  <LogP>  (15) 
3.7

>  <TPSA>  (15) 
77.2

>  <HBA>  (15) 
3

>  <HBD>  (15) 
3

>  <NRB>  (15) 
6

>  <Indications>  (15) 
nan

>  <Targets>  (15) 
KDR; FLT4; FLT1

>  <Kinase families>  (15) 
Tyr

>  <Canonical_Smiles>  (15) 
CCN(CC)CCNC(=O)c1c([nH]c\2c1CCC/C2=C/3\c4cc(ccc4NC3=O)F)C

>  <InChiKey>  (15) 
KGSRYTUWXUESJK-FXBPSFAMSA-N

>  <First_Approval>  (15) 
nan

>  <SC_Patent>  (15) 
None

>  <Chirality>  (15) 
Achiral Molecule

>  <Synonyms>  (15) 
SIM 010603 | SIM-010603 | TAFETINIB

>  <FDA_approved>  (15) 


>  <Melting points>  (15) 


$$$$
Rivoceranib
     RDKit          2D

 35 37  0  0  0  0  0  0  0  0999 V2000
   -1.2990    6.8508    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    7.6008    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.7500    6.3018    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7500    8.8999    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.2990    8.3508    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.6655   -4.3318    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1919   -4.0517    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6977   -2.6354    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6771   -1.4993    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1507   -1.7794    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.6449   -3.1956    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1828   -0.0831    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.1622    1.0531    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6680    2.4693    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6474    3.6054    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1531    5.0217    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6795    5.3018    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.7001    4.1656    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1944    2.7494    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2241   -2.3553    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2447   -3.4915    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.7298   -0.9391    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7438   -0.6590    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2380    0.7572    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7116    1.0373    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6910   -0.0988    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1968   -1.5150    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7232   -1.7951    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1646    0.1813    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5478    0.7617    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.5272   -0.3745    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.7493   -1.6570    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2892   -1.3135    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7320    1.6176    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2994    3.0538    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  2  0
  2  5  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
  9 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
  8 20  1  0
 20 21  2  0
 20 22  1  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 26 29  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
 29 34  1  0
 34 35  3  0
 11  6  1  0
 19 14  1  0
 28 23  1  0
 33 29  1  0
M  END
>  <BrandName>  (16) 
nan

>  <Phase>  (16) 
1.0

>  <Applicants>  (16) 
Advenchen Laboratories

>  <Links>  (16) 
|http://www.chemspider.com/Chemical-Structure.28294976.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3545414|http://pubchem.ncbi.nlm.nih.gov/compound/45139106|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=TK02X14ASJ|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50152828

>  <LigID>  (16) 
nan

>  <pdbID>  (16) 
nan

>  <Type>  (16) 
nan

>  <RoF>  (16) 
0

>  <MW>  (16) 
493.2

>  <LogP>  (16) 
4.2

>  <TPSA>  (16) 
145.1

>  <HBA>  (16) 
7

>  <HBD>  (16) 
3

>  <NRB>  (16) 
6

>  <Indications>  (16) 
Rivoceranib Mesylate is a novel selective inhibitor of vascular endothelial growth factor receptor 2 (vegfr2)

>  <Targets>  (16) 
nan

>  <Kinase families>  (16) 


>  <Canonical_Smiles>  (16) 
CS(=O)(=O)O.c1cc(c(nc1)NCc2ccncc2)C(=O)Nc3ccc(cc3)C4(CCCC4)C#N

>  <InChiKey>  (16) 
FYJROXRIVQPKRY-UHFFFAOYSA-N

>  <First_Approval>  (16) 
nan

>  <SC_Patent>  (16) 
nan

>  <Chirality>  (16) 
nan

>  <Synonyms>  (16) 
AITAN | APATINIB (REGISTERED NAME IN CHINA) | APATINIB MESYLATE | RIVOCERANIB MESYLATE | YN-968D1

>  <FDA_approved>  (16) 


>  <Melting points>  (16) 


$$$$
Zotiraciclib
     RDKit          2D

 28 31  0  0  0  0  0  0  0  0999 V2000
   -5.7736   -2.6673    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3450   -2.2098    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6465   -3.5372    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5360   -4.5457    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1477   -5.1135    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3512   -5.1722    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7797   -4.7148    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9657   -3.7963    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.7799   -2.1715    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2787   -2.2303    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0790   -0.9616    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3805    0.3658    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8816    0.4245    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0813   -0.8441    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1830    1.7520    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6819    3.2107    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9834    4.5382    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4845    4.5969    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.6842    3.3282    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0726    2.7604    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8146    3.3869    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2432    2.9295    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5932    3.6741    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0217    3.2166    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3398    1.7507    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2294    0.7423    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4291    2.0110    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5475   -0.7236    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 13 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 19 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 26 28  1  0
 28  2  1  0
 14  9  2  0
 20 15  2  0
 27 22  2  0
M  END
>  <BrandName>  (17) 
nan

>  <Phase>  (17) 
1.0

>  <Applicants>  (17) 
S*BIO

>  <Links>  (17) 
|http://www.chemspider.com/Chemical-Structure.20571045.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL1944698|http://pubchem.ncbi.nlm.nih.gov/compound/16739650|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9095|http://zinc15.docking.org/substances/ZINC000068251500|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=40D08182TT|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50363196

>  <LigID>  (17) 
nan

>  <pdbID>  (17) 
nan

>  <Type>  (17) 
nan

>  <RoF>  (17) 
0

>  <MW>  (17) 
372.2

>  <LogP>  (17) 
4.7

>  <TPSA>  (17) 
50.3

>  <HBA>  (17) 
5

>  <HBD>  (17) 
1

>  <NRB>  (17) 
0

>  <Indications>  (17) 
nan

>  <Targets>  (17) 
nan

>  <Kinase families>  (17) 


>  <Canonical_Smiles>  (17) 
CN1C/C=C/CCOc2cccc(c2)-c3ccnc(n3)Nc4cccc(c4)C1

>  <InChiKey>  (17) 
VXBAJLGYBMTJCY-NSCUHMNNSA-N

>  <First_Approval>  (17) 
nan

>  <SC_Patent>  (17) 
None

>  <Chirality>  (17) 
Single Stereoisomer

>  <Synonyms>  (17) 
EX45 | SB-1317 | SB1317 | TG-02 | TG02 | ZOTIRACICLIB

>  <FDA_approved>  (17) 


>  <Melting points>  (17) 


$$$$
Vecabrutinib
     RDKit          2D

 36 39  0  0  0  0  0  0  0  0999 V2000
   -4.4899    0.3104    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9844    0.4378    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6214    1.7959    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7637    3.0265    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2691    2.8991    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6322    1.5410    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1376    1.4136    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5007    0.0555    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3584   -1.1751    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7214   -2.5332    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2268   -2.6606    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6308   -1.4300    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0061   -0.0719    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8515    1.1587    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.1254   -1.5574    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9830   -0.3268    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4776   -0.4542    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.1145   -1.8123    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2569   -3.0429    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7623   -2.9155    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9047   -4.1461    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4101   -4.0186    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5416   -5.5041    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.3352    0.7764    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6983    2.1345    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5560    3.3651    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0505    3.2377    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.6875    1.8796    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8298    0.6490    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.9190    4.7232    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.2037    2.2619    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4007    4.3846    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -6.8421   -0.7928    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.6997   -2.0234    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -8.0727    0.0648    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6115   -1.6505    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  8  7  1  1
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 15 12  1  1
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  6
 21 22  2  0
 21 23  1  0
 17 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 26 30  1  0
 25 31  1  0
  4 32  1  0
  2 33  1  0
 33 34  1  0
 33 35  1  0
 33 36  1  0
  6  1  1  0
 13  8  1  0
 20 15  1  0
 29 24  1  0
M  END
>  <BrandName>  (18) 
nan

>  <Phase>  (18) 
1.0

>  <Applicants>  (18) 
Sunesis Pharmaceuticals

>  <Links>  (18) 
|http://www.chemspider.com/Chemical-Structure.64835225.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL4297640|http://pubchem.ncbi.nlm.nih.gov/compound/72547837|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10231|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=PQ7O0OB5GU

>  <LigID>  (18) 
nan

>  <pdbID>  (18) 
nan

>  <Type>  (18) 
nan

>  <RoF>  (18) 
1

>  <MW>  (18) 
529.2

>  <LogP>  (18) 
2.7

>  <TPSA>  (18) 
130.5

>  <HBA>  (18) 
7

>  <HBD>  (18) 
3

>  <NRB>  (18) 
5

>  <Indications>  (18) 
nan

>  <Targets>  (18) 
nan

>  <Kinase families>  (18) 


>  <Canonical_Smiles>  (18) 
c1c(cc(cc1N[C@@H]2CCCN(C2=O)[C@H]3CN(CC[C@@H]3C(=O)N)c4c(c(ncn4)N)F)Cl)C(F)(F)F

>  <InChiKey>  (18) 
QLRRJMOBVVGXEJ-XHSDSOJGSA-N

>  <First_Approval>  (18) 
nan

>  <SC_Patent>  (18) 
None

>  <Chirality>  (18) 
Single Stereoisomer

>  <Synonyms>  (18) 
BIIB-062 | BSK-4841 | FP-0182 | FP0182 | SNS-062 | VECABRUTINIB

>  <FDA_approved>  (18) 


>  <Melting points>  (18) 


$$$$
Panulisib
     RDKit          2D

 39 43  0  0  0  0  0  0  0  0999 V2000
    3.2049   -1.9866    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5148   -3.3184    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8247   -4.6502    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8466   -4.0085    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1784   -4.6987    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1830   -2.6283    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0806   -3.4366    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4124   -2.7465    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4806   -1.2481    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2171   -0.4397    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1147   -1.1298    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8125   -0.5579    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0370    0.9252    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0850    2.0844    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6051    1.8396    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3468    2.9988    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1811    4.4029    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6610    4.6476    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6130    3.4884    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0929    3.7332    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0448    2.5740    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5169    1.1700    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2070   -0.1619    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1536   -1.2298    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3984   -2.7096    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8024   -3.2376    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.2064   -3.7656    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6901   -0.3864    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8267    2.7540    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3546    1.3500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8345    1.1052    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7865    2.2645    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2585    3.6685    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.7786    3.9133    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2664    2.0197    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.3625   -0.2988    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8904   -1.7028    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    5.7665    0.2292    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.9585   -0.8267    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  3  0
  2  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
  9 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  2  3
 25 26  1  0
 26 27  3  0
 23 28  1  0
 16 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 32 33  1  0
 33 34  2  0
 32 35  1  0
 31 36  1  0
 36 37  1  0
 36 38  1  0
 36 39  1  0
 11  6  1  0
 24 12  1  0
 22 13  2  0
 19 14  1  0
 34 29  1  0
M  END
>  <BrandName>  (19) 
nan

>  <Phase>  (19) 
1.0

>  <Applicants>  (19) 
Piramal Enterprises

>  <Links>  (19) 
|http://www.chemspider.com/Chemical-Structure.29165869.html|http://pubchem.ncbi.nlm.nih.gov/compound/56947515|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9916|http://zinc15.docking.org/substances/ZINC000301055099

>  <LigID>  (19) 
nan

>  <pdbID>  (19) 
nan

>  <Type>  (19) 
nan

>  <RoF>  (19) 
1

>  <MW>  (19) 
527.2

>  <LogP>  (19) 
4.8

>  <TPSA>  (19) 
134.5

>  <HBA>  (19) 
9

>  <HBD>  (19) 
1

>  <NRB>  (19) 
3

>  <Indications>  (19) 
nan

>  <Targets>  (19) 
PIK3CA; MTOR

>  <Kinase families>  (19) 
Atypical

>  <Canonical_Smiles>  (19) 
CC(C)(C#N)c1ccc(cn1)n2c3c4cc(ccc4ncc3n(c2=NC#N)C)c5cc(c(nc5)N)C(F)(F)F

>  <InChiKey>  (19) 
VJLRLTSXTLICIR-UHFFFAOYSA-N

>  <First_Approval>  (19) 
nan

>  <SC_Patent>  (19) 
None

>  <Chirality>  (19) 
Single Stereoisomer

>  <Synonyms>  (19) 
nan

>  <FDA_approved>  (19) 


>  <Melting points>  (19) 


$$$$
Ravoxertinib
     RDKit          2D

 31 34  0  0  0  0  0  0  0  0999 V2000
   -8.6136    1.0548    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.1789    1.4927    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9814    0.5895    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7523    1.4493    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1902    2.8839    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6900    2.9108    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0082   -0.9103    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7228   -1.6834    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7497   -3.1832    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4643   -3.9563    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1520   -3.2297    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1252   -1.7299    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4106   -0.9568    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8129   -1.0033    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4725   -1.7764    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7847   -1.0498    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8116    0.4500    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.5262    1.2231    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5530    2.7229    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7861    0.4965    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1238    1.1766    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1507    2.6764    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4629    3.4030    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.4093    0.4035    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3824   -1.0963    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6678   -1.8694    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9801   -1.1428    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0069    0.3570    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7215    1.1301    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3192    1.0836    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    8.2655   -1.9159    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  3  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 18 20  1  0
 17 21  1  0
 21 22  1  6
 22 23  1  0
 21 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 28 30  1  0
 27 31  1  0
  6  2  1  0
 13  8  1  0
 20 14  2  0
 29 24  1  0
M  END
>  <BrandName>  (20) 
nan

>  <Phase>  (20) 
1.0

>  <Applicants>  (20) 
Genentech

>  <Links>  (20) 
|http://www.chemspider.com/Chemical-Structure.32501977.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3544964|http://pubchem.ncbi.nlm.nih.gov/compound/71727581|http://www.drugbank.ca/drugs/DB15281| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=6QB|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/6QB|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9229|http://zinc15.docking.org/substances/ZINC000144904566|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=R6AXV96CRH|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=120095

>  <LigID>  (20) 
'6QB'

>  <pdbID>  (20) 
5k4i 5k4j 6oph

>  <Type>  (20) 
nan

>  <RoF>  (20) 
0

>  <MW>  (20) 
440.1

>  <LogP>  (20) 
3.2

>  <TPSA>  (20) 
97.9

>  <HBA>  (20) 
8

>  <HBD>  (20) 
2

>  <NRB>  (20) 
6

>  <Indications>  (20) 
nan

>  <Targets>  (20) 
nan

>  <Kinase families>  (20) 


>  <Canonical_Smiles>  (20) 
Cn1c(ccn1)Nc2nccc(n2)c3ccn(c(=O)c3)[C@H](CO)c4ccc(c(c4)F)Cl

>  <InChiKey>  (20) 
RZUOCXOYPYGSKL-GOSISDBHSA-N

>  <First_Approval>  (20) 
nan

>  <SC_Patent>  (20) 
None

>  <Chirality>  (20) 
Single Stereoisomer

>  <Synonyms>  (20) 
GDC-0994 | GDC0994 | RAVOXERTINIB | RG-7842

>  <FDA_approved>  (20) 


>  <Melting points>  (20) 


$$$$
Branebrutinib
     RDKit          2D

 27 29  0  0  0  0  0  0  0  0999 V2000
    9.2550    2.1525    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9853    1.3538    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7157    0.5551    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4460   -0.2437    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5029   -1.7426    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.1195    0.4565    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.8498   -0.3422    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9067   -1.8411    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6370   -2.6398    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3105   -1.9396    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2536   -0.4407    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.5233    0.3580    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0729    0.2595    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1298    1.7584    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4564    2.4586    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7260    1.6599    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6692    0.1610    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3426   -0.5392    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5986   -2.0172    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0834   -2.2305    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7450   -0.8843    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7836   -3.5570    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5534   -3.0931    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0526    2.3601    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.3222    1.5614    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1095    3.8590    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.1398    2.5571    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  3  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  7  6  1  1
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 11 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 20 22  1  0
 19 23  1  0
 16 24  1  0
 24 25  2  0
 24 26  1  0
 14 27  1  0
 12  7  1  0
 18 13  1  0
 21 17  1  0
M  END
>  <BrandName>  (21) 
nan

>  <Phase>  (21) 
1.0

>  <Applicants>  (21) 
Bristol Myers Squibb

>  <Links>  (21) 
|http://www.chemspider.com/Chemical-Structure.64835069.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL4297674|http://pubchem.ncbi.nlm.nih.gov/compound/121293929|http://www.drugbank.ca/drugs/DB15347|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9869|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=7LBRZUYSHU|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=164638

>  <LigID>  (21) 
nan

>  <pdbID>  (21) 
nan

>  <Type>  (21) 
nan

>  <RoF>  (21) 
0

>  <MW>  (21) 
370.2

>  <LogP>  (21) 
2.1

>  <TPSA>  (21) 
91.2

>  <HBA>  (21) 
3

>  <HBD>  (21) 
3

>  <NRB>  (21) 
3

>  <Indications>  (21) 
nan

>  <Targets>  (21) 
nan

>  <Kinase families>  (21) 


>  <Canonical_Smiles>  (21) 
CC#CC(=O)N[C@H]1CCCN(C1)c2c(cc(c3c2c(c([nH]3)C)C)C(=O)N)F

>  <InChiKey>  (21) 
VJPPLCNBDLZIFG-ZDUSSCGKSA-N

>  <First_Approval>  (21) 
nan

>  <SC_Patent>  (21) 
None

>  <Chirality>  (21) 
Single Stereoisomer

>  <Synonyms>  (21) 
BMS-986195 | BRANEBRUTINIB

>  <FDA_approved>  (21) 


>  <Melting points>  (21) 


$$$$
Dubermatinib
     RDKit          2D

 35 38  0  0  0  0  0  0  0  0999 V2000
   -9.6076   -3.4404    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.8712   -2.1337    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -9.6346   -0.8425    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.8982    0.4643    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.3982    0.4799    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6348   -0.8113    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.3712   -2.1181    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6618    1.7866    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1619    1.8022    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3984    0.5110    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8985    0.5266    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1620    1.8334    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9255    3.1246    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4254    3.1090    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6621    1.8490    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.1014    0.5578    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6351   -0.7489    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.1284   -2.0401    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6283   -2.0245    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3647   -0.7178    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6013    0.5734    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.8646   -0.7022    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.6011    0.6046    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8376    1.8958    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5741    3.2025    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0740    3.2181    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8375    1.9269    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1010    0.6202    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8645   -0.6710    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    8.1557    0.0925    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.5733   -1.4345    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.6279   -1.9622    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.1279   -1.9466    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8915   -3.2689    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3917   -3.3157    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  5  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 12 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 20 22  1  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 29 31  2  0
 29 32  1  0
 32 33  1  0
 32 34  1  0
 19 35  1  0
  7  2  1  0
 14  9  1  0
 21 16  1  0
 28 23  1  0
M  END
>  <BrandName>  (22) 
nan

>  <Phase>  (22) 
1.0

>  <Applicants>  (22) 
Tolero Pharmaceuticals

>  <Links>  (22) 
|http://www.chemspider.com/Chemical-Structure.28516684.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL2022968|http://pubchem.ncbi.nlm.nih.gov/compound/56839178|http://www.drugbank.ca/drugs/DB15187|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8863|http://zinc15.docking.org/substances/ZINC000084617535|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=14D65TV20J|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50382425

>  <LigID>  (22) 
nan

>  <pdbID>  (22) 
nan

>  <Type>  (22) 
nan

>  <RoF>  (22) 
1

>  <MW>  (22) 
515.2

>  <LogP>  (22) 
3.6

>  <TPSA>  (22) 
93.7

>  <HBA>  (22) 
8

>  <HBD>  (22) 
2

>  <NRB>  (22) 
8

>  <Indications>  (22) 
nan

>  <Targets>  (22) 
nan

>  <Kinase families>  (22) 


>  <Canonical_Smiles>  (22) 
CN1CCN(CC1)Cc2ccc(cc2)Nc3ncc(c(n3)Nc4ccccc4S(=O)(=O)N(C)C)Cl

>  <InChiKey>  (22) 
YUAALFPUEOYPNX-UHFFFAOYSA-N

>  <First_Approval>  (22) 
nan

>  <SC_Patent>  (22) 
None

>  <Chirality>  (22) 
Achiral Molecule

>  <Synonyms>  (22) 
DUBERMATINIB | TP 0903 | TP-0903

>  <FDA_approved>  (22) 


>  <Melting points>  (22) 


$$$$
Peposertib
     RDKit          2D

 24 25  0  0  0  0  0  0  0  0999 V2000
   -8.4741   -0.4658    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.1088    0.1553    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8881   -0.7165    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5228   -0.0953    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3022   -0.9672    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9368   -0.3460    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7921    1.1470    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4268    1.7682    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7938    0.8963    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6491   -0.5967    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7162   -1.2178    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8609   -2.7108    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2263   -3.3320    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1592    1.5175    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3798    0.6457    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2351   -0.8473    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4557   -1.7192    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.8210   -1.0980    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9657    0.3950    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.7451    1.2669    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8898    2.7599    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.0416   -1.9698    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0127    2.0188    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8680    3.5118    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
  9 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 18 22  1  0
  7 23  1  0
 23 24  1  0
 11  6  1  0
 20 15  1  0
M  END
>  <BrandName>  (23) 
nan

>  <Phase>  (23) 
1.0

>  <Applicants>  (23) 
Merck

>  <Links>  (23) 
|http://www.chemspider.com/Chemical-Structure.58910.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL32039|http://pubchem.ncbi.nlm.nih.gov/compound/65450|http://zinc15.docking.org/substances/ZINC000002020087|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=5R6712AY0K|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50029760

>  <LigID>  (23) 
nan

>  <pdbID>  (23) 
nan

>  <Type>  (23) 
nan

>  <RoF>  (23) 
0

>  <MW>  (23) 
334.2

>  <LogP>  (23) 
1.3

>  <TPSA>  (23) 
114.7

>  <HBA>  (23) 
8

>  <HBD>  (23) 
2

>  <NRB>  (23) 
8

>  <Indications>  (23) 
nan

>  <Targets>  (23) 
nan

>  <Kinase families>  (23) 


>  <Canonical_Smiles>  (23) 
COCCOc1c(cc(cc1OC)Cc2cnc(nc2N)N)OC

>  <InChiKey>  (23) 
WSWJIZXMAUYHOE-UHFFFAOYSA-N

>  <First_Approval>  (23) 
nan

>  <SC_Patent>  (23) 
nan

>  <Chirality>  (23) 
nan

>  <Synonyms>  (23) 
TETROXOPRIM

>  <FDA_approved>  (23) 


>  <Melting points>  (23) 
154.0 C

$$$$
Theliatinib
     RDKit          2D

 33 37  0  0  0  0  0  0  0  0999 V2000
   -6.4669    4.5457    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6285    3.0544    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -7.9299    2.3087    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.6228    0.8404    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1316    0.6788    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5170    2.0471    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0258    1.8855    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7187    0.4173    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0201   -0.3285    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3503   -0.1973    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1339    0.6805    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1984   -1.6895    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8300   -2.3041    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3863   -1.4263    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7547   -2.0409    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9066   -3.5332    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6903   -4.4109    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6781   -3.7964    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8944   -4.6741    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7425   -6.1664    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2750   -4.1477    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.4914   -3.2700    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3394   -1.7777    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.9711   -1.1631    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8191    0.3291    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.0355    1.2069    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4038    0.5923    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6202    1.4701    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4682    2.9624    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0999    3.5769    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8835    2.6992    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9479    5.0692    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7960    6.5615    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  5  4  1  1
  5  6  1  0
  6  7  1  1
  7  8  1  0
  8  9  1  0
  8 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  1  0
 16 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 30 32  1  0
 32 33  3  0
  6  2  1  0
  9  5  1  0
 18 13  1  0
 24 15  1  0
 31 26  1  0
M  END
>  <BrandName>  (24) 
nan

>  <Phase>  (24) 
1.0

>  <Applicants>  (24) 
Hutchison MediPharma

>  <Links>  (24) 
|http://www.chemspider.com/Chemical-Structure.68025614.html|http://pubchem.ncbi.nlm.nih.gov/compound/54759275|http://zinc15.docking.org/substances/ZINC000113384840|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=6ZZ3B7NZ0B

>  <LigID>  (24) 
nan

>  <pdbID>  (24) 
nan

>  <Type>  (24) 
nan

>  <RoF>  (24) 
0

>  <MW>  (24) 
442.2

>  <LogP>  (24) 
3.5

>  <TPSA>  (24) 
82.6

>  <HBA>  (24) 
6

>  <HBD>  (24) 
2

>  <NRB>  (24) 
4

>  <Indications>  (24) 
nan

>  <Targets>  (24) 
nan

>  <Kinase families>  (24) 


>  <Canonical_Smiles>  (24) 
CN1CC[C@H]2[C@@H]1CN(C2)C(=O)Nc3cc4c(cc3OC)ncnc4Nc5cccc(c5)C#C

>  <InChiKey>  (24) 
FSXCKIBROURMFT-VGSWGCGISA-N

>  <First_Approval>  (24) 
nan

>  <SC_Patent>  (24) 
None

>  <Chirality>  (24) 
Single Stereoisomer

>  <Synonyms>  (24) 
nan

>  <FDA_approved>  (24) 


>  <Melting points>  (24) 


$$$$
Delgocitinib
     RDKit          2D

 23 26  0  0  0  0  0  0  0  0999 V2000
    0.8311    3.8127    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6825    2.5777    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1578    2.3065    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8866    0.8313    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.4113    1.1025    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3743   -0.3971    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0633   -0.8252    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9148    0.4097    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0034    1.6011    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4143    0.4468    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1962   -0.8333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7681   -2.2709    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0030   -3.1223    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1944   -2.2109    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6957   -0.7962    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4134    0.5210    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6315    1.8011    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1320    1.7640    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.7380   -0.4037    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0942   -1.7585    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.2332   -0.2838    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0846   -1.5188    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9361   -2.7537    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  8 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
  4 19  1  0
 19 20  2  0
 19 21  1  0
 21 22  1  0
 22 23  3  0
  5  2  1  0
  9  5  1  0
 18 10  1  0
 15 11  1  0
M  END
>  <BrandName>  (25) 
nan

>  <Phase>  (25) 
1.0

>  <Applicants>  (25) 
Japan Tobacco

>  <Links>  (25) 
|http://www.chemspider.com/Chemical-Structure.34960249.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3689518|http://pubchem.ncbi.nlm.nih.gov/compound/50913622|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=109868

>  <LigID>  (25) 
nan

>  <pdbID>  (25) 
nan

>  <Type>  (25) 
nan

>  <RoF>  (25) 
0

>  <MW>  (25) 
310.2

>  <LogP>  (25) 
1.3

>  <TPSA>  (25) 
88.9

>  <HBA>  (25) 
5

>  <HBD>  (25) 
1

>  <NRB>  (25) 
2

>  <Indications>  (25) 
nan

>  <Targets>  (25) 
nan

>  <Kinase families>  (25) 


>  <Canonical_Smiles>  (25) 
CC1CN(C12CCN(C2)c3c4cc[nH]c4ncn3)C(=O)CC#N

>  <InChiKey>  (25) 
LOWWYYZBZNSPDT-UHFFFAOYSA-N

>  <First_Approval>  (25) 
nan

>  <SC_Patent>  (25) 
None

>  <Chirality>  (25) 
Single Stereoisomer

>  <Synonyms>  (25) 
nan

>  <FDA_approved>  (25) 


>  <Melting points>  (25) 


$$$$
Henatinib
     RDKit          2D

 34 38  0  0  0  0  0  0  0  0999 V2000
    1.2445   -2.8037    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2210   -1.3039    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4206   -0.4033    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9347    1.0159    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.4349    0.9924    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0062   -0.4413    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4021   -0.9903    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5131   -2.4862    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7017   -0.2412    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9263    1.2418    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9068    2.3421    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4109    2.2311    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9404   -1.0871    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2924   -0.4373    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5311   -1.2831    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.8830   -0.6333    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -7.9962    0.8625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.3481    1.5123    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.5869    0.6665    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  -10.4737   -0.8293    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.1218   -1.4791    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4055    1.0585    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.8542   -0.8444    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9531    0.1767    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4250   -0.1122    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1953   -1.3993    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6951   -1.3758    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4247   -0.0651    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6544    1.2220    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1546    1.1985    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1335    2.2973    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.7729    1.6658    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4623    2.3954    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.4654   -2.6629    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
  9 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 14 22  1  1
  3 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  1  0
 32 33  2  0
 27 34  1  0
  6  2  1  0
 12  5  1  0
 21 16  1  0
 24 32  1  0
 30 25  1  0
M  END
>  <BrandName>  (26) 
nan

>  <Phase>  (26) 
1.0

>  <Applicants>  (26) 
Jiangsu Hengrui Medicine

>  <Links>  (26) 
|http://www.chemspider.com/Chemical-Structure.26354883.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL1277072|http://pubchem.ncbi.nlm.nih.gov/compound/25116064|http://www.drugbank.ca/drugs/DB13019|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9930|http://zinc15.docking.org/substances/ZINC000064454147|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=TE20GB753F|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50331032

>  <LigID>  (26) 
nan

>  <pdbID>  (26) 
nan

>  <Type>  (26) 
nan

>  <RoF>  (26) 
0

>  <MW>  (26) 
468.2

>  <LogP>  (26) 
2

>  <TPSA>  (26) 
97.9

>  <HBA>  (26) 
5

>  <HBD>  (26) 
3

>  <NRB>  (26) 
5

>  <Indications>  (26) 
nan

>  <Targets>  (26) 
KDR

>  <Kinase families>  (26) 
Tyr

>  <Canonical_Smiles>  (26) 
Cc1c([nH]c2c1C(=O)N(CCC2)C[C@@H](CN3CCOCC3)O)/C=C\4/c5cc(ccc5NC4=O)F

>  <InChiKey>  (26) 
MCTXSDCWFQAGFS-UEXNTNOUSA-N

>  <First_Approval>  (26) 
nan

>  <SC_Patent>  (26) 
None

>  <Chirality>  (26) 
Single Stereoisomer

>  <Synonyms>  (26) 
nan

>  <FDA_approved>  (26) 


>  <Melting points>  (26) 


$$$$
Empesertib
     RDKit          2D

 40 44  0  0  0  0  0  0  0  0999 V2000
   -9.2328    3.0446    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.6026    1.6834    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.4663    0.4570    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.9602    0.5918    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -11.8239   -0.6345    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -11.1937   -1.9957    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.6998   -2.1306    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.8361   -0.9042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -12.0575   -3.2221    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -7.1086    1.5485    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2449    2.7749    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4784    0.1873    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9845    0.0525    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3543   -1.3087    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8604   -1.4435    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9966   -0.2171    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6268    1.1440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1208    1.2789    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5027   -0.3520    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1275   -1.7132    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6214   -1.8480    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4851   -0.6216    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9745   -0.4429    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.2647    1.0287    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9548    1.7595    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.8549    0.7396    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.3610    0.8744    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6259    1.6589    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.8523    0.7952    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7174   -0.6987    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9438   -1.5625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3050   -0.9323    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4398    0.5617    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2135    1.4254    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3483    2.9193    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.7095    3.5495    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5314   -1.7960    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   11.3951   -0.5696    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.6676   -3.0223    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.7577   -2.6597    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  1
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  6  9  1  0
  2 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 16 19  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  1  0
 24 28  1  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 32 33  1  0
 33 34  2  0
 34 35  1  0
 35 36  1  0
 32 37  1  0
 37 38  2  0
 37 39  2  0
 37 40  1  0
  8  3  1  0
 18 13  1  0
 27 19  2  0
 26 22  1  0
 34 29  1  0
M  END
>  <BrandName>  (27) 
nan

>  <Phase>  (27) 
1.0

>  <Applicants>  (27) 
Bayer

>  <Links>  (27) 
|http://www.chemspider.com/Chemical-Structure.35308224.html|http://pubchem.ncbi.nlm.nih.gov/compound/71599640| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=8QW|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/8QW|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9427|http://zinc15.docking.org/substances/ZINC000206769279|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=02Y3Z2756M|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=329334

>  <LigID>  (27) 
'8QW'

>  <pdbID>  (27) 
5n9s 6tnb

>  <Type>  (27) 
nan

>  <RoF>  (27) 
2

>  <MW>  (27) 
559.2

>  <LogP>  (27) 
5.4

>  <TPSA>  (27) 
114.7

>  <HBA>  (27) 
8

>  <HBD>  (27) 
2

>  <NRB>  (27) 
8

>  <Indications>  (27) 
nan

>  <Targets>  (27) 
nan

>  <Kinase families>  (27) 


>  <Canonical_Smiles>  (27) 
C[C@H](c1ccc(cc1)F)C(=O)Nc2ccc(cc2)c3ccc4nc(nn4c3)Nc5ccc(cc5OC)S(=O)(=O)C

>  <InChiKey>  (27) 
NRJKIOCCERLIDG-GOSISDBHSA-N

>  <First_Approval>  (27) 
nan

>  <SC_Patent>  (27) 
None

>  <Chirality>  (27) 
Single Stereoisomer

>  <Synonyms>  (27) 
|BAY 1161909|MPS1-IN-5|(-)-BAY-1161909

>  <FDA_approved>  (27) 


>  <Melting points>  (27) 


$$$$
Mubritinib
     RDKit          2D

 34 37  0  0  0  0  0  0  0  0999 V2000
    5.2394   -0.9781    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8161   -1.4517    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6944   -0.4560    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9958    1.0134    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4191    1.4871    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5409    0.4913    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9642    0.9649    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0860   -0.0309    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5092    0.4427    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6310   -0.5531    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.0543   -0.0795    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.5077    1.3504    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0077    1.3610    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4813   -0.0623    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.2740   -0.9525    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.2711   -0.9296    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.1493    0.0662    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2740   -0.4074    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7274   -1.8372    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2274   -1.8478    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7010   -0.4246    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4937    0.4657    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1308    0.0288    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2384   -0.9827    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.6682   -0.5293    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.9905    0.9357    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.4203    1.3891    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.5279    0.3775    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.2056   -1.0874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.7758   -1.5409    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -11.9577    0.8309    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -13.3875    1.2844    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  -11.5043    2.2608    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  -12.4111   -0.5989    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
  3 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  1  0
 21 22  2  0
 21 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 28 31  1  0
 31 32  1  0
 31 33  1  0
 31 34  1  0
  6  1  1  0
 15 11  1  0
 22 18  1  0
 30 25  1  0
M  END
>  <BrandName>  (28) 
nan

>  <Phase>  (28) 
1.0

>  <Applicants>  (28) 
Takeda

>  <Links>  (28) 
|http://www.chemspider.com/Chemical-Structure.4948554.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL1614707|http://pubchem.ncbi.nlm.nih.gov/compound/6444692|http://www.drugbank.ca/drugs/DB12682|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6011|http://zinc15.docking.org/substances/ZINC11679877|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=V734AZP9BR

>  <LigID>  (28) 
nan

>  <pdbID>  (28) 
nan

>  <Type>  (28) 
nan

>  <RoF>  (28) 
1

>  <MW>  (28) 
468.2

>  <LogP>  (28) 
6.1

>  <TPSA>  (28) 
66

>  <HBA>  (28) 
6

>  <HBD>  (28) 
0

>  <NRB>  (28) 
10

>  <Indications>  (28) 
nan

>  <Targets>  (28) 
EGFR; ERBB2

>  <Kinase families>  (28) 
Tyr

>  <Canonical_Smiles>  (28) 
c1cc(ccc1CCCCn2ccnn2)OCc3coc(n3)/C=C/c4ccc(cc4)C(F)(F)F

>  <InChiKey>  (28) 
ZTFBIUXIQYRUNT-MDWZMJQESA-N

>  <First_Approval>  (28) 
nan

>  <SC_Patent>  (28) 
None

>  <Chirality>  (28) 
Achiral Molecule

>  <Synonyms>  (28) 
MUBRITINIB | TAK-165

>  <FDA_approved>  (28) 


>  <Melting points>  (28) 


$$$$
Nedisertib
     RDKit          2D

 34 38  0  0  0  0  0  0  0  0999 V2000
   -9.3526   -1.2937    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.3211   -2.3826    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.8622   -2.0338    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4349   -0.5959    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9760   -0.2471    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9445   -1.3361    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3718   -2.7739    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8307   -3.1228    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4856   -0.9872    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0583    0.4506    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5994    0.7995    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1721    2.2373    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2037    3.3263    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6625    2.9775    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0899    1.5396    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5487    1.1908    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.7764    4.7642    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    1.2868    2.5862    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3183    1.4972    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8910    0.0593    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9225   -1.0296    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3814   -0.6808    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8087    0.7571    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7772    1.8460    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2045    3.2839    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.1729    4.3729    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7141    4.0240    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.4130   -1.7698    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.9856   -3.2076    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0172   -4.2966    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4761   -3.9478    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.9034   -2.5099    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8718   -1.4209    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4541   -2.0762    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  6  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 13 17  1  0
 12 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 22 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
  9 34  1  0
  8  3  1  0
 15 10  1  0
 27 18  2  0
 24 19  1  0
 33 28  1  0
M  END
>  <BrandName>  (29) 
nan

>  <Phase>  (29) 
1.0

>  <Applicants>  (29) 
nan

>  <Links>  (29) 
|http://www.chemspider.com/Chemical-Structure.68007068.html|http://pubchem.ncbi.nlm.nih.gov/compound/117696445|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315705

>  <LigID>  (29) 
nan

>  <pdbID>  (29) 
nan

>  <Type>  (29) 
nan

>  <RoF>  (29) 
0

>  <MW>  (29) 
481.1

>  <LogP>  (29) 
3.8

>  <TPSA>  (29) 
93.5

>  <HBA>  (29) 
8

>  <HBD>  (29) 
1

>  <NRB>  (29) 
5

>  <Indications>  (29) 
nan

>  <Targets>  (29) 
nan

>  <Kinase families>  (29) 


>  <Canonical_Smiles>  (29) 
COc1ccc(nn1)C(c2cc(c(cc2Cl)F)c3c4ccc(cc4ncn3)N5CCOCC5)O

>  <InChiKey>  (29) 
MOWXJLUYGFNTAL-UHFFFAOYSA-N

>  <First_Approval>  (29) 
nan

>  <SC_Patent>  (29) 
None

>  <Chirality>  (29) 
Single Stereoisomer

>  <Synonyms>  (29) 
|MSC-2490484A|M3814|MSC 2490484A|MSC2490484A|M-3814

>  <FDA_approved>  (29) 


>  <Melting points>  (29) 


$$$$
Ningetinib
     RDKit          2D

 41 45  0  0  0  0  0  0  0  0999 V2000
   -5.2884   -2.9213    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1066   -1.6641    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5704   -0.2632    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.7371    0.6796    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6600    2.1776    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -7.9943   -0.1386    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -7.6046   -1.5871    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -8.5474   -2.7537    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.3952    0.3976    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.6313    1.8789    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -11.0322    2.4151    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -12.1970    1.4700    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -11.9608   -0.0113    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.5599   -0.5475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1219    0.1264    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7351    1.5757    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0602   -0.9332    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6117   -0.5435    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5500   -1.6032    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8985   -1.2135    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2853    0.2358    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2236    1.2954    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2249    0.9057    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6104    2.7446    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.7338    0.6254    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.7955   -0.4342    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4087   -1.8835    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4704   -2.9431    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9189   -2.5535    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.3057   -1.1042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2440   -0.0446    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6308    1.4047    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0793    1.7943    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1410    0.7347    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7542   -0.7145    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5896    1.1244    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.6513    0.0648    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.0998    0.4544    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7101    1.9029    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4894   -0.9941    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.5483    0.8441    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  6  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
  3 15  1  0
 15 16  2  0
 15 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 22 24  1  0
 21 25  1  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 32  1  0
 32 33  2  0
 33 34  1  0
 34 35  2  0
 34 36  1  0
 36 37  1  0
 37 38  1  0
 38 39  1  0
 38 40  1  0
 38 41  1  0
  7  2  1  0
 14  9  1  0
 23 18  1  0
 31 26  1  0
 35 30  1  0
M  END
>  <BrandName>  (30) 
nan

>  <Phase>  (30) 
1.5

>  <Applicants>  (30) 
HEC Pharm

>  <Links>  (30) 
|http://www.chemspider.com/Chemical-Structure.61719564.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3984441|http://pubchem.ncbi.nlm.nih.gov/compound/60165029|http://zinc15.docking.org/substances/ZINC000143426755|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=PW3Q92Z6A4|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180270

>  <LigID>  (30) 
nan

>  <pdbID>  (30) 
nan

>  <Type>  (30) 
nan

>  <RoF>  (30) 
2

>  <MW>  (30) 
556.2

>  <LogP>  (30) 
5.4

>  <TPSA>  (30) 
107.6

>  <HBA>  (30) 
8

>  <HBD>  (30) 
2

>  <NRB>  (30) 
8

>  <Indications>  (30) 
Ningetinib, also known as CT-053 or DE-120, is a VEGF and PDGF inhibitor potentially for the treatment of wet age-related macular degeneration.

>  <Targets>  (30) 
nan

>  <Kinase families>  (30) 


>  <Canonical_Smiles>  (30) 
Cc1c(c(=O)n(n1C)c2ccccc2)C(=O)Nc3ccc(c(c3)F)Oc4ccnc5c4ccc(c5)OCC(C)(C)O

>  <InChiKey>  (30) 
VQYYQSZNRVQLIS-UHFFFAOYSA-N

>  <First_Approval>  (30) 
nan

>  <SC_Patent>  (30) 
nan

>  <Chirality>  (30) 
nan

>  <Synonyms>  (30) 
nan

>  <FDA_approved>  (30) 


>  <Melting points>  (30) 


$$$$
Selitrectinib
     RDKit          2D

 28 32  0  0  0  0  0  0  0  0999 V2000
    1.2118   -5.1741    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9538   -3.6964    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5426   -3.5933    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8197   -2.8065    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5849   -1.5163    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6629   -0.0184    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9991    0.6631    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2574   -0.1534    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1795   -1.6514    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8432   -2.3328    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5937    0.5281    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0358    1.3443    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2733    2.1918    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8497    3.6308    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3503    3.6725    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8472    2.2594    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.6304    2.5173    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3588    3.5248    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8349    3.2579    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3417    1.8461    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.1104    0.9895    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0587    2.0590    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.5446   -0.4463    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0443   -0.4771    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5369    0.9397    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.2618   -1.9194    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6244   -2.5465    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.3268   -3.0924    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  6
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
  8 11  1  0
  6 12  1  0
 12 13  1  1
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 21 23  2  0
 23 24  1  0
 24 25  2  0
 23 26  1  0
 26 27  2  0
 26 28  1  0
 28  2  1  0
 10  5  1  0
 16 12  1  0
 22 17  2  0
 25 20  1  0
M  END
>  <BrandName>  (31) 
nan

>  <Phase>  (31) 
1.5

>  <Applicants>  (31) 
Bayer

>  <Links>  (31) 
|http://www.chemspider.com/Chemical-Structure.64853862.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL4297627|http://pubchem.ncbi.nlm.nih.gov/compound/129103609|http://www.drugbank.ca/drugs/DB14896|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10314|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=0J45910S3X

>  <LigID>  (31) 
nan

>  <pdbID>  (31) 
nan

>  <Type>  (31) 
nan

>  <RoF>  (31) 
0

>  <MW>  (31) 
380.2

>  <LogP>  (31) 
2.7

>  <TPSA>  (31) 
75.4

>  <HBA>  (31) 
6

>  <HBD>  (31) 
1

>  <NRB>  (31) 
0

>  <Indications>  (31) 
nan

>  <Targets>  (31) 
nan

>  <Kinase families>  (31) 


>  <Canonical_Smiles>  (31) 
C[C@@H]1CCc2c(cc(cn2)F)[C@H]3CCCN3c4ccn5c(n4)c(cn5)C(=O)N1

>  <InChiKey>  (31) 
OEBIHOVSAMBXIB-SJKOYZFVSA-N

>  <First_Approval>  (31) 
nan

>  <SC_Patent>  (31) 
None

>  <Chirality>  (31) 
Single Stereoisomer

>  <Synonyms>  (31) 
LOXO-195 | SELITRECTINIB

>  <FDA_approved>  (31) 


>  <Melting points>  (31) 


$$$$
Lerociclib
     RDKit          2D

 35 40  0  0  0  0  0  0  0  0999 V2000
   10.6116   -2.1083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1439   -0.6830    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1444    0.4346    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6758   -0.3754    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.6753   -1.4930    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2072   -1.1854    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7396    0.2399    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.7400    1.3575    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2081    1.0498    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2714    0.5475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8038    1.9727    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3357    2.2803    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3352    1.1627    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8029   -0.2625    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.2710   -0.5701    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1329    1.4704    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1334    0.3527    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6657   -1.0725    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6662   -2.1901    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1343   -1.8825    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3453   -2.7677    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5614   -1.8895    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1020   -0.4616    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6020   -0.4572    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6015    0.6604    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1089    0.6502    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6426    0.9663    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1832    2.3943    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1901    3.5061    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6564    3.1900    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.1158    1.7621    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.5752    0.3341    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.0346   -1.0938    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -7.0277   -2.2056    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.4871   -3.6335    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  7 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 13 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  1  0
 24 25  2  0
 23 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 26 32  1  0
 32 33  1  0
 33 34  1  0
 34 35  2  0
  9  4  1  0
 15 10  1  0
 25 17  1  0
 24 20  1  0
 34 22  1  0
 31 26  1  0
M  END
>  <BrandName>  (32) 
nan

>  <Phase>  (32) 
1.5

>  <Applicants>  (32) 
G1 Therapeutics

>  <Links>  (32) 
|http://www.chemspider.com/Chemical-Structure.68007293.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3904602|http://pubchem.ncbi.nlm.nih.gov/compound/86269224|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10313|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=WBH8AY6ENB|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=253941

>  <LigID>  (32) 
nan

>  <pdbID>  (32) 
nan

>  <Type>  (32) 
nan

>  <RoF>  (32) 
0

>  <MW>  (32) 
474.3

>  <LogP>  (32) 
3.5

>  <TPSA>  (32) 
91.2

>  <HBA>  (32) 
8

>  <HBD>  (32) 
2

>  <NRB>  (32) 
4

>  <Indications>  (32) 
nan

>  <Targets>  (32) 
nan

>  <Kinase families>  (32) 


>  <Canonical_Smiles>  (32) 
CC(C)N1CCN(CC1)c2ccc(nc2)Nc3ncc4cc5n(c4n3)C6(CCCCC6)CNC5=O

>  <InChiKey>  (32) 
YPJRHEKCFKOVRT-UHFFFAOYSA-N

>  <First_Approval>  (32) 
nan

>  <SC_Patent>  (32) 
None

>  <Chirality>  (32) 
Achiral Molecule

>  <Synonyms>  (32) 
G1T38 | G1T38 FREE BASE | LEROCICLIB

>  <FDA_approved>  (32) 


>  <Melting points>  (32) 


$$$$
Vactosertib
     RDKit          2D

 30 34  0  0  0  0  0  0  0  0999 V2000
   -1.1512   -6.1698    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7289   -4.7856    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2166   -4.5938    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7944   -3.2096    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8845   -2.0171    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3968   -2.2088    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8190   -3.5931    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4869   -1.0163    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9168    0.4207    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3171    1.2737    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.5096    0.3638    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0127   -1.0515    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.9467    0.7937    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0375   -0.2359    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.4746    0.1940    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5654   -0.8355    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0025   -0.4056    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3487    1.0539    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2579    2.0834    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8208    1.6535    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7300    2.6831    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3321    0.9176    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4701   -0.0596    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8854    0.4372    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1627    1.9114    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4438    2.6917    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0976    4.1512    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6025    4.2729    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0248    2.8886    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6094    2.3918    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 11 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
  9 22  1  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  1  0
  7  2  1  0
 12  8  1  0
 20 15  1  0
 30 22  2  0
 29 25  1  0
M  END
>  <BrandName>  (33) 
nan

>  <Phase>  (33) 
1.5

>  <Applicants>  (33) 
MedPacto

>  <Links>  (33) 
|http://www.chemspider.com/Chemical-Structure.32813335.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3260567|http://pubchem.ncbi.nlm.nih.gov/compound/54766013|http://www.drugbank.ca/drugs/DB15310|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8107|http://zinc15.docking.org/substances/ZINC000113391423|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=6T4O391P5Y|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50015639

>  <LigID>  (33) 
nan

>  <pdbID>  (33) 
nan

>  <Type>  (33) 
nan

>  <RoF>  (33) 
0

>  <MW>  (33) 
399.2

>  <LogP>  (33) 
4.2

>  <TPSA>  (33) 
83.8

>  <HBA>  (33) 
6

>  <HBD>  (33) 
2

>  <NRB>  (33) 
5

>  <Indications>  (33) 
Vactosertib (EW-7197) acts as in inhibitor of transforming growth factor beta receptor 1B (ALK5) and activin A receptor type IB (ALK4). The compound is potent, selective, and orally bioavailable, and exhibits experimental anti-tumour activity.

>  <Targets>  (33) 
nan

>  <Kinase families>  (33) 


>  <Canonical_Smiles>  (33) 
Cc1cccc(n1)c2c(nc([nH]2)CNc3ccccc3F)c4ccc5ncnn5c4

>  <InChiKey>  (33) 
FJCDSQATIJKQKA-UHFFFAOYSA-N

>  <First_Approval>  (33) 
nan

>  <SC_Patent>  (33) 
None

>  <Chirality>  (33) 
Achiral Molecule

>  <Synonyms>  (33) 
TEW 7197 | TEW-7197 | VACTOSERTIB

>  <FDA_approved>  (33) 


>  <Melting points>  (33) 


$$$$
Tirabrutinib
     RDKit          2D

 34 38  0  0  0  0  0  0  0  0999 V2000
    9.3898   -1.5495    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5598   -0.3000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7298    0.9495    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8999    2.1989    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5670    3.5424    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.4028    2.1049    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.4468    3.2608    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0521    2.7087    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1461    1.2117    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5990    0.8385    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9903    0.2557    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.0843   -1.2414    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6896   -1.7934    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4703   -3.2773    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6457   -4.2091    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.0405   -3.6571    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2597   -2.1732    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9244   -3.8293    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2665   -0.6375    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.5374    0.6289    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0146    2.0236    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7635   -0.7316    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5935    0.5179    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0905    0.4239    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7576   -0.9196    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9276   -2.1691    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4306   -2.0751    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2546   -1.0137    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -7.0846    0.2358    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4175    1.5793    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.2475    2.8288    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.7445    2.7347    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.4116    1.3912    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.5817    0.1418    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  3  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  9 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 14 18  1  0
 13 19  1  0
 19 20  1  0
 20 21  2  0
 19 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 25 28  1  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 32 33  1  0
 33 34  2  0
 10  6  1  0
 20 11  1  0
 17 12  2  0
 27 22  1  0
 34 29  1  0
M  END
>  <BrandName>  (34) 
nan

>  <Phase>  (34) 
2.0

>  <Applicants>  (34) 
Ono Pharmaceutical

>  <Links>  (34) 
|http://www.chemspider.com/Chemical-Structure.34979967.html|http://pubchem.ncbi.nlm.nih.gov/compound/54755435

>  <LigID>  (34) 
nan

>  <pdbID>  (34) 
nan

>  <Type>  (34) 
nan

>  <RoF>  (34) 
0

>  <MW>  (34) 
454.2

>  <LogP>  (34) 
2.8

>  <TPSA>  (34) 
108.3

>  <HBA>  (34) 
8

>  <HBD>  (34) 
1

>  <NRB>  (34) 
4

>  <Indications>  (34) 
nan

>  <Targets>  (34) 
nan

>  <Kinase families>  (34) 


>  <Canonical_Smiles>  (34) 
CC#CC(=O)N1CCC(C1)n2c3c(c(ncn3)N)n(c2=O)c4ccc(cc4)Oc5ccccc5

>  <InChiKey>  (34) 
SEJLPXCPMNSRAM-UHFFFAOYSA-N

>  <First_Approval>  (34) 
nan

>  <SC_Patent>  (34) 
None

>  <Chirality>  (34) 
Single Stereoisomer

>  <Synonyms>  (34) 
|ONO-4059(FREE BASE)|ONO-4059|GS-4059

>  <FDA_approved>  (34) 


>  <Melting points>  (34) 


$$$$
Bentamapimod
     RDKit          2D

 33 37  0  0  0  0  0  0  0  0999 V2000
   -8.1455    0.4356    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6456    0.4177    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1457    0.3999    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4112   -0.9079    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0376   -2.2709    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9349   -3.2878    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9527   -4.7877    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6626   -5.5531    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3548   -4.8186    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3370   -3.3187    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6270   -2.5533    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9214   -1.0825    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3803    1.6899    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8804    1.6721    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1151    2.9621    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6152    2.9443    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.1193    1.6365    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6192    1.6186    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3538    0.3108    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8536    0.2929    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6190    1.5830    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8845    2.8908    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3846    2.9087    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1189    1.5651    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8534    0.2573    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.0880   -1.0327    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8226   -2.3406    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3224   -2.3584    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.0878   -1.0684    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3533    0.2395    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8496    4.2700    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3495    4.2878    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1148    2.9978    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  3  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
  3 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 21 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 15 31  2  0
 31 32  1  0
 32 33  2  0
 12  4  1  0
 11  6  1  0
 23 18  1  0
 30 25  1  0
 33 13  1  0
M  END
>  <BrandName>  (35) 
nan

>  <Phase>  (35) 
2.0

>  <Applicants>  (35) 
PregLem

>  <Links>  (35) 
|http://www.chemspider.com/Chemical-Structure.8370750.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3545213|http://pubchem.ncbi.nlm.nih.gov/compound/10195250|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9926

>  <LigID>  (35) 
nan

>  <pdbID>  (35) 
nan

>  <Type>  (35) 
nan

>  <RoF>  (35) 
0

>  <MW>  (35) 
457.2

>  <LogP>  (35) 
4.2

>  <TPSA>  (35) 
84.2

>  <HBA>  (35) 
8

>  <HBD>  (35) 
0

>  <NRB>  (35) 
7

>  <Indications>  (35) 
nan

>  <Targets>  (35) 
MAPK8; MAPK9

>  <Kinase families>  (35) 
CMGC

>  <Canonical_Smiles>  (35) 
N#CC(c1nc2ccccc2s1)c5nc(OCc3ccc(cc3)CN4CCOCC4)ncc5

>  <InChiKey>  (35) 
XCPPIJCBCWUBNT-UHFFFAOYSA-N

>  <First_Approval>  (35) 
nan

>  <SC_Patent>  (35) 
None

>  <Chirality>  (35) 
Racemic Mixture

>  <Synonyms>  (35) 
AS-602801 | BENTAMAPIMOD | PGL-5001

>  <FDA_approved>  (35) 


>  <Melting points>  (35) 


$$$$
Sonolisib
     RDKit          2D

 38 41  0  0  0  0  0  0  0  0999 V2000
   -5.1358    2.9700    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5258    1.5997    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4075    0.3862    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0340    1.4429    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4239    0.0725    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3056   -1.1410    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6955   -2.5113    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2037   -2.6681    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8919   -4.1353    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1909   -4.8853    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3056   -3.8816    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7729   -4.1934    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3220   -1.4546    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9321   -0.0843    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0504    1.1292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6605    2.4996    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2212    3.7131    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.7130    3.5562    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5947    4.7698    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.3231    2.1859    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8148    2.0291    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4249    0.6588    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.9167    0.5020    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5268   -0.8684    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0186   -1.0252    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5432   -0.5547    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1533   -1.9251    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2716   -3.1386    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4414    0.9724    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0514   -0.3979    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1697   -1.6114    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7798   -2.9818    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.8005   -0.6706    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1523    2.6564    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7624    4.0267    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2541    4.1835    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5422    1.2860    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1955   -2.5113    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  5  4  1  1
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  6
  9 10  1  0
 10 11  1  0
 11 12  2  0
  8 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 18 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  2  0
 22 26  1  0
 26 27  1  0
 27 28  2  0
 20 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 30 33  1  0
 16 34  1  1
 34 35  1  0
 35 36  1  0
 15 37  1  6
  7 38  1  6
 14  5  1  0
 11  7  1  0
 31 13  1  0
 29 15  1  0
M  END
>  <BrandName>  (36) 
nan

>  <Phase>  (36) 
2.0

>  <Applicants>  (36) 
Cascadian Therapeutics

>  <Links>  (36) 
|http://www.chemspider.com/Chemical-Structure.8025448.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL411907|http://pubchem.ncbi.nlm.nih.gov/compound/9849735|http://www.drugbank.ca/drugs/DB12601|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7941|http://zinc15.docking.org/substances/ZINC000029134545|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=987796874T

>  <LigID>  (36) 
nan

>  <pdbID>  (36) 
nan

>  <Type>  (36) 
nan

>  <RoF>  (36) 
1

>  <MW>  (36) 
525.2

>  <LogP>  (36) 
3.1

>  <TPSA>  (36) 
119.4

>  <HBA>  (36) 
9

>  <HBD>  (36) 
1

>  <NRB>  (36) 
8

>  <Indications>  (36) 
nan

>  <Targets>  (36) 
PIK3CA; PIK3CB; PIK3CG

>  <Kinase families>  (36) 
Atypical

>  <Canonical_Smiles>  (36) 
CC(=O)O[C@@H]1C[C@]2([C@@H](CCC2=O)C3=C1[C@]4([C@H](OC(=O)/C(=C/N(CC=C)CC=C)/C4=C(C3=O)O)COC)C)C

>  <InChiKey>  (36) 
QIUASFSNWYMDFS-NILGECQDSA-N

>  <First_Approval>  (36) 
nan

>  <SC_Patent>  (36) 
None

>  <Chirality>  (36) 
Single Stereoisomer

>  <Synonyms>  (36) 
PX-866 | SONOLISIB

>  <FDA_approved>  (36) 


>  <Melting points>  (36) 


$$$$
Bimiralisib
     RDKit          2D

 29 32  0  0  0  0  0  0  0  0999 V2000
    4.5694    1.0558    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1993    0.4452    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9855    1.3263    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1416    2.8182    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5117    3.4289    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.7256    2.5477    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0957    3.1584    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.6154    0.7157    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5985    1.5969    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9686    0.9862    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1247   -0.5057    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9109   -1.3868    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4592   -0.7762    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0670   -2.8787    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4371   -3.4894    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5933   -4.9812    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3794   -5.8624    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0093   -5.2517    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1469   -3.7599    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1825    1.8674    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0263    3.3592    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2402    4.2404    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6102    3.6297    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7664    2.1379    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5525    1.2567    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0432   -1.0467    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8870   -2.5385    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    4.5350   -1.2029    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    1.5513   -0.8905    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  3  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 10 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
  2 26  1  0
 26 27  1  0
 26 28  1  0
 26 29  1  0
  6  1  1  0
 13  8  1  0
 19 14  1  0
 25 20  1  0
M  END
>  <BrandName>  (37) 
nan

>  <Phase>  (37) 
2.0

>  <Applicants>  (37) 
Piqur Therapeutics

>  <Links>  (37) 
|http://www.chemspider.com/Chemical-Structure.35033288.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL4084907|http://pubchem.ncbi.nlm.nih.gov/compound/58507717|http://www.drugbank.ca/drugs/DB14846| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=A3W|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/A3W|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8383|http://zinc15.docking.org/substances/ZINC000068203488|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=6Z3QHB00LB|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50240975

>  <LigID>  (37) 
'A3W'

>  <pdbID>  (37) 
5oq4

>  <Type>  (37) 
nan

>  <RoF>  (37) 
0

>  <MW>  (37) 
411.2

>  <LogP>  (37) 
1

>  <TPSA>  (37) 
103.2

>  <HBA>  (37) 
8

>  <HBD>  (37) 
2

>  <NRB>  (37) 
3

>  <Indications>  (37) 
Bimiralisib (PQR309) is a novel dual inhibitor of phosphoinositol 3-kinase (PI3K) and mechanistic target of rapamycin (mTOR) kinases, with expected utility as an anti-cancer agent.

>  <Targets>  (37) 
nan

>  <Kinase families>  (37) 


>  <Canonical_Smiles>  (37) 
c1c(c(c[nH]c1=N)c2nc(nc(n2)N3CCOCC3)N4CCOCC4)C(F)(F)F

>  <InChiKey>  (37) 
ADGGYDAFIHSYFI-UHFFFAOYSA-N

>  <First_Approval>  (37) 
nan

>  <SC_Patent>  (37) 
None

>  <Chirality>  (37) 
Achiral Molecule

>  <Synonyms>  (37) 
BIMIRALISIB | NC-B5 | NCB5 | PI3K-IN-2 | PQR-309 | PQR309

>  <FDA_approved>  (37) 


>  <Melting points>  (37) 


$$$$
Berzosertib
     RDKit          2D

 33 36  0  0  0  0  0  0  0  0999 V2000
    8.9417   -2.8875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4874   -3.2551    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0786   -4.6983    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4420   -2.1794    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    7.5177   -1.1340    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.3663   -3.2248    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.3966   -1.1037    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9423   -1.4713    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8969   -0.3956    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3057    1.0476    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7600    1.4151    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8054    0.3395    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2603    2.1233    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6691    3.5665    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6236    4.6421    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.1694    4.2746    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2395    2.8314    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8060    1.7557    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6937    2.4638    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2512    1.0713    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7479    1.1711    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1154    2.6254    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8459    3.4243    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7084    0.0190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1864    0.2747    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.1469   -0.8774    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6294   -2.2853    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1513   -2.5411    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1908   -1.3889    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.5898   -3.4375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.0679   -3.1817    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  -10.0284   -4.3339    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8761    5.3503    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  2  0
  4  6  2  0
  4  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 10 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 21 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 27 30  1  0
 30 31  1  0
 31 32  1  0
 16 33  1  0
 12  7  1  0
 18 13  1  0
 23 19  1  0
 29 24  1  0
M  END
>  <BrandName>  (38) 
nan

>  <Phase>  (38) 
2.0

>  <Applicants>  (38) 
Vertex Pharmaceuticals

>  <Links>  (38) 
|http://www.chemspider.com/Chemical-Structure.30773968.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3989870|http://pubchem.ncbi.nlm.nih.gov/compound/59472121|http://www.drugbank.ca/drugs/DB11794|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8003|http://zinc15.docking.org/substances/ZINC000096170459|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=L423PRV3V3|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50226746

>  <LigID>  (38) 
nan

>  <pdbID>  (38) 
nan

>  <Type>  (38) 
nan

>  <RoF>  (38) 
0

>  <MW>  (38) 
463.2

>  <LogP>  (38) 
3.9

>  <TPSA>  (38) 
124

>  <HBA>  (38) 
8

>  <HBD>  (38) 
2

>  <NRB>  (38) 
7

>  <Indications>  (38) 
nan

>  <Targets>  (38) 
nan

>  <Kinase families>  (38) 


>  <Canonical_Smiles>  (38) 
CC(C)S(=O)(=O)c1ccc(cc1)c2cnc(c(n2)c3cc(no3)c4ccc(cc4)CNC)N

>  <InChiKey>  (38) 
JZCWLJDSIRUGIN-UHFFFAOYSA-N

>  <First_Approval>  (38) 
nan

>  <SC_Patent>  (38) 
None

>  <Chirality>  (38) 
Achiral Molecule

>  <Synonyms>  (38) 
BERZOSERTIB | M-6620 | M6620 | VE-822 | VX-970 | VX970

>  <FDA_approved>  (38) 


>  <Melting points>  (38) 


$$$$
Bemcentinib
     RDKit          2D

 38 44  0  0  0  0  0  0  0  0999 V2000
   -9.6875   -2.4743    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.5183   -0.9839    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.1430   -0.3852    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.9368   -1.2769    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.1060   -2.7673    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.4813   -3.3660    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0462   -3.8288    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5555   -3.6621    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7564   -2.3926    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2507   -0.9764    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6661   -0.4798    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9438    0.9942    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8060    1.9717    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3906    1.4752    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1129    0.0011    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2529    2.4527    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3749    3.9477    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9908    4.5258    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0133    3.3880    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7933    2.1068    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.4817    3.5101    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.3350    2.2764    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6932    0.9206    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5464   -0.3131    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0414   -0.1910    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6832    1.1648    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8300    2.3985    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1433    1.5083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3223    0.5809    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3323   -0.9191    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1658   -1.8621    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7012   -1.5381    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6881   -1.5609    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.0042   -0.8413    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0953   -1.8706    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4535   -3.2264    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9657   -3.0349    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6562    4.7277    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 14 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 19 21  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 26 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 30 33  1  1
 33 34  1  0
 34 35  1  0
 35 36  1  0
 36 37  1  0
 17 38  1  0
  6  1  1  0
  4 11  1  0
 15 10  1  0
 20 16  1  0
 27 22  1  0
 32 25  1  0
 37 33  1  0
M  END
>  <BrandName>  (39) 
nan

>  <Phase>  (39) 
2.0

>  <Applicants>  (39) 
BerGenBio

>  <Links>  (39) 
|http://www.chemspider.com/Chemical-Structure.28637805.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3809489|http://pubchem.ncbi.nlm.nih.gov/compound/46215462|http://www.drugbank.ca/drugs/DB12411|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10478|http://zinc15.docking.org/substances/ZINC000051951669|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=0ICW2LX8AS|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50172079

>  <LigID>  (39) 
nan

>  <pdbID>  (39) 
nan

>  <Type>  (39) 
nan

>  <RoF>  (39) 
1

>  <MW>  (39) 
506.3

>  <LogP>  (39) 
4.9

>  <TPSA>  (39) 
97.8

>  <HBA>  (39) 
8

>  <HBD>  (39) 
2

>  <NRB>  (39) 
4

>  <Indications>  (39) 
nan

>  <Targets>  (39) 
AXL

>  <Kinase families>  (39) 
Tyr

>  <Canonical_Smiles>  (39) 
c1ccc-2c(c1)CCCc3c2nnc(c3)n4c(nc(n4)Nc5ccc6c(c5)CC[C@H](CC6)N7CCCC7)N

>  <InChiKey>  (39) 
KXMZDGSRSGHMMK-VWLOTQADSA-N

>  <First_Approval>  (39) 
nan

>  <SC_Patent>  (39) 
None

>  <Chirality>  (39) 
Single Stereoisomer

>  <Synonyms>  (39) 
BEMCENTINIB | BGB 324 | BGB324 | CS-1046 | HY-15150 | KB-80319 | QC-11751 | R428 | SYN-1131 | W-5845

>  <FDA_approved>  (39) 


>  <Melting points>  (39) 


$$$$
Voxtalisib
     RDKit          2D

 20 22  0  0  0  0  0  0  0  0999 V2000
    2.5838    3.2352    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1021    3.0014    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5638    1.6013    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.5071    0.4351    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9688   -0.9650    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5129   -1.1988    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4562   -0.0325    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9179    1.3675    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8612    2.5338    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9379   -0.2664    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6196   -1.6025    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1010   -1.3670    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3349    0.1147    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9980    0.7949    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.9121   -2.1312    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3937   -1.8974    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.9321   -0.4973    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9888    0.6689    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.4137   -0.2635    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.3737   -3.5313    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  7 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
  5 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 17 19  1  0
 15 20  1  0
  8  3  1  0
 18  4  1  0
 14 10  1  0
M  END
>  <BrandName>  (40) 
nan

>  <Phase>  (40) 
2.0

>  <Applicants>  (40) 
Sanofi

>  <Links>  (40) 
|http://www.chemspider.com/Chemical-Structure.17279963.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3545366|http://pubchem.ncbi.nlm.nih.gov/compound/16123056|http://www.drugbank.ca/drugs/DB12400|http://zinc15.docking.org/substances/ZINC000035308805|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=CVL1685GPH

>  <LigID>  (40) 
nan

>  <pdbID>  (40) 
nan

>  <Type>  (40) 
nan

>  <RoF>  (40) 
0

>  <MW>  (40) 
270.1

>  <LogP>  (40) 
1.1

>  <TPSA>  (40) 
102.5

>  <HBA>  (40) 
6

>  <HBD>  (40) 
2

>  <NRB>  (40) 
2

>  <Indications>  (40) 
nan

>  <Targets>  (40) 
PIK3CA; MTOR

>  <Kinase families>  (40) 
Atypical

>  <Canonical_Smiles>  (40) 
CCn1c2c(cc(c1=O)c3ccn[nH]3)c(nc(n2)N)C

>  <InChiKey>  (40) 
RGHYDLZMTYDBDT-UHFFFAOYSA-N

>  <First_Approval>  (40) 
nan

>  <SC_Patent>  (40) 
None

>  <Chirality>  (40) 
Achiral Molecule

>  <Synonyms>  (40) 
SAR-245409 | SAR245409 | VOXTALISIB | XL-765

>  <FDA_approved>  (40) 


>  <Melting points>  (40) 


$$$$
Decernotinib
     RDKit          2D

 28 30  0  0  0  0  0  0  0  0999 V2000
   -3.4226    0.6104    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1004   -0.0980    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0527   -1.5972    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0050   -3.0964    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5520   -1.6449    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2603   -2.9671    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3429   -0.3704    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8421   -0.4181    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6331    0.8565    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.4240    2.1310    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -7.9076    0.0656    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3585    1.6474    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5535   -1.5495    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.1548   -0.2273    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6361    1.0472    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0722    2.3695    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5715    2.4172    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.3624    1.1426    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6541   -0.1796    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.8616    1.1903    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7043    2.4313    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1449    2.0133    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.1926    0.5141    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7814    0.0054    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5164   -1.4709    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6625   -2.4387    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0736   -1.9300    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3386   -0.4537    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  6
  3  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  9 11  1  0
  9 12  1  0
  3 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 18 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 19 14  1  0
 24 20  1  0
 28 23  1  0
M  END
>  <BrandName>  (41) 
nan

>  <Phase>  (41) 
2.0

>  <Applicants>  (41) 
Vertex Pharmaceuticals

>  <Links>  (41) 
|http://www.chemspider.com/Chemical-Structure.30843790.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3039513|http://pubchem.ncbi.nlm.nih.gov/compound/59422203|http://www.drugbank.ca/drugs/DB12566| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=VJK|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/VJK|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8309|http://zinc15.docking.org/substances/ZINC000096941867|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=MZK2GP0RHK|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50021655

>  <LigID>  (41) 
'VJK'

>  <pdbID>  (41) 
4yti

>  <Type>  (41) 
1

>  <RoF>  (41) 
0

>  <MW>  (41) 
392.2

>  <LogP>  (41) 
3.3

>  <TPSA>  (41) 
95.6

>  <HBA>  (41) 
5

>  <HBD>  (41) 
3

>  <NRB>  (41) 
6

>  <Indications>  (41) 
nan

>  <Targets>  (41) 
JAK3

>  <Kinase families>  (41) 
Tyr

>  <Canonical_Smiles>  (41) 
CC[C@](C)(C(=O)NCC(F)(F)F)Nc1ccnc(n1)c2c[nH]c3c2cccn3

>  <InChiKey>  (41) 
ASUGUQWIHMTFJL-QGZVFWFLSA-N

>  <First_Approval>  (41) 
nan

>  <SC_Patent>  (41) 
None

>  <Chirality>  (41) 
Single Stereoisomer

>  <Synonyms>  (41) 
ADELATINIB | DECERNOTINIB | VRT-831509 | VX-509

>  <FDA_approved>  (41) 


>  <Melting points>  (41) 


$$$$
Bafetinib
     RDKit          2D

 42 46  0  0  0  0  0  0  0  0999 V2000
   -8.0934    1.8219    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6012    1.9751    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9879    3.3440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4957    3.4972    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6169    2.2816    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2303    0.9127    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7225    0.7595    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.3358   -0.6094    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4570   -1.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0704   -3.1938    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1916   -4.4095    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6994   -4.2562    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0861   -2.8874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9649   -1.6717    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5939   -2.7341    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7151   -3.9497    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7770   -3.7965    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.3904   -2.4276    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5116   -1.2120    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9806   -1.3652    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1248    2.4349    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2460    1.2192    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8594   -0.1496    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.2462    1.3725    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1249    0.1569    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6171    0.3101    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2305    1.6790    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3517    2.8946    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8595    2.7413    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9650    4.2635    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5784    5.6323    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    1.5962    4.8768    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    4.3339    3.6501    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    4.7226    1.8322    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6014    0.6166    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.1014    0.6130    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5615   -0.8147    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3459   -1.6934    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1345   -0.8089    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3423   -3.1934    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.0415   -3.9403    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6396   -3.9465    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
  5 21  1  0
 21 22  1  0
 22 23  2  0
 22 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 28 30  1  0
 30 31  1  0
 30 32  1  0
 30 33  1  0
 27 34  1  0
 34 35  1  0
 35 36  1  0
 36 37  1  0
 37 38  1  0
 38 39  1  0
 38 40  1  6
 40 41  1  0
 40 42  1  0
  7  2  1  0
 14  9  1  0
 20 15  1  0
 29 24  1  0
 39 35  1  0
M  END
>  <BrandName>  (42) 
nan

>  <Phase>  (42) 
2.0

>  <Applicants>  (42) 
Innovive Pharmaceuticals

>  <Links>  (42) 
|http://www.chemspider.com/Chemical-Structure.9562515.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL206834|http://pubchem.ncbi.nlm.nih.gov/compound/11387605|http://www.drugbank.ca/drugs/DB11851| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=406|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/406|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7906|http://zinc15.docking.org/substances/ZINC000022940637|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=NVW4Z03I9B|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50178612

>  <LigID>  (42) 
'406'

>  <pdbID>  (42) 
2e2b

>  <Type>  (42) 
2

>  <RoF>  (42) 
2

>  <MW>  (42) 
576.3

>  <LogP>  (42) 
5.4

>  <TPSA>  (42) 
99.2

>  <HBA>  (42) 
8

>  <HBD>  (42) 
2

>  <NRB>  (42) 
8

>  <Indications>  (42) 
nan

>  <Targets>  (42) 
LYN; ABL1

>  <Kinase families>  (42) 
Tyr

>  <Canonical_Smiles>  (42) 
Cc1ccc(cc1Nc2nccc(n2)c3cncnc3)NC(=O)c4ccc(c(c4)C(F)(F)F)CN5CC[C@@H](C5)N(C)C

>  <InChiKey>  (42) 
ZGBAJMQHJDFTQJ-DEOSSOPVSA-N

>  <First_Approval>  (42) 
nan

>  <SC_Patent>  (42) 
None

>  <Chirality>  (42) 
Single Stereoisomer

>  <Synonyms>  (42) 
BAFETINIB | CNS-9 | INNO-406 | NS-187

>  <FDA_approved>  (42) 


>  <Melting points>  (42) 


$$$$
Galunisertib
     RDKit          2D

 28 32  0  0  0  0  0  0  0  0999 V2000
   -7.0093   -0.8762    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6737   -0.1933    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5973    1.3047    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2618    1.9876    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0026    1.1724    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0790   -0.3257    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4146   -1.0085    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8199   -1.1409    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4203   -0.6014    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5253   -1.7658    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2899   -3.0249    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7393   -2.6387    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.6558   -4.1893    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0554   -3.6498    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9748   -2.1520    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0341    0.8481    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0962    1.9072    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7100    3.3567    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7383    3.7469    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.8005    2.6877    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4143    1.2383    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4764    0.1791    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9248    0.5694    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3110    2.0188    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2488    3.0780    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9869   -0.4898    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6007   -1.9392    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.4352   -0.0995    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 11 13  1  0
 13 14  1  0
 14 15  1  0
  9 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 23 26  1  0
 26 27  2  0
 26 28  1  0
  7  2  1  0
 12  8  2  0
 15 10  1  0
 21 16  1  0
 25 20  1  0
M  END
>  <BrandName>  (43) 
nan

>  <Phase>  (43) 
2.0

>  <Applicants>  (43) 
Eli Lilly

>  <Links>  (43) 
|http://www.chemspider.com/Chemical-Structure.8266022.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL2364611|http://pubchem.ncbi.nlm.nih.gov/compound/10090485|http://www.drugbank.ca/drugs/DB11911|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7797|http://zinc15.docking.org/substances/ZINC03959536|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=3OKH1W5LZE|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50015640

>  <LigID>  (43) 
nan

>  <pdbID>  (43) 
nan

>  <Type>  (43) 
nan

>  <RoF>  (43) 
0

>  <MW>  (43) 
369.2

>  <LogP>  (43) 
3.5

>  <TPSA>  (43) 
86.7

>  <HBA>  (43) 
5

>  <HBD>  (43) 
1

>  <NRB>  (43) 
3

>  <Indications>  (43) 
nan

>  <Targets>  (43) 
TGFBR1

>  <Kinase families>  (43) 
TKL

>  <Canonical_Smiles>  (43) 
Cc1cccc(n1)c2c(c3n(n2)CCC3)c4ccnc5c4cc(cc5)C(=O)N

>  <InChiKey>  (43) 
IVRXNBXKWIJUQB-UHFFFAOYSA-N

>  <First_Approval>  (43) 
nan

>  <SC_Patent>  (43) 
None

>  <Chirality>  (43) 
Achiral Molecule

>  <Synonyms>  (43) 
GALUNISERTIB | LY-2157299 | LY2157299

>  <FDA_approved>  (43) 


>  <Melting points>  (43) 


$$$$
Gedatolisib
     RDKit          2D

 45 50  0  0  0  0  0  0  0  0999 V2000
  -10.2676   -5.1102    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.9116   -4.4690    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -7.6783   -5.3228    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.7888   -2.9740    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.0221   -2.1202    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.8993   -0.6253    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.5433    0.0159    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -7.3100   -0.8379    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.4327   -2.3329    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.4205    1.5109    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.6538    2.3647    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -7.0644    2.1521    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8312    1.2983    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4751    1.9394    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3523    3.4344    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5856    4.2882    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.9417    3.6470    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9963    4.0756    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7630    3.2218    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8857    1.7268    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4069    3.8629    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.8264    3.0091    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7036    1.5142    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9369    0.6604    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2930    1.3015    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4158    2.7965    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1825    3.6503    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5263    0.4477    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4035   -1.0472    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.6368   -1.9010    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9929   -1.2599    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.1157    0.2351    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8824    1.0889    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.4717    0.8763    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.7050    0.0225    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0611    0.6636    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1838    2.1586    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.9505    3.0124    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5945    2.3712    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5141   -3.3960    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.1580   -4.0372    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0352   -5.5321    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2685   -6.3859    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.6246   -5.7448    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7474   -4.2498    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  7 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 15 18  1  0
 18 19  1  0
 19 20  2  0
 19 21  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 25 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 32  1  0
 32 33  2  0
 32 34  1  0
 34 35  1  0
 35 36  1  0
 36 37  1  0
 37 38  1  0
 38 39  1  0
 30 40  1  0
 40 41  1  0
 41 42  1  0
 42 43  1  0
 43 44  1  0
 44 45  1  0
  9  4  1  0
 17 12  1  0
 27 22  1  0
 33 28  1  0
 39 34  1  0
 45 40  1  0
M  END
>  <BrandName>  (44) 
nan

>  <Phase>  (44) 
2.0

>  <Applicants>  (44) 
Pfizer

>  <Links>  (44) 
|http://www.chemspider.com/Chemical-Structure.24644946.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL592445|http://pubchem.ncbi.nlm.nih.gov/compound/44516953|http://www.drugbank.ca/drugs/DB11896|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7940|http://zinc15.docking.org/substances/ZINC000049757175|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=96265TNH2R|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50308135

>  <LigID>  (44) 
nan

>  <pdbID>  (44) 
nan

>  <Type>  (44) 
nan

>  <RoF>  (44) 
1

>  <MW>  (44) 
615.3

>  <LogP>  (44) 
3

>  <TPSA>  (44) 
128.3

>  <HBA>  (44) 
10

>  <HBD>  (44) 
2

>  <NRB>  (44) 
7

>  <Indications>  (44) 
nan

>  <Targets>  (44) 
PIK3CA; PIK3CB; PIK3CG; PIK3CD; MTOR

>  <Kinase families>  (44) 
Atypical

>  <Canonical_Smiles>  (44) 
CN(C)C1CCN(CC1)C(=O)c2ccc(cc2)NC(=O)Nc3ccc(cc3)c4nc(nc(n4)N5CCOCC5)N6CCOCC6

>  <InChiKey>  (44) 
DWZAEMINVBZMHQ-UHFFFAOYSA-N

>  <First_Approval>  (44) 
nan

>  <SC_Patent>  (44) 
None

>  <Chirality>  (44) 
Achiral Molecule

>  <Synonyms>  (44) 
GEDATOLISIB | PF-05212384 | PKI-587

>  <FDA_approved>  (44) 


>  <Melting points>  (44) 


$$$$
Poseltinib
     RDKit          2D

 35 39  0  0  0  0  0  0  0  0999 V2000
   11.3586    1.2439    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8599    1.1826    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.1636   -0.1460    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6649   -0.2074    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8624    1.0599    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.5587    2.3885    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0574    2.4499    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3637    0.9986    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5612    2.2659    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0624    2.2045    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3662    0.8759    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1687   -0.3914    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6674   -0.3300    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8674    0.8146    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.1712   -0.5140    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9736   -1.7813    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.2774   -3.1099    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7989   -4.5164    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3776   -5.4469    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6262   -4.6156    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2214   -3.1713    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0238   -1.9040    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3276   -0.5754    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5226   -1.9653    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3251   -0.6980    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6288    0.6306    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4313    1.8979    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9301    1.8365    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6263    0.5079    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8238   -0.7594    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.1251    0.4466    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -8.9275    1.7139    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.2313    3.0425    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  -10.4263    1.6525    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -11.2288    2.9198    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  5  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 11 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  2  0
 22 24  1  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 29 31  1  0
 31 32  1  0
 32 33  2  0
 32 34  1  0
 34 35  2  0
  7  2  1  0
 13  8  1  0
 23 15  1  0
 21 17  2  0
 30 25  1  0
M  END
>  <BrandName>  (45) 
nan

>  <Phase>  (45) 
2.0

>  <Applicants>  (45) 
Hanmi Pharmaceutical

>  <Links>  (45) 
|http://www.chemspider.com/Chemical-Structure.58826582.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL4163691|http://pubchem.ncbi.nlm.nih.gov/compound/56644522|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9862|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=D01E4B1U35

>  <LigID>  (45) 
nan

>  <pdbID>  (45) 
nan

>  <Type>  (45) 
nan

>  <RoF>  (45) 
0

>  <MW>  (45) 
470.2

>  <LogP>  (45) 
4.6

>  <TPSA>  (45) 
95.8

>  <HBA>  (45) 
8

>  <HBD>  (45) 
2

>  <NRB>  (45) 
7

>  <Indications>  (45) 
nan

>  <Targets>  (45) 
nan

>  <Kinase families>  (45) 


>  <Canonical_Smiles>  (45) 
CN1CCN(CC1)c2ccc(cc2)Nc3nc4ccoc4c(n3)Oc5cccc(c5)NC(=O)C=C

>  <InChiKey>  (45) 
LZMJNVRJMFMYQS-UHFFFAOYSA-N

>  <First_Approval>  (45) 
nan

>  <SC_Patent>  (45) 
None

>  <Chirality>  (45) 
Achiral Molecule

>  <Synonyms>  (45) 
HM71224 | LY3337641 | POSELTINIB

>  <FDA_approved>  (45) 


>  <Melting points>  (45) 


$$$$
Verosudil
     RDKit          2D

 23 25  0  0  0  0  0  0  0  0999 V2000
   -4.8623   -2.2966    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3972   -1.9749    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3861   -3.0829    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9433   -0.5453    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9544    0.5627    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4451    0.3959    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0644    1.7621    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9565    2.7732    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6524    2.0320    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4782   -0.2236    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0242    1.2061    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4670   -1.3315    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.9981   -1.0098    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0092   -2.1178    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4743   -1.7961    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9283   -0.3664    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9171    0.7415    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4520    0.4198    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3711    2.1712    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8361    2.4929    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8473    1.3849    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.3933   -0.0447    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4045   -1.1527    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  4 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  1  0
 22 23  2  0
  9  5  2  0
 18 13  1  0
 22 16  1  0
M  END
>  <BrandName>  (46) 
nan

>  <Phase>  (46) 
2.0

>  <Applicants>  (46) 
Aerie Pharmaceutical

>  <Links>  (46) 
|http://www.chemspider.com/Chemical-Structure.32742441.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3545065|http://pubchem.ncbi.nlm.nih.gov/compound/66906051|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8911

>  <LigID>  (46) 
nan

>  <pdbID>  (46) 
nan

>  <Type>  (46) 
nan

>  <RoF>  (46) 
0

>  <MW>  (46) 
327.1

>  <LogP>  (46) 
2.8

>  <TPSA>  (46) 
65.2

>  <HBA>  (46) 
4

>  <HBD>  (46) 
2

>  <NRB>  (46) 
4

>  <Indications>  (46) 
nan

>  <Targets>  (46) 
nan

>  <Kinase families>  (46) 


>  <Canonical_Smiles>  (46) 
CN(C)C(c1ccsc1)C(=O)Nc2ccc3c(c2)cc[nH]c3=O

>  <InChiKey>  (46) 
VDYRZXYYQMMFJW-UHFFFAOYSA-N

>  <First_Approval>  (46) 
nan

>  <SC_Patent>  (46) 
None

>  <Chirality>  (46) 
Racemic Mixture

>  <Synonyms>  (46) 
AR-12286 | AR-12286 FREE BASE | VEROSUDIL

>  <FDA_approved>  (46) 


>  <Melting points>  (46) 


$$$$
Dactolisib
     RDKit          2D

 36 41  0  0  0  0  0  0  0  0999 V2000
    2.3510   -3.0258    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4534   -4.2276    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5559   -5.4294    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6553   -5.1251    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8571   -6.0227    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.2516   -3.3300    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1266   -3.9220    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3284   -3.0245    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1520   -1.5349    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7738   -0.9429    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4280   -1.8404    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3539   -0.6373    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3341    0.8626    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2063    1.8515    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7859    1.3692    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3419    2.3582    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0494    3.8294    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3710    4.3116    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4988    3.3227    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9192    3.8049    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0470    2.8160    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7545    1.3448    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6520    0.1430    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7864   -1.0820    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2687   -2.5024    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -7.1519    0.1627    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7623    1.8759    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8901    2.8649    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3104    2.3826    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4383    3.3716    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8586    2.8893    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1512    1.4181    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0233    0.4292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6030    0.9114    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4752   -0.0775    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.0548    0.4047    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  3  0
  2  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
  9 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  2  0
 23 26  1  0
 16 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 32 33  1  0
 33 34  2  0
 34 35  1  0
 35 36  2  0
 11  6  1  0
 24 12  1  0
 22 13  2  0
 19 14  1  0
 36 27  1  0
 34 29  1  0
M  END
>  <BrandName>  (47) 
nan

>  <Phase>  (47) 
2.0

>  <Applicants>  (47) 
Novartis

>  <Links>  (47) 
|http://www.chemspider.com/Chemical-Structure.10151099.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL1879463|http://pubchem.ncbi.nlm.nih.gov/compound/11977753|http://www.drugbank.ca/drugs/DB11651|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7950|http://zinc15.docking.org/substances/ZINC24760115|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=RUJ6Z9Y0DT|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=92862

>  <LigID>  (47) 
nan

>  <pdbID>  (47) 
nan

>  <Type>  (47) 
nan

>  <RoF>  (47) 
1

>  <MW>  (47) 
469.2

>  <LogP>  (47) 
5.9

>  <TPSA>  (47) 
76.5

>  <HBA>  (47) 
6

>  <HBD>  (47) 
0

>  <NRB>  (47) 
3

>  <Indications>  (47) 
nan

>  <Targets>  (47) 
PIK3CA; PIK3CB; PIK3CG; PIK3CD; MTOR

>  <Kinase families>  (47) 
Atypical

>  <Canonical_Smiles>  (47) 
CC(C)(C#N)c1ccc(cc1)n2c3c4cc(ccc4ncc3n(c2=O)C)c5cc6ccccc6nc5

>  <InChiKey>  (47) 
JOGKUKXHTYWRGZ-UHFFFAOYSA-N

>  <First_Approval>  (47) 
nan

>  <SC_Patent>  (47) 
None

>  <Chirality>  (47) 
Achiral Molecule

>  <Synonyms>  (47) 
BEZ-235 | BEZ235 | DACTOLISIB | NVP-BEZ235 | NVP-BEZ235-NX

>  <FDA_approved>  (47) 


>  <Melting points>  (47) 


$$$$
Fenebrutinib
     RDKit          2D

 49 56  0  0  0  0  0  0  0  0999 V2000
    9.6038    2.2700    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7480    0.7769    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1131    0.1553    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2574   -1.3377    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.0365   -2.2092    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6713   -1.5876    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5271   -0.0945    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.1620    0.5271    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0177    2.0202    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6526    2.6418    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4317    1.7703    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5759    0.2773    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.9411   -0.3443    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0665    2.3919    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.8456    1.5205    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4805    2.1421    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7404    1.2707    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5962   -0.2224    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7690   -0.8440    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.9899    0.0274    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3550   -0.5942    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.9132   -2.3370    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1055    1.8923    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2498    3.3853    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6149    4.0069    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8358    3.1355    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6916    1.6425    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3264    1.0208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1822   -0.4722    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4031   -1.3436    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9125    0.7710    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7682   -0.7220    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.9891   -1.5935    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.3543   -0.9719    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -8.4985    0.5212    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.9630    0.8454    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.7239   -0.4473    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.7297   -1.5704    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.4906   -2.8631    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -11.9551   -2.5389    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -12.0994   -1.0459    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -12.1244   -4.0293    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -13.4551   -2.5263    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.2776    1.3926    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.4218    2.8857    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.6225   -1.9593    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.1483   -3.3642    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.5531   -2.8384    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.0273   -1.4336    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  1
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 11 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  1  0
 20 21  2  0
 19 22  1  0
 17 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  1  0
 27 31  1  0
 31 32  1  0
 32 33  1  0
 33 34  1  0
 34 35  1  0
 35 36  2  0
 36 37  1  0
 37 38  2  0
 38 39  1  0
 39 40  1  0
 40 41  1  0
 40 42  1  0
 40 43  1  0
 35 44  1  0
 44 45  2  0
  4 46  1  0
 46 47  1  0
 47 48  1  0
 48 49  1  0
  7  2  1  0
 13  8  1  0
 20 15  1  0
 28 23  1  0
 44 31  1  0
 38 34  1  0
 41 37  1  0
 49 46  1  0
M  END
>  <BrandName>  (48) 
nan

>  <Phase>  (48) 
2.0

>  <Applicants>  (48) 
Genentech

>  <Links>  (48) 
|http://www.chemspider.com/Chemical-Structure.58145210.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL4065122|http://pubchem.ncbi.nlm.nih.gov/compound/86567195|http://www.drugbank.ca/drugs/DB14785| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=9AJ|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/9AJ|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9299|http://zinc15.docking.org/substances/ZINC000220197997|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=E9L2885WUL|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50244440

>  <LigID>  (48) 
'9AJ'

>  <pdbID>  (48) 
5vfi

>  <Type>  (48) 
nan

>  <RoF>  (48) 
2

>  <MW>  (48) 
664.3

>  <LogP>  (48) 
3.6

>  <TPSA>  (48) 
121

>  <HBA>  (48) 
11

>  <HBD>  (48) 
2

>  <NRB>  (48) 
7

>  <Indications>  (48) 
nan

>  <Targets>  (48) 
nan

>  <Kinase families>  (48) 


>  <Canonical_Smiles>  (48) 
C[C@H]1CN(CCN1c2ccc(nc2)Nc3cc(cn(c3=O)C)c4ccnc(c4CO)N5CCn6c(cc7c6CC(C7)(C)C)C5=O)C8COC8

>  <InChiKey>  (48) 
WNEODWDFDXWOLU-QHCPKHFHSA-N

>  <First_Approval>  (48) 
nan

>  <SC_Patent>  (48) 
None

>  <Chirality>  (48) 
Single Stereoisomer

>  <Synonyms>  (48) 
FENEBRUTINIB | G-02599853 | G02599853 | GDC-0853 | RG-7845 | RG7845 | RO-7010939 | RO7010939

>  <FDA_approved>  (48) 


>  <Melting points>  (48) 


$$$$
Derazantinib
     RDKit          2D

 35 39  0  0  0  0  0  0  0  0999 V2000
  -14.4304    0.1382    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -13.0591    0.7462    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  -11.8469   -0.1373    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.4757    0.4707    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.2635   -0.4128    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -7.8923    0.1952    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6801   -0.6883    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3088   -0.0803    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1498    1.4112    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7785    2.0192    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5663    1.1357    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7254   -0.3558    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0967   -0.9639    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5132   -1.2394    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1420   -0.6314    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0171    0.8602    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.3883    1.4682    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6005    0.5847    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4414   -0.9069    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0702   -1.5149    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.6536   -1.7904    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4946   -3.2819    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7067   -4.1655    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0780   -3.5575    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2370   -2.0659    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0249   -1.1824    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1839    0.3092    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9718    1.1927    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5552    0.9172    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7674    0.0336    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1386    0.6417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2977    2.1332    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0855    3.0167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7143    2.4087    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5021    3.2922    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 19 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  1  0
 27 29  1  1
 29 30  2  0
 30 31  1  0
 31 32  2  0
 32 33  1  0
 33 34  2  0
 34 35  1  0
 13  8  1  0
 20 15  1  0
 28 18  1  0
 26 21  1  0
 34 29  1  0
M  END
>  <BrandName>  (49) 
nan

>  <Phase>  (49) 
2.0

>  <Applicants>  (49) 
ArQule

>  <Links>  (49) 
|http://www.chemspider.com/Chemical-Structure.59718644.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL4297187|http://pubchem.ncbi.nlm.nih.gov/compound/46834118|http://www.drugbank.ca/drugs/DB14889|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9785|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=N9B0H171MJ

>  <LigID>  (49) 
nan

>  <pdbID>  (49) 
nan

>  <Type>  (49) 
nan

>  <RoF>  (49) 
1

>  <MW>  (49) 
468.2

>  <LogP>  (49) 
5.5

>  <TPSA>  (49) 
59.1

>  <HBA>  (49) 
5

>  <HBD>  (49) 
2

>  <NRB>  (49) 
9

>  <Indications>  (49) 
Derazantinib (ARQ087) is an orally bioavailable, non-selective FGFR inhibitor being investigated for antineoplastic activity.

>  <Targets>  (49) 
nan

>  <Kinase families>  (49) 


>  <Canonical_Smiles>  (49) 
COCCNCCc1cccc(c1)Nc2ncc3c(n2)-c4ccccc4[C@@H](C3)c5ccccc5F

>  <InChiKey>  (49) 
KPJDVVCDVBFRMU-AREMUKBSSA-N

>  <First_Approval>  (49) 
nan

>  <SC_Patent>  (49) 
None

>  <Chirality>  (49) 
Single Stereoisomer

>  <Synonyms>  (49) 
ARQ 087 | ARQ-087 | ARQ087 | DERAZANTINIB

>  <FDA_approved>  (49) 


>  <Melting points>  (49) 


$$$$
Foretinib
     RDKit          2D

 46 51  0  0  0  0  0  0  0  0999 V2000
    6.8697    3.4256    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3739    3.3144    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.7222    1.9633    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2264    1.8521    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5747    0.5011    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0788    0.3899    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4272   -0.9612    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2714   -2.2011    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7673   -2.0899    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.4189   -0.7388    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9148   -0.6276    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5665    0.7235    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0623    0.8346    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.9066   -0.4052    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4024   -0.2940    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2467   -1.5339    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7425   -1.4227    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.5868   -2.6626    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0827   -2.5514    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7343   -1.2003    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.8901    0.0396    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3942   -0.0716    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2346    1.6297    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2613    1.5185    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1055    2.7584    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6014    2.6472    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2530    1.2962    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4088    0.0563    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9129    0.1675    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0687   -1.0724    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7489    1.1850    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5931    2.4248    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9415    3.7759    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -8.0890    2.3136    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.5327    2.7208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.4583    3.7675    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.2392    0.8212    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.0219   -0.0552    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -9.6069    0.2051    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -9.7571   -1.2874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -11.1248   -1.9035    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -11.2750   -3.3960    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.0576   -4.2723    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.6900   -3.6562    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.5397   -2.1637    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.2079   -5.7648    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
  6 23  1  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 27 31  1  0
 31 32  1  0
 32 33  2  0
 32 34  1  0
 34 35  1  0
 35 36  1  0
 34 37  1  0
 37 38  2  0
 37 39  1  0
 39 40  1  0
 40 41  2  0
 41 42  1  0
 42 43  2  0
 43 44  1  0
 44 45  2  0
 43 46  1  0
 12  3  1  0
 10  5  1  0
 22 17  1  0
 29 24  1  0
 36 34  1  0
 45 40  1  0
M  END
>  <BrandName>  (50) 
nan

>  <Phase>  (50) 
2.0

>  <Applicants>  (50) 
GlaxoSmithKline

>  <Links>  (50) 
|http://www.chemspider.com/Chemical-Structure.24608641.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL1230609|http://pubchem.ncbi.nlm.nih.gov/compound/42642645|http://www.drugbank.ca/drugs/DB12307| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=88Z|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/88Z|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5679|http://zinc15.docking.org/substances/ZINC43204048|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=81FH7VK1C4|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50399540

>  <LigID>  (50) 
'88Z'

>  <pdbID>  (50) 
3lq8 5ia4 6i2y 6sd9 6sdc

>  <Type>  (50) 
2

>  <RoF>  (50) 
2

>  <MW>  (50) 
632.2

>  <LogP>  (50) 
5.8

>  <TPSA>  (50) 
111.2

>  <HBA>  (50) 
8

>  <HBD>  (50) 
2

>  <NRB>  (50) 
12

>  <Indications>  (50) 
nan

>  <Targets>  (50) 
MET; KDR

>  <Kinase families>  (50) 
Tyr

>  <Canonical_Smiles>  (50) 
COc1cc2c(ccnc2cc1OCCCN3CCOCC3)Oc4ccc(cc4F)NC(=O)C5(CC5)C(=O)Nc6ccc(cc6)F

>  <InChiKey>  (50) 
CXQHYVUVSFXTMY-UHFFFAOYSA-N

>  <First_Approval>  (50) 
nan

>  <SC_Patent>  (50) 
None

>  <Chirality>  (50) 
Achiral Molecule

>  <Synonyms>  (50) 
EXEL-2880 | FORETINIB | GSK-089 | GSK-1363089 | GSK-1363089G | GSK1363089G | XL-880 | XL880

>  <FDA_approved>  (50) 


>  <Melting points>  (50) 


$$$$
Defactinib
     RDKit          2D

 35 37  0  0  0  0  0  0  0  0999 V2000
  -11.0438    0.5161    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.6014    0.9276    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -8.5238   -0.1158    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.8887   -1.5708    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -7.0813    0.2957    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.7165    1.7506    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2740    2.1621    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1964    1.1186    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5613   -0.3363    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0038   -0.7478    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7540    1.5301    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6764    0.4867    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0413   -0.9683    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9637   -2.0117    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4788   -1.6002    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8437   -0.1453    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2339    0.8982    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.2861    0.2662    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.6510    1.7211    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0934    2.1326    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1710    1.0892    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6135    1.5007    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.9783    2.9556    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9007    3.9991    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4583    3.5876    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.8061   -0.3658    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.3637   -0.7773    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8837   -1.4092    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    6.9272   -0.3316    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.8403   -2.4868    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.9613   -2.4527    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5564   -2.6437    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6340   -3.6872    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.5129   -3.7213    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.5998   -1.5661    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
  8 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 16 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 21 26  1  0
 26 27  1  0
 26 28  1  0
 28 29  2  0
 28 30  2  0
 28 31  1  0
 15 32  1  0
 32 33  1  0
 32 34  1  0
 32 35  1  0
 10  5  1  0
 17 12  1  0
 25 20  1  0
M  END
>  <BrandName>  (51) 
nan

>  <Phase>  (51) 
2.0

>  <Applicants>  (51) 
Verastem

>  <Links>  (51) 
|http://www.chemspider.com/Chemical-Structure.32695161.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3137331|http://pubchem.ncbi.nlm.nih.gov/compound/25117126|http://www.drugbank.ca/drugs/DB12282| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=7KD|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/7KD|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7910|http://zinc15.docking.org/substances/ZINC000103297739|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=53O87HA2QU

>  <LigID>  (51) 
'7KD'

>  <pdbID>  (51) 
5mah

>  <Type>  (51) 
1

>  <RoF>  (51) 
1

>  <MW>  (51) 
510.1

>  <LogP>  (51) 
2.4

>  <TPSA>  (51) 
142.1

>  <HBA>  (51) 
9

>  <HBD>  (51) 
3

>  <NRB>  (51) 
8

>  <Indications>  (51) 
nan

>  <Targets>  (51) 
PTK2; PTK2B

>  <Kinase families>  (51) 
Tyr

>  <Canonical_Smiles>  (51) 
CNC(=O)c1ccc(cc1)Nc2ncc(c(n2)NCc3c(nccn3)N(C)S(=O)(=O)C)C(F)(F)F

>  <InChiKey>  (51) 
FWLMVFUGMHIOAA-UHFFFAOYSA-N

>  <First_Approval>  (51) 
nan

>  <SC_Patent>  (51) 
None

>  <Chirality>  (51) 
Achiral Molecule

>  <Synonyms>  (51) 
DEFACTINIB | PF-04554878 | VS-6063

>  <FDA_approved>  (51) 


>  <Melting points>  (51) 


$$$$
Afuresertib
     RDKit          2D

 27 29  0  0  0  0  0  0  0  0999 V2000
   -5.8253   -0.5770    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9725    0.6570    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4730    0.6924    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0433    2.1296    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2773    2.9823    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4697    2.0722    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6281    2.6267    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -2.5628   -0.4999    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0633   -0.4644    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5661   -1.8797    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7585   -2.7898    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9925   -1.9370    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4077   -2.4342    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.8710   -2.3093    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2175   -3.7688    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.9617   -1.2796    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.3988   -1.7092    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4895   -0.6795    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1430    0.7800    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2337    1.8097    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8872    3.2692    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4501    3.6988    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3594    2.6691    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7059    1.2096    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9223    3.0988    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    3.7453   -3.1687    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6546   -4.1984    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  4  7  1  0
  3  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 10 14  1  0
 14 15  2  0
 14 16  1  0
 16 17  1  0
 17 18  1  1
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 23 25  1  0
 17 26  1  0
 26 27  1  0
  6  2  1  0
 12  8  2  0
 24 19  1  0
M  END
>  <BrandName>  (52) 
nan

>  <Phase>  (52) 
2.0

>  <Applicants>  (52) 
GlaxoSmithKline

>  <Links>  (52) 
|http://www.chemspider.com/Chemical-Structure.28651809.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL2219422|http://pubchem.ncbi.nlm.nih.gov/compound/46843057|http://www.drugbank.ca/drugs/DB11648|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7890|http://zinc15.docking.org/substances/ZINC000043197674|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=8739X25QI3

>  <LigID>  (52) 
nan

>  <pdbID>  (52) 
nan

>  <Type>  (52) 
nan

>  <RoF>  (52) 
0

>  <MW>  (52) 
426

>  <LogP>  (52) 
3.9

>  <TPSA>  (52) 
72.9

>  <HBA>  (52) 
5

>  <HBD>  (52) 
2

>  <NRB>  (52) 
6

>  <Indications>  (52) 
nan

>  <Targets>  (52) 
AKT1; AKT2; AKT3

>  <Kinase families>  (52) 
AGC

>  <Canonical_Smiles>  (52) 
Cn1c(c(cn1)Cl)c2cc(sc2Cl)C(=O)N[C@@H](Cc3cccc(c3)F)CN

>  <InChiKey>  (52) 
AFJRDFWMXUECEW-LBPRGKRZSA-N

>  <First_Approval>  (52) 
nan

>  <SC_Patent>  (52) 
None

>  <Chirality>  (52) 
Single Stereoisomer

>  <Synonyms>  (52) 
AFURESERTIB | GSK-2110183 | GSK-2110183C | GSK2110183C

>  <FDA_approved>  (52) 


>  <Melting points>  (52) 


$$$$
Doramapimod
     RDKit          2D

 39 43  0  0  0  0  0  0  0  0999 V2000
   -9.1924   -3.4405    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.1957   -2.3196    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.7265   -2.6223    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7298   -1.5014    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2021   -0.0777    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.6713    0.2250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.6680   -0.8959    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2054    1.0432    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7126    0.8956    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1110    2.2697    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2320    3.2665    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5263    2.5084    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0844    4.7592    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5772    4.9068    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5917    4.6117    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9369    6.2519    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9546   -0.3987    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4546   -0.3894    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7127    0.9142    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6966   -1.6838    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.8034   -1.6745    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5453   -0.3708    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0453   -0.3615    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8033   -1.6559    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0614   -2.9596    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5614   -2.9689    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8195   -4.2725    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5775   -5.5669    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0775   -5.5576    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8194   -4.2539    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3033   -1.6466    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.0452   -0.3429    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5452   -0.3336    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2871    0.9700    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.7871    0.9793    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5290    2.2830    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7710    3.5774    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.2710    3.5681    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5291    2.2644    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  5  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  1  0
 13 15  1  0
 13 16  1  0
  9 17  1  0
 17 18  1  0
 18 19  2  0
 18 20  1  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 24 31  1  0
 31 32  1  0
 32 33  1  0
 33 34  1  0
 34 35  1  0
 35 36  1  0
 36 37  1  0
 37 38  1  0
 38 39  1  0
  7  2  1  0
 12  8  1  0
 26 21  1  0
 30 25  1  0
 39 34  1  0
M  END
>  <BrandName>  (53) 
nan

>  <Phase>  (53) 
2.0

>  <Applicants>  (53) 
Boehringer Ingelheim

>  <Links>  (53) 
|http://www.chemspider.com/Chemical-Structure.137746.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL103667|http://pubchem.ncbi.nlm.nih.gov/compound/156422|http://www.drugbank.ca/drugs/DB03044| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=B96|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/B96|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5668|http://zinc15.docking.org/substances/ZINC24044436|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=HO1A8B3YVV|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13533

>  <LigID>  (53) 
'B96'

>  <pdbID>  (53) 
1kv2 3fzs 3npc 4jvg 4twn 5n66 6gtt

>  <Type>  (53) 
2

>  <RoF>  (53) 
2

>  <MW>  (53) 
527.3

>  <LogP>  (53) 
6

>  <TPSA>  (53) 
80.7

>  <HBA>  (53) 
6

>  <HBD>  (53) 
2

>  <NRB>  (53) 
7

>  <Indications>  (53) 
nan

>  <Targets>  (53) 
MAPK14

>  <Kinase families>  (53) 
CMGC

>  <Canonical_Smiles>  (53) 
Cc1ccc(cc1)n2c(cc(n2)C(C)(C)C)NC(=O)Nc3ccc(c4c3cccc4)OCCN5CCOCC5

>  <InChiKey>  (53) 
MVCOAUNKQVWQHZ-UHFFFAOYSA-N

>  <First_Approval>  (53) 
nan

>  <SC_Patent>  (53) 
None

>  <Chirality>  (53) 
Achiral Molecule

>  <Synonyms>  (53) 
BIRB 796 BS | BIRB-796 | BIRB-796 BS | DORAMAPIMOD

>  <FDA_approved>  (53) 


>  <Melting points>  (53) 


$$$$
Golvatinib
     RDKit          2D

 46 51  0  0  0  0  0  0  0  0999 V2000
  -10.3280   -6.4061    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.5612   -5.1169    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  -10.2942   -3.8082    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.5274   -2.5191    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.0275   -2.5386    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -7.2945   -3.8473    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.0613   -5.1365    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.2606   -1.2494    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7608   -1.2690    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9939    0.0202    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7269    1.3289    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -7.2268    1.3484    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.9937    0.0593    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9601    2.6180    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6931    3.9267    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4602    2.5985    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6933    3.8877    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1935    3.8681    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4266    5.1573    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1596    6.4660    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6595    6.4855    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4264    5.1964    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.0732    5.1378    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.8063    3.8291    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0394    2.5399    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7724    1.2312    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2723    1.2117    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0392    2.5008    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3061    3.8095    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5390    2.4813    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    4.0053   -0.0970    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.2385   -1.3862    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7386   -1.3666    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.9715   -2.6949    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2127   -4.1754    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8100   -3.6440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3876   -2.2002    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6673   -0.7265    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.5240   -3.1793    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.9401   -2.6847    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0765   -3.6637    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4926   -3.1691    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7723   -1.6954    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6359   -0.7163    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2198   -1.2110    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.1884   -1.2008    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  5  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 11 14  1  0
 14 15  2  0
 14 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 19 23  1  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 28 30  1  0
 27 31  1  0
 31 32  1  0
 32 33  2  0
 32 34  1  0
 34 35  1  0
 35 36  1  0
 34 37  1  0
 37 38  2  0
 37 39  1  0
 39 40  1  0
 40 41  2  0
 41 42  1  0
 42 43  2  0
 43 44  1  0
 44 45  2  0
 43 46  1  0
  7  2  1  0
 13  8  1  0
 22 17  1  0
 29 24  1  0
 36 34  1  0
 45 40  1  0
M  END
>  <BrandName>  (54) 
nan

>  <Phase>  (54) 
2.0

>  <Applicants>  (54) 
Eisai

>  <Links>  (54) 
|http://www.chemspider.com/Chemical-Structure.17275597.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3039525|http://pubchem.ncbi.nlm.nih.gov/compound/16118392|http://www.drugbank.ca/drugs/DB11977| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=GV0|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/GV0|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7956|http://zinc15.docking.org/substances/ZINC000043195317|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=516Z3YP58E|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50100615

>  <LigID>  (54) 
'GV0'

>  <pdbID>  (54) 
5ia5

>  <Type>  (54) 
2

>  <RoF>  (54) 
1

>  <MW>  (54) 
633.3

>  <LogP>  (54) 
4.8

>  <TPSA>  (54) 
119.1

>  <HBA>  (54) 
7

>  <HBD>  (54) 
3

>  <NRB>  (54) 
8

>  <Indications>  (54) 
nan

>  <Targets>  (54) 
MET; KDR

>  <Kinase families>  (54) 
Tyr

>  <Canonical_Smiles>  (54) 
CN1CCN(CC1)C2CCN(CC2)C(=O)Nc3cc(ccn3)Oc4ccc(c(c4)F)NC(=O)C5(CC5)C(=O)Nc6ccc(cc6)F

>  <InChiKey>  (54) 
UQRCJCNVNUFYDX-UHFFFAOYSA-N

>  <First_Approval>  (54) 
nan

>  <SC_Patent>  (54) 
None

>  <Chirality>  (54) 
Achiral Molecule

>  <Synonyms>  (54) 
E-7050 | E7050 | GOLVATINIB

>  <FDA_approved>  (54) 


>  <Melting points>  (54) 


$$$$
Tepotinib
     RDKit          2D

 37 41  0  0  0  0  0  0  0  0999 V2000
   12.8705   -2.6323    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4297   -2.2149    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.3478   -3.2539    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9071   -2.8365    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5482   -1.3800    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6301   -0.3410    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0708   -0.7584    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1075   -0.9626    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7486    0.4938    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.3078    0.9112    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9490    2.3677    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5082    2.7851    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.4263    1.7461    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7852    0.2896    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.2260   -0.1278    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9856    2.1635    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6267    3.6199    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8140    4.0374    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8959    2.9983    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5370    1.5419    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0963    1.1245    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6189    0.5029    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0597    0.9203    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4185    2.3767    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3367    3.4158    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8593    2.7942    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.9412    1.7551    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5823    0.2987    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1415   -0.1187    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -7.6642   -0.7403    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.1049   -0.3229    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.1868   -1.3619    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.8279   -2.8183    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.3871   -3.2358    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.3053   -2.1967    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.0283   -4.6922    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.6694   -6.1486    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  5  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 13 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 20 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  2  0
 24 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 28 30  1  0
 30 31  2  0
 31 32  1  0
 32 33  2  0
 33 34  1  0
 34 35  2  0
 34 36  1  0
 36 37  3  0
  7  2  1  0
 15 10  1  0
 21 16  1  0
 29 23  1  0
 35 30  1  0
M  END
>  <BrandName>  (55) 
nan

>  <Phase>  (55) 
2.0

>  <Applicants>  (55) 
Merck

>  <Links>  (55) 
|http://www.chemspider.com/Chemical-Structure.28637823.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3402762|http://pubchem.ncbi.nlm.nih.gov/compound/25171648|http://www.drugbank.ca/drugs/DB15133| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=3E8|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/3E8|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8293|http://zinc15.docking.org/substances/ZINC000043202335|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=1IJV77EI07|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50065457

>  <LigID>  (55) 
'3E8'

>  <pdbID>  (55) 
4r1v

>  <Type>  (55) 
1

>  <RoF>  (55) 
0

>  <MW>  (55) 
492.2

>  <LogP>  (55) 
4

>  <TPSA>  (55) 
96.9

>  <HBA>  (55) 
8

>  <HBD>  (55) 
0

>  <NRB>  (55) 
7

>  <Indications>  (55) 
nan

>  <Targets>  (55) 
MET

>  <Kinase families>  (55) 
Tyr

>  <Canonical_Smiles>  (55) 
CN1CCC(CC1)COc2cnc(nc2)c3cccc(c3)Cn4c(=O)ccc(n4)c5cccc(c5)C#N

>  <InChiKey>  (55) 
AHYMHWXQRWRBKT-UHFFFAOYSA-N

>  <First_Approval>  (55) 
nan

>  <SC_Patent>  (55) 
None

>  <Chirality>  (55) 
Achiral Molecule

>  <Synonyms>  (55) 
EMD 1214063 | EMD-1214063 | MSC-2156119 | MSC-2156119J | TEPOTINIB

>  <FDA_approved>  (55) 


>  <Melting points>  (55) 


$$$$
Ilorasertib
     RDKit          2D

 35 39  0  0  0  0  0  0  0  0999 V2000
    8.9384   -2.4232    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8249   -1.4182    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1385    0.0487    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5657    0.5105    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6792   -0.4945    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3656   -1.9614    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.1063   -0.0327    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    7.0250    1.0537    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.5979    0.5919    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2843   -0.8750    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.4844    1.5969    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.0572    1.1351    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9437    2.1401    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5166    1.6783    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2030    0.2114    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3165   -0.7936    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7436   -0.3318    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2242   -0.2504    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6894   -1.6764    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1894   -1.6746    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6512   -0.2475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4366    0.6327    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5917    2.1247    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9613    2.7364    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1758    1.8562    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0208    0.3642    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2354   -0.5160    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2372   -2.0160    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.6643   -2.4778    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -8.5445   -1.2632    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -7.6614   -0.0508    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.0445   -1.2615    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.7930    0.0385    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -12.2930    0.0403    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3771    3.0049    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  3  8  1  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 15 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  1  0
 30 32  1  0
 32 33  1  0
 33 34  1  0
 23 35  1  0
  6  1  1  0
 17 12  1  0
 22 18  1  0
 26 21  1  0
 31 27  2  0
M  END
>  <BrandName>  (56) 
ABT-348, A-968660

>  <Phase>  (56) 
2.0

>  <Applicants>  (56) 
Abbott Laboratories

>  <Links>  (56) 
|http://www.chemspider.com/Chemical-Structure.24809095.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL1980297|http://pubchem.ncbi.nlm.nih.gov/compound/46207586|http://www.drugbank.ca/drugs/DB11694|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9914|http://zinc15.docking.org/substances/ZINC000063298074|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=6L5D03D975|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50381716

>  <LigID>  (56) 
nan

>  <pdbID>  (56) 
nan

>  <Type>  (56) 
nan

>  <RoF>  (56) 
1

>  <MW>  (56) 
488.1

>  <LogP>  (56) 
5.2

>  <TPSA>  (56) 
118.1

>  <HBA>  (56) 
7

>  <HBD>  (56) 
4

>  <NRB>  (56) 
6

>  <Indications>  (56) 
nan

>  <Targets>  (56) 
AURKA; AURKB; AURKC; FLT1; PDGFRA; PDGFRB

>  <Kinase families>  (56) 
Other<br>Tyr

>  <Canonical_Smiles>  (56) 
c1cc(cc(c1)F)NC(=O)Nc2ccc(cc2)c3csc4c3c(ncc4c5cnn(c5)CCO)N

>  <InChiKey>  (56) 
WPHKIQPVPYJNAX-UHFFFAOYSA-N

>  <First_Approval>  (56) 
nan

>  <SC_Patent>  (56) 
None

>  <Chirality>  (56) 
Achiral Molecule

>  <Synonyms>  (56) 
A-968660 | A-968660.0 | ABBOTT-968660 | ABT-348 | ABT-348, A-968660 | ILORASERTIB

>  <FDA_approved>  (56) 


>  <Melting points>  (56) 


$$$$
Adavosertib
     RDKit          2D

 37 41  0  0  0  0  0  0  0  0999 V2000
   -7.8781    0.1129    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.0496    1.6030    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.2212    3.0932    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5595    1.7746    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9629    3.1509    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4728    3.3224    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5791    2.1177    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1757    0.7414    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6658    0.5698    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2820   -0.4633    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7821   -0.4485    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3045   -1.8704    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1658   -2.1678    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1584   -1.0432    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.6808    0.3788    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7895    0.6761    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.6734    1.5034    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.1436    1.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6212   -0.2159    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0915   -0.5132    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0841    0.6114    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6065    2.0333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1362    2.3306    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5543    0.3140    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.0319   -1.1079    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5022   -1.4052    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4948   -0.2806    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.0172    1.1413    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5469    1.4386    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9650   -0.5780    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5092   -2.7641    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4944   -4.2640    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7314   -1.8944    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1533   -2.3721    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4507   -3.8423    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.8726   -4.3199    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.5398    1.4315    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 15 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 21 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 27 30  1  0
 12 31  1  0
 31 32  2  0
 31 33  1  0
 33 34  1  0
 34 35  1  0
 35 36  2  0
  2 37  1  0
  9  4  1  0
 33 10  1  0
 16 11  2  0
 23 18  1  0
 29 24  1  0
M  END
>  <BrandName>  (57) 
nan

>  <Phase>  (57) 
2.0

>  <Applicants>  (57) 
Astrazeneca

>  <Links>  (57) 
|http://www.chemspider.com/Chemical-Structure.24808590.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL1976040|http://pubchem.ncbi.nlm.nih.gov/compound/24856436|http://www.drugbank.ca/drugs/DB11740| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=8X7|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/8X7|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7702|http://zinc15.docking.org/substances/ZINC000063539231|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=K2T6HJX3I3|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50240826

>  <LigID>  (57) 
'8X7'

>  <pdbID>  (57) 
5v5y 5vd0 5vdk

>  <Type>  (57) 
1

>  <RoF>  (57) 
1

>  <MW>  (57) 
500.3

>  <LogP>  (57) 
2.9

>  <TPSA>  (57) 
104.3

>  <HBA>  (57) 
10

>  <HBD>  (57) 
2

>  <NRB>  (57) 
7

>  <Indications>  (57) 
nan

>  <Targets>  (57) 
WEE1

>  <Kinase families>  (57) 
Other

>  <Canonical_Smiles>  (57) 
CC(C)(c1cccc(n1)n2c3c(cnc(n3)Nc4ccc(cc4)N5CCN(CC5)C)c(=O)n2CC=C)O

>  <InChiKey>  (57) 
BKWJAKQVGHWELA-UHFFFAOYSA-N

>  <First_Approval>  (57) 
nan

>  <SC_Patent>  (57) 
None

>  <Chirality>  (57) 
Achiral Molecule

>  <Synonyms>  (57) 
ADAVOSERTIB | AZD 1775 | AZD-1775 | AZD1775 | MK-1775

>  <FDA_approved>  (57) 


>  <Melting points>  (57) 


$$$$
Miransertib
     RDKit          2D

 33 38  0  0  0  0  0  0  0  0999 V2000
   -7.2537    1.6240    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8759    2.2171    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6734    1.3205    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8486   -0.1693    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2264   -0.7624    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.4289    0.1342    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6461   -1.0659    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8213   -2.5556    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6188   -3.4522    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2410   -2.8591    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0658   -1.3693    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2683   -0.4727    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.4052   -1.0756    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1391   -2.3838    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1217   -3.4861    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.6288   -2.5590    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5254   -1.3565    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0151   -1.5317    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6083   -2.9095    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7116   -4.1120    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.2219   -3.9368    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3253   -5.1393    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.0322    0.2870    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5258    0.4254    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1528    1.7881    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2861    3.0124    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7925    2.8741    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1655    1.5114    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9131    4.3751    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5505    5.0021    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1775    6.3647    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5401    5.7377    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1298    4.5231    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  4  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  1  0
 14 15  2  0
 14 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 13 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 26 29  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 29 33  1  0
  6  1  1  0
 12  7  1  0
 15 10  1  0
 21 16  1  0
 28 23  1  0
 32 29  1  0
M  END
>  <BrandName>  (58) 
nan

>  <Phase>  (58) 
2.0

>  <Applicants>  (58) 
Merck

>  <Links>  (58) 
|http://www.chemspider.com/Chemical-Structure.57251282.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL4297188|http://pubchem.ncbi.nlm.nih.gov/compound/53262401|http://www.drugbank.ca/drugs/DB14982| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=6S1|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/6S1|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9429|http://zinc15.docking.org/substances/ZINC000072315647|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=T1DQI1B52Y

>  <LigID>  (58) 
'6S1'

>  <pdbID>  (58) 
5kcv

>  <Type>  (58) 
nan

>  <RoF>  (58) 
1

>  <MW>  (58) 
432.2

>  <LogP>  (58) 
5.1

>  <TPSA>  (58) 
95.6

>  <HBA>  (58) 
6

>  <HBD>  (58) 
2

>  <NRB>  (58) 
4

>  <Indications>  (58) 
nan

>  <Targets>  (58) 
nan

>  <Kinase families>  (58) 


>  <Canonical_Smiles>  (58) 
c1ccc(cc1)c2ccc3c(n2)n(c(n3)c4cccnc4N)c5ccc(cc5)C6(CCC6)N

>  <InChiKey>  (58) 
HNFMVVHMKGFCMB-UHFFFAOYSA-N

>  <First_Approval>  (58) 
nan

>  <SC_Patent>  (58) 
None

>  <Chirality>  (58) 
Achiral Molecule

>  <Synonyms>  (58) 
ARQ 092 | ARQ 092 FREE BASE | ARQ-092 | MIRANSERTIB

>  <FDA_approved>  (58) 


>  <Melting points>  (58) 


$$$$
Amuvatinib
     RDKit          2D

 32 37  0  0  0  0  0  0  0  0999 V2000
   -9.3655    0.9668    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.7044    2.3132    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.2078    2.4139    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.3723    1.1681    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.0334   -0.1783    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.5300   -0.2790    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9572   -1.2232    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6309   -0.5225    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8875    0.9554    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3609   -1.3207    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4173   -2.8196    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7435   -3.5203    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0135   -2.7221    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0347   -0.6200    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7647   -1.4182    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5616   -0.7175    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6179    0.7814    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6521    1.5796    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9783    0.8789    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9442    1.4821    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0005    2.9810    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    3.2141    0.6839    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.5404    1.3846    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8104    0.5863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7541   -0.9126    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0240   -1.7109    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3503   -1.0102    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4066    0.4888    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1367    1.2870    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8496    0.8984    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.6851   -0.3474    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7585   -1.5269    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  2  0
  8  9  1  0
  8 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 10 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 17 20  1  0
 20 21  2  0
 20 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 28 30  1  0
 30 31  1  0
 31 32  1  0
  6  1  1  0
  9  4  1  0
 13  7  1  0
 19 14  1  0
 29 24  1  0
 32 27  1  0
M  END
>  <BrandName>  (59) 
nan

>  <Phase>  (59) 
2.0

>  <Applicants>  (59) 
Supergen

>  <Links>  (59) 
|http://www.chemspider.com/Chemical-Structure.9457280.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL2103851|http://pubchem.ncbi.nlm.nih.gov/compound/11282283|http://www.drugbank.ca/drugs/DB12742|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7932|http://zinc15.docking.org/substances/ZINC34951302|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=SO9S6QZB4R|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50172081

>  <LigID>  (59) 
nan

>  <pdbID>  (59) 
nan

>  <Type>  (59) 
nan

>  <RoF>  (59) 
0

>  <MW>  (59) 
447.1

>  <LogP>  (59) 
3.3

>  <TPSA>  (59) 
75.9

>  <HBA>  (59) 
7

>  <HBD>  (59) 
1

>  <NRB>  (59) 
3

>  <Indications>  (59) 
Amuvatinib is a selective multi-targeted tyrosine kinase inhibitor that suppresses c-MET, c-RET and the mutant forms of c-KIT, PDGFR and FLT3. Amuvatinib also suppresses Rad51 protein, a critical comp
onent of double-stranded DNA repair in cancer cells.

>  <Targets>  (59) 
KIT; MET; RET; FLT3; PDGFRB

>  <Kinase families>  (59) 
Tyr

>  <Canonical_Smiles>  (59) 
c1ccc2c(c1)c3c(o2)c(ncn3)N4CCN(CC4)C(=S)NCc5ccc6c(c5)OCO6

>  <InChiKey>  (59) 
FOFDIMHVKGYHRU-UHFFFAOYSA-N

>  <First_Approval>  (59) 
nan

>  <SC_Patent>  (59) 
None

>  <Chirality>  (59) 
Achiral Molecule

>  <Synonyms>  (59) 
AMUVATINIB | HPK 56 | HPK-56 | HPK56 | MP 470 | MP-470

>  <FDA_approved>  (59) 


>  <Melting points>  (59) 


$$$$
Selonsertib
     RDKit          2D

 33 37  0  0  0  0  0  0  0  0999 V2000
    5.4893   -3.3903    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1043   -2.8144    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9130   -3.7259    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5280   -3.1500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3342   -1.6626    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5254   -0.7511    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9105   -1.3269    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1017   -0.4154    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.0645    1.0841    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4791    1.5830    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3907    0.3917    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.5394   -0.8433    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9071    3.0206    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5589    4.4796    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9965    4.0517    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0509   -1.0867    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2421   -1.9983    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2447    0.4007    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6297    0.9766    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8235    2.4640    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2086    3.0399    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3998    2.1283    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2060    0.6409    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8210    0.0650    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3973   -0.2706    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3600   -1.7702    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.7746   -2.2690    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -7.6862   -1.0777    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.8349    0.1573    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -7.3337    1.5720    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.8083    1.8473    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.3580    2.7113    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3367   -4.0616    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 10 13  1  0
 13 14  1  0
 14 15  1  0
  5 16  1  0
 16 17  2  0
 16 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 23 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 30 32  1  0
  4 33  1  0
  7  2  1  0
 12  8  1  0
 15 13  1  0
 24 19  1  0
 29 25  1  0
M  END
>  <BrandName>  (60) 
nan

>  <Phase>  (60) 
2.0

>  <Applicants>  (60) 
Gilead Sciences

>  <Links>  (60) 
|http://www.chemspider.com/Chemical-Structure.44209497.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3916717|http://pubchem.ncbi.nlm.nih.gov/compound/71245288|http://www.drugbank.ca/drugs/DB14916| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=NJV|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/NJV|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9040|http://zinc15.docking.org/substances/ZINC000149387856|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=NS3988A2TC|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50212258

>  <LigID>  (60) 
'NJV'

>  <pdbID>  (60) 
6oyt

>  <Type>  (60) 
nan

>  <RoF>  (60) 
0

>  <MW>  (60) 
445.2

>  <LogP>  (60) 
4.7

>  <TPSA>  (60) 
90.5

>  <HBA>  (60) 
7

>  <HBD>  (60) 
1

>  <NRB>  (60) 
6

>  <Indications>  (60) 
nan

>  <Targets>  (60) 
MAP3K5

>  <Kinase families>  (60) 
STE

>  <Canonical_Smiles>  (60) 
Cc1cc(c(cc1n2cc(nc2)C3CC3)C(=O)Nc4cccc(n4)c5nncn5C(C)C)F

>  <InChiKey>  (60) 
YIDDLAAKOYYGJG-UHFFFAOYSA-N

>  <First_Approval>  (60) 
nan

>  <SC_Patent>  (60) 
None

>  <Chirality>  (60) 
Achiral Molecule

>  <Synonyms>  (60) 
GS-4997 | SELONSERTIB

>  <FDA_approved>  (60) 


>  <Melting points>  (60) 


$$$$
Amcasertib
     RDKit          2D

 39 43  0  0  0  0  0  0  0  0999 V2000
  -12.5966   -1.6608    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -11.3958   -0.7617    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.0169   -1.3521    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -9.8387   -2.8415    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -11.0395   -3.7405    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.8162   -0.4531    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.4372   -1.0435    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2365   -0.1445    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8575   -0.7348    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6793   -2.2242    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6568    0.1642    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2237   -0.2788    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3595    0.9472    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2585    2.1480    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6783    1.6640    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9044    2.5282    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1403    0.9688    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8716    2.2784    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3610    2.4566    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4900    1.4690    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9098    1.9530    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2005    3.4245    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0715    4.4121    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6517    3.9282    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3421    4.6594    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.2419    3.6398    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2297    3.9306    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.0388    0.9654    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5014    1.2983    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2699    0.0101    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    7.2823   -1.1189    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9034   -0.5285    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.6152   -2.5815    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5150   -3.6011    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8479   -5.0636    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2810   -5.5066    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3812   -4.4870    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0483   -3.0245    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7397   -1.6986    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  3  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 13 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  1  0
 26 27  2  0
 21 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  1  0
 31 32  2  0
 31 33  1  0
 33 34  2  0
 34 35  1  0
 35 36  2  0
 36 37  1  0
 37 38  2  0
 12 39  1  0
 15 11  2  0
 18 26  1  0
 24 19  1  0
 32 28  1  0
 38 33  1  0
M  END
>  <BrandName>  (61) 
nan

>  <Phase>  (61) 
2.0

>  <Applicants>  (61) 
Boston Biomedical

>  <Links>  (61) 
|http://www.chemspider.com/Chemical-Structure.44208821.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3707349|http://pubchem.ncbi.nlm.nih.gov/compound/25190990|http://www.drugbank.ca/drugs/DB14866|http://zinc15.docking.org/substances/ZINC000059029686|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=GLY8ABW25V

>  <LigID>  (61) 
nan

>  <pdbID>  (61) 
nan

>  <Type>  (61) 
nan

>  <RoF>  (61) 
2

>  <MW>  (61) 
539.2

>  <LogP>  (61) 
6

>  <TPSA>  (61) 
90.1

>  <HBA>  (61) 
5

>  <HBD>  (61) 
3

>  <NRB>  (61) 
9

>  <Indications>  (61) 
nan

>  <Targets>  (61) 
PDGFRA

>  <Kinase families>  (61) 
Tyr

>  <Canonical_Smiles>  (61) 
CCN(CC)CCNC(=O)c1c(c([nH]c1C)/C=C\2/c3cc(ccc3NC2=O)c4csc(n4)c5ccccc5)C

>  <InChiKey>  (61) 
QDWKGEFGLQMDAM-ULJHMMPZSA-N

>  <First_Approval>  (61) 
nan

>  <SC_Patent>  (61) 
None

>  <Chirality>  (61) 
Achiral Molecule

>  <Synonyms>  (61) 
AMCASERTIB | BBI503

>  <FDA_approved>  (61) 


>  <Melting points>  (61) 


$$$$
Lucitanib
     RDKit          2D

 33 37  0  0  0  0  0  0  0  0999 V2000
   -9.3171   -2.7471    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.7300   -1.3668    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -7.2410   -1.1851    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.3392   -2.3837    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6539    0.1952    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.5557    1.3939    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.9685    2.7742    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4796    2.9558    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5778    1.7572    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1649    0.3769    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2631   -0.8217    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7741   -0.6401    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1870    0.7402    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0888    1.9389    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6980    0.9219    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.2038   -0.2767    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3834   -1.6570    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5185   -2.8557    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0074   -2.6740    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.5946   -1.2937    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6927   -0.0951    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2799    1.2853    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7688    1.4669    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6707    0.2683    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0835   -1.1120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1596    0.4500    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.0614   -0.7487    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5504   -0.5670    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0117   -0.9055    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9879   -2.0018    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6300    0.9309    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.3560    2.8472    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.8450    3.0289    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 24 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 28 31  1  0
 23 32  1  0
 32 33  1  0
 10  5  1  0
 14  9  1  0
 21 16  1  0
 25 20  1  0
 30 28  1  0
M  END
>  <BrandName>  (62) 
nan

>  <Phase>  (62) 
2.0

>  <Applicants>  (62) 
Clovis Oncology

>  <Links>  (62) 
|http://www.chemspider.com/Chemical-Structure.28189586.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL2220486|http://pubchem.ncbi.nlm.nih.gov/compound/25031915|http://www.drugbank.ca/drugs/DB11845| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=3ZC|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/3ZC|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7649|http://zinc15.docking.org/substances/ZINC000077024213|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=PP449XA4BH|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50399539

>  <LigID>  (62) 
'3ZC'

>  <pdbID>  (62) 
4rwl

>  <Type>  (62) 
1

>  <RoF>  (62) 
0

>  <MW>  (62) 
443.2

>  <LogP>  (62) 
4.4

>  <TPSA>  (62) 
95.7

>  <HBA>  (62) 
6

>  <HBD>  (62) 
2

>  <NRB>  (62) 
7

>  <Indications>  (62) 
nan

>  <Targets>  (62) 
FLT1; KDR; FLT4; FGFR1; FGFR2

>  <Kinase families>  (62) 
Tyr

>  <Canonical_Smiles>  (62) 
CNC(=O)c1cccc2c1ccc(c2)Oc3ccnc4c3cc(c(c4)OCC5(CC5)N)OC

>  <InChiKey>  (62) 
CUDVHEFYRIWYQD-UHFFFAOYSA-N

>  <First_Approval>  (62) 
nan

>  <SC_Patent>  (62) 
None

>  <Chirality>  (62) 
Achiral Molecule

>  <Synonyms>  (62) 
AL-3810 | CO-3810 | E-3810 | LUCITANIB | S 80881

>  <FDA_approved>  (62) 


>  <Melting points>  (62) 


$$$$
Dilmapimod
     RDKit          2D

 33 36  0  0  0  0  0  0  0  0999 V2000
   -3.4989   -1.9827    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3110   -0.7216    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8092   -0.7943    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6213    0.4669    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9352    1.8007    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4369    1.8735    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6249    0.6123    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1266    0.6850    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3145   -0.5761    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0007   -1.9100    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1886   -3.1712    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3097   -3.0985    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1217   -4.3596    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.9958   -1.7646    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.1837   -0.5034    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8699    0.8304    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0578    2.0916    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4405    2.0189    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.7439    3.4255    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.2421    3.4982    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9283    4.8320    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4265    4.9048    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.0542    2.2370    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5525    2.3097    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4940   -1.6919    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3061   -2.9530    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8044   -2.8803    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4905   -1.5464    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6784   -0.2853    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1802   -0.3580    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3681    0.9032    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.6200   -4.2869    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -8.1196    0.3942    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 20 23  1  0
 23 24  1  0
 14 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 26 32  1  0
  4 33  1  0
  7  2  1  0
 18  8  1  0
 15  9  1  0
 30 25  1  0
M  END
>  <BrandName>  (63) 
nan

>  <Phase>  (63) 
2.0

>  <Applicants>  (63) 
GlaxoSmithKline

>  <Links>  (63) 
|http://www.chemspider.com/Chemical-Structure.8473450.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL2103838|http://pubchem.ncbi.nlm.nih.gov/compound/10297982|http://www.drugbank.ca/drugs/DB12140|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7815|http://zinc15.docking.org/substances/ZINC000034997404|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=Q3238VQW0N

>  <LigID>  (63) 
nan

>  <pdbID>  (63) 
nan

>  <Type>  (63) 
nan

>  <RoF>  (63) 
0

>  <MW>  (63) 
456.1

>  <LogP>  (63) 
2.9

>  <TPSA>  (63) 
100.3

>  <HBA>  (63) 
7

>  <HBD>  (63) 
3

>  <NRB>  (63) 
6

>  <Indications>  (63) 
Dilmapimod has been used in trials studying the treatment and diagnostic of Nerve Trauma, Inflammation, Pain, Neuropathic, Arthritis, Rheumatoid, and Coronary Heart Disease, among others.

>  <Targets>  (63) 
MAPK14; MAPK11; MAPK13; MAPK12

>  <Kinase families>  (63) 
CMGC

>  <Canonical_Smiles>  (63) 
Cc1cc(ccc1c2c3ccc(=O)n(c3nc(n2)NC(CO)CO)c4c(cccc4F)F)F

>  <InChiKey>  (63) 
ORVNHOYNEHYKJG-UHFFFAOYSA-N

>  <First_Approval>  (63) 
nan

>  <SC_Patent>  (63) 
None

>  <Chirality>  (63) 
Achiral Molecule

>  <Synonyms>  (63) 
DILMAPIMOD | GW-681323 | SB-681323 | SB681323

>  <FDA_approved>  (63) 


>  <Melting points>  (63) 


$$$$
Almonertinib
     RDKit          2D

 39 43  0  0  0  0  0  0  0  0999 V2000
  -10.8243    0.9640    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.4388    0.3892    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -9.2438   -1.0981    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.2483    1.3017    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.8628    0.7270    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6723    1.6395    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8673    3.1268    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2868    1.0648    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0963    1.9773    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7107    1.4025    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5202    2.3151    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7153    3.8023    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5157   -0.0847    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7062   -0.9973    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0917   -0.4225    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2823   -1.3350    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0872   -2.8223    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7017   -3.3970    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2777   -3.7348    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0827   -5.2221    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1302   -0.6595    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.0603    0.2530    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4458   -0.3217    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.6363    0.5908    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4413    2.0781    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0558    2.6528    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8653    1.7403    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.0218    0.0161    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3713   -1.4427    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8666   -1.5611    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.6497   -2.8405    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9675   -3.5569    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6881   -4.3400    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4413   -0.1756    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8555    0.3244    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1297    1.7991    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9896    2.7739    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5753    2.2739    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3012    0.7992    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  6  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 10 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  2  0
 13 21  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 24 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
 30 34  1  0
 34 35  2  0
 35 36  1  0
 36 37  2  0
 37 38  1  0
 38 39  2  0
 15  8  1  0
 27 22  1  0
 39 28  1  0
 33 31  1  0
 39 34  1  0
M  END
>  <BrandName>  (64) 
nan

>  <Phase>  (64) 
2.0

>  <Applicants>  (64) 
Jiangsu Hansoh Pharmaceutical

>  <Links>  (64) 
|http://www.chemspider.com/Chemical-Structure.75535991.html|http://pubchem.ncbi.nlm.nih.gov/compound/121280087

>  <LigID>  (64) 
nan

>  <pdbID>  (64) 
nan

>  <Type>  (64) 
nan

>  <RoF>  (64) 
2

>  <MW>  (64) 
525.3

>  <LogP>  (64) 
5.3

>  <TPSA>  (64) 
87.6

>  <HBA>  (64) 
8

>  <HBD>  (64) 
2

>  <NRB>  (64) 
11

>  <Indications>  (64) 
nan

>  <Targets>  (64) 
nan

>  <Kinase families>  (64) 


>  <Canonical_Smiles>  (64) 
CN(C)CCN(C)C1C=C(OC)C(=CC=1NC(=O)C=C)NC1N=C(C=CN=1)C1=CN(C2CC2)C2C=CC=CC=21

>  <InChiKey>  (64) 
DOEOECWDNSEFDN-UHFFFAOYSA-N

>  <First_Approval>  (64) 
nan

>  <SC_Patent>  (64) 
nan

>  <Chirality>  (64) 
nan

>  <Synonyms>  (64) 
|HS-10296

>  <FDA_approved>  (64) 


>  <Melting points>  (64) 


$$$$
Silmitasertib
     RDKit          2D

 25 28  0  0  0  0  0  0  0  0999 V2000
   -3.3592    2.7010    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5279    1.4524    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1934    0.1082    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6904    0.0124    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5217    1.2610    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8562    2.6052    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.0187    1.1652    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -2.3620   -1.1403    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8651   -1.0446    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0337   -2.2931    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6993   -3.6374    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1321   -4.8859    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6290   -4.7902    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.2946   -3.4459    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4632   -2.1974    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1288   -0.8531    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6257   -0.7574    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2913    0.5869    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4599    1.8354    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9630    1.7396    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2974    0.3954    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1995    0.2996    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.1255    3.1796    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2941    4.4282    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.6224    3.2754    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  3  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 19 23  1  0
 23 24  2  0
 23 25  1  0
  6  1  1  0
 22  9  2  0
 15 10  1  0
 21 16  1  0
M  END
>  <BrandName>  (65) 
nan

>  <Phase>  (65) 
2.0

>  <Applicants>  (65) 
Senhwa Biosciences

>  <Links>  (65) 
|http://www.chemspider.com/Chemical-Structure.25057795.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL1230165|http://pubchem.ncbi.nlm.nih.gov/compound/24748573|http://www.drugbank.ca/drugs/DB15408| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=3NG|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/3NG|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8126|http://zinc15.docking.org/substances/ZINC000058638454|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=C6RWP0N0L2|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50335638

>  <LigID>  (65) 
'3NG'

>  <pdbID>  (65) 
3nga 3pe1 5o11 6fyl 6fyp 6fyv 6hmb 6isj 6k3l 6khd 6khe 6khf 6p5s

>  <Type>  (65) 
1

>  <RoF>  (65) 
0

>  <MW>  (65) 
349.1

>  <LogP>  (65) 
4.9

>  <TPSA>  (65) 
75.1

>  <HBA>  (65) 
4

>  <HBD>  (65) 
2

>  <NRB>  (65) 
3

>  <Indications>  (65) 
nan

>  <Targets>  (65) 
CSNK2A1; CSNK2A2

>  <Kinase families>  (65) 
Other

>  <Canonical_Smiles>  (65) 
c1cc(cc(c1)Cl)Nc2c3ccncc3c4ccc(cc4n2)C(=O)O

>  <InChiKey>  (65) 
MUOKSQABCJCOPU-UHFFFAOYSA-N

>  <First_Approval>  (65) 
nan

>  <SC_Patent>  (65) 
None

>  <Chirality>  (65) 
Achiral Molecule

>  <Synonyms>  (65) 
CX 4945 | CX-4945 | CX4945 | SILMITASERTIB

>  <FDA_approved>  (65) 


>  <Melting points>  (65) 


$$$$
Foslinanib
     RDKit          2D

 25 27  0  0  0  0  0  0  0  0999 V2000
    5.1788   -2.7093    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4959   -1.3738    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9978   -1.2974    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1827   -2.5566    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6846   -2.4803    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0017   -1.1447    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8169    0.1144    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3149    0.0381    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1301    1.2973    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.6282    1.2209    0.0000 P   0  0  0  0  0  0  0  0  0  0  0  0
    4.7045    2.7190    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.5518   -0.2772    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.1262    1.1445    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.1340    1.4500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9491    2.7092    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3641    1.5263    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1792    0.2672    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4963   -1.0684    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6773    0.3435    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3602    1.6791    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8582    1.7554    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6734    0.4962    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9905   -0.8393    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4924   -0.9156    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.8056   -2.0985    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 10 13  1  0
  7 14  1  0
 14 15  2  0
 14 16  1  0
 16 17  2  0
 17 18  1  0
 17 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 23 25  1  0
  8  3  1  0
 18  6  1  0
 24 19  1  0
M  END
>  <BrandName>  (66) 
nan

>  <Phase>  (66) 
2.0

>  <Applicants>  (66) 
TaiRx

>  <Links>  (66) 
|http://www.chemspider.com/Chemical-Structure.26374637.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL1615993|http://pubchem.ncbi.nlm.nih.gov/compound/49840582|http://zinc15.docking.org/substances/ZINC000064447756|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=2X2DNM7NGX

>  <LigID>  (66) 
nan

>  <pdbID>  (66) 
nan

>  <Type>  (66) 
nan

>  <RoF>  (66) 
0

>  <MW>  (66) 
365

>  <LogP>  (66) 
2.8

>  <TPSA>  (66) 
108.8

>  <HBA>  (66) 
4

>  <HBD>  (66) 
3

>  <NRB>  (66) 
4

>  <Indications>  (66) 
nan

>  <Targets>  (66) 
nan

>  <Kinase families>  (66) 


>  <Canonical_Smiles>  (66) 
COc1ccc2c(c1OP(=O)(O)O)c(=O)cc([nH]2)c3cccc(c3)F

>  <InChiKey>  (66) 
ZDWFMAHQGDEALT-UHFFFAOYSA-N

>  <First_Approval>  (66) 
nan

>  <SC_Patent>  (66) 
None

>  <Chirality>  (66) 
Unknown

>  <Synonyms>  (66) 
nan

>  <FDA_approved>  (66) 


>  <Melting points>  (66) 


$$$$
Tanzisertib
     RDKit          2D

 32 36  0  0  0  0  0  0  0  0999 V2000
   -5.8888    1.6004    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4970    1.0411    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2854   -0.4439    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4657   -1.3696    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.8575   -0.8104    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.0691    0.6746    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.4609    1.2339    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2541   -2.8547    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8936   -1.0032    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7133   -0.0775    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2706   -0.4882    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.5658    0.7569    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0508    0.9685    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.6101    2.3604    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6843    3.5406    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.1993    3.3291    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3599    1.9372    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7685    1.4215    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.0951    2.5719    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.0208    1.3917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4615   -0.0002    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3873   -1.1804    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8723   -0.9689    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4315    0.4230    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5058    1.6032    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7980   -2.1491    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.2451   -1.8968    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6877   -2.3075    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7429   -3.8065    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.3344   -4.3222    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5914   -3.1419    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3167    1.9668    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  4  8  1  0
  3  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 14 19  1  0
 20 19  1  6
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 23 26  1  1
 27 11  1  6
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
  2 32  1  0
  6  1  1  0
 18 10  2  0
 17 12  1  0
 25 20  1  0
 31 27  1  0
M  END
>  <BrandName>  (67) 
nan

>  <Phase>  (67) 
2.0

>  <Applicants>  (67) 
Celgene

>  <Links>  (67) 
|http://www.chemspider.com/Chemical-Structure.28492361.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL1950289|http://www.drugbank.ca/drugs/DB11798| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=KBI|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/KBI|http://zinc15.docking.org/substances/ZINC000102930548|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=M5O06306UO|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50364378

>  <LigID>  (67) 
'KBI'

>  <pdbID>  (67) 
3tti

>  <Type>  (67) 
1

>  <RoF>  (67) 
0

>  <MW>  (67) 
448.2

>  <LogP>  (67) 
3.7

>  <TPSA>  (67) 
97.1

>  <HBA>  (67) 
8

>  <HBD>  (67) 
3

>  <NRB>  (67) 
5

>  <Indications>  (67) 
nan

>  <Targets>  (67) 
MAPK8

>  <Kinase families>  (67) 
CMGC

>  <Canonical_Smiles>  (67) 
c1c(c(c(cc1F)F)Nc2n(c3nc(ncc3n2)N[C@H]4CC[C@@H](CC4)O)[C@@H]5COCC5)F

>  <InChiKey>  (67) 
IBGLGMOPHJQDJB-IHRRRGAJSA-N

>  <First_Approval>  (67) 
nan

>  <SC_Patent>  (67) 
None

>  <Chirality>  (67) 
Single Stereoisomer

>  <Synonyms>  (67) 
CC-930 | JNK 930 | JNK-930 | TANZISERTIB

>  <FDA_approved>  (67) 


>  <Melting points>  (67) 


$$$$
Glesatinib
     RDKit          2D

 43 47  0  0  0  0  0  0  0  0999 V2000
   16.4367    2.9921    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.0357    3.5278    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.8712    2.5823    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4701    3.1180    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3056    2.1725    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.9046    2.7082    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7401    1.7627    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9767    0.2814    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8122   -0.6641    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4111   -0.1284    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1745    1.3528    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.3390    2.2984    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2467   -1.0739    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3272   -2.5717    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9275   -3.1111    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9820   -1.9467    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7973   -0.6876    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    1.5008   -2.1833    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9651   -3.5844    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9106   -4.7488    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3918   -4.5122    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.5552   -1.0188    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9260   -1.2554    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8715   -0.0909    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3527   -0.3275    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8884   -1.7286    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9429   -2.8931    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4617   -2.6565    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5162   -3.8210    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3697   -1.9652    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.3152   -0.8008    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7795    0.6003    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -7.7964   -1.0374    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -8.7419    0.1271    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.2062    1.5282    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  -10.2231   -0.1095    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -11.1687    1.0550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.6329    2.4560    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -11.5785    3.6205    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -13.0597    3.3839    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -13.5954    1.9828    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -12.6499    0.8184    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -14.0052    4.5484    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 10 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 16 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 18 22  1  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 26 30  1  0
 30 31  1  0
 31 32  2  0
 31 33  1  0
 33 34  1  0
 34 35  2  0
 34 36  1  0
 36 37  1  0
 37 38  2  0
 38 39  1  0
 39 40  2  0
 40 41  1  0
 41 42  2  0
 40 43  1  0
 12  7  1  0
 17 13  1  0
 21 15  1  0
 28 23  1  0
 42 37  1  0
M  END
>  <BrandName>  (68) 
nan

>  <Phase>  (68) 
2.0

>  <Applicants>  (68) 
Mirati Therapeutics

>  <Links>  (68) 
|http://www.chemspider.com/Chemical-Structure.52084900.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3989914|http://pubchem.ncbi.nlm.nih.gov/compound/25181472|http://www.drugbank.ca/drugs/DB06302|http://zinc15.docking.org/substances/ZINC000113139653|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=7Q29OXD98N

>  <LigID>  (68) 
nan

>  <pdbID>  (68) 
nan

>  <Type>  (68) 
nan

>  <RoF>  (68) 
2

>  <MW>  (68) 
619.2

>  <LogP>  (68) 
6.2

>  <TPSA>  (68) 
97.4

>  <HBA>  (68) 
8

>  <HBD>  (68) 
3

>  <NRB>  (68) 
11

>  <Indications>  (68) 
nan

>  <Targets>  (68) 
MET; TEK; FLT1; KDR; FLT4; MST1R

>  <Kinase families>  (68) 
Tyr

>  <Canonical_Smiles>  (68) 
COCCNCc1ccc(nc1)c2cc3c(s2)c(ccn3)Oc4ccc(cc4F)NC(=S)NC(=O)Cc5ccc(cc5)F

>  <InChiKey>  (68) 
YRCHYHRCBXNYNU-UHFFFAOYSA-N

>  <First_Approval>  (68) 
nan

>  <SC_Patent>  (68) 
None

>  <Chirality>  (68) 
Achiral Molecule

>  <Synonyms>  (68) 
GLESATINIB | MG-90265 | MG-90265X | MG90265 | MG90265GLY | MG90265H9 | MG90265X | MGCD-265 | MGCD265

>  <FDA_approved>  (68) 


>  <Melting points>  (68) 


$$$$
Milciclib
     RDKit          2D

 34 38  0  0  0  0  0  0  0  0999 V2000
   -6.0997   -1.8298    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6009   -1.7684    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1716   -2.2233    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0629   -1.2128    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6336   -1.6677    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4751   -0.6573    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.1543    0.8080    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2750    1.2629    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3836    0.2525    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8130    0.7074    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9216   -0.3030    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2252    0.4391    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9222    1.9082    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4314    2.0740    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6892    3.3775    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.5918   -0.1793    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.7396   -1.6720    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -8.8106    0.6951    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  -10.1772    0.0767    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2630    1.8184    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.6923    1.3635    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0131   -0.1018    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4424   -0.5567    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5511    0.4537    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2303    1.9190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8010    2.3739    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9804   -0.0012    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.3011   -1.4665    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7305   -1.9214    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8391   -0.9110    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.5184    0.5543    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0891    1.0092    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2685   -1.3659    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8007   -3.2550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 12 16  1  0
 16 17  2  0
 16 18  1  0
 18 19  1  0
  7 20  1  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 24 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 30 33  1  0
  2 34  1  0
 11  2  1  0
  9  4  1  0
 14 10  1  0
 26 21  1  0
 32 27  1  0
M  END
>  <BrandName>  (69) 
nan

>  <Phase>  (69) 
2.0

>  <Applicants>  (69) 
Nerviano Medical Sciences

>  <Links>  (69) 
|http://www.chemspider.com/Chemical-Structure.16788113.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL564829|http://pubchem.ncbi.nlm.nih.gov/compound/16718576| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=P48|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/P48|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7938|http://zinc15.docking.org/substances/ZINC000053119602|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=688000M8S8|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=31545

>  <LigID>  (69) 
'P48'

>  <pdbID>  (69) 
2wih 5vc6 5vd1

>  <Type>  (69) 
1

>  <RoF>  (69) 
0

>  <MW>  (69) 
460.3

>  <LogP>  (69) 
2.6

>  <TPSA>  (69) 
91.2

>  <HBA>  (69) 
8

>  <HBD>  (69) 
2

>  <NRB>  (69) 
4

>  <Indications>  (69) 
nan

>  <Targets>  (69) 
CDK1; NTRK1

>  <Kinase families>  (69) 
Tyr<br>CMGC

>  <Canonical_Smiles>  (69) 
CC1(Cc2cnc(nc2-c3c1c(nn3C)C(=O)NC)Nc4ccc(cc4)N5CCN(CC5)C)C

>  <InChiKey>  (69) 
RXZMYLDMFYNEIM-UHFFFAOYSA-N

>  <First_Approval>  (69) 
nan

>  <SC_Patent>  (69) 
None

>  <Chirality>  (69) 
Achiral Molecule

>  <Synonyms>  (69) 
MILCICLIB | PHA 848125 | PHA-848125

>  <FDA_approved>  (69) 


>  <Melting points>  (69) 


$$$$
Telatinib
     RDKit          2D

 29 32  0  0  0  0  0  0  0  0999 V2000
   -7.1929    4.3811    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.3118    3.1671    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.9227    1.7971    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.4146    1.6412    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0417    0.5831    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5498    0.7391    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6688   -0.4749    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2796   -1.8449    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7715   -2.0009    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6525   -0.7868    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1769   -0.3189    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2959   -1.5329    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.1960   -1.3769    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0770   -2.5909    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5689   -2.4349    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1782   -3.8056    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0630   -4.8087    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7643   -4.0580    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.1797   -1.0649    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2987    0.1491    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.8068   -0.0069    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.6716   -0.9090    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.2824    0.4610    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7743    0.6170    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3851    1.9870    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5041    3.2010    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0122    3.0450    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4014    1.6750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1150    4.5710    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
  7 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 15 19  1  0
 19 20  2  0
 20 21  1  0
 19 22  1  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 26 29  1  0
 10  5  1  0
 21 13  2  0
 18 14  1  0
 28 23  1  0
M  END
>  <BrandName>  (70) 
nan

>  <Phase>  (70) 
2.0

>  <Applicants>  (70) 
Bayer

>  <Links>  (70) 
|http://www.chemspider.com/Chemical-Structure.7984603.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL2079588|http://pubchem.ncbi.nlm.nih.gov/compound/9808844|http://www.drugbank.ca/drugs/DB15393|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10476|http://zinc15.docking.org/substances/ZINC00590964|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=18P7197Q7J|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50399538

>  <LigID>  (70) 
nan

>  <pdbID>  (70) 
nan

>  <Type>  (70) 
nan

>  <RoF>  (70) 
0

>  <MW>  (70) 
409.1

>  <LogP>  (70) 
4

>  <TPSA>  (70) 
102.2

>  <HBA>  (70) 
7

>  <HBD>  (70) 
2

>  <NRB>  (70) 
6

>  <Indications>  (70) 
nan

>  <Targets>  (70) 
KDR; FLT4

>  <Kinase families>  (70) 
Tyr

>  <Canonical_Smiles>  (70) 
CNC(=O)c1cc(ccn1)COc2c3c(cco3)c(nn2)Nc4ccc(cc4)Cl

>  <InChiKey>  (70) 
QFCXANHHBCGMAS-UHFFFAOYSA-N

>  <First_Approval>  (70) 
nan

>  <SC_Patent>  (70) 
None

>  <Chirality>  (70) 
Achiral Molecule

>  <Synonyms>  (70) 
BAY 57-9352 | BAY-57-9352 | BAY-579352 | TELATINIB

>  <FDA_approved>  (70) 


>  <Melting points>  (70) 


$$$$
Entospletinib
     RDKit          2D

 31 36  0  0  0  0  0  0  0  0999 V2000
    0.9908   -1.0030    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3314   -0.3300    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5845   -1.1545    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4970   -2.6519    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1565   -3.3249    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9034   -2.5005    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4372   -3.1735    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6903   -2.3490    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0308   -3.0220    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4277   -4.4686    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9261   -4.5381    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4553   -3.1346    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2839   -2.1976    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1965   -0.7001    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8559   -0.0271    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6028   -0.8516    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7685    1.4703    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0216    2.2948    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9342    3.7922    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5936    4.4652    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1967    5.9118    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6984    5.9813    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1692    4.5778    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3405    3.6408    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4279    2.1433    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9250   -0.4815    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.1781   -1.3059    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5187   -0.6329    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6061    0.8645    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.3530    1.6890    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0125    1.0160    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 15 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  1  0
 24 25  2  0
  3 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
  6  1  1  0
 16  8  2  0
 13  9  1  0
 25 17  1  0
 24 20  1  0
 31 26  1  0
M  END
>  <BrandName>  (71) 
nan

>  <Phase>  (71) 
2.0

>  <Applicants>  (71) 
Gilead Sciences

>  <Links>  (71) 
|http://www.chemspider.com/Chemical-Structure.31042596.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3265032|http://pubchem.ncbi.nlm.nih.gov/compound/59473233|http://www.drugbank.ca/drugs/DB12121| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=CG9|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/CG9|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7889|http://zinc15.docking.org/substances/ZINC000098208742|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=6I3O3W6O3B|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50015448

>  <LigID>  (71) 
'CG9'

>  <pdbID>  (71) 
4puz

>  <Type>  (71) 
1

>  <RoF>  (71) 
0

>  <MW>  (71) 
411.2

>  <LogP>  (71) 
3.9

>  <TPSA>  (71) 
83.4

>  <HBA>  (71) 
7

>  <HBD>  (71) 
2

>  <NRB>  (71) 
4

>  <Indications>  (71) 
nan

>  <Targets>  (71) 
SYK

>  <Kinase families>  (71) 
Tyr

>  <Canonical_Smiles>  (71) 
c1cc(ccc1Nc2c3nccn3cc(n2)c4ccc5cn[nH]c5c4)N6CCOCC6

>  <InChiKey>  (71) 
XSMSNFMDVXXHGJ-UHFFFAOYSA-N

>  <First_Approval>  (71) 
nan

>  <SC_Patent>  (71) 
None

>  <Chirality>  (71) 
Achiral Molecule

>  <Synonyms>  (71) 
ENTOSPLETINIB | GS-9973 | SYK INHIBITOR GS-9973

>  <FDA_approved>  (71) 


>  <Melting points>  (71) 


$$$$
Serabelisib
     RDKit          2D

 27 31  0  0  0  0  0  0  0  0999 V2000
   -2.4770   -1.3012    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7460   -2.1009    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0731   -1.4016    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1311    0.0972    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8620    0.8969    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5349    0.1977    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2659    0.9973    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3238    2.4962    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0547    3.2958    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2723    2.5966    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6799    3.1149    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.6078    1.9364    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7737    0.6897    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3303    1.0977    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0612    0.2981    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2920   -0.7179    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3322   -1.8706    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.7702   -0.9729    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.2885   -2.3805    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7667   -2.6354    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7266   -1.4827    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.2083   -0.0751    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7301    0.1798    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5745    0.5053    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -7.4086   -0.7414    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4807   -1.9200    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -8.9075   -0.7994    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 13 16  1  0
 16 17  2  0
 16 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
  4 24  1  0
 24 25  2  0
 25 26  1  0
 25 27  1  0
  6  1  1  0
 26  3  1  0
 15  7  2  0
 14 10  1  0
 23 18  1  0
M  END
>  <BrandName>  (72) 
nan

>  <Phase>  (72) 
2.0

>  <Applicants>  (72) 
Takeda

>  <Links>  (72) 
|http://www.chemspider.com/Chemical-Structure.35143228.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3935857|http://pubchem.ncbi.nlm.nih.gov/compound/70798655|http://www.drugbank.ca/drugs/DB14935|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8969|http://zinc15.docking.org/substances/ZINC000146965425|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=43J9Q56T3W|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=119531

>  <LigID>  (72) 
nan

>  <pdbID>  (72) 
nan

>  <Type>  (72) 
nan

>  <RoF>  (72) 
0

>  <MW>  (72) 
363.1

>  <LogP>  (72) 
2.2

>  <TPSA>  (72) 
98.9

>  <HBA>  (72) 
7

>  <HBD>  (72) 
1

>  <NRB>  (72) 
2

>  <Indications>  (72) 
nan

>  <Targets>  (72) 
nan

>  <Kinase families>  (72) 


>  <Canonical_Smiles>  (72) 
c1cc2c(cc1c3ccc4ncc(n4c3)C(=O)N5CCOCC5)nc(o2)N

>  <InChiKey>  (72) 
BLGWHBSBBJNKJO-UHFFFAOYSA-N

>  <First_Approval>  (72) 
nan

>  <SC_Patent>  (72) 
None

>  <Chirality>  (72) 
Achiral Molecule

>  <Synonyms>  (72) 
AGN-PC-0DB6FL | INK1117 | MLN-1117 | MLN1117 | SERABELISIB | TAK-117

>  <FDA_approved>  (72) 


>  <Melting points>  (72) 


$$$$
Ceralasertib
     RDKit          2D

 29 33  0  0  0  0  0  0  0  0999 V2000
    4.3137   -0.8773    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5841   -2.1879    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3543   -3.4751    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6246   -4.7857    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.1248   -4.8091    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3546   -3.5219    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0843   -2.2113    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.3141   -0.9241    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0438    0.3865    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2736    1.6736    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2262    1.6503    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9559    0.3397    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1857   -0.9475    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4557    0.3163    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2259    1.6035    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7257    1.5801    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4553    0.2695    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6852   -1.0177    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1853   -0.9943    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6996   -2.4135    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8993   -3.3140    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1264   -2.4513    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.0032    2.9842    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1371    3.9662    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4206    2.4932    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8393    3.9304    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1069    2.7664    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.7854    5.0943    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3247    4.8765    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 10 23  1  0
 23 24  1  0
 24 25  1  0
 23 26  1  0
 26 27  2  0
 26 28  2  0
 26 29  1  0
  7  2  1  0
 13  8  1  0
 19 14  1  0
 22 18  1  0
 25 23  1  0
M  END
>  <BrandName>  (73) 
nan

>  <Phase>  (73) 
2.0

>  <Applicants>  (73) 
Astrazeneca

>  <Links>  (73) 
|http://www.chemspider.com/Chemical-Structure.64879993.html|http://pubchem.ncbi.nlm.nih.gov/compound/76189946

>  <LigID>  (73) 
nan

>  <pdbID>  (73) 
nan

>  <Type>  (73) 
nan

>  <RoF>  (73) 
0

>  <MW>  (73) 
412.2

>  <LogP>  (73) 
2.9

>  <TPSA>  (73) 
107.8

>  <HBA>  (73) 
7

>  <HBD>  (73) 
2

>  <NRB>  (73) 
4

>  <Indications>  (73) 
Ceralasertib, also known as AZD6738, is an orally available morpholino-pyrimidine-based inhibitor of ataxia telangiectasia and rad3 related (ATR) kinase, with potential antineoplastic activity. Upon oral administration, ATR kinase inhibitor Ceralasertib selectively inhibits ATR activity by blocking the downstream phosphorylation of the serine/threonine protein kinase CHK1. This prevents ATR-mediated signaling, and results in the inhibition of DNA damage checkpoint activation, disruption of DNA damage repair, and the induction of tumor cell apoptosis.

>  <Targets>  (73) 
nan

>  <Kinase families>  (73) 


>  <Canonical_Smiles>  (73) 
CC1COCCN1c2cc(nc(n2)c3cncc4c3cc[nH]4)C5(CC5)S(=N)(=O)C

>  <InChiKey>  (73) 
DTTJKLNXNZAVSM-UHFFFAOYSA-N

>  <First_Approval>  (73) 
nan

>  <SC_Patent>  (73) 
None

>  <Chirality>  (73) 
Single Stereoisomer

>  <Synonyms>  (73) 
AZD6738

>  <FDA_approved>  (73) 


>  <Melting points>  (73) 


$$$$
Merestinib
     RDKit          2D

 41 46  0  0  0  0  0  0  0  0999 V2000
    8.2665   -2.6851    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8088   -2.3313    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7736   -3.4169    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3159   -3.0631    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8935   -1.6238    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9287   -0.5383    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5062    0.9010    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.3863   -0.8921    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.4215    0.1935    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8792   -0.1603    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9144    0.9252    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4920    2.3645    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0343    2.7183    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9991    1.6327    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5272    3.4500    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.4358   -1.2701    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4006   -2.3556    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.0133    0.1692    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.5556    0.5229    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1331    1.9622    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3246    2.3160    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3598    1.2304    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9373   -0.2088    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4796   -0.5626    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9725   -1.2943    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8175    1.5842    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8527    0.4987    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4302   -0.9406    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4654   -2.0261    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3514   -3.5218    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.7386   -4.0924    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -7.7100   -2.9494    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.9231   -1.6724    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.3456   -0.2331    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.3104    0.8524    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.7329    2.2917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.1456    2.7959    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.1026    4.2953    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6634    4.7178    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8168    3.4795    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.2056   -3.0634    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 12 15  1  0
  5 16  1  0
 16 17  2  0
 16 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 23 25  1  0
 22 26  1  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  1  0
 30 31  2  0
 31 32  1  0
 32 33  1  0
 33 34  1  0
 34 35  2  0
 35 36  1  0
 36 37  2  0
 37 38  1  0
 38 39  1  0
 39 40  2  0
 32 41  1  0
  8  2  1  0
 14  9  1  0
 24 19  1  0
 35 27  1  0
 33 29  2  0
 40 36  1  0
M  END
>  <BrandName>  (74) 
nan

>  <Phase>  (74) 
2.0

>  <Applicants>  (74) 
Eli Lilly

>  <Links>  (74) 
|http://www.chemspider.com/Chemical-Structure.29361338.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3545307|http://pubchem.ncbi.nlm.nih.gov/compound/44603533|http://www.drugbank.ca/drugs/DB12381| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=L1X|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/L1X|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9841|http://zinc15.docking.org/substances/ZINC000095926668|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=5OGS5K699E|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50172078

>  <LigID>  (74) 
'L1X'

>  <pdbID>  (74) 
4eev

>  <Type>  (74) 
2

>  <RoF>  (74) 
2

>  <MW>  (74) 
552.2

>  <LogP>  (74) 
5.7

>  <TPSA>  (74) 
106.8

>  <HBA>  (74) 
7

>  <HBD>  (74) 
2

>  <NRB>  (74) 
6

>  <Indications>  (74) 
nan

>  <Targets>  (74) 
MET

>  <Kinase families>  (74) 
Tyr

>  <Canonical_Smiles>  (74) 
Cc1ccc(c(=O)n1c2ccc(cc2)F)C(=O)Nc3ccc(c(c3)F)Oc4cc5cnn(c5cc4c6c[nH]nc6)C

>  <InChiKey>  (74) 
QHADVLVFMKEIIP-UHFFFAOYSA-N

>  <First_Approval>  (74) 
nan

>  <SC_Patent>  (74) 
None

>  <Chirality>  (74) 
Achiral Molecule

>  <Synonyms>  (74) 
LY-2801653 | LY2801653 | MERESTINIB

>  <FDA_approved>  (74) 


>  <Melting points>  (74) 


$$$$
Tenalisib
     RDKit          2D

 31 35  0  0  0  0  0  0  0  0999 V2000
   -1.5190    3.5791    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1251    3.0248    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0919    1.5406    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4857    0.9864    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7027   -0.4978    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0965   -1.0520    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3135   -2.5363    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.2734   -0.1220    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6673   -0.6763    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8442    0.2538    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6272    1.7380    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2334    2.2922    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0565    1.3622    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6626    1.9164    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.5258   -1.4278    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8681   -0.8736    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0450   -1.8036    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8280   -3.2879    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4342   -3.8421    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7427   -2.9121    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2172   -5.3263    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0850    0.6106    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4789    1.1648    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6558    0.2348    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0497    0.7890    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0075   -0.3653    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2056   -1.6330    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7522   -1.2621    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2666    2.2733    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0897    3.2033    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6959    2.6490    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  3  2  1  1
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
  5 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 19 21  1  0
  3 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  1  0
 27 28  2  0
 25 29  1  0
 29 30  2  0
 30 31  1  0
 14  4  1  0
 13  8  1  0
 20 15  1  0
 31 23  2  0
 28 24  1  0
M  END
>  <BrandName>  (75) 
nan

>  <Phase>  (75) 
2.0

>  <Applicants>  (75) 
Rhizen Pharmaceuticals

>  <Links>  (75) 
|http://www.chemspider.com/Chemical-Structure.52083673.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL4297584|http://pubchem.ncbi.nlm.nih.gov/compound/86291103|http://www.drugbank.ca/drugs/DB15295|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9907|http://zinc15.docking.org/substances/ZINC000220062787|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=2261HH611H

>  <LigID>  (75) 
nan

>  <pdbID>  (75) 
nan

>  <Type>  (75) 
nan

>  <RoF>  (75) 
0

>  <MW>  (75) 
415.1

>  <LogP>  (75) 
4.8

>  <TPSA>  (75) 
96.7

>  <HBA>  (75) 
6

>  <HBD>  (75) 
2

>  <NRB>  (75) 
5

>  <Indications>  (75) 
nan

>  <Targets>  (75) 
nan

>  <Kinase families>  (75) 


>  <Canonical_Smiles>  (75) 
CC[C@@H](c1c(c(=O)c2ccccc2o1)c3cccc(c3)F)Nc4c5c([nH]cn5)ncn4

>  <InChiKey>  (75) 
HDXDQPRPFRKGKZ-INIZCTEOSA-N

>  <First_Approval>  (75) 
nan

>  <SC_Patent>  (75) 
None

>  <Chirality>  (75) 
Single Stereoisomer

>  <Synonyms>  (75) 
TENALISIB

>  <FDA_approved>  (75) 


>  <Melting points>  (75) 


$$$$
Talmapimod
     RDKit          2D

 36 39  0  0  0  0  0  0  0  0999 V2000
   -1.3305   -4.4610    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0505   -3.1451    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5501   -3.1107    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2701   -1.7948    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4905   -0.5133    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9909   -0.5477    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2709   -1.8636    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.2287   -1.8980    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9487   -3.2139    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.0083   -0.6165    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5079   -0.6509    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2875    0.6306    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5675    1.9465    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0679    1.9809    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2883    0.6994    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2113    0.7338    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    3.5965    3.0379    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.9524    2.3965    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7615    0.9087    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8529   -0.1203    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5075   -1.5799    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.2897    0.3104    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6352    1.7701    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.3811   -0.7186    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.8180   -0.2879    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0357   -2.1782    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3183    4.5119    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2105    0.8026    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7697   -1.7604    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4897   -0.4445    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7101    0.8370    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4302    2.1529    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.9298    2.1873    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.7094    0.9058    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.9893   -0.4101    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.6498    3.5032    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  6
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 13 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 20 22  1  0
 22 23  2  0
 22 24  1  0
 24 25  1  0
 24 26  1  0
 17 27  1  0
  5 28  1  1
  4 29  1  0
 29 30  1  0
 30 31  2  0
 31 32  1  0
 32 33  2  0
 33 34  1  0
 34 35  2  0
 33 36  1  0
  7  2  1  0
 15 10  1  0
 19 12  1  0
 35 30  1  0
M  END
>  <BrandName>  (76) 
nan

>  <Phase>  (76) 
2.0

>  <Applicants>  (76) 
Scios inc

>  <Links>  (76) 
|http://www.chemspider.com/Chemical-Structure.8046764.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL514201|http://pubchem.ncbi.nlm.nih.gov/compound/9871074|http://www.drugbank.ca/drugs/DB05412| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=469|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/469|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7817|http://zinc15.docking.org/substances/ZINC000034001955|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=B1E00KQ6NT|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50266947

>  <LigID>  (76) 
'469'

>  <pdbID>  (76) 
3hub 3zsh

>  <Type>  (76) 
1

>  <RoF>  (76) 
1

>  <MW>  (76) 
512.2

>  <LogP>  (76) 
4

>  <TPSA>  (76) 
65.9

>  <HBA>  (76) 
5

>  <HBD>  (76) 
0

>  <NRB>  (76) 
5

>  <Indications>  (76) 
Investigated for use/treatment in pain (acute or chronic) and rheumatoid arthritis.

>  <Targets>  (76) 
MAPK14

>  <Kinase families>  (76) 
CMGC

>  <Canonical_Smiles>  (76) 
C[C@@H]1CN([C@H](CN1C(=O)c2cc3c(cc2Cl)n(cc3C(=O)C(=O)N(C)C)C)C)Cc4ccc(cc4)F

>  <InChiKey>  (76) 
ZMELOYOKMZBMRB-DLBZAZTESA-N

>  <First_Approval>  (76) 
nan

>  <SC_Patent>  (76) 
None

>  <Chirality>  (76) 
Single Stereoisomer

>  <Synonyms>  (76) 
SCIO 469 | SCIO-469 | TALMAPIMOD

>  <FDA_approved>  (76) 


>  <Melting points>  (76) 


$$$$
Tandutinib
     RDKit          2D

 41 45  0  0  0  0  0  0  0  0999 V2000
   13.9813    2.0599    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6506    1.3675    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5848   -0.1310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3857    2.1738    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.0550    1.4814    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9893   -0.0171    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6586   -0.7095    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3937    0.0967    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4594    1.5953    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7901    2.2876    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0630   -0.5956    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.7981    0.2106    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8639    1.7092    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.4674   -0.4817    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.2025    0.3245    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8719   -0.3678    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8061   -1.8664    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.0710   -2.6726    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4017   -1.9803    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5245   -2.5587    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7895   -1.7525    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7237   -0.2540    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9886    0.5523    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3193   -0.1401    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3850   -1.6386    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1201   -2.4449    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1859   -3.9434    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9210   -4.7496    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5903   -4.0573    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5842    0.6661    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.9149   -0.0262    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.1798    0.7800    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.5105    0.0877    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.7754    0.8939    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  -10.7096    2.3925    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -11.9745    3.1987    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -13.3052    2.5063    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -13.3709    1.0078    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -12.1060    0.2016    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9229    2.0508    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5922    2.7432    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
  8 11  1  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 17 20  1  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 24 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
 33 34  1  0
 34 35  1  0
 35 36  1  0
 36 37  1  0
 37 38  1  0
 38 39  1  0
 23 40  1  0
 40 41  1  0
 10  5  1  0
 19 14  1  0
 29 20  2  0
 26 21  1  0
 39 34  1  0
M  END
>  <BrandName>  (77) 
nan

>  <Phase>  (77) 
2.0

>  <Applicants>  (77) 
Takeda

>  <Links>  (77) 
|http://www.chemspider.com/Chemical-Structure.2302085.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL124660|http://pubchem.ncbi.nlm.nih.gov/compound/3038522|http://www.drugbank.ca/drugs/DB05465|http://zinc15.docking.org/substances/ZINC000003966243|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=E1IO3ICJ9A|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13535

>  <LigID>  (77) 
nan

>  <pdbID>  (77) 
nan

>  <Type>  (77) 
nan

>  <RoF>  (77) 
2

>  <MW>  (77) 
562.3

>  <LogP>  (77) 
5

>  <TPSA>  (77) 
92.3

>  <HBA>  (77) 
8

>  <HBD>  (77) 
1

>  <NRB>  (77) 
10

>  <Indications>  (77) 
Investigated for use/treatment in leukemia (myeloid).

>  <Targets>  (77) 
FLT3; PDGFD

>  <Kinase families>  (77) 
Tyr<br>(*)

>  <Canonical_Smiles>  (77) 
CC(C)Oc1ccc(cc1)NC(=O)N2CCN(CC2)c3c4cc(c(cc4ncn3)OCCCN5CCCCC5)OC

>  <InChiKey>  (77) 
UXXQOJXBIDBUAC-UHFFFAOYSA-N

>  <First_Approval>  (77) 
nan

>  <SC_Patent>  (77) 
None

>  <Chirality>  (77) 
Achiral Molecule

>  <Synonyms>  (77) 
CT-53518 | CT53518 | MLN-0518 | MLN-518 | TANDUTINIB

>  <FDA_approved>  (77) 


>  <Melting points>  (77) 


$$$$
Mavelertinib
     RDKit          2D

 30 33  0  0  0  0  0  0  0  0999 V2000
   -3.1480    6.2495    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8429    4.7808    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8516    3.6707    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1076    2.3683    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6389    2.6734    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4753    4.1645    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5288    1.6647    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.8999    2.1217    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7239    1.0007    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8478   -0.2168    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4641   -1.5843    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5880   -2.8018    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0955   -2.6519    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4791   -1.2843    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3553   -0.0668    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.0133   -1.1343    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.7692    0.1613    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2350   -0.1573    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3850   -1.6498    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0119   -2.2536    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6806   -2.4057    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    4.3543    0.8413    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.7788    0.3713    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0839   -1.0973    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.8980    1.3699    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3225    0.8999    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4752   -4.0113    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8996   -3.5413    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8928   -2.0413    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0182   -5.4400    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  1  0
  4  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 14 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 19 21  1  6
 18 22  1  1
 22 23  1  0
 23 24  2  0
 23 25  1  0
 25 26  2  0
 12 27  1  0
 27 28  1  0
 28 29  2  0
 27 30  1  0
  6  2  1  0
 15 10  1  0
 29 11  1  0
 20 16  1  0
M  END
>  <BrandName>  (78) 
nan

>  <Phase>  (78) 
2.0

>  <Applicants>  (78) 
Pfizer

>  <Links>  (78) 
|http://www.chemspider.com/Chemical-Structure.49070873.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3989970|http://pubchem.ncbi.nlm.nih.gov/compound/91668194|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9765|http://zinc15.docking.org/substances/ZINC000231225813|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=YXX2180047

>  <LigID>  (78) 
nan

>  <pdbID>  (78) 
nan

>  <Type>  (78) 
nan

>  <RoF>  (78) 
0

>  <MW>  (78) 
415.2

>  <LogP>  (78) 
0.7

>  <TPSA>  (78) 
115

>  <HBA>  (78) 
10

>  <HBD>  (78) 
2

>  <NRB>  (78) 
6

>  <Indications>  (78) 
nan

>  <Targets>  (78) 
nan

>  <Kinase families>  (78) 


>  <Canonical_Smiles>  (78) 
Cn1cc(c(n1)OC)Nc2c3c(nc(n2)N4C[C@H]([C@@H](C4)F)NC(=O)C=C)n(cn3)C

>  <InChiKey>  (78) 
JYIUNVOCEFIUIU-GHMZBOCLSA-N

>  <First_Approval>  (78) 
nan

>  <SC_Patent>  (78) 
None

>  <Chirality>  (78) 
Single Stereoisomer

>  <Synonyms>  (78) 
MAVELERTINIB | PF-06747775

>  <FDA_approved>  (78) 


>  <Melting points>  (78) 


$$$$
Ripasudil
     RDKit          2D

 22 24  0  0  0  0  0  0  0  0999 V2000
   -1.0610    2.0019    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2429    1.0783    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5878    1.7424    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9457    1.1050    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2939   -0.3540    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3703   -1.5360    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8704   -1.5508    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9236   -0.3873    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4646   -0.7356    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8128   -2.1946    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1163    0.7235    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.9945   -1.0838    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4224   -2.5214    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8814   -2.8696    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9125   -1.7802    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4846   -0.3425    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0255    0.0057    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5976    1.4433    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6287    2.5328    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0877    2.1846    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.5156    0.7469    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1386    1.7915    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  6
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
  9 11  2  0
  9 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 18 22  1  0
  8  2  1  0
 17 12  1  0
 21 16  1  0
M  END
>  <BrandName>  (79) 
nan

>  <Phase>  (79) 
2.0

>  <Applicants>  (79) 
Kowa Pharmaceutical

>  <Links>  (79) 
|http://www.chemspider.com/Chemical-Structure.8039366.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3426621|http://pubchem.ncbi.nlm.nih.gov/compound/9863672|http://www.drugbank.ca/drugs/DB13165|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10423|http://zinc15.docking.org/substances/ZINC000003940873|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=11978226XX|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50087135

>  <LigID>  (79) 
nan

>  <pdbID>  (79) 
nan

>  <Type>  (79) 
nan

>  <RoF>  (79) 
0

>  <MW>  (79) 
323.1

>  <LogP>  (79) 
1.7

>  <TPSA>  (79) 
62.3

>  <HBA>  (79) 
4

>  <HBD>  (79) 
1

>  <NRB>  (79) 
2

>  <Indications>  (79) 
nan

>  <Targets>  (79) 
nan

>  <Kinase families>  (79) 


>  <Canonical_Smiles>  (79) 
C[C@H]1CNCCCN1S(=O)(=O)c2cccc3c2c(cnc3)F

>  <InChiKey>  (79) 
QSKQVZWVLOIIEV-NSHDSACASA-N

>  <First_Approval>  (79) 
nan

>  <SC_Patent>  (79) 
nan

>  <Chirality>  (79) 
nan

>  <Synonyms>  (79) 
nan

>  <FDA_approved>  (79) 


>  <Melting points>  (79) 


$$$$
Nemiralisib
     RDKit          2D

 33 38  0  0  0  0  0  0  0  0999 V2000
    9.3898   -1.0894    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8880    0.3241    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8613    1.4655    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4129    0.5963    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.4396   -0.5451    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9645   -0.2729    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4627    1.1407    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.4360    2.2821    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9111    2.0099    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9876    1.4129    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0143    0.2715    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3656   -1.1868    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0873   -1.9715    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0541   -0.9983    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5189    0.3880    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5124   -1.3496    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5457   -0.2624    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0040   -0.6137    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4289   -2.0523    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3955   -3.1395    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9372   -2.7882    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1525   -4.0665    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1257   -5.2079    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5120   -4.6350    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0374    0.4736    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4957    0.1222    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.5291    1.2095    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.1042    2.6480    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6459    2.9994    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6125    1.9121    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2592    2.5590    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4561    4.0460    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9312    4.3182    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  7 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 14 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 18 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 32 33  1  0
  9  4  1  0
 15 11  1  0
 21 16  1  0
 24 20  1  0
 30 25  1  0
 33 29  1  0
M  END
>  <BrandName>  (80) 
nan

>  <Phase>  (80) 
2.0

>  <Applicants>  (80) 
GlaxosmithKline

>  <Links>  (80) 
|http://www.chemspider.com/Chemical-Structure.28651123.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL2216859|http://pubchem.ncbi.nlm.nih.gov/compound/49784002| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=VVX|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/VVX|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9425|http://zinc15.docking.org/substances/ZINC000095564436|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=OEP8JJ3OZR|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50004529

>  <LigID>  (80) 
'VVX'

>  <pdbID>  (80) 
5ae8

>  <Type>  (80) 
nan

>  <RoF>  (80) 
0

>  <MW>  (80) 
440.2

>  <LogP>  (80) 
4.9

>  <TPSA>  (80) 
77

>  <HBA>  (80) 
5

>  <HBD>  (80) 
2

>  <NRB>  (80) 
5

>  <Indications>  (80) 
nan

>  <Targets>  (80) 
nan

>  <Kinase families>  (80) 


>  <Canonical_Smiles>  (80) 
CC(C)N1CCN(CC1)Cc2cnc(o2)c3cc(cc4c3cn[nH]4)c5cccc6c5cc[nH]6

>  <InChiKey>  (80) 
MCIDWGZGWVSZMK-UHFFFAOYSA-N

>  <First_Approval>  (80) 
nan

>  <SC_Patent>  (80) 
None

>  <Chirality>  (80) 
Achiral Molecule

>  <Synonyms>  (80) 
GSK-2269557 | GSK-2269557 FREE BASE | GSK-2269557A | GSK2269557A | NEMIRALISIB

>  <FDA_approved>  (80) 


>  <Melting points>  (80) 


$$$$
Sapitinib
     RDKit          2D

 33 36  0  0  0  0  0  0  0  0999 V2000
    6.8433    1.9203    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8865    3.0755    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.4077    2.8244    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8856    1.4182    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.4508    3.9796    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9720    3.7286    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.4500    2.3224    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0289    2.0713    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9857    3.2266    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4637    4.6328    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0152    4.8838    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4645    2.9755    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9866    1.5693    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0297    0.4141    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5518   -0.9921    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0306   -1.2432    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9874   -0.0880    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4654    1.3183    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4222    2.4735    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9002    3.8797    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5526   -2.6494    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5958   -3.8046    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1170   -3.5536    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5949   -2.1473    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1161   -1.8963    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.8407   -3.0515    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3187   -4.4578    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2755   -5.6130    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7544   -5.3619    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2764   -3.9557    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3196   -2.8005    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8416   -1.3943    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    4.7552   -3.7047    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
  9 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  1  0
 16 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 32  1  0
 30 33  1  0
 11  6  1  0
 18 13  1  0
 24 15  1  0
 31 26  1  0
M  END
>  <BrandName>  (81) 
nan

>  <Phase>  (81) 
2.0

>  <Applicants>  (81) 
Astrazeneca

>  <Links>  (81) 
|http://www.chemspider.com/Chemical-Structure.9663133.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL2408045|http://pubchem.ncbi.nlm.nih.gov/compound/11488320|http://www.drugbank.ca/drugs/DB12183|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7717|http://zinc15.docking.org/substances/ZINC000034587071|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=3499328002|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50437353

>  <LigID>  (81) 
nan

>  <pdbID>  (81) 
nan

>  <Type>  (81) 
nan

>  <RoF>  (81) 
0

>  <MW>  (81) 
473.2

>  <LogP>  (81) 
3.8

>  <TPSA>  (81) 
88.6

>  <HBA>  (81) 
7

>  <HBD>  (81) 
2

>  <NRB>  (81) 
7

>  <Indications>  (81) 
nan

>  <Targets>  (81) 
EGFR; ERBB2; ERBB4; ERBB3

>  <Kinase families>  (81) 
Tyr

>  <Canonical_Smiles>  (81) 
CNC(=O)CN1CCC(CC1)Oc2cc3c(cc2OC)ncnc3Nc4cccc(c4F)Cl

>  <InChiKey>  (81) 
DFJSJLGUIXFDJP-UHFFFAOYSA-N

>  <First_Approval>  (81) 
nan

>  <SC_Patent>  (81) 
None

>  <Chirality>  (81) 
Achiral Molecule

>  <Synonyms>  (81) 
AZD-8931 | AZD8931 | SAPITINIB

>  <FDA_approved>  (81) 


>  <Melting points>  (81) 


$$$$
Acumapimod
     RDKit          2D

 29 32  0  0  0  0  0  0  0  0999 V2000
   -1.6548   -4.2330    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5803   -3.0526    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0654   -3.2639    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9909   -2.0834    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4313   -0.6917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9463   -0.4804    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0208   -1.6608    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5357   -1.4495    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.1662   -0.1239    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6439   -0.3819    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8552   -1.8669    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5081   -2.5268    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.7211    0.6620    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3557    2.1168    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.1637    0.2510    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5291   -1.2039    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9717   -1.6148    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0489   -0.5710    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6835    0.8838    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2409    1.2948    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7607    1.9276    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8380    2.9715    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4936    1.2231    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3568    0.4887    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.8419    0.2774    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7973    1.8805    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7228    3.0609    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.1145    3.6204    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9341    4.5460    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 10 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 19 21  1  0
 21 22  3  0
  9 23  1  0
  5 24  1  0
 24 25  2  0
 24 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
  7  2  1  0
 12  8  1  0
 20 15  1  0
 29 27  1  0
M  END
>  <BrandName>  (82) 
nan

>  <Phase>  (82) 
2.0

>  <Applicants>  (82) 
Mereo BioPharma

>  <Links>  (82) 
|http://www.chemspider.com/Chemical-Structure.9513071.html|http://pubchem.ncbi.nlm.nih.gov/compound/11338127|http://www.drugbank.ca/drugs/DB15448|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9203|http://zinc15.docking.org/substances/ZINC000116024237|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=2F16KW647L

>  <LigID>  (82) 
nan

>  <pdbID>  (82) 
nan

>  <Type>  (82) 
nan

>  <RoF>  (82) 
0

>  <MW>  (82) 
385.2

>  <LogP>  (82) 
2.8

>  <TPSA>  (82) 
113.8

>  <HBA>  (82) 
6

>  <HBD>  (82) 
2

>  <NRB>  (82) 
5

>  <Indications>  (82) 
nan

>  <Targets>  (82) 
MAPK14; MAPK11; MAPK13; MAPK12

>  <Kinase families>  (82) 
CMGC

>  <Canonical_Smiles>  (82) 
Cc1ccc(cc1n2c(c(cn2)C(=O)c3cccc(c3)C#N)N)C(=O)NC4CC4

>  <InChiKey>  (82) 
VGUSQKZDZHAAEE-UHFFFAOYSA-N

>  <First_Approval>  (82) 
nan

>  <SC_Patent>  (82) 
None

>  <Chirality>  (82) 
Single Stereoisomer

>  <Synonyms>  (82) 
nan

>  <FDA_approved>  (82) 


>  <Melting points>  (82) 


$$$$
Olmutinib
     RDKit          2D

 35 39  0  0  0  0  0  0  0  0999 V2000
   11.3586    1.2439    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8599    1.1826    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.1636   -0.1460    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6649   -0.2074    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8624    1.0599    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.5587    2.3885    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0574    2.4499    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3637    0.9986    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5612    2.2659    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0624    2.2045    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3662    0.8759    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1687   -0.3914    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6674   -0.3300    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8674    0.8146    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.1712   -0.5140    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9736   -1.7813    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.2774   -3.1099    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7989   -4.5164    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3776   -5.4469    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6262   -4.6156    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2214   -3.1713    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0238   -1.9040    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3276   -0.5754    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5226   -1.9653    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3251   -0.6980    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6288    0.6306    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4313    1.8979    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9301    1.8365    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6263    0.5079    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8238   -0.7594    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.1251    0.4466    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -8.9275    1.7139    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.2313    3.0425    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  -10.4263    1.6525    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -11.2288    2.9198    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  5  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 11 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  2  0
 22 24  1  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 29 31  1  0
 31 32  1  0
 32 33  2  0
 32 34  1  0
 34 35  2  0
  7  2  1  0
 13  8  1  0
 23 15  1  0
 21 17  2  0
 30 25  1  0
M  END
>  <BrandName>  (83) 
nan

>  <Phase>  (83) 
2.0

>  <Applicants>  (83) 
Hanmi Pharmaceutical

>  <Links>  (83) 
|http://www.chemspider.com/Chemical-Structure.45743494.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3786343|http://pubchem.ncbi.nlm.nih.gov/compound/54758501|http://www.drugbank.ca/drugs/DB13164|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9196|http://zinc15.docking.org/substances/ZINC000198970879|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=CHL9B67L95|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50160871

>  <LigID>  (83) 
nan

>  <pdbID>  (83) 
nan

>  <Type>  (83) 
nan

>  <RoF>  (83) 
1

>  <MW>  (83) 
486.2

>  <LogP>  (83) 
5.1

>  <TPSA>  (83) 
82.6

>  <HBA>  (83) 
8

>  <HBD>  (83) 
2

>  <NRB>  (83) 
7

>  <Indications>  (83) 
For use in treatment of metastatic T790M mutation positive non-small cell lung cancer

>  <Targets>  (83) 
EGFR

>  <Kinase families>  (83) 
Tyr

>  <Canonical_Smiles>  (83) 
CN1CCN(CC1)c2ccc(cc2)Nc3nc4ccsc4c(n3)Oc5cccc(c5)NC(=O)C=C

>  <InChiKey>  (83) 
FDMQDKQUTRLUBU-UHFFFAOYSA-N

>  <First_Approval>  (83) 
nan

>  <SC_Patent>  (83) 
None

>  <Chirality>  (83) 
Achiral Molecule

>  <Synonyms>  (83) 
BI 1482694 | BI-1482694 | HM-61713 | HM61713 | OLMUTINIB

>  <FDA_approved>  (83) 


>  <Melting points>  (83) 


$$$$
Parsaclisib
     RDKit          2D

 30 33  0  0  0  0  0  0  0  0999 V2000
    0.1849   -3.1918    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9704   -1.9139    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2564   -0.5948    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.0419    0.6832    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3279    2.0023    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1134    3.2802    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6128    3.2390    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3268    1.9198    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5413    0.6419    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2553   -0.6773    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7422   -0.8751    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0136   -2.3504    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3666   -2.9979    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.6944   -3.0643    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.6077   -2.0303    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8262    1.8785    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    3.3983    4.5169    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -1.1715    2.0436    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8855    3.3628    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9570    0.7657    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4525    0.6500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8046   -0.8080    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5267   -1.5935    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3848   -0.6209    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4111   -3.0890    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2434   -1.2321    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.3301   -0.1981    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9780    1.2599    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5392    1.6840    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5956   -2.6902    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
 10  9  1  1
 10 11  1  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
  8 16  1  0
  7 17  1  0
  5 18  1  0
 18 19  1  1
 18 20  1  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 23 25  1  0
 22 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 26 30  1  0
  9  4  1  0
 15 10  1  0
 24 20  1  0
 29 21  1  0
M  END
>  <BrandName>  (84) 
nan

>  <Phase>  (84) 
2.0

>  <Applicants>  (84) 
Incyte Corporation

>  <Links>  (84) 
|http://www.chemspider.com/Chemical-Structure.64835232.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL4297615|http://pubchem.ncbi.nlm.nih.gov/compound/86677874|http://www.drugbank.ca/drugs/DB14867|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10098|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=OS7097575K|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=272573

>  <LigID>  (84) 
nan

>  <pdbID>  (84) 
nan

>  <Type>  (84) 
nan

>  <RoF>  (84) 
0

>  <MW>  (84) 
432.1

>  <LogP>  (84) 
3.1

>  <TPSA>  (84) 
107.9

>  <HBA>  (84) 
7

>  <HBD>  (84) 
2

>  <NRB>  (84) 
5

>  <Indications>  (84) 
Parsaclisib (INCB050465) is a PI3K&delta; inhibitor that was developed by Incyte Corporation as an antineoplastic and immunomodulatory agent, as claimed in their patent WO2014134426A1 [<a href='javascript:callRef("ReferenceDisplayForward?referenceId=36232&displayId=1", 960, 600)' title="1. Li Y-L, Yao W, Combs AP, Yue EW, Mei S, Zhu W, Glenn J Jr, Maduskuie TP, Sparks RB, Douty B, He C. (2014) USE OF PYRAZOLOPYRIMIDINE DERIVATIVES FOR THE TREATMENT OF PI3K RELATED DISORDERS. Patent no. WO2014134426A1.">1</a>]. The chemical structure is one of those claimed in patent WO2013033569A1, but it is not clear which example it is from a mixture of diastereoisomers 345-348 (although 347 and 348 had the highest inhibitory potency <i>vs</i>. PI3K&delta; and 347 was tested <i>in vivo</i> [<a href='javascript:callRef("ReferenceDisplayForward?referenceId=36233&displayId=2", 960, 600)' title="2. Li Y-L, Yao W, Combs AP, Yue EW, Mei S, Zhu W, Glenn J, Maduskuie TP Jr, Sparks RB, Douty B. (2013) Heterocyclylamines as pi3k inhibitors. Patent no. WO2013033569A1.">2</a>].

>  <Targets>  (84) 
nan

>  <Kinase families>  (84) 


>  <Canonical_Smiles>  (84) 
CCOc1c(cc(c(c1[C@H]2CC(=O)NC2)F)Cl)[C@H](C)n3c4c(c(n3)C)c(ncn4)N

>  <InChiKey>  (84) 
ZQPDJCIXJHUERQ-QWRGUYRKSA-N

>  <First_Approval>  (84) 
nan

>  <SC_Patent>  (84) 
None

>  <Chirality>  (84) 
Single Stereoisomer

>  <Synonyms>  (84) 
INCB-050465 | INCB050465 | PARSACLISIB

>  <FDA_approved>  (84) 


>  <Melting points>  (84) 


$$$$
Rabusertib
     RDKit          2D

 27 29  0  0  0  0  0  0  0  0999 V2000
   -2.5903   -5.1727    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8525   -3.8666    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6147   -2.5747    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8770   -1.2687    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3771   -1.2545    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3851   -2.5464    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3526   -3.8525    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4096   -5.1444    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
    0.3606    0.0515    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.8606    0.0656    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6228   -1.2263    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5983    1.3717    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.0982    1.3858    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8604    0.0939    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3604    0.1081    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.0981    1.4141    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3359    2.7060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8360    2.6919    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.5980    1.4282    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6392    0.0232    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1392    0.0091    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9014    1.3010    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1636    2.6071    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9258    3.8990    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4258    3.8848    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.1635    2.5788    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4013    1.2869    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  5  9  1  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 16 19  1  0
  4 20  1  0
 20 21  1  0
 22 21  1  1
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
  7  2  1  0
 18 13  1  0
 27 22  1  0
M  END
>  <BrandName>  (85) 
nan

>  <Phase>  (85) 
2.0

>  <Applicants>  (85) 
Eli Lilly

>  <Links>  (85) 
|http://www.chemspider.com/Chemical-Structure.10130131.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3039517|http://pubchem.ncbi.nlm.nih.gov/compound/11955855|http://www.drugbank.ca/drugs/DB11662|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7960|http://zinc15.docking.org/substances/ZINC000070466463|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=3S9L1NU6U7

>  <LigID>  (85) 
nan

>  <pdbID>  (85) 
nan

>  <Type>  (85) 
nan

>  <RoF>  (85) 
0

>  <MW>  (85) 
435.1

>  <LogP>  (85) 
2.9

>  <TPSA>  (85) 
97.4

>  <HBA>  (85) 
6

>  <HBD>  (85) 
3

>  <NRB>  (85) 
5

>  <Indications>  (85) 
nan

>  <Targets>  (85) 
CHEK1

>  <Kinase families>  (85) 
CAMK

>  <Canonical_Smiles>  (85) 
Cc1cc(c(cc1Br)NC(=O)Nc2cnc(cn2)C)OC[C@@H]3CNCCO3

>  <InChiKey>  (85) 
SYYBDNPGDKKJDU-ZDUSSCGKSA-N

>  <First_Approval>  (85) 
nan

>  <SC_Patent>  (85) 
None

>  <Chirality>  (85) 
Single Stereoisomer

>  <Synonyms>  (85) 
IC-83 | LY-2603618 | LY2603618 | RABUSERTIB

>  <FDA_approved>  (85) 


>  <Melting points>  (85) 


$$$$
Brepocitinib
     RDKit          2D

 28 32  0  0  0  0  0  0  0  0999 V2000
    5.9758   -2.3830    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7643   -1.4986    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.7677    0.0014    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3422    0.4683    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4578   -0.7432    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3366   -1.9588    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.8820    1.8959    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.4155    2.2112    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9553    3.6388    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5112    3.9541    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5175    2.8417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0573    1.4140    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4092    1.0988    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0635    0.3016    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6033   -1.1260    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6096   -2.2384    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9103   -2.9854    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0227   -1.9792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4095   -0.6102    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5300    0.6169    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9180   -0.7705    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9118    0.3419    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3720    1.7696    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4453    0.0267    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9824    0.4869    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6671   -0.9796    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0566   -1.5447    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1307   -2.2498    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  4  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 16 15  1  1
 16 17  1  0
 17 18  1  0
 19 18  1  1
 19 20  1  0
 19 21  1  0
 21 22  1  0
 22 23  2  0
 24 22  1  6
 24 25  1  0
 25 26  1  0
 26 27  1  0
 26 28  1  0
  6  2  1  0
 13  8  1  0
 20 14  1  0
 21 16  1  0
 26 24  1  0
M  END
>  <BrandName>  (86) 
nan

>  <Phase>  (86) 
2.0

>  <Applicants>  (86) 
Pfizer

>  <Links>  (86) 
|http://www.chemspider.com/Chemical-Structure.71107316.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL4297477|http://pubchem.ncbi.nlm.nih.gov/compound/118878093|http://www.drugbank.ca/drugs/DB15003| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=G4J|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/G4J|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10459|http://zinc15.docking.org/substances/ZINC000526061580|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=3X8387Q25N|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=329924

>  <LigID>  (86) 
'G4J'

>  <pdbID>  (86) 
6dbm 6dbn

>  <Type>  (86) 
nan

>  <RoF>  (86) 
0

>  <MW>  (86) 
389.2

>  <LogP>  (86) 
1.8

>  <TPSA>  (86) 
79.2

>  <HBA>  (86) 
7

>  <HBD>  (86) 
1

>  <NRB>  (86) 
4

>  <Indications>  (86) 
nan

>  <Targets>  (86) 
nan

>  <Kinase families>  (86) 


>  <Canonical_Smiles>  (86) 
Cn1cc(cn1)Nc2nccc(n2)N3C[C@H]4CC[C@@H](C3)N4C(=O)[C@@H]5CC5(F)F

>  <InChiKey>  (86) 
BUWBRTXGQRBBHG-MJBXVCDLSA-N

>  <First_Approval>  (86) 
nan

>  <SC_Patent>  (86) 
None

>  <Chirality>  (86) 
Single Stereoisomer

>  <Synonyms>  (86) 
BREPOCITINIB | PF-06700841

>  <FDA_approved>  (86) 


>  <Melting points>  (86) 


$$$$
Roniciclib
     RDKit          2D

 29 31  0  0  0  0  0  0  0  0999 V2000
    0.9989   -2.4021    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3274   -1.7015    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5973   -2.4998    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5410   -3.9987    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9237   -1.7991    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9800   -0.3002    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3064    0.4004    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3627    1.8994    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0928    2.6977    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7665    1.9970    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7101    0.4981    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4966    2.7953    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.8297    2.0947    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8861    0.5958    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2124   -0.1049    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4824    0.6934    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4260    2.1924    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0997    2.8930    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8087   -0.0072    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    5.5093    1.3191    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.1080   -1.3335    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.1350   -0.7079    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6339   -0.6515    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9333   -1.9778    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5763   -0.3979    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.8462   -1.1962    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -6.3746    0.8721    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7780   -1.6678    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3838   -0.2025    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  6
  2  3  1  0
  3  4  1  1
  3  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 19 16  1  1
 19 20  2  0
 19 21  2  0
 19 22  1  0
 22 23  1  0
 23 24  1  0
  7 25  1  0
 25 26  1  0
 25 27  1  0
 25 28  1  0
  2 29  1  0
 11  6  1  0
 18 13  1  0
 24 22  1  0
M  END
>  <BrandName>  (87) 
nan

>  <Phase>  (87) 
2.0

>  <Applicants>  (87) 
Bayer

>  <Links>  (87) 
|http://www.chemspider.com/Chemical-Structure.32697590.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL4282338|http://pubchem.ncbi.nlm.nih.gov/compound/71494949|http://www.drugbank.ca/drugs/DB12974|http://zinc15.docking.org/substances/ZINC000095616570|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=0W9Q8U337A

>  <LigID>  (87) 
nan

>  <pdbID>  (87) 
nan

>  <Type>  (87) 
nan

>  <RoF>  (87) 
0

>  <MW>  (87) 
430.1

>  <LogP>  (87) 
4

>  <TPSA>  (87) 
108.2

>  <HBA>  (87) 
7

>  <HBD>  (87) 
3

>  <NRB>  (87) 
7

>  <Indications>  (87) 
nan

>  <Targets>  (87) 
CDK1; CDK2; CDK4; CDK9

>  <Kinase families>  (87) 
CMGC

>  <Canonical_Smiles>  (87) 
C[C@H]([C@@H](C)Oc1c(cnc(n1)Nc2ccc(cc2)[S@](=N)(=O)C3CC3)C(F)(F)F)O

>  <InChiKey>  (87) 
UELYDGOOJPRWGF-SRQXXRKNSA-N

>  <First_Approval>  (87) 
nan

>  <SC_Patent>  (87) 
None

>  <Chirality>  (87) 
Single Stereoisomer

>  <Synonyms>  (87) 
nan

>  <FDA_approved>  (87) 


>  <Melting points>  (87) 


$$$$
Pelitinib
     RDKit          2D

 33 35  0  0  0  0  0  0  0  0999 V2000
    3.4050   -4.6409    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0006   -4.1140    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7547   -2.6343    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.3503   -2.1075    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8082   -3.0603    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2127   -2.5334    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4586   -1.0537    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3001   -0.1009    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1043   -0.6278    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2628    0.3251    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.6673   -0.2018    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9132   -1.6815    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.8258    0.7510    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2302    0.2242    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3887    1.1770    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7931    0.6501    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.9516    1.6029    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0390   -0.8296    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8630   -0.5268    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0215   -1.4797    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7756   -2.9594    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3712   -3.4862    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4259   -0.9528    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.8304   -0.4259    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1089    0.9529    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9504    1.9057    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5460    1.3788    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3875    2.3317    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6334    3.8114    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0379    4.3382    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1964    3.3854    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2838    5.8179    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.5251    4.7642    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 16 18  1  0
  7 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 20 23  1  0
 23 24  3  0
 19 25  1  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 30 32  1  0
 29 33  1  0
  9  4  1  0
 22  6  1  0
 31 26  1  0
M  END
>  <BrandName>  (88) 
nan

>  <Phase>  (88) 
2.0

>  <Applicants>  (88) 
Wyeth

>  <Links>  (88) 
|http://www.chemspider.com/Chemical-Structure.4949255.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL607707|http://pubchem.ncbi.nlm.nih.gov/compound/6445562|http://www.drugbank.ca/drugs/DB05524| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=93J|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/93J|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7644|http://zinc15.docking.org/substances/ZINC000000602803|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=X5DWL380Z6|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=31090

>  <LigID>  (88) 
'93J'

>  <pdbID>  (88) 
5vcw

>  <Type>  (88) 
1

>  <RoF>  (88) 
1

>  <MW>  (88) 
467.2

>  <LogP>  (88) 
5.1

>  <TPSA>  (88) 
90.3

>  <HBA>  (88) 
6

>  <HBD>  (88) 
2

>  <NRB>  (88) 
8

>  <Indications>  (88) 
nan

>  <Targets>  (88) 
EGFR; ERBB2

>  <Kinase families>  (88) 
Tyr

>  <Canonical_Smiles>  (88) 
CCOc1cc2c(cc1NC(=O)/C=C/CN(C)C)c(c(cn2)C#N)Nc3ccc(c(c3)Cl)F

>  <InChiKey>  (88) 
WVUNYSQLFKLYNI-AATRIKPKSA-N

>  <First_Approval>  (88) 
nan

>  <SC_Patent>  (88) 
None

>  <Chirality>  (88) 
Achiral Molecule

>  <Synonyms>  (88) 
EKB-569 | PELITINIB | WAY-EKB-569

>  <FDA_approved>  (88) 


>  <Melting points>  (88) 


$$$$
Pictilisib
     RDKit          2D

 35 40  0  0  0  0  0  0  0  0999 V2000
    8.7595   -2.1866    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5676   -1.2760    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    8.4782   -0.0840    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.6569   -2.4679    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.3756   -0.3653    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.9910   -0.9423    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7990   -0.0316    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9917    1.4559    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.3763    2.0329    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5683    1.1222    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7997    2.3666    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4151    1.7896    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0680    0.3303    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4271    0.2095    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0040    1.5941    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1345    2.5707    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4916    1.7867    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4022    0.5948    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8253   -0.7898    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3377   -0.9825    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7359   -1.9818    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2235   -1.7891    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1341   -2.9811    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5572   -4.3657    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0696   -4.5583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1590   -3.3664    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7439   -3.8641    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7801   -5.3637    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2174   -5.7927    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0685    3.1713    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1579    4.3633    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7349    5.7479    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2224    5.9405    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1331    4.7486    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5561    3.3640    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  2  0
  2  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  8 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 15 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 19 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 17 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
 33 34  1  0
 34 35  1  0
 10  5  1  0
 16 12  1  0
 20 14  1  0
 26 21  1  0
 29 25  1  0
 35 30  1  0
M  END
>  <BrandName>  (89) 
nan

>  <Phase>  (89) 
2.0

>  <Applicants>  (89) 
Hoffmann-La Roche

>  <Links>  (89) 
|http://www.chemspider.com/Chemical-Structure.21437049.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL521851|http://pubchem.ncbi.nlm.nih.gov/compound/17755052|http://www.drugbank.ca/drugs/DB11663| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=GD9|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/GD9|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5682|http://zinc15.docking.org/substances/ZINC16052714|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=ICY00EMP8P|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25028

>  <LigID>  (89) 
'GD9'

>  <pdbID>  (89) 
2wxp 2y3a 3dbs

>  <Type>  (89) 
1

>  <RoF>  (89) 
1

>  <MW>  (89) 
513.2

>  <LogP>  (89) 
2.1

>  <TPSA>  (89) 
107.6

>  <HBA>  (89) 
9

>  <HBD>  (89) 
1

>  <NRB>  (89) 
5

>  <Indications>  (89) 
nan

>  <Targets>  (89) 
PIK3CA; PIK3CB; PIK3CD; PIK3CG

>  <Kinase families>  (89) 
Atypical

>  <Canonical_Smiles>  (89) 
CS(=O)(=O)N1CCN(CC1)Cc2cc3c(s2)c(nc(n3)c4cccc5c4cn[nH]5)N6CCOCC6

>  <InChiKey>  (89) 
LHNIIDJUOCFXAP-UHFFFAOYSA-N

>  <First_Approval>  (89) 
nan

>  <SC_Patent>  (89) 
None

>  <Chirality>  (89) 
Achiral Molecule

>  <Synonyms>  (89) 
CDC-0941 | GDC 0941 | GDC-0941 | PICTILISIB | RG-7321

>  <FDA_approved>  (89) 


>  <Melting points>  (89) 


$$$$
Pimasertib
     RDKit          2D

 23 24  0  0  0  0  0  0  0  0999 V2000
    4.6692   -2.5075    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1901   -2.2576    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6671   -0.8517    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6231    0.3042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1021    0.0542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6251   -1.3517    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1042   -1.6016    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0
    3.1001    1.7100    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    1.1881   -0.6018    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.6650    0.8041    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6210    1.9600    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0980    3.3658    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3810    3.6158    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3370    2.4599    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8140    1.0541    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7700   -0.1018    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2469   -1.5077    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2490    0.1481    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2050   -1.0077    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6840   -0.7578    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6400   -1.9137    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.1190   -1.6637    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2071    0.6481    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  4  8  1  0
  3  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 16 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 20 23  1  1
  6  1  1  0
 15 10  1  0
M  END
>  <BrandName>  (90) 
 AS703026; EMD 1036239;MSC1936369A;MSC1936369A; AS703026; EMD 1036239

>  <Phase>  (90) 
2.0

>  <Applicants>  (90) 
Merck

>  <Links>  (90) 
|http://www.chemspider.com/Chemical-Structure.24747378.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL2107832|http://pubchem.ncbi.nlm.nih.gov/compound/44187362|http://www.drugbank.ca/drugs/DB14904|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7872|http://zinc15.docking.org/substances/ZINC38226009|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=6ON9RK82AL|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50014412

>  <LigID>  (90) 
nan

>  <pdbID>  (90) 
nan

>  <Type>  (90) 
nan

>  <RoF>  (90) 
0

>  <MW>  (90) 
431

>  <LogP>  (90) 
1.7

>  <TPSA>  (90) 
94.5

>  <HBA>  (90) 
5

>  <HBD>  (90) 
4

>  <NRB>  (90) 
6

>  <Indications>  (90) 
nan

>  <Targets>  (90) 
MAP2K1; MAP2K2

>  <Kinase families>  (90) 
STE

>  <Canonical_Smiles>  (90) 
c1cc(c(cc1I)F)Nc2cnccc2C(=O)NC[C@@H](CO)O

>  <InChiKey>  (90) 
VIUAUNHCRHHYNE-JTQLQIEISA-N

>  <First_Approval>  (90) 
nan

>  <SC_Patent>  (90) 
None

>  <Chirality>  (90) 
Single Stereoisomer

>  <Synonyms>  (90) 
AS 703026 | AS-703026 | AS703026 | EMD 1036239 | EMD-1036239 | G-02443714 | MSC-1936369A | MSC-1936369B | MSC1936369A | MSC1936369A; AS703026; EMD 1036239 | PIMASERTIB

>  <FDA_approved>  (90) 


>  <Melting points>  (90) 


$$$$
Acalisib
     RDKit          2D

 30 34  0  0  0  0  0  0  0  0999 V2000
   -1.1075    1.7366    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7253    0.2861    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7220   -0.1081    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1042   -1.5586    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.5515   -1.9528    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9337   -3.4033    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3810   -3.7975    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4460   -2.7413    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0638   -1.2908    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6165   -0.8965    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2343    0.5539    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2993    1.6102    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.7870    0.9482    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.4048    2.3986    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4698    3.4549    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0876    4.9054    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6403    5.2996    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4247    4.2434    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0425    2.7929    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8933   -3.1355    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7903   -0.7701    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2376   -0.3759    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3027   -1.4322    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7499   -1.0380    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5721   -2.2926    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6329   -3.4622    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2303   -2.9304    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1321    0.4125    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0671    1.4688    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6198    1.0746    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  1
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
  8 20  1  0
  2 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 24 28  1  0
 28 29  2  0
 29 30  1  0
 13  3  1  0
 10  5  1  0
 19 14  1  0
 30 22  2  0
 27 23  1  0
M  END
>  <BrandName>  (91) 
nan

>  <Phase>  (91) 
2.0

>  <Applicants>  (91) 
Gilead Sciences

>  <Links>  (91) 
|http://www.chemspider.com/Chemical-Structure.9793017.html|http://pubchem.ncbi.nlm.nih.gov/compound/11618268|http://www.drugbank.ca/drugs/DB15407|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10096|http://zinc15.docking.org/substances/ZINC000035943170|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=OVW60IDW1D|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=217352

>  <LigID>  (91) 
nan

>  <pdbID>  (91) 
nan

>  <Type>  (91) 
nan

>  <RoF>  (91) 
0

>  <MW>  (91) 
401.1

>  <LogP>  (91) 
3.4

>  <TPSA>  (91) 
101.4

>  <HBA>  (91) 
7

>  <HBD>  (91) 
2

>  <NRB>  (91) 
4

>  <Indications>  (91) 
nan

>  <Targets>  (91) 
PIK3CA

>  <Kinase families>  (91) 
Atypical

>  <Canonical_Smiles>  (91) 
C[C@@H](c1nc2ccc(cc2c(=O)n1c3ccccc3)F)Nc4c5c(nc[nH]5)ncn4

>  <InChiKey>  (91) 
DOCINCLJNAXZQF-LBPRGKRZSA-N

>  <First_Approval>  (91) 
nan

>  <SC_Patent>  (91) 
None

>  <Chirality>  (91) 
Single Stereoisomer

>  <Synonyms>  (91) 
|CAL-120

>  <FDA_approved>  (91) 


>  <Melting points>  (91) 


$$$$
Refametinib
     RDKit          2D

 31 33  0  0  0  0  0  0  0  0999 V2000
   -3.2633    2.0696    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9883    1.2795    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6665    1.9887    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6198    3.4880    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7020    4.1972    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9770    3.4071    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9303    1.9078    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6085    1.1986    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5618   -0.3006    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7600   -1.0098    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4691    0.3119    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0508   -2.3316    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0817   -1.7190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0812   -2.8375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6129   -3.1438    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0097   -0.5405    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4943   -0.7548    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4222    0.4237    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.9068    0.2094    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0510   -2.1477    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.2053    1.1177    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.1586   -0.3816    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8368   -1.0907    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7901   -2.5900    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0652   -3.3801    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3869   -2.6709    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4337   -1.1717    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7554   -0.4625    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    3.0185   -4.8794    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0
    3.2988    4.1163    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.7487    5.6964    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 10 12  2  0
 10 13  1  0
 13 14  1  0
 14 15  1  0
 13 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 17 20  1  6
  7 21  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 25 29  1  0
  6 30  1  0
  5 31  1  0
  8  3  1  0
 15 13  1  0
 27 22  1  0
M  END
>  <BrandName>  (92) 
nan

>  <Phase>  (92) 
2.0

>  <Applicants>  (92) 
Bayer

>  <Links>  (92) 
|http://www.chemspider.com/Chemical-Structure.25058723.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL1236682|http://pubchem.ncbi.nlm.nih.gov/compound/44182295|http://www.drugbank.ca/drugs/DB06309| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=VRA|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/VRA|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7942|http://zinc15.docking.org/substances/ZINC39187987|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=JPX07AFM0N

>  <LigID>  (92) 
'VRA'

>  <pdbID>  (92) 
3e8n

>  <Type>  (92) 
nan

>  <RoF>  (92) 
1

>  <MW>  (92) 
572

>  <LogP>  (92) 
3.5

>  <TPSA>  (92) 
107.9

>  <HBA>  (92) 
6

>  <HBD>  (92) 
4

>  <NRB>  (92) 
9

>  <Indications>  (92) 
nan

>  <Targets>  (92) 
MAP2K1

>  <Kinase families>  (92) 
STE

>  <Canonical_Smiles>  (92) 
COc1cc(c(c(c1NS(=O)(=O)C2(CC2)C[C@@H](CO)O)Nc3ccc(cc3F)I)F)F

>  <InChiKey>  (92) 
RDSACQWTXKSHJT-NSHDSACASA-N

>  <First_Approval>  (92) 
nan

>  <SC_Patent>  (92) 
None

>  <Chirality>  (92) 
Single Stereoisomer

>  <Synonyms>  (92) 
BAY 869766 | BAY 8697661 | BAY-86-9766 | BAY-869766 | BAY-8697661 | BAY86-9766 | RDEA 119 | RDEA-119 | REFAMETINIB

>  <FDA_approved>  (92) 


>  <Melting points>  (92) 


$$$$
Rebastinib
     RDKit          2D

 41 45  0  0  0  0  0  0  0  0999 V2000
    4.7071    5.4105    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2360    5.1173    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7650    4.8241    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9428    6.5883    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5292    3.6462    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5114    2.5443    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2449    1.2359    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7159    1.5291    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.8917    3.0187    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.8178    0.5113    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2502    0.9567    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3520   -0.0611    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0216   -1.5243    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5892   -1.9696    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4873   -0.9518    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2587   -3.4328    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3606   -4.4505    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7929   -4.0052    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1234   -2.5420    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.6174   -0.1266    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1238   -0.2644    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2576    0.9602    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.4963   -1.6269    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9974   -1.7647    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8636   -0.5400    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3572   -0.6779    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9847   -2.0403    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1185   -3.2650    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6248   -3.1271    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7587   -4.3518    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4783   -2.1781    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.3445   -0.9535    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7171    0.4089    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5832    1.6336    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.0769    1.4957    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -8.7044    0.1333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.8382   -1.0913    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.1980   -0.0045    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.8255   -1.3670    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  -11.0642    1.2201    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  -12.5579    1.0823    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  2  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  8 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 14 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
  7 20  1  0
 20 21  1  0
 21 22  2  0
 21 23  1  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 27 31  1  0
 31 32  1  0
 32 33  2  0
 33 34  1  0
 34 35  2  0
 35 36  1  0
 36 37  2  0
 36 38  1  0
 38 39  2  0
 38 40  1  0
 40 41  1  0
  9  5  2  0
 15 10  1  0
 19 13  1  0
 29 24  1  0
 37 32  1  0
M  END
>  <BrandName>  (93) 
DP-1919

>  <Phase>  (93) 
2.0

>  <Applicants>  (93) 
Deciphera Pharmaceuticals

>  <Links>  (93) 
|http://www.chemspider.com/Chemical-Structure.26325986.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL1738757|http://pubchem.ncbi.nlm.nih.gov/compound/25066467|http://www.drugbank.ca/drugs/DB13005| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=919|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/919|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9173|http://zinc15.docking.org/substances/ZINC63933734|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=75017Q6I97|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=185674

>  <LigID>  (93) 
'919'

>  <pdbID>  (93) 
3qri 3qrj 5g6v 6cnh 6mwe

>  <Type>  (93) 
2

>  <RoF>  (93) 
2

>  <MW>  (93) 
553.2

>  <LogP>  (93) 
6

>  <TPSA>  (93) 
123.1

>  <HBA>  (93) 
7

>  <HBD>  (93) 
3

>  <NRB>  (93) 
6

>  <Indications>  (93) 
nan

>  <Targets>  (93) 
FLT3; TEK; KDR; LYN; BCR; ABL1; NTRK1

>  <Kinase families>  (93) 
Tyr<br>Atypical

>  <Canonical_Smiles>  (93) 
CC(C)(C)c1cc(n(n1)c2ccc3c(c2)cccn3)NC(=O)Nc4ccc(cc4F)Oc5ccnc(c5)C(=O)NC

>  <InChiKey>  (93) 
WVXNSAVVKYZVOE-UHFFFAOYSA-N

>  <First_Approval>  (93) 
nan

>  <SC_Patent>  (93) 
None

>  <Chirality>  (93) 
Achiral Molecule

>  <Synonyms>  (93) 
DCC-2036 | DCC-2036 FREE BASE | DP-1919 | REBASTINIB

>  <FDA_approved>  (93) 


>  <Melting points>  (93) 


$$$$
Prexasertib
     RDKit          2D

 27 29  0  0  0  0  0  0  0  0999 V2000
   -2.6180   -5.2908    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1320   -3.8717    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1179   -2.7412    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5899   -3.0299    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5759   -1.8994    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0898   -0.4803    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6178   -0.1917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6319   -1.3222    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1599   -1.0336    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5282    0.3269    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9609    0.1466    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2495   -1.3254    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0612   -2.0548    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.9821    1.2453    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.4442    0.9102    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8851   -0.5235    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3472   -0.8585    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.3684    0.2401    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9275    1.6739    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4654    2.0089    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.8305   -0.0949    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2926   -0.4299    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1318    1.2274    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1177    2.3578    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6317    3.7769    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6176    4.9073    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1316    6.3264    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 11 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 18 21  1  0
 21 22  3  0
  7 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
  8  3  1  0
 13  9  1  0
 20 15  1  0
M  END
>  <BrandName>  (94) 
nan

>  <Phase>  (94) 
2.0

>  <Applicants>  (94) 
Eli Lilly

>  <Links>  (94) 
|http://www.chemspider.com/Chemical-Structure.32738771.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3544911|http://pubchem.ncbi.nlm.nih.gov/compound/46700756|http://www.drugbank.ca/drugs/DB12008|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9549|http://zinc15.docking.org/substances/ZINC000095837013|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=820NH671E6

>  <LigID>  (94) 
nan

>  <pdbID>  (94) 
nan

>  <Type>  (94) 
nan

>  <RoF>  (94) 
0

>  <MW>  (94) 
365.2

>  <LogP>  (94) 
2.2

>  <TPSA>  (94) 
134.8

>  <HBA>  (94) 
8

>  <HBD>  (94) 
3

>  <NRB>  (94) 
8

>  <Indications>  (94) 
nan

>  <Targets>  (94) 
CHEK1; CHEK2

>  <Kinase families>  (94) 
CAMK

>  <Canonical_Smiles>  (94) 
COc1cccc(c1c2cc(n[nH]2)Nc3cnc(cn3)C#N)OCCCN

>  <InChiKey>  (94) 
DOTGPNHGTYJDEP-UHFFFAOYSA-N

>  <First_Approval>  (94) 
nan

>  <SC_Patent>  (94) 
None

>  <Chirality>  (94) 
Achiral Molecule

>  <Synonyms>  (94) 
LY2606368 | PREXASERTIB

>  <FDA_approved>  (94) 


>  <Melting points>  (94) 


$$$$
Ralimetinib
     RDKit          2D

 31 34  0  0  0  0  0  0  0  0999 V2000
   -5.5614   -2.4115    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2323   -1.7161    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9032   -1.0207    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5369   -3.0451    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9277   -0.3870    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1244    0.8798    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6274    0.9745    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2549    2.4275    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8103    2.8314    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2618    1.7822    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1107    0.3292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5553   -0.0747    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.9613   -0.7199    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4403   -0.4692    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1357   -1.7983    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.0865   -2.8704    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7427   -2.2039    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.3372   -4.3493    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8583   -4.5999    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8161   -4.0986    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5879   -5.8282    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1067    0.8746    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2762    2.1237    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9427    3.4675    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4397    3.5622    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2702    2.3131    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6037    0.9693    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1062    4.9060    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5217    3.2308    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6771    2.2742    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1301    2.6468    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  2  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 16 18  1  0
 18 19  1  0
 18 20  1  0
 18 21  1  0
 14 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 25 28  1  0
  8 29  1  0
 29 30  2  0
 30 31  1  0
 30  6  1  0
 12  7  1  0
 17 13  1  0
 27 22  1  0
M  END
>  <BrandName>  (95) 
nan

>  <Phase>  (95) 
2.0

>  <Applicants>  (95) 
Eli Lilly

>  <Links>  (95) 
|http://www.chemspider.com/Chemical-Structure.9713805.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL2364626|http://pubchem.ncbi.nlm.nih.gov/compound/11539025|http://www.drugbank.ca/drugs/DB11787|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7959|http://zinc15.docking.org/substances/ZINC34630490|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=73I34XW4HD

>  <LigID>  (95) 
nan

>  <pdbID>  (95) 
nan

>  <Type>  (95) 
nan

>  <RoF>  (95) 
1

>  <MW>  (95) 
420.2

>  <LogP>  (95) 
5.6

>  <TPSA>  (95) 
85.4

>  <HBA>  (95) 
5

>  <HBD>  (95) 
2

>  <NRB>  (95) 
3

>  <Indications>  (95) 
nan

>  <Targets>  (95) 
MAPK14; MAPK11

>  <Kinase families>  (95) 
CMGC

>  <Canonical_Smiles>  (95) 
CC(C)(C)Cn1c2c(ccc(n2)c3c(nc([nH]3)C(C)(C)C)c4ccc(cc4)F)nc1N

>  <InChiKey>  (95) 
XPPBBJCBDOEXDN-UHFFFAOYSA-N

>  <First_Approval>  (95) 
nan

>  <SC_Patent>  (95) 
None

>  <Chirality>  (95) 
Achiral Molecule

>  <Synonyms>  (95) 
LSN-2322600 FREE BASE | LSN2322600 FREE BASE | LY-2228820 | LY2228820 | LY22288220 | RALIMETINIB

>  <FDA_approved>  (95) 


>  <Melting points>  (95) 


$$$$
Poziotinib
     RDKit          2D

 33 36  0  0  0  0  0  0  0  0999 V2000
   -1.9114    6.7012    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3000    5.2524    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2396    4.1915    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2094    4.5794    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2698    3.5184    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8812    2.0696    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5678    1.6818    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6282    2.7427    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0772    2.3549    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4658    0.9061    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9148    0.5182    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3034   -0.9306    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2430   -1.9915    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7940   -1.6036    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4054   -0.1549    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6316   -3.4403    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5712   -4.5012    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0806   -3.8282    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4692   -5.2769    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9416    1.0087    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3906    1.3966    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.7792    2.8454    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7188    3.9063    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.5530   -0.4401    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.6134   -1.5010    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2248   -2.9498    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2851   -4.0107    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7341   -3.6229    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1227   -2.1741    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0623   -1.1131    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4509    0.3356    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    6.5717   -1.7862    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    5.7945   -4.6838    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 13 16  1  0
 16 17  2  0
 16 18  1  0
 18 19  2  0
  6 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 20 24  1  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 29 32  1  0
 28 33  1  0
  8  3  1  0
 23  5  1  0
 15 10  1  0
 30 25  1  0
M  END
>  <BrandName>  (96) 
nan

>  <Phase>  (96) 
2.0

>  <Applicants>  (96) 
Hanmi Pharmaceutical

>  <Links>  (96) 
|http://www.chemspider.com/Chemical-Structure.30687714.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3545154|http://pubchem.ncbi.nlm.nih.gov/compound/25127713|http://www.drugbank.ca/drugs/DB12114|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7903|http://zinc15.docking.org/substances/ZINC000095930125|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=OEI6OOU6IK

>  <LigID>  (96) 
nan

>  <pdbID>  (96) 
nan

>  <Type>  (96) 
nan

>  <RoF>  (96) 
1

>  <MW>  (96) 
490.1

>  <LogP>  (96) 
5.4

>  <TPSA>  (96) 
76.6

>  <HBA>  (96) 
6

>  <HBD>  (96) 
1

>  <NRB>  (96) 
6

>  <Indications>  (96) 
nan

>  <Targets>  (96) 
EGFR

>  <Kinase families>  (96) 
Tyr

>  <Canonical_Smiles>  (96) 
COc1cc2c(cc1OC3CCN(CC3)C(=O)C=C)c(ncn2)Nc4ccc(c(c4F)Cl)Cl

>  <InChiKey>  (96) 
LPFWVDIFUFFKJU-UHFFFAOYSA-N

>  <First_Approval>  (96) 
nan

>  <SC_Patent>  (96) 
None

>  <Chirality>  (96) 
Achiral Molecule

>  <Synonyms>  (96) 
HM 781-36B | HM-781-36B | NOV-120101 | POZIOTINIB

>  <FDA_approved>  (96) 


>  <Melting points>  (96) 


$$$$
Tarloxotinib
     RDKit          2D

 39 41  0  0  0  0  0  0  0  0999 V2000
   -5.5014    1.0971    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.0006    1.1446    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -7.8434    2.3855    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.2839    1.9675    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -9.3315    0.4682    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.9203   -0.0403    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.5023   -1.4809    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0457   -1.8391    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6874   -0.3825    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4039   -3.2957    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5891   -2.1973    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5505   -1.1150    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0939   -1.4733    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0554   -0.3909    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4735    1.0496    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.4012   -0.7492    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.4397    0.3332    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8963   -0.0251    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9349    1.0573    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5168    2.4978    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0602    2.8561    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0217    1.7737    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.5553    3.5802    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.0119    3.2219    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4300    1.7814    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.3915    0.6990    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8095   -0.7415    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.2661   -1.0998    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6842   -2.5403    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1408   -2.8986    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1793   -1.8162    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7612   -0.3757    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3046   -0.0174    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7998    0.7066    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
   11.6359   -2.1745    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  -10.5724   -0.3745    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  -10.4630   -1.8705    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  -11.9227    0.2787    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    4.5802    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  8 10  1  0
  8 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 14 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 20 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 32  1  0
 32 33  2  0
 32 34  1  0
 31 35  1  0
  5 36  1  0
 36 37  2  0
 36 38  1  0
  6  2  1  0
 22 17  1  0
 26 19  1  0
 33 28  1  0
M  CHG  4   8   1  36   1  38  -1  39  -1
M  END
>  <BrandName>  (97) 
nan

>  <Phase>  (97) 
2.0

>  <Applicants>  (97) 
Threshold Pharmaceuticals

>  <Links>  (97) 
|http://www.chemspider.com/Chemical-Structure.46518771.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL4297662|http://pubchem.ncbi.nlm.nih.gov/compound/51038315|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=3Y31FJ8K50

>  <LigID>  (97) 
nan

>  <pdbID>  (97) 
nan

>  <Type>  (97) 
nan

>  <RoF>  (97) 
1

>  <MW>  (97) 
679

>  <LogP>  (97) 
1.6

>  <TPSA>  (97) 
140.8

>  <HBA>  (97) 
9

>  <HBD>  (97) 
2

>  <NRB>  (97) 
9

>  <Indications>  (97) 
nan

>  <Targets>  (97) 
EGFR

>  <Kinase families>  (97) 
Tyr

>  <Canonical_Smiles>  (97) 
Cn1cnc(c1C[N+](C)(C)C/C=C/C(=O)Nc2cc3c(cn2)ncnc3Nc4ccc(c(c4)Br)Cl)[N+](=O)[O-].[Br-]

>  <InChiKey>  (97) 
WAKIMVYUBWMMHJ-FXRZFVDSSA-N

>  <First_Approval>  (97) 
nan

>  <SC_Patent>  (97) 
None

>  <Chirality>  (97) 
Achiral Molecule

>  <Synonyms>  (97) 
TARLOXOTINIB BROMIDE

>  <FDA_approved>  (97) 


>  <Melting points>  (97) 


$$$$
Seletalisib
     RDKit          2D

 34 38  0  0  0  0  0  0  0  0999 V2000
    6.7285   -1.3616    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3533   -1.9606    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1470   -1.0692    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7718   -1.6682    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5654   -0.7767    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7343    0.7137    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1095    1.3127    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.3158    0.4213    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6910    1.0203    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8974    0.1288    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8599    2.5108    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.5279    1.6052    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8473    1.0062    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0537    1.8976    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8848    3.3881    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5096    3.9871    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.6968    3.0957    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3408    5.4776    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.1902   -1.3757    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0214   -2.8662    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1475   -4.3567    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4691   -2.6974    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    1.5118   -3.0351    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0161   -0.4843    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3914   -1.0833    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5977   -0.1918    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9729   -0.7908    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1793    0.1006    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0104    1.5911    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6352    2.1901    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4289    1.2986    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1418   -2.2813    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9354   -3.1728    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5602   -2.5738    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
  6 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 16 18  1  0
  5 19  1  0
 19 20  1  0
 20 21  1  0
 20 22  1  0
 20 23  1  0
 19 24  1  6
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 27 32  1  0
 32 33  2  0
 33 34  1  0
 10  1  1  0
  8  3  1  0
 17 12  1  0
 34 25  2  0
 31 26  2  0
M  CHG  2  16   1  18  -1
M  END
>  <BrandName>  (98) 
nan

>  <Phase>  (98) 
2.0

>  <Applicants>  (98) 
UCB

>  <Links>  (98) 
|http://www.chemspider.com/Chemical-Structure.34985875.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL4297648|http://pubchem.ncbi.nlm.nih.gov/compound/56928390|http://www.drugbank.ca/drugs/DB12706|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9800|http://zinc15.docking.org/substances/ZINC000144763934|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=64CW205BDD

>  <LigID>  (98) 
nan

>  <pdbID>  (98) 
nan

>  <Type>  (98) 
nan

>  <RoF>  (98) 
1

>  <MW>  (98) 
482.1

>  <LogP>  (98) 
5.2

>  <TPSA>  (98) 
90.5

>  <HBA>  (98) 
6

>  <HBD>  (98) 
1

>  <NRB>  (98) 
4

>  <Indications>  (98) 
nan

>  <Targets>  (98) 
nan

>  <Kinase families>  (98) 


>  <Canonical_Smiles>  (98) 
c1cc2cc(c(nc2c(c1)Cl)c3ccc[n+](c3)[O-])[C@H](C(F)(F)F)Nc4c5c(cccn5)ncn4

>  <InChiKey>  (98) 
LNLJHGXOFYUARS-OAQYLSRUSA-N

>  <First_Approval>  (98) 
nan

>  <SC_Patent>  (98) 
None

>  <Chirality>  (98) 
Single Stereoisomer

>  <Synonyms>  (98) 
SELETALISIB | UCB-5857 | UCB5857

>  <FDA_approved>  (98) 


>  <Melting points>  (98) 


$$$$
Solcitinib
     RDKit          2D

 29 33  0  0  0  0  0  0  0  0999 V2000
   -6.7790    3.7937    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5480    2.9365    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3171    2.0794    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1742    0.8484    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4052    1.7056    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9099   -0.6281    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0564   -1.5953    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4990   -1.1375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2346   -2.6140    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8238   -3.1233    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6772   -2.1561    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9416   -0.6796    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3524   -0.1703    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7337   -2.6655    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9980   -4.1420    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4089   -4.6513    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5554   -3.6841    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2911   -2.2076    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8802   -1.6983    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.9286   -0.1991    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.3694    0.2182    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2115   -1.0232    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.8788    1.6291    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.3553    1.8934    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3225    0.7469    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.8646    3.3043    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6003    4.7808    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0111    4.2715    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6909    4.1675    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  4  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 11 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 21 23  1  0
 23 24  1  0
 24 25  2  0
 24 26  1  0
 26 27  1  0
 27 28  1  0
  2 29  1  0
  5  2  1  0
 13  8  1  0
 19 14  1  0
 22 18  2  0
 28 26  1  0
M  END
>  <BrandName>  (99) 
nan

>  <Phase>  (99) 
2.0

>  <Applicants>  (99) 
GlaxoSmithKline

>  <Links>  (99) 
|http://www.chemspider.com/Chemical-Structure.31389944.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3301606|http://pubchem.ncbi.nlm.nih.gov/compound/44603362|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9697|http://zinc15.docking.org/substances/ZINC000118401631|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=3V7GQ1260K|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=128101

>  <LigID>  (99) 
nan

>  <pdbID>  (99) 
nan

>  <Type>  (99) 
nan

>  <RoF>  (99) 
0

>  <MW>  (99) 
389.2

>  <LogP>  (99) 
3.2

>  <TPSA>  (99) 
79.6

>  <HBA>  (99) 
5

>  <HBD>  (99) 
1

>  <NRB>  (99) 
4

>  <Indications>  (99) 
nan

>  <Targets>  (99) 
JAK1

>  <Kinase families>  (99) 
Tyr

>  <Canonical_Smiles>  (99) 
CC1(CN(C1)C(=O)c2ccc(cc2)c3cccc4n3nc(n4)NC(=O)C5CC5)C

>  <InChiKey>  (99) 
MPYACSQFXVMWNO-UHFFFAOYSA-N

>  <First_Approval>  (99) 
nan

>  <SC_Patent>  (99) 
None

>  <Chirality>  (99) 
Achiral Molecule

>  <Synonyms>  (99) 
G154578 | GLPG-0778 | GLPG-0788 | GLPG0778 | GSK-2586184 | GSK-2586184A | GSK2586184A | SOLCITINIB

>  <FDA_approved>  (99) 


>  <Melting points>  (99) 


$$$$
Uprosertib
     RDKit          2D

 28 30  0  0  0  0  0  0  0  0999 V2000
   -5.9815   -0.1961    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0158    0.9517    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5196    0.8451    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9559    2.2351    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1037    3.2008    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3768    2.4076    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5000    2.5961    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -2.7264   -0.4280    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2302   -0.5346    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8693   -1.9906    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1424   -2.7838    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2902   -1.8181    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7461   -2.1790    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.5208   -2.5543    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7276   -4.0400    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.7040   -1.6324    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.0940   -2.1961    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2773   -1.2742    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0705    0.2115    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2537    1.1334    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0469    2.6191    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6569    3.1829    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4736    2.2609    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6804    0.7752    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0836    2.8247    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    3.4501    4.6685    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    3.3008   -3.6818    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1176   -4.6037    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  4  7  1  0
  3  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 10 14  1  0
 14 15  2  0
 14 16  1  0
 16 17  1  0
 17 18  1  1
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 23 25  1  0
 22 26  1  0
 17 27  1  0
 27 28  1  0
  6  2  1  0
 12  8  2  0
 24 19  1  0
M  END
>  <BrandName>  (100) 
nan

>  <Phase>  (100) 
2.0

>  <Applicants>  (100) 
GlaxoSmithKline

>  <Links>  (100) 
|http://www.chemspider.com/Chemical-Structure.32701836.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3137336|http://pubchem.ncbi.nlm.nih.gov/compound/51042438|http://www.drugbank.ca/drugs/DB11969|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7902|http://zinc15.docking.org/substances/ZINC000043197676|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=ZXM835LQ5E|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50170284

>  <LigID>  (100) 
nan

>  <pdbID>  (100) 
nan

>  <Type>  (100) 
nan

>  <RoF>  (100) 
0

>  <MW>  (100) 
428.1

>  <LogP>  (100) 
3.6

>  <TPSA>  (100) 
86.1

>  <HBA>  (100) 
5

>  <HBD>  (100) 
2

>  <NRB>  (100) 
6

>  <Indications>  (100) 
nan

>  <Targets>  (100) 
AKT1; AKT2; AKT3

>  <Kinase families>  (100) 
AGC

>  <Canonical_Smiles>  (100) 
Cn1c(c(cn1)Cl)c2cc(oc2Cl)C(=O)N[C@@H](Cc3ccc(c(c3)F)F)CN

>  <InChiKey>  (100) 
AXTAPYRUEKNRBA-JTQLQIEISA-N

>  <First_Approval>  (100) 
nan

>  <SC_Patent>  (100) 
None

>  <Chirality>  (100) 
Single Stereoisomer

>  <Synonyms>  (100) 
GSK-2141795 | GSK-2141795C | GSK2141795 | GSK2141795C | UPROSERTIB

>  <FDA_approved>  (100) 


>  <Melting points>  (100) 


$$$$
Tamatinib
     RDKit          2D

 34 37  0  0  0  0  0  0  0  0999 V2000
   -8.8557   -2.0564    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.3456   -0.6458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.3488    0.8542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.6495    1.6014    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -7.0514    1.6070    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7508    0.8598    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7476   -0.6402    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4469   -1.3875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1495   -0.6347    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1527    0.8653    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4533    1.6125    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8553    1.6181    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5546    0.8708    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5514   -0.6291    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7492   -1.3764    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0466   -0.6236    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.0434    0.8764    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7428    1.6236    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.3409    1.6292    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.6415    0.8819    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6447   -0.6181    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9453   -1.3653    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2428   -0.6125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2396    0.8875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9389    1.6347    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5370    1.6403    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.5338    3.1402    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5434   -1.3597    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.8408   -0.6070    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9485   -2.8653    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.6511   -3.6181    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8489   -1.3819    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -7.0450   -1.3930    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -9.8234   -0.3885    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 24 26  1  0
 26 27  1  0
 23 28  1  0
 28 29  1  0
 22 30  1  0
 30 31  1  0
 14 32  1  0
  7 33  1  0
  2 34  1  0
 33  2  1  0
 11  6  1  0
 18 13  1  0
 25 20  1  0
M  END
>  <BrandName>  (101) 
nan

>  <Phase>  (101) 
2.0

>  <Applicants>  (101) 
Rigel Pharmaceuticals

>  <Links>  (101) 
|http://www.chemspider.com/Chemical-Structure.9388620.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL475251|http://pubchem.ncbi.nlm.nih.gov/compound/11213558|http://www.drugbank.ca/drugs/DB07159| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=585|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/585|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7425|http://zinc15.docking.org/substances/ZINC06745792|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=RC3A285J2G|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=60665

>  <LigID>  (101) 
'585'

>  <pdbID>  (101) 
3fqs 3piy

>  <Type>  (101) 
1

>  <RoF>  (101) 
0

>  <MW>  (101) 
470.2

>  <LogP>  (101) 
3.6

>  <TPSA>  (101) 
128.8

>  <HBA>  (101) 
10

>  <HBD>  (101) 
3

>  <NRB>  (101) 
7

>  <Indications>  (101) 
nan

>  <Targets>  (101) 
SYK

>  <Kinase families>  (101) 
Tyr

>  <Canonical_Smiles>  (101) 
CC1(C(=O)Nc2c(ccc(n2)Nc3c(cnc(n3)Nc4cc(c(c(c4)OC)OC)OC)F)O1)C

>  <InChiKey>  (101) 
NHHQJBCNYHBUSI-UHFFFAOYSA-N

>  <First_Approval>  (101) 
nan

>  <SC_Patent>  (101) 
nan

>  <Chirality>  (101) 
nan

>  <Synonyms>  (101) 
R-406

>  <FDA_approved>  (101) 


>  <Melting points>  (101) 


$$$$
Vistusertib
     RDKit          2D

 34 38  0  0  0  0  0  0  0  0999 V2000
   -1.0315   -3.6070    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5311   -3.5725    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3107   -4.8540    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8104   -4.8196    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5304   -3.5037    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7508   -2.2222    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2511   -2.2566    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4715   -0.9752    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9719   -1.0096    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2519   -2.3255    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2477   -2.3599    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0273   -1.0784    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3073    0.2375    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1923    0.2719    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9123    1.5878    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4120    1.6222    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1916    0.3407    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1320    2.9381    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3524    4.2196    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0724    5.5355    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5720    5.5699    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3516    4.2884    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6316    2.9725    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4112    1.6911    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5269   -1.1128    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2469   -2.4287    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7465   -2.4631    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5261   -1.1816    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8061    0.1343    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3065    0.1687    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5857    1.4158    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8657    2.7317    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.0853    1.3814    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.8649    2.6629    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  1
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 16 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  1
 12 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 29 31  1  0
 31 32  2  0
 31 33  1  0
 33 34  1  0
  7  2  1  0
 17  8  2  0
 14  9  1  0
 23 18  1  0
 30 25  1  0
M  END
>  <BrandName>  (102) 
nan

>  <Phase>  (102) 
2.0

>  <Applicants>  (102) 
Astrazeneca

>  <Links>  (102) 
|http://www.chemspider.com/Chemical-Structure.28294977.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL2336325|http://pubchem.ncbi.nlm.nih.gov/compound/25262792|http://www.drugbank.ca/drugs/DB11925|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7699|http://zinc15.docking.org/substances/ZINC000059258964|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=0BSC3P4H5X|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50429701

>  <LigID>  (102) 
nan

>  <pdbID>  (102) 
nan

>  <Type>  (102) 
nan

>  <RoF>  (102) 
0

>  <MW>  (102) 
462.2

>  <LogP>  (102) 
2.5

>  <TPSA>  (102) 
92.7

>  <HBA>  (102) 
8

>  <HBD>  (102) 
1

>  <NRB>  (102) 
4

>  <Indications>  (102) 
nan

>  <Targets>  (102) 
MTOR

>  <Kinase families>  (102) 
Atypical

>  <Canonical_Smiles>  (102) 
C[C@H]1COCCN1c2c3ccc(nc3nc(n2)N4CCOC[C@@H]4C)c5cccc(c5)C(=O)NC

>  <InChiKey>  (102) 
JUSFANSTBFGBAF-IRXDYDNUSA-N

>  <First_Approval>  (102) 
nan

>  <SC_Patent>  (102) 
None

>  <Chirality>  (102) 
Single Stereoisomer

>  <Synonyms>  (102) 
AZD-2014 | AZD2014 | VISTUSERTIB

>  <FDA_approved>  (102) 


>  <Melting points>  (102) 


$$$$
Spebrutinib
     RDKit          2D

 31 33  0  0  0  0  0  0  0  0999 V2000
  -11.1890    2.2147    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.6892    2.2381    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -8.9191    0.9508    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.4193    0.9742    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6492   -0.3130    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1493   -0.2897    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4196    1.0209    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9198    1.0442    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1497   -0.2430    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8794   -1.5536    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3792   -1.5769    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6499   -0.2197    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.1202   -1.5069    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6095   -2.8174    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.1607   -4.1046    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6605   -4.0813    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3902   -2.7707    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6201   -1.4835    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.8900   -2.7474    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.6197   -1.4368    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1195   -1.4135    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8492   -0.1030    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0791    1.1843    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5793    1.1609    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8496   -0.1496    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8091    2.4481    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.5388    3.7587    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0387    3.7820    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.7687    5.0459    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4984    6.3564    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4306   -5.3685    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
  9 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 24 26  1  0
 26 27  1  0
 27 28  2  0
 27 29  1  0
 29 30  2  0
 16 31  1  0
 11  6  1  0
 18 13  1  0
 25 20  1  0
M  END
>  <BrandName>  (103) 
nan

>  <Phase>  (103) 
2.0

>  <Applicants>  (103) 
Celgene

>  <Links>  (103) 
|http://www.chemspider.com/Chemical-Structure.29361342.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3301625|http://pubchem.ncbi.nlm.nih.gov/compound/59174488|http://www.drugbank.ca/drugs/DB11764|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7837|http://zinc15.docking.org/substances/ZINC000072319585|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=DRU6NG543J|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50161162

>  <LigID>  (103) 
nan

>  <pdbID>  (103) 
nan

>  <Type>  (103) 
nan

>  <RoF>  (103) 
0

>  <MW>  (103) 
423.2

>  <LogP>  (103) 
4.3

>  <TPSA>  (103) 
97.4

>  <HBA>  (103) 
7

>  <HBD>  (103) 
3

>  <NRB>  (103) 
10

>  <Indications>  (103) 
nan

>  <Targets>  (103) 
BTK

>  <Kinase families>  (103) 
Tyr

>  <Canonical_Smiles>  (103) 
COCCOc1ccc(cc1)Nc2ncc(c(n2)Nc3cccc(c3)NC(=O)C=C)F

>  <InChiKey>  (103) 
KXBDTLQSDKGAEB-UHFFFAOYSA-N

>  <First_Approval>  (103) 
nan

>  <SC_Patent>  (103) 
None

>  <Chirality>  (103) 
Achiral Molecule

>  <Synonyms>  (103) 
AVL-292 | CC-292 | SPEBRUTINIB

>  <FDA_approved>  (103) 


>  <Melting points>  (103) 


$$$$
Apitolisib
     RDKit          2D

 35 39  0  0  0  0  0  0  0  0999 V2000
    1.0836   -4.2403    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7309   -2.7824    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6559   -2.2108    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5408   -0.7152    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.9171   -0.3625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7031   -1.6401    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2025   -1.5982    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.9159   -0.2787    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1299    0.9989    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.6305    0.9570    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8446    2.2346    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.5580    3.5540    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7720    4.8316    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7274    4.7897    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4408    3.4703    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6549    2.1927    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4153   -0.2368    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2013   -1.5144    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7007   -1.4726    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.4142   -0.1531    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6282    1.1245    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.1288    1.0826    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9136   -0.1112    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9335   -2.9968    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2530   -2.2833    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2949   -0.7839    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6143   -0.0705    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8919   -0.8565    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8500   -2.3559    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5306   -3.0693    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.2114   -0.1430    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.4890   -0.9290    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -7.2533    1.3564    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.5728    2.0698    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9757    2.1424    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
  8 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 20 23  1  0
  3 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 28 31  1  0
 31 32  2  0
 31 33  1  0
 33 34  1  6
 33 35  1  0
  6  2  1  0
 10  5  1  0
 16 11  1  0
 22 17  1  0
 30 25  1  0
M  END
>  <BrandName>  (104) 
nan

>  <Phase>  (104) 
2.0

>  <Applicants>  (104) 
Hoffmann-La Roche

>  <Links>  (104) 
|http://www.chemspider.com/Chemical-Structure.26325996.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL1922094|http://pubchem.ncbi.nlm.nih.gov/compound/25254071|http://www.drugbank.ca/drugs/DB12180| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=980|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/980|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7888|http://zinc15.docking.org/substances/ZINC000059224388|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=1C854K1MIJ|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50358204

>  <LigID>  (104) 
'980'

>  <pdbID>  (104) 
3tl5

>  <Type>  (104) 
nan

>  <RoF>  (104) 
1

>  <MW>  (104) 
498.2

>  <LogP>  (104) 
0.9

>  <TPSA>  (104) 
133.8

>  <HBA>  (104) 
11

>  <HBD>  (104) 
2

>  <NRB>  (104) 
5

>  <Indications>  (104) 
nan

>  <Targets>  (104) 
PIK3CA; MTOR

>  <Kinase families>  (104) 
Atypical

>  <Canonical_Smiles>  (104) 
Cc1c(sc2c1nc(nc2N3CCOCC3)c4cnc(nc4)N)CN5CCN(CC5)C(=O)[C@H](C)O

>  <InChiKey>  (104) 
YOVVNQKCSKSHKT-HNNXBMFYSA-N

>  <First_Approval>  (104) 
nan

>  <SC_Patent>  (104) 
None

>  <Chirality>  (104) 
Single Stereoisomer

>  <Synonyms>  (104) 
APITOLISIB | G-038390 | G-038390.1 | GDC-0980 | GDC-0980.1 | RG-7422 | RG7422

>  <FDA_approved>  (104) 


>  <Melting points>  (104) 


$$$$
Neflamapimod
     RDKit          2D

 28 31  0  0  0  0  0  0  0  0999 V2000
   -4.3541   -3.6169    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3234   -2.4722    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8167   -1.0603    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3407   -0.7932    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3714   -1.9379    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8780   -3.3497    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8953   -1.6708    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -2.8340    0.6186    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3580    0.8858    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3887   -0.2589    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0874    0.0082    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5940    1.4200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6247    2.5647    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8514    2.2976    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8207    3.4423    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2967    3.1752    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8034    1.7633    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2794    1.4962    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.0700    1.6872    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    4.0394    0.5425    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5327   -0.8694    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5021   -2.0141    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9781   -1.7470    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4848   -0.3351    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5154    0.8096    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0221    2.2214    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    6.9475   -2.8917    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7861    0.0844    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  4  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 12 19  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 23 27  1  0
  3 28  1  0
  6  1  1  0
 17  8  1  0
 14  9  1  0
 25 20  1  0
M  END
>  <BrandName>  (105) 
nan

>  <Phase>  (105) 
2.0

>  <Applicants>  (105) 
EIP Pharma

>  <Links>  (105) 
|http://www.chemspider.com/Chemical-Structure.2302086.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL119385|http://pubchem.ncbi.nlm.nih.gov/compound/3038525|http://www.drugbank.ca/drugs/DB07138| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=52P|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/52P|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5719|http://zinc15.docking.org/substances/ZINC13493055|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=TYL52QM320|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=15244

>  <LigID>  (105) 
'52P'

>  <pdbID>  (105) 
3fc1 3hp5 3zsi

>  <Type>  (105) 
nan

>  <RoF>  (105) 
1

>  <MW>  (105) 
435

>  <LogP>  (105) 
5.5

>  <TPSA>  (105) 
47.3

>  <HBA>  (105) 
5

>  <HBD>  (105) 
0

>  <NRB>  (105) 
3

>  <Indications>  (105) 
nan

>  <Targets>  (105) 
MAPK14

>  <Kinase families>  (105) 
CMGC

>  <Canonical_Smiles>  (105) 
c1cc(c(c(c1)Cl)c2c3ccc(nn3cnc2=O)Sc4ccc(cc4F)F)Cl

>  <InChiKey>  (105) 
VEPKQEUBKLEPRA-UHFFFAOYSA-N

>  <First_Approval>  (105) 
nan

>  <SC_Patent>  (105) 
None

>  <Chirality>  (105) 
Achiral Molecule

>  <Synonyms>  (105) 
745 | NEFLAMAPIMOD | VD-31 | VD-31,745 | VD-31745 | VRT-031745 | VX-745

>  <FDA_approved>  (105) 


>  <Melting points>  (105) 


$$$$
Simurosertib
     RDKit          2D

 24 28  0  0  0  0  0  0  0  0999 V2000
    5.5301    1.7920    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6119    0.2943    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4483   -0.6523    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9890   -2.0515    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4867   -1.9696    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.8718   -0.5199    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.9986   -0.2673    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8350   -1.2138    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5751   -0.3997    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9602    1.0501    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4579    1.1319    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1029    2.1084    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2822    3.5581    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5509    1.7170    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9359    0.2672    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8729   -0.7911    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3158   -0.9584    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2769   -0.0015    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8949    0.5426    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2800   -0.9071    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2170   -1.9654    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7689   -1.5740    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3839   -0.1242    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4469    0.9341    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  3  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 10 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  2  0
 15 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
  6  2  2  0
 11  7  1  0
 16  9  1  0
 22 17  1  0
 24 19  1  0
M  END
>  <BrandName>  (106) 
nan

>  <Phase>  (106) 
2.0

>  <Applicants>  (106) 
Takeda

>  <Links>  (106) 
|http://www.chemspider.com/Chemical-Structure.64879789.html|http://pubchem.ncbi.nlm.nih.gov/compound/71147529

>  <LigID>  (106) 
nan

>  <pdbID>  (106) 
nan

>  <Type>  (106) 
nan

>  <RoF>  (106) 
0

>  <MW>  (106) 
341.1

>  <LogP>  (106) 
2.8

>  <TPSA>  (106) 
77.7

>  <HBA>  (106) 
5

>  <HBD>  (106) 
2

>  <NRB>  (106) 
2

>  <Indications>  (106) 
nan

>  <Targets>  (106) 
nan

>  <Kinase families>  (106) 


>  <Canonical_Smiles>  (106) 
Cc1c(c[nH]n1)c2cc3c(s2)c(=O)[nH]c(n3)C4CC5CCN4CC5

>  <InChiKey>  (106) 
XGVXKJKTISMIOW-UHFFFAOYSA-N

>  <First_Approval>  (106) 
nan

>  <SC_Patent>  (106) 
None

>  <Chirality>  (106) 
Single Stereoisomer

>  <Synonyms>  (106) 
|TAK-931

>  <FDA_approved>  (106) 


>  <Melting points>  (106) 


$$$$
Seliciclib
     RDKit          2D

 26 28  0  0  0  0  0  0  0  0999 V2000
    0.5807    6.1771    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6535    5.3245    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5322    3.8295    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8232    3.1869    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0574    4.0395    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7664    2.9769    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6451    1.4818    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2897    0.8393    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1684   -0.6558    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1870   -1.2984    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.4211   -0.4458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7766   -1.0883    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8978   -2.5834    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2532   -3.2260    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4874   -2.3734    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3661   -0.8783    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0107   -0.2358    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4026   -1.5084    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5948   -2.9960    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0691   -3.2729    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7879   -1.9564    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2756   -1.7641    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1859   -2.9563    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8529   -0.3797    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7580   -0.8658    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8793    0.6292    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  3  2  1  6
  3  4  1  0
  4  5  1  0
  3  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
  9 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 22 24  1  0
 21 25  1  0
 25 26  2  0
 26  7  1  0
 17 12  1  0
 25 18  1  0
M  END
>  <BrandName>  (107) 
nan

>  <Phase>  (107) 
2.0

>  <Applicants>  (107) 
Cyclacel pharmaceuticals

>  <Links>  (107) 
|http://www.chemspider.com/Chemical-Structure.140922.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL14762|http://pubchem.ncbi.nlm.nih.gov/compound/160355|http://www.drugbank.ca/drugs/DB06195| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=RRC|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/RRC|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6035|http://zinc15.docking.org/substances/ZINC01649340|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=0ES1C2KQ94|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=7533

>  <LigID>  (107) 
'RRC'

>  <pdbID>  (107) 
1unl 1ygk 2a4l 3ddq

>  <Type>  (107) 
1

>  <RoF>  (107) 
0

>  <MW>  (107) 
354.2

>  <LogP>  (107) 
3.2

>  <TPSA>  (107) 
87.9

>  <HBA>  (107) 
7

>  <HBD>  (107) 
3

>  <NRB>  (107) 
8

>  <Indications>  (107) 
nan

>  <Targets>  (107) 
CDK2; CDK7; CDK9

>  <Kinase families>  (107) 
CMGC

>  <Canonical_Smiles>  (107) 
CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1

>  <InChiKey>  (107) 
BTIHMVBBUGXLCJ-OAHLLOKOSA-N

>  <First_Approval>  (107) 
nan

>  <SC_Patent>  (107) 
None

>  <Chirality>  (107) 
Single Stereoisomer

>  <Synonyms>  (107) 
AL-39256 | CYC-202 | NSC-701554 | SELICICLIB

>  <FDA_approved>  (107) 


>  <Melting points>  (107) 


$$$$
Sapanisertib
     RDKit          2D

 23 26  0  0  0  0  0  0  0  0999 V2000
    3.3243    3.9627    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7846    2.5351    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2511    2.2199    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7784    1.4226    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.0870   -0.0453    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7863   -0.7924    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6738    0.2138    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2870    1.5828    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7941   -0.0948    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2609   -1.5203    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7288   -1.8289    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7300   -0.7119    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2632    0.7136    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7953    1.0222    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4748    1.5981    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6903    0.7191    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2300   -0.7085    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -7.1158    1.1858    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.7829   -2.2924    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0802   -3.0453    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.3810   -2.2982    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3843   -0.7982    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.4822   -3.0395    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  2  0
 16 17  1  0
 16 18  1  0
  6 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 19 23  1  0
  8  4  1  0
 22  5  1  0
 14  9  1  0
 17 12  1  0
M  END
>  <BrandName>  (108) 
nan

>  <Phase>  (108) 
2.0

>  <Applicants>  (108) 
Takeda

>  <Links>  (108) 
|http://www.chemspider.com/Chemical-Structure.28189069.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3545097|http://pubchem.ncbi.nlm.nih.gov/compound/45375953|http://www.drugbank.ca/drugs/DB11836| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=FE5|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/FE5|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7933|http://zinc15.docking.org/substances/ZINC000073069271|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=JGH0DF1U03|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315477

>  <LigID>  (108) 
'FE5'

>  <pdbID>  (108) 
6gvf

>  <Type>  (108) 
nan

>  <RoF>  (108) 
0

>  <MW>  (108) 
309.1

>  <LogP>  (108) 
2.4

>  <TPSA>  (108) 
121.7

>  <HBA>  (108) 
8

>  <HBD>  (108) 
2

>  <NRB>  (108) 
2

>  <Indications>  (108) 
nan

>  <Targets>  (108) 
MTOR

>  <Kinase families>  (108) 
Atypical

>  <Canonical_Smiles>  (108) 
CC(C)n1c2c(c(n1)c3ccc4c(c3)nc(o4)N)c(ncn2)N

>  <InChiKey>  (108) 
GYLDXIAOMVERTK-UHFFFAOYSA-N

>  <First_Approval>  (108) 
nan

>  <SC_Patent>  (108) 
None

>  <Chirality>  (108) 
Achiral Molecule

>  <Synonyms>  (108) 
INK-128 | INK128 | MLN-0128 | MLN0128 | SAPANISERTIB | TAK-228

>  <FDA_approved>  (108) 


>  <Melting points>  (108) 


$$$$
Samotolisib
     RDKit          2D

 30 33  0  0  0  0  0  0  0  0999 V2000
   -0.4488   -4.0828    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5886   -3.1076    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3139   -1.6330    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4536   -0.6578    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3346    0.8375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1437    1.7495    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2416    1.1743    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4325    2.0863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2380    3.5737    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1473    4.1489    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3381    3.2369    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7234    3.8122    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9143    2.9001    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7199    1.4128    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6951    0.2730    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9125   -1.0066    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4878   -2.3919    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1903    0.3921    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8177    1.5110    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0122    0.0237    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3975   -0.5516    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5883    0.3605    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3939    1.8478    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.0086    2.4231    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5919   -2.0389    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0793   -1.8445    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1046   -2.2334    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7864   -3.5263    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0030   -3.6071    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2777   -5.0817    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  6
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 15 18  1  0
  8 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 21 25  1  0
 25 26  1  0
 25 27  1  0
 25 28  1  0
  2 29  1  0
 29 30  1  0
 16  4  1  0
 14  5  1  0
 11  6  1  0
 24 19  1  0
M  END
>  <BrandName>  (109) 
nan

>  <Phase>  (109) 
2.0

>  <Applicants>  (109) 
Eli Lilly

>  <Links>  (109) 
|http://www.chemspider.com/Chemical-Structure.35142771.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL4297181|http://pubchem.ncbi.nlm.nih.gov/compound/57519748|http://www.drugbank.ca/drugs/DB12167|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8918|http://zinc15.docking.org/substances/ZINC000143116580|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=C88817F47Y

>  <LigID>  (109) 
nan

>  <pdbID>  (109) 
nan

>  <Type>  (109) 
nan

>  <RoF>  (109) 
0

>  <MW>  (109) 
406.2

>  <LogP>  (109) 
3.2

>  <TPSA>  (109) 
82.2

>  <HBA>  (109) 
7

>  <HBD>  (109) 
1

>  <NRB>  (109) 
5

>  <Indications>  (109) 
LY3023414 is a dual inhibitor of phosphoinositide 3-kinase &alpha; (PI3K&alpha;) and the serine/threonine kinase mTOR (mechanistic target of rapamycin), with potential antineoplastic activity.

>  <Targets>  (109) 
nan

>  <Kinase families>  (109) 


>  <Canonical_Smiles>  (109) 
C[C@@H](Cn1c2c3cc(ccc3ncc2n(c1=O)C)c4cc(cnc4)C(C)(C)O)OC

>  <InChiKey>  (109) 
ACCFLVVUVBJNGT-AWEZNQCLSA-N

>  <First_Approval>  (109) 
nan

>  <SC_Patent>  (109) 
None

>  <Chirality>  (109) 
Single Stereoisomer

>  <Synonyms>  (109) 
LY 3023414 | LY-3023414 | LY3023414 | SAMOTOLISIB

>  <FDA_approved>  (109) 


>  <Melting points>  (109) 


$$$$
Edicotinib
     RDKit          2D

 34 37  0  0  0  0  0  0  0  0999 V2000
    3.0545   -5.4261    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6911   -4.8007    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1960   -4.6794    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4465   -3.3240    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4062   -2.0898    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9012   -2.2112    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5437   -3.5666    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2363   -0.7344    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6163    0.4997    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0261    1.8552    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5212    1.9765    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3738    0.7424    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7314   -0.6131    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8689    0.8637    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5114    2.2192    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0065    2.3405    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.8591    1.1064    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2166   -0.2490    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7215   -0.3704    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0765   -1.7425    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.6631   -0.6464    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.3699    2.9659    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6273    3.7918    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1114    0.3784    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.9640    1.6125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3216    2.9679    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.4591    1.4911    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4361    2.6294    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.8205    2.0520    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6992    0.5569    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2397    0.2103    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.1014    2.8326    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3822    3.6132    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.3120   -6.2520    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  5  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 18 20  1  0
 18 21  1  0
 16 22  1  0
 16 23  1  0
  9 24  1  0
 24 25  1  0
 25 26  2  0
 25 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 29 32  1  0
 32 33  3  0
  2 34  1  0
  7  2  1  0
 13  8  2  0
 19 14  1  0
 31 27  2  0
M  END
>  <BrandName>  (110) 
nan

>  <Phase>  (110) 
2.0

>  <Applicants>  (110) 
Janssen

>  <Links>  (110) 
|http://www.chemspider.com/Chemical-Structure.34951020.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3674570|http://pubchem.ncbi.nlm.nih.gov/compound/25230468|http://www.drugbank.ca/drugs/DB12504|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8942|http://zinc15.docking.org/substances/ZINC000043208574|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=3NU609VYNF|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=98634

>  <LigID>  (110) 
nan

>  <pdbID>  (110) 
nan

>  <Type>  (110) 
nan

>  <RoF>  (110) 
1

>  <MW>  (110) 
461.3

>  <LogP>  (110) 
6

>  <TPSA>  (110) 
103.7

>  <HBA>  (110) 
5

>  <HBD>  (110) 
2

>  <NRB>  (110) 
4

>  <Indications>  (110) 
nan

>  <Targets>  (110) 
nan

>  <Kinase families>  (110) 


>  <Canonical_Smiles>  (110) 
CC1(CCC(=CC1)c2c(ccc(n2)C3CC(OC(C3)(C)C)(C)C)NC(=O)c4[nH]c(cn4)C#N)C

>  <InChiKey>  (110) 
BNVPFDRNGHMRJS-UHFFFAOYSA-N

>  <First_Approval>  (110) 
nan

>  <SC_Patent>  (110) 
None

>  <Chirality>  (110) 
Achiral Molecule

>  <Synonyms>  (110) 
EDICOTINIB | JNJ-40346527

>  <FDA_approved>  (110) 


>  <Melting points>  (110) 


$$$$
Tomivosertib
     RDKit          2D

 25 28  0  0  0  0  0  0  0  0999 V2000
   -0.4206    3.4185    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0604    1.9624    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1414    0.9224    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7812   -0.5337    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6600   -0.9498    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0201   -2.4060    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.7409    0.0901    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.3807    1.5463    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6542    2.3388    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7617    3.8349    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.8015    1.3725    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.2370   -0.0173    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5304   -1.3404    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3229   -2.6139    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8221   -2.5643    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5287   -1.2412    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7362    0.0323    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8621   -1.5737    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3032   -1.1576    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6634    0.2985    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1045    0.7147    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1855   -0.3253    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8253   -1.7814    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3842   -2.1976    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4647    2.1708    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
  4 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 21 25  1  0
  8  2  2  0
 12  7  1  0
 17 12  1  0
 24 19  1  0
M  END
>  <BrandName>  (111) 
nan

>  <Phase>  (111) 
2.0

>  <Applicants>  (111) 
Effector Therapeutics

>  <Links>  (111) 
|http://www.chemspider.com/Chemical-Structure.57617704.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL4073443|http://pubchem.ncbi.nlm.nih.gov/compound/118598754|http://www.drugbank.ca/drugs/DB15219| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=N45|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/N45|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10167|http://zinc15.docking.org/substances/ZINC000575623807|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=U2H19X4WBV|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50263263

>  <LigID>  (111) 
'N45'

>  <pdbID>  (111) 
6ck6

>  <Type>  (111) 
nan

>  <RoF>  (111) 
0

>  <MW>  (111) 
340.2

>  <LogP>  (111) 
1.6

>  <TPSA>  (111) 
114.9

>  <HBA>  (111) 
7

>  <HBD>  (111) 
3

>  <NRB>  (111) 
2

>  <Indications>  (111) 
Tomivosertib, also known as eFT508 is a MNK1/2 inhibitor. Tomivosertib binds to and inhibits the activity of MNK1 and 2. This prevents MNK1/2-mediated signaling, and inhibits the phosphorylation of certain regulatory proteins, including eukaryotic translation initiation factor 4E (eIF4E), that regulate the translation of messenger RNAs (mRNAs) involved in tumor cell proliferation, angiogenesis, survival and immune signaling

>  <Targets>  (111) 
nan

>  <Kinase families>  (111) 


>  <Canonical_Smiles>  (111) 
Cc1cc(c(=O)n2c1C(=O)NC23CCCCC3)Nc4cc(ncn4)N

>  <InChiKey>  (111) 
HKTBYUWLRDZAJK-UHFFFAOYSA-N

>  <First_Approval>  (111) 
nan

>  <SC_Patent>  (111) 
None

>  <Chirality>  (111) 
Achiral Molecule

>  <Synonyms>  (111) 
EFT-508 | EFT508 | TOMIVOSERTIB

>  <FDA_approved>  (111) 


>  <Melting points>  (111) 


$$$$
Trilaciclib
     RDKit          2D

 33 38  0  0  0  0  0  0  0  0999 V2000
   10.7857   -0.9565    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3243   -0.6187    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.3010   -1.7154    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8395   -1.3775    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4014    0.0570    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.4247    1.1538    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8862    0.8159    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9399    0.3949    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5018    1.8295    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0403    2.1673    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0170    1.0706    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4551   -0.3640    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.9166   -0.7018    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5556    1.4085    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4678    0.3118    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0296   -1.1228    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0530   -2.2196    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5144   -1.8817    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7434   -2.7417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9411   -1.8386    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4523   -0.4205    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9525   -0.4471    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9292    0.6496    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4361    0.7119    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9635    0.9976    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4748    2.4158    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4585    3.5481    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9310    3.2623    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4198    1.8442    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.9086    0.4261    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.3974   -0.9921    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4136   -2.1244    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.9024   -3.5425    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  5  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 11 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  1  0
 22 23  2  0
 21 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 24 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  2  0
  7  2  1  0
 13  8  1  0
 23 15  1  0
 22 18  1  0
 32 20  1  0
 29 24  1  0
M  END
>  <BrandName>  (112) 
nan

>  <Phase>  (112) 
2.0

>  <Applicants>  (112) 
G1 Therapeutics

>  <Links>  (112) 
|http://www.chemspider.com/Chemical-Structure.58825997.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3894860|http://pubchem.ncbi.nlm.nih.gov/compound/68029831|http://www.drugbank.ca/drugs/DB15442|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9626|http://zinc15.docking.org/substances/ZINC000143683854|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=U6072DO9XG|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=253928

>  <LigID>  (112) 
nan

>  <pdbID>  (112) 
nan

>  <Type>  (112) 
nan

>  <RoF>  (112) 
0

>  <MW>  (112) 
446.3

>  <LogP>  (112) 
2.7

>  <TPSA>  (112) 
91.2

>  <HBA>  (112) 
8

>  <HBD>  (112) 
2

>  <NRB>  (112) 
3

>  <Indications>  (112) 
nan

>  <Targets>  (112) 
CDK4; CDK6

>  <Kinase families>  (112) 
CMGC

>  <Canonical_Smiles>  (112) 
CN1CCN(CC1)c2ccc(nc2)Nc3ncc4cc5n(c4n3)C6(CCCCC6)CNC5=O

>  <InChiKey>  (112) 
PDGKHKMBHVFCMG-UHFFFAOYSA-N

>  <First_Approval>  (112) 
nan

>  <SC_Patent>  (112) 
None

>  <Chirality>  (112) 
Achiral Molecule

>  <Synonyms>  (112) 
G1T28 | TRILACICLIB

>  <FDA_approved>  (112) 


>  <Melting points>  (112) 


$$$$
Rogaratinib
     RDKit          2D

 33 37  0  0  0  0  0  0  0  0999 V2000
    7.6853    0.2232    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2020    0.4459    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2674   -0.7274    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7840   -0.5047    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6259   -1.4580    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3614   -0.6512    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7379    0.8007    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    3.2352    0.8913    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1698    2.0646    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6531    1.8419    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6209    3.4606    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.5555    4.6339    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0346   -1.2001    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2991   -0.3933    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4572   -1.3466    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9084   -2.7426    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4111   -2.6520    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4159   -3.9034    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2543   -5.2454    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7515   -5.3359    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5786   -4.0846    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.9132   -3.8128    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9092   -0.9701    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3091    0.4757    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2570    1.5448    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6569    2.9905    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1089    3.3671    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1609    2.2979    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.6129    2.6744    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7610    0.8522    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3897    1.1040    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1383    1.9311    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2289    3.4283    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  1  0
  6 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 18 22  1  0
 15 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  2  0
 28 30  1  0
 14 31  1  0
 31 32  1  0
 32 33  1  0
 10  2  1  0
  8  4  2  0
 17 13  2  0
 21 16  1  0
 30 24  1  0
M  END
>  <BrandName>  (113) 
nan

>  <Phase>  (113) 
2.0

>  <Applicants>  (113) 
Bayer

>  <Links>  (113) 
|http://www.chemspider.com/Chemical-Structure.58828032.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3963485|http://pubchem.ncbi.nlm.nih.gov/compound/71611869|http://www.drugbank.ca/drugs/DB15078|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9789|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=98BSN6N516|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=194820

>  <LigID>  (113) 
nan

>  <pdbID>  (113) 
nan

>  <Type>  (113) 
nan

>  <RoF>  (113) 
0

>  <MW>  (113) 
466.2

>  <LogP>  (113) 
2.6

>  <TPSA>  (113) 
107

>  <HBA>  (113) 
9

>  <HBD>  (113) 
2

>  <NRB>  (113) 
6

>  <Indications>  (113) 
Rogaratinib (BAY-1163877) is a FGFR-selective kinase inhibitor that is being investigated for antineoplastic activity.

>  <Targets>  (113) 
nan

>  <Kinase families>  (113) 


>  <Canonical_Smiles>  (113) 
Cc1cc2cc(sc2c(c1)OC)c3c(c(n4c3c(ncn4)N)CN5CCNC(=O)C5)COC

>  <InChiKey>  (113) 
HNLRRJSKGXOYNO-UHFFFAOYSA-N

>  <First_Approval>  (113) 
nan

>  <SC_Patent>  (113) 
None

>  <Chirality>  (113) 
Achiral Molecule

>  <Synonyms>  (113) 
BAY-1163877 | ROGARATINIB

>  <FDA_approved>  (113) 


>  <Melting points>  (113) 


$$$$
Sotrastaurin
     RDKit          2D

 33 38  0  0  0  0  0  0  0  0999 V2000
   -0.4308   -7.0995    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1205   -5.7045    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8119   -4.5295    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2606   -3.1345    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2232   -2.9145    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.1556   -4.0895    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6043   -5.4845    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7746   -1.5195    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2583   -1.2995    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.8097    0.0955    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2935    0.3155    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8448    1.7105    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9124    2.8855    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4286    2.6655    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8773    1.2705    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3935    1.0505    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8421   -0.3445    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.4611    2.2255    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0376    2.1618    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5613    3.5674    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0063    3.9699    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3863    4.4998    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.8636    3.6704    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2692    4.1941    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8669    0.9119    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3432   -0.4937    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5182   -1.4262    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7681   -0.5968    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3656    0.8482    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4157    1.9192    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8684    1.5453    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2709    0.1004    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2207   -0.9707    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  5  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 16 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 20 22  1  0
 22 23  1  0
 23 24  2  0
 19 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 32  1  0
 32 33  2  0
  7  2  1  0
 17  8  1  0
 15 10  1  0
 23 18  1  0
 29 25  1  0
 33 28  1  0
M  END
>  <BrandName>  (114) 
nan

>  <Phase>  (114) 
2.0

>  <Applicants>  (114) 
Novartis

>  <Links>  (114) 
|http://www.chemspider.com/Chemical-Structure.8472351.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL565612|http://pubchem.ncbi.nlm.nih.gov/compound/10296883|http://www.drugbank.ca/drugs/DB12369| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=LW4|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/LW4|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7946|http://zinc15.docking.org/substances/ZINC000003973984|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=7I279E1NZ8|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=33971

>  <LigID>  (114) 
'LW4'

>  <pdbID>  (114) 
3iw4

>  <Type>  (114) 
nan

>  <RoF>  (114) 
0

>  <MW>  (114) 
438.2

>  <LogP>  (114) 
2.4

>  <TPSA>  (114) 
94.2

>  <HBA>  (114) 
6

>  <HBD>  (114) 
2

>  <NRB>  (114) 
3

>  <Indications>  (114) 
nan

>  <Targets>  (114) 
nan

>  <Kinase families>  (114) 


>  <Canonical_Smiles>  (114) 
CN1CCN(CC1)c2nc3ccccc3c(n2)C4=C(C(=O)NC4=O)c5c[nH]c6c5cccc6

>  <InChiKey>  (114) 
OAVGBZOFDPFGPJ-UHFFFAOYSA-N

>  <First_Approval>  (114) 
nan

>  <SC_Patent>  (114) 
None

>  <Chirality>  (114) 
Achiral Molecule

>  <Synonyms>  (114) 
AEB-071 | AEB071 | NVP-AEB071 | SOTRASTAURIN

>  <FDA_approved>  (114) 


>  <Melting points>  (114) 


$$$$
Onvansertib
     RDKit          2D

 38 42  0  0  0  0  0  0  0  0999 V2000
    2.3628    5.7948    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2767    4.7603    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.6295    3.3024    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5433    2.2679    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8957    2.6913    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2485    4.1492    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1623    5.1837    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9819    1.6568    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4209    2.0802    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5071    1.0457    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1543   -0.4123    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7153   -0.8357    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6291    0.1988    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3625   -2.2936    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9235   -2.7170    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5706   -4.1749    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.8684   -4.5983    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9545   -3.5638    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6017   -2.1059    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1627   -1.6825    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.6879   -1.0714    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1269   -1.4948    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9743   -0.2571    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0590    0.9313    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.6459    0.4280    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.4082    1.2754    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0555    0.6272    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1822    1.4745    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.4737   -0.2151    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2598   -1.4926    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.1870    1.1044    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.4797   -2.9527    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3935   -3.9872    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2405   -1.4468    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6795   -1.0233    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.1185   -0.5999    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -7.1029   -2.4623    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2560    0.4157    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  5  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 19 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 23 29  1  0
 29 30  2  0
 29 31  1  0
 22 32  1  0
 32 33  1  0
 11 34  1  0
 34 35  1  0
 35 36  1  0
 35 37  1  0
 35 38  1  0
  7  2  1  0
 13  8  1  0
 20 15  1  0
 33 18  1  0
 25 21  1  0
M  END
>  <BrandName>  (115) 
nan

>  <Phase>  (115) 
2.0

>  <Applicants>  (115) 
Cardiff Oncology

>  <Links>  (115) 
|http://www.chemspider.com/Chemical-Structure.26325993.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL1738758|http://pubchem.ncbi.nlm.nih.gov/compound/49792852|http://www.drugbank.ca/drugs/DB15110| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=937|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/937|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7918|http://zinc15.docking.org/substances/ZINC000043196885|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=67RM91WDHQ|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343559

>  <LigID>  (115) 
'937'

>  <pdbID>  (115) 
2yac

>  <Type>  (115) 
nan

>  <RoF>  (115) 
1

>  <MW>  (115) 
532.2

>  <LogP>  (115) 
1.9

>  <TPSA>  (115) 
134.7

>  <HBA>  (115) 
10

>  <HBD>  (115) 
3

>  <NRB>  (115) 
7

>  <Indications>  (115) 
nan

>  <Targets>  (115) 
nan

>  <Kinase families>  (115) 


>  <Canonical_Smiles>  (115) 
CN1CCN(CC1)c2ccc(c(c2)Nc3ncc4c(n3)-c5c(c(nn5CCO)C(=O)N)CC4)OC(F)(F)F

>  <InChiKey>  (115) 
QHLVBNKYJGBCQJ-UHFFFAOYSA-N

>  <First_Approval>  (115) 
nan

>  <SC_Patent>  (115) 
None

>  <Chirality>  (115) 
Achiral Molecule

>  <Synonyms>  (115) 
NMS-1286937 | NMS-P937 | ONVANSERTIB | PCM-075

>  <FDA_approved>  (115) 


>  <Melting points>  (115) 


$$$$
Pilaralisib
     RDKit          2D

 37 40  0  0  0  0  0  0  0  0999 V2000
   -6.8529   -1.0140    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.5794    0.2983    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.3060    1.6106    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2671    1.0249    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2402    2.5247    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9818    0.2517    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6695    0.9782    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6425    2.4780    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3302    3.2045    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0449    2.4313    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0718    0.9316    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3841    0.2050    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2135    0.1584    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.9867    1.4437    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5597   -1.1270    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.4989   -0.6149    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.8112    0.1117    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0965   -0.6615    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4088    0.0650    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.4358    1.5648    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7481    2.2913    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7750    3.7911    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4897    4.5643    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1774    3.8377    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1504    2.3380    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8381    1.6114    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.0696   -2.1613    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.7573   -2.8878    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4719   -2.1146    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1596   -2.8412    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1327   -4.3409    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4181   -5.1141    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7304   -4.3876    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0157   -5.1608    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -1.1257   -2.0680    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4380   -2.7945    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.8917   -0.4282    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  2  0
 13 15  2  0
 13 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 18 27  1  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 32  1  0
 32 33  2  0
 33 34  1  0
 30 35  1  0
 35 36  1  0
  2 37  1  0
 12  7  1  0
 26 17  2  0
 25 20  1  0
 33 28  1  0
M  END
>  <BrandName>  (116) 
nan

>  <Phase>  (116) 
2.0

>  <Applicants>  (116) 
Sanofi

>  <Links>  (116) 
|http://www.chemspider.com/Chemical-Structure.29340997.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3360203|http://pubchem.ncbi.nlm.nih.gov/compound/56599306|http://www.drugbank.ca/drugs/DB11772|http://zinc15.docking.org/substances/ZINC000100472223|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=60ES45KTMK|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50197062

>  <LigID>  (116) 
nan

>  <pdbID>  (116) 
nan

>  <Type>  (116) 
nan

>  <RoF>  (116) 
1

>  <MW>  (116) 
540.1

>  <LogP>  (116) 
4.5

>  <TPSA>  (116) 
148.3

>  <HBA>  (116) 
8

>  <HBD>  (116) 
4

>  <NRB>  (116) 
8

>  <Indications>  (116) 
nan

>  <Targets>  (116) 
PIK3CA; PIK3CB; PIK3CD; PIK3CG

>  <Kinase families>  (116) 
Atypical

>  <Canonical_Smiles>  (116) 
CC(C)(C(=O)Nc1cccc(c1)S(=O)(=O)Nc2c(nc3ccccc3n2)Nc4cc(ccc4Cl)OC)N

>  <InChiKey>  (116) 
QINPEPAQOBZPOF-UHFFFAOYSA-N

>  <First_Approval>  (116) 
nan

>  <SC_Patent>  (116) 
None

>  <Chirality>  (116) 
Achiral Molecule

>  <Synonyms>  (116) 
PILARALISIB | SAR-245408 | SAR245408 | XL-147 | XL147

>  <FDA_approved>  (116) 


>  <Melting points>  (116) 


$$$$
Tozasertib
     RDKit          2D

 33 37  0  0  0  0  0  0  0  0999 V2000
   -9.2158    2.5379    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.8059    2.0257    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.3916    0.5841    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8925    0.5326    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3803    1.9425    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5629    2.8652    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0530   -0.7104    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5567   -0.6049    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7172   -1.8480    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2209   -1.7425    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5641   -0.3939    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4036    0.8492    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8999    0.7437    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7469    2.1978    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.7494    2.3033    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5889    1.0602    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0852    1.1657    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7420    2.5143    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9024    3.7574    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4062    3.6519    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2382    2.6198    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.0778    1.3768    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4210    0.0282    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.5741    1.4823    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8171    2.3218    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9226    0.8255    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3813   -2.9855    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0381   -4.3341    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1986   -5.5772    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2977   -5.4716    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.9545   -4.1231    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1149   -2.8800    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1372   -6.7147    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  4  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 18 21  1  0
 21 22  1  0
 22 23  2  0
 22 24  1  0
 24 25  1  0
 25 26  1  0
 10 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 30 33  1  0
  6  2  1  0
 13  8  1  0
 20 15  1  0
 26 24  1  0
 32 27  1  0
M  END
>  <BrandName>  (117) 
nan

>  <Phase>  (117) 
2.0

>  <Applicants>  (117) 
Merck

>  <Links>  (117) 
|http://www.chemspider.com/Chemical-Structure.4591897.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL572878|http://pubchem.ncbi.nlm.nih.gov/compound/5494449| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=VX6|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/VX6|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5718|http://zinc15.docking.org/substances/ZINC13125756|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=234335M86K|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50004205

>  <LigID>  (117) 
'VX6'

>  <pdbID>  (117) 
2f4j 2xyn 3amb 3e5a 4af3 4b8m 4jbq 4zog 5wnm 6brj 6gr9

>  <Type>  (117) 
1

>  <RoF>  (117) 
0

>  <MW>  (117) 
464.2

>  <LogP>  (117) 
3.5

>  <TPSA>  (117) 
102.1

>  <HBA>  (117) 
8

>  <HBD>  (117) 
3

>  <NRB>  (117) 
7

>  <Indications>  (117) 
nan

>  <Targets>  (117) 
AURKA; AURKB; AURKC

>  <Kinase families>  (117) 
Other

>  <Canonical_Smiles>  (117) 
Cc1cc(n[nH]1)Nc2cc(nc(n2)Sc3ccc(cc3)NC(=O)C4CC4)N5CCN(CC5)C

>  <InChiKey>  (117) 
GCIKSSRWRFVXBI-UHFFFAOYSA-N

>  <First_Approval>  (117) 
nan

>  <SC_Patent>  (117) 
None

>  <Chirality>  (117) 
Achiral Molecule

>  <Synonyms>  (117) 
MK-045 | MK-0457 | TOZASERTIB | VX-68 | VX-680

>  <FDA_approved>  (117) 


>  <Melting points>  (117) 


$$$$
Danusertib
     RDKit          2D

 35 39  0  0  0  0  0  0  0  0999 V2000
  -11.4022    2.1642    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.9775    1.6948    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -8.8587    2.6939    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.4340    2.2246    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.1282    0.7561    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -8.2470   -0.2430    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.6717    0.2263    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7035    0.2867    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3977   -1.1818    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9730   -1.6512    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8542   -0.6521    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1600    0.8164    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5847    1.2858    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4295   -1.1214    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3107   -0.1223    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1237   -2.5899    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.3010   -3.0593    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5181   -2.1826    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7280   -3.0693    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2587   -4.4939    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.7587   -4.4878    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.9452   -2.1926    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4875   -0.7641    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.9875   -0.7580    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3742    0.4458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7697    1.8186    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.8653    0.2829    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7519    1.4928    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2431    1.3298    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1297    2.5397    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5253    3.9126    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0341    4.0755    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1475    2.8656    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4698   -1.0899    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.9609   -1.2529    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  5  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 11 14  1  0
 14 15  2  0
 14 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  1  0
 19 22  1  0
 22 23  1  0
 23 24  1  0
 23 25  1  0
 25 26  2  0
 25 27  1  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 32  1  0
 32 33  2  0
 27 34  1  1
 34 35  1  0
  7  2  1  0
 13  8  1  0
 21 17  2  0
 24 18  1  0
 33 28  1  0
M  END
>  <BrandName>  (118) 
nan

>  <Phase>  (118) 
2.0

>  <Applicants>  (118) 
Nerviano Medical Sciences

>  <Links>  (118) 
|http://www.chemspider.com/Chemical-Structure.9617754.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL402548|http://pubchem.ncbi.nlm.nih.gov/compound/11442891|http://www.drugbank.ca/drugs/DB11778| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=627|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/627|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7937|http://zinc15.docking.org/substances/ZINC000006718723|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=M3X659D0FY|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=209858

>  <LigID>  (118) 
'627'

>  <pdbID>  (118) 
2j50 2v7a 4qo9 5i9z

>  <Type>  (118) 
1

>  <RoF>  (118) 
0

>  <MW>  (118) 
474.2

>  <LogP>  (118) 
2.6

>  <TPSA>  (118) 
93.8

>  <HBA>  (118) 
6

>  <HBD>  (118) 
2

>  <NRB>  (118) 
6

>  <Indications>  (118) 
nan

>  <Targets>  (118) 
AURKA; AURKB; AURKC

>  <Kinase families>  (118) 
Other

>  <Canonical_Smiles>  (118) 
CN1CCN(CC1)c2ccc(cc2)C(=O)Nc3c4c([nH]n3)CN(C4)C(=O)[C@@H](c5ccccc5)OC

>  <InChiKey>  (118) 
XKFTZKGMDDZMJI-HSZRJFAPSA-N

>  <First_Approval>  (118) 
nan

>  <SC_Patent>  (118) 
None

>  <Chirality>  (118) 
Single Stereoisomer

>  <Synonyms>  (118) 
DANUSERTIB | PHA-739358

>  <FDA_approved>  (118) 


>  <Melting points>  (118) 


$$$$
Pamapimod
     RDKit          2D

 29 31  0  0  0  0  0  0  0  0999 V2000
   -0.8153    2.9326    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8337    1.4327    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.4561    0.6669    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4378   -0.8330    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8703   -1.5671    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1601   -0.8013    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1418    0.6986    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4315    1.4644    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4682   -1.5353    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7580   -0.7695    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7396    0.7304    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0294    1.4962    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.3375    0.7621    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.3558   -0.7378    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0661   -1.5036    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0844   -3.0035    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -8.6273    1.5279    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    1.7276   -1.5988    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0357   -0.8647    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.0540    0.6352    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7642    1.4010    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.3621    1.3692    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.6519    0.6034    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9600    1.3375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2498    0.5717    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5579    1.3058    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.6336   -0.8965    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9233   -1.6623    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9050   -3.1622    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  6  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 13 17  1  0
  4 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 20 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 23 27  1  0
 27 28  1  0
 28 29  1  0
  7  2  1  0
 21  3  1  0
 15 10  1  0
M  END
>  <BrandName>  (119) 
nan

>  <Phase>  (119) 
2.0

>  <Applicants>  (119) 
Hoffmann-La Roche

>  <Links>  (119) 
|http://www.chemspider.com/Chemical-Structure.17347490.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL1090089|http://pubchem.ncbi.nlm.nih.gov/compound/16220188| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=FLW|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/FLW|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9915|http://zinc15.docking.org/substances/ZINC30691792|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=8S2C9V11K4|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50314070

>  <LigID>  (119) 
'FLW'

>  <pdbID>  (119) 
3flw

>  <Type>  (119) 
1

>  <RoF>  (119) 
0

>  <MW>  (119) 
406.1

>  <LogP>  (119) 
1.9

>  <TPSA>  (119) 
109.5

>  <HBA>  (119) 
8

>  <HBD>  (119) 
3

>  <NRB>  (119) 
8

>  <Indications>  (119) 
nan

>  <Targets>  (119) 
MAPK14; MAPK11

>  <Kinase families>  (119) 
CMGC

>  <Canonical_Smiles>  (119) 
Cn1c2c(cc(c1=O)Oc3ccc(cc3F)F)cnc(n2)NC(CCO)CCO

>  <InChiKey>  (119) 
JYYLVUFNAHSSFE-UHFFFAOYSA-N

>  <First_Approval>  (119) 
nan

>  <SC_Patent>  (119) 
None

>  <Chirality>  (119) 
Achiral Molecule

>  <Synonyms>  (119) 
JTT-705 | PAMAPIMOD | R-1503 | R1503 | RO-4402257

>  <FDA_approved>  (119) 


>  <Melting points>  (119) 


$$$$
Ilginatinib
     RDKit          2D

 29 32  0  0  0  0  0  0  0  0999 V2000
    2.7063    1.3605    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1562   -0.0705    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6204   -0.3964    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0702   -1.8273    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5344   -2.1532    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5487   -1.0481    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0988    0.3828    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6347    0.7087    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0129   -1.3740    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.1419   -1.1756    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.6777   -0.8497    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2278    0.5812    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2363    0.9071    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2506   -0.1980    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8008   -1.6289    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3366   -1.9548    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8151   -2.7340    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2792   -2.4081    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7291   -0.9772    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1933   -0.6513    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -7.2076   -1.7564    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.7577   -3.1873    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2935   -3.5132    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6862    2.3381    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1083    2.8152    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0940    4.3151    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6630    4.7650    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7930    3.5431    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1859    6.1871    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  6  9  1  0
  2 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 15 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 13 24  1  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  1  0
 27 29  1  0
  8  3  1  0
 16 11  1  0
 23 18  1  0
 28 24  2  0
M  END
>  <BrandName>  (120) 
nan

>  <Phase>  (120) 
2.0

>  <Applicants>  (120) 
Nippon Shinyaku

>  <Links>  (120) 
|http://www.chemspider.com/Chemical-Structure.64880076.html|http://pubchem.ncbi.nlm.nih.gov/compound/75236651

>  <LigID>  (120) 
nan

>  <pdbID>  (120) 
nan

>  <Type>  (120) 
nan

>  <RoF>  (120) 
0

>  <MW>  (120) 
389.2

>  <LogP>  (120) 
4.3

>  <TPSA>  (120) 
80.6

>  <HBA>  (120) 
7

>  <HBD>  (120) 
2

>  <NRB>  (120) 
6

>  <Indications>  (120) 
nan

>  <Targets>  (120) 
nan

>  <Kinase families>  (120) 


>  <Canonical_Smiles>  (120) 
CC(c1ccc(cc1)F)Nc2cc(cc(n2)Nc3cnccn3)c4cnn(c4)C

>  <InChiKey>  (120) 
UQTPDWDAYHAZNT-UHFFFAOYSA-N

>  <First_Approval>  (120) 
nan

>  <SC_Patent>  (120) 
None

>  <Chirality>  (120) 
Single Stereoisomer

>  <Synonyms>  (120) 
|NS-018

>  <FDA_approved>  (120) 


>  <Melting points>  (120) 


$$$$
Ulixertinib
     RDKit          2D

 29 31  0  0  0  0  0  0  0  0999 V2000
    6.7429   -4.1190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0171   -2.8063    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5174   -2.7784    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7911   -1.5214    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.0653   -0.2086    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5656   -0.1808    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8398    1.1319    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6138    2.4168    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1135    2.3890    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8393    1.0762    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.8880    3.7296    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    2.3401    1.1598    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4360   -0.0372    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0183    0.4527    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0461    1.9525    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.4811    2.3894    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2114   -0.4063    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0823   -1.9007    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5701    0.2292    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7998   -0.6298    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6707   -2.1243    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9004   -2.9833    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1586    0.0056    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2877    1.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6464    2.1355    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.8761    1.2764    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.7470   -0.2180    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.3883   -0.8534    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.9767   -1.0770    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
  8 11  1  0
  7 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 14 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  1  0
 20 21  1  6
 21 22  1  0
 20 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 27 29  1  0
 10  5  1  0
 16 12  2  0
 28 23  1  0
M  END
>  <BrandName>  (121) 
nan

>  <Phase>  (121) 
2.0

>  <Applicants>  (121) 
BioMed Valley Discoveries

>  <Links>  (121) 
|http://www.chemspider.com/Chemical-Structure.9893722.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3590106|http://pubchem.ncbi.nlm.nih.gov/compound/11719003|http://www.drugbank.ca/drugs/DB13930| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=EVK|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/EVK|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9210|http://zinc15.docking.org/substances/ZINC000034642570|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=16ZDH50O1U

>  <LigID>  (121) 
'EVK'

>  <pdbID>  (121) 
6gdq

>  <Type>  (121) 
nan

>  <RoF>  (121) 
0

>  <MW>  (121) 
432.1

>  <LogP>  (121) 
4.7

>  <TPSA>  (121) 
90

>  <HBA>  (121) 
4

>  <HBD>  (121) 
4

>  <NRB>  (121) 
7

>  <Indications>  (121) 
nan

>  <Targets>  (121) 
MAPK1; MAPK3

>  <Kinase families>  (121) 
CMGC

>  <Canonical_Smiles>  (121) 
CC(C)Nc1cc(c(cn1)Cl)c2cc([nH]c2)C(=O)N[C@H](CO)c3cccc(c3)Cl

>  <InChiKey>  (121) 
KSERXGMCDHOLSS-LJQANCHMSA-N

>  <First_Approval>  (121) 
nan

>  <SC_Patent>  (121) 
None

>  <Chirality>  (121) 
Single Stereoisomer

>  <Synonyms>  (121) 
nan

>  <FDA_approved>  (121) 


>  <Melting points>  (121) 


$$$$
Voruciclib
     RDKit          2D

 32 35  0  0  0  0  0  0  0  0999 V2000
   -4.1207   -4.8903    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3075   -3.6298    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8098   -3.5469    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4259   -2.0968    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6863   -1.2836    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8492   -2.2311    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2993   -1.8471    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.3568   -2.9110    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7693    0.2141    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1078    0.8911    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1908    2.3888    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9352    3.2095    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5967    2.5325    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5137    1.0348    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1752    0.3578    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.0804    1.1785    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9974    2.6762    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3411    3.3532    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4241    4.8509    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4189    0.5015    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5019   -0.9962    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8404   -1.6732    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0960   -0.8525    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0130    0.6452    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6745    1.3222    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5915    2.8199    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    6.4345   -1.5295    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7730   -2.2065    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    5.7575   -2.8681    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    7.1115   -0.1910    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0182    4.7072    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3634    0.0704    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  1
  7  8  1  0
  5  9  1  6
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 16 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 23 27  1  0
 27 28  1  0
 27 29  1  0
 27 30  1  0
 12 31  1  0
 10 32  1  0
  6  2  1  0
 14  9  1  0
 18 13  1  0
 25 20  1  0
M  END
>  <BrandName>  (122) 
nan

>  <Phase>  (122) 
2.0

>  <Applicants>  (122) 
Piramal Enterprises

>  <Links>  (122) 
|http://www.chemspider.com/Chemical-Structure.29165867.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3905910|http://pubchem.ncbi.nlm.nih.gov/compound/67409219|http://www.drugbank.ca/drugs/DB15157|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9923|http://zinc15.docking.org/substances/ZINC000118905502|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=W66XP666AM|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50193104

>  <LigID>  (122) 
nan

>  <pdbID>  (122) 
nan

>  <Type>  (122) 
nan

>  <RoF>  (122) 
0

>  <MW>  (122) 
469.1

>  <LogP>  (122) 
4.3

>  <TPSA>  (122) 
94.1

>  <HBA>  (122) 
6

>  <HBD>  (122) 
3

>  <NRB>  (122) 
3

>  <Indications>  (122) 
nan

>  <Targets>  (122) 
CDK4

>  <Kinase families>  (122) 
CMGC

>  <Canonical_Smiles>  (122) 
CN1CC[C@H]([C@@H]1CO)c2c(cc(c3c2oc(cc3=O)c4ccc(cc4Cl)C(F)(F)F)O)O

>  <InChiKey>  (122) 
MRPGRAKIAJJGMM-OCCSQVGLSA-N

>  <First_Approval>  (122) 
nan

>  <SC_Patent>  (122) 
None

>  <Chirality>  (122) 
Single Stereoisomer

>  <Synonyms>  (122) 
nan

>  <FDA_approved>  (122) 


>  <Melting points>  (122) 


$$$$
Leniolisib
     RDKit          2D

 32 35  0  0  0  0  0  0  0  0999 V2000
    9.1778    0.0144    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6857    0.1681    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0728    1.5372    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9520    2.7525    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.5807    1.6910    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.8281    2.9885    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3615    2.6737    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2077    1.1816    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5793    0.5742    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9102    0.4289    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.9132   -1.0710    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6157   -1.8237    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6188   -3.3237    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9193   -4.0710    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.2168   -3.3184    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2138   -1.8184    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6788   -4.0763    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9793   -3.3289    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9823   -1.8289    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6848   -1.0763    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2829   -1.0816    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2859    0.4184    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5865    1.1658    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8840    0.4132    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8810   -1.0868    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5804   -1.8342    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.1846    1.1606    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -8.4821    0.4079    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5895    2.6658    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5925    4.1658    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0895    2.6688    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0895    2.6628    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  8 10  1  1
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 13 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 19 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 24 27  1  0
 27 28  1  0
 23 29  1  0
 29 30  1  0
 29 31  1  0
 29 32  1  0
  9  5  1  0
 16 11  1  0
 20 12  1  0
 26 21  1  0
M  END
>  <BrandName>  (123) 
nan

>  <Phase>  (123) 
2.0

>  <Applicants>  (123) 
Novartis

>  <Links>  (123) 
|http://www.chemspider.com/Chemical-Structure.52083264.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3643413|http://pubchem.ncbi.nlm.nih.gov/compound/57495353| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=9NQ|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/9NQ|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9424|http://zinc15.docking.org/substances/ZINC000113570569|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=L22772Z9CP|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=118299

>  <LigID>  (123) 
'9NQ'

>  <pdbID>  (123) 
5o83

>  <Type>  (123) 
nan

>  <RoF>  (123) 
0

>  <MW>  (123) 
450.2

>  <LogP>  (123) 
2.9

>  <TPSA>  (123) 
83.5

>  <HBA>  (123) 
7

>  <HBD>  (123) 
1

>  <NRB>  (123) 
5

>  <Indications>  (123) 
nan

>  <Targets>  (123) 
nan

>  <Kinase families>  (123) 


>  <Canonical_Smiles>  (123) 
CCC(=O)N1CC[C@@H](C1)Nc2c3c(ncn2)CCN(C3)c4cc(c(nc4)OC)C(F)(F)F

>  <InChiKey>  (123) 
MWKYMZXCGYXLPL-ZDUSSCGKSA-N

>  <First_Approval>  (123) 
nan

>  <SC_Patent>  (123) 
None

>  <Chirality>  (123) 
Single Stereoisomer

>  <Synonyms>  (123) 
CDZ173-NX | LENIOLISIB

>  <FDA_approved>  (123) 


>  <Melting points>  (123) 


$$$$
Riviciclib
     RDKit          2D

 28 31  0  0  0  0  0  0  0  0999 V2000
   -4.7229   -3.7399    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5267   -2.8349    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0914   -3.2706    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2334   -2.0402    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1385   -0.8440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5558   -1.3352    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7862   -0.4772    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1444   -1.1138    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7027    0.5913    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7279    1.6863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2921    3.1216    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8312    3.4619    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1939    2.3669    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2418    0.9316    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7833   -0.1635    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.2442    0.1768    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6799    1.6121    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6548    2.7072    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0906    4.1425    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.2693   -0.9182    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8336   -2.3535    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8587   -3.4486    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3196   -3.1083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7554   -1.6730    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7302   -0.5779    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1660    0.8574    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.3955    4.8972    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1888    1.3460    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  1
  7  8  1  0
  5  9  1  6
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 16 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 12 27  1  0
 10 28  1  0
  6  2  1  0
 14  9  1  0
 18 13  1  0
 25 20  1  0
M  END
>  <BrandName>  (124) 
nan

>  <Phase>  (124) 
2.0

>  <Applicants>  (124) 
Piramal Enterprises

>  <Links>  (124) 
|http://www.chemspider.com/Chemical-Structure.29165868.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3969723|http://pubchem.ncbi.nlm.nih.gov/compound/23643976|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7934|http://zinc15.docking.org/substances/ZINC000003937395|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=9EK26WE8QN|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50193086

>  <LigID>  (124) 
nan

>  <pdbID>  (124) 
nan

>  <Type>  (124) 
nan

>  <RoF>  (124) 
0

>  <MW>  (124) 
401.1

>  <LogP>  (124) 
3.3

>  <TPSA>  (124) 
94.1

>  <HBA>  (124) 
6

>  <HBD>  (124) 
3

>  <NRB>  (124) 
3

>  <Indications>  (124) 
nan

>  <Targets>  (124) 
CDK1; CDK4; CDK9

>  <Kinase families>  (124) 
CMGC

>  <Canonical_Smiles>  (124) 
CN1CC[C@H]([C@@H]1CO)c2c(cc(c3c2oc(cc3=O)c4ccccc4Cl)O)O

>  <InChiKey>  (124) 
QLUYMIVVAYRECT-OCCSQVGLSA-N

>  <First_Approval>  (124) 
nan

>  <SC_Patent>  (124) 
None

>  <Chirality>  (124) 
Racemic Mixture

>  <Synonyms>  (124) 
nan

>  <FDA_approved>  (124) 


>  <Melting points>  (124) 


$$$$
Gandotinib
     RDKit          2D

 33 37  0  0  0  0  0  0  0  0999 V2000
    1.0312   -7.5557    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0095   -6.0559    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2102   -5.1568    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7261   -3.7371    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2263   -3.7587    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2166   -5.1918    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.5902   -2.5109    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.9603   -1.1496    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8244    0.0766    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1946    1.4379    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7007    1.5732    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1984    2.7738    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6182    2.2898    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5965    0.7899    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1634    0.3470    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.4665   -1.0143    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7972   -0.1092    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1762    0.4811    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3545    1.9704    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7335    2.5607    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.9341    1.6616    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.7558    0.1722    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3768   -0.4181    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1985   -1.9074    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -8.3131    2.2518    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -2.8443    3.1538    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0586    2.6641    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5525    2.5288    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.1824    1.1675    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6762    1.0322    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5403    2.2584    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.9105    3.6197    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4166    3.7550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  4  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 14 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 21 25  1  0
 13 26  1  0
 10 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
  6  2  1  0
 16  8  2  0
 15 11  1  0
 23 18  1  0
 33 28  1  0
M  END
>  <BrandName>  (125) 
nan

>  <Phase>  (125) 
2.0

>  <Applicants>  (125) 
Eli Lilly

>  <Links>  (125) 
|http://www.chemspider.com/Chemical-Structure.25027412.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL2107823|http://pubchem.ncbi.nlm.nih.gov/compound/46213929|http://www.drugbank.ca/drugs/DB13040|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7909|http://zinc15.docking.org/substances/ZINC68245097|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=ANC71R916O

>  <LigID>  (125) 
nan

>  <pdbID>  (125) 
nan

>  <Type>  (125) 
nan

>  <RoF>  (125) 
0

>  <MW>  (125) 
469.2

>  <LogP>  (125) 
4

>  <TPSA>  (125) 
83.4

>  <HBA>  (125) 
7

>  <HBD>  (125) 
2

>  <NRB>  (125) 
6

>  <Indications>  (125) 
nan

>  <Targets>  (125) 
JAK2

>  <Kinase families>  (125) 
Tyr

>  <Canonical_Smiles>  (125) 
Cc1cc(n[nH]1)Nc2cc(c3nc(c(n3n2)Cc4ccc(cc4F)Cl)C)CN5CCOCC5

>  <InChiKey>  (125) 
SQSZANZGUXWJEA-UHFFFAOYSA-N

>  <First_Approval>  (125) 
nan

>  <SC_Patent>  (125) 
None

>  <Chirality>  (125) 
Achiral Molecule

>  <Synonyms>  (125) 
GANDOTINIB | LY-2784544 | LY2784544

>  <FDA_approved>  (125) 


>  <Melting points>  (125) 


$$$$
Opaganib
     RDKit          2D

 27 31  0  0  0  0  0  0  0  0999 V2000
   -2.0968   -1.2807    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4597   -2.7362    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9016   -3.1496    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9806   -2.1075    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6177   -0.6521    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1758   -0.2387    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8128    1.2167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3709    1.6301    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0080    3.0856    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0870    4.1276    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5289    3.7142    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8918    2.2588    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7474    0.9510    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2919    0.5881    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0710    2.0435    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7339    0.1747    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7870   -0.4539    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4241   -1.9093    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.2289   -0.0405    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.3079   -1.0825    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7498   -0.6691    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8288   -1.7111    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2707   -1.2977    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6336    0.1577    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.5547    1.1997    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1127    0.7863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2646   -4.6050    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 11 13  1  0
 13 14  1  0
 14 15  1  0
 14 16  1  0
 14 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
  3 27  1  0
  6  1  1  0
 12  7  1  0
 16  7  1  0
 15  9  1  0
 26 21  1  0
M  END
>  <BrandName>  (126) 
nan

>  <Phase>  (126) 
2.5

>  <Applicants>  (126) 
RedHill Biopharma

>  <Links>  (126) 
|http://www.chemspider.com/Chemical-Structure.13079494.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL2158685|http://pubchem.ncbi.nlm.nih.gov/compound/15604015|http://www.drugbank.ca/drugs/DB12764|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6624|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=DRG21OQ517|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50393642

>  <LigID>  (126) 
nan

>  <pdbID>  (126) 
nan

>  <Type>  (126) 
nan

>  <RoF>  (126) 
0

>  <MW>  (126) 
380.2

>  <LogP>  (126) 
4.9

>  <TPSA>  (126) 
42

>  <HBA>  (126) 
2

>  <HBD>  (126) 
1

>  <NRB>  (126) 
4

>  <Indications>  (126) 
nan

>  <Targets>  (126) 
nan

>  <Kinase families>  (126) 


>  <Canonical_Smiles>  (126) 
c1cc(ccc1C23CC4CC(C2)CC(C4)(C3)C(=O)NCc5ccncc5)Cl

>  <InChiKey>  (126) 
CAOTVXGYTWCKQE-UHFFFAOYSA-N

>  <First_Approval>  (126) 
nan

>  <SC_Patent>  (126) 
None

>  <Chirality>  (126) 
Achiral Molecule

>  <Synonyms>  (126) 
ABC 294640 | ABC-294640 | OPAGANIB

>  <FDA_approved>  (126) 


>  <Melting points>  (126) 


$$$$
Cerdulatinib
     RDKit          2D

 31 34  0  0  0  0  0  0  0  0999 V2000
  -10.0043   -2.0059    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.5143   -0.5882    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.0415   -0.3038    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -7.7571   -1.7766    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -8.3259    1.1690    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5687   -0.0194    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0786    1.3983    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6058    1.6827    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6231    0.5494    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1132   -0.8682    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5860   -1.1527    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1503    0.8339    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1676   -0.2994    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3052   -0.0150    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7953    1.4027    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1874    2.5360    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6602    2.2515    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2681    1.6871    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.2508    0.5538    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7607   -0.8638    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.7434   -1.9971    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2162   -1.7127    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7063   -0.2950    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7236    0.8383    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.1790   -0.0106    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.6691    1.4071    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3847    2.8799    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8024    2.3898    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1989   -2.8459    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6717   -2.5615    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.7088   -4.2636    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  2  0
  3  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
  9 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 15 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 23 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 22 29  1  0
 29 30  2  0
 29 31  1  0
 11  6  1  0
 17 12  1  0
 24 19  1  0
 28 26  1  0
M  END
>  <BrandName>  (127) 
nan

>  <Phase>  (127) 
2.5

>  <Applicants>  (127) 
Portola pharmaceuticals

>  <Links>  (127) 
|http://www.chemspider.com/Chemical-Structure.32822046.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL4116008|http://pubchem.ncbi.nlm.nih.gov/compound/44595079|http://www.drugbank.ca/drugs/DB15499|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8957|http://zinc15.docking.org/substances/ZINC000114483165|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=D1LXQ45S1O

>  <LigID>  (127) 
nan

>  <pdbID>  (127) 
nan

>  <Type>  (127) 
nan

>  <RoF>  (127) 
0

>  <MW>  (127) 
445.2

>  <LogP>  (127) 
1.4

>  <TPSA>  (127) 
133.6

>  <HBA>  (127) 
8

>  <HBD>  (127) 
3

>  <NRB>  (127) 
8

>  <Indications>  (127) 
nan

>  <Targets>  (127) 
JAK1; SYK

>  <Kinase families>  (127) 
Tyr

>  <Canonical_Smiles>  (127) 
CCS(=O)(=O)N1CCN(CC1)c2ccc(cc2)Nc3ncc(c(n3)NC4CC4)C(=O)N

>  <InChiKey>  (127) 
BGLPECHZZQDNCD-UHFFFAOYSA-N

>  <First_Approval>  (127) 
nan

>  <SC_Patent>  (127) 
None

>  <Chirality>  (127) 
Single Stereoisomer

>  <Synonyms>  (127) 
nan

>  <FDA_approved>  (127) 


>  <Melting points>  (127) 


$$$$
Varlitinib
     RDKit          2D

 32 36  0  0  0  0  0  0  0  0999 V2000
   -3.0266    4.4079    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2824    3.5876    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6842    4.1213    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6251    2.9531    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8047    1.6973    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3569    2.0894    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.3385    0.2954    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3914   -0.8677    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9251   -2.2695    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9780   -3.4327    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4971   -3.1941    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9633   -1.7922    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9105   -0.6291    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4825   -1.5536    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5353   -2.7168    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0691   -4.1186    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5500   -4.3572    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9487   -0.1518    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.5322    0.0869    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4793   -1.0763    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9602   -0.8376    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4940    0.5642    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5469    1.7273    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0660    1.4887    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0807    3.1292    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    4.9749    0.8028    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.9220   -0.3603    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4029   -0.1217    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0803    1.2166    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.5624    0.9860    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8011   -0.4949    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4664   -1.1795    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  1
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 14 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 23 25  1  0
 22 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 32  1  0
  6  2  1  0
 13  8  1  0
 17 11  1  0
 24 19  1  0
 32 28  1  0
M  END
>  <BrandName>  (128) 
nan

>  <Phase>  (128) 
2.5

>  <Applicants>  (128) 
Array Biopharma

>  <Links>  (128) 
|http://www.chemspider.com/Chemical-Structure.25027380.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL2103842|http://pubchem.ncbi.nlm.nih.gov/compound/42642648|http://www.drugbank.ca/drugs/DB05944|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7645|http://zinc15.docking.org/substances/ZINC000013980035|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=846Y8197W1|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50205268

>  <LigID>  (128) 
nan

>  <pdbID>  (128) 
nan

>  <Type>  (128) 
nan

>  <RoF>  (128) 
1

>  <MW>  (128) 
466.1

>  <LogP>  (128) 
5.2

>  <TPSA>  (128) 
93.5

>  <HBA>  (128) 
9

>  <HBD>  (128) 
2

>  <NRB>  (128) 
6

>  <Indications>  (128) 
Investigated for use/treatment in cancer/tumors (unspecified).

>  <Targets>  (128) 
EGFR; ERBB2

>  <Kinase families>  (128) 
Tyr

>  <Canonical_Smiles>  (128) 
C[C@@H]1COC(=N1)Nc2ccc3c(c2)c(ncn3)Nc4ccc(c(c4)Cl)OCc5nccs5

>  <InChiKey>  (128) 
UWXSAYUXVSFDBQ-CYBMUJFWSA-N

>  <First_Approval>  (128) 
nan

>  <SC_Patent>  (128) 
None

>  <Chirality>  (128) 
Single Stereoisomer

>  <Synonyms>  (128) 
AR-00334543 | ARRY-334543 | ARRY-543 | ASLAN-001 | ASLAN001 | VARLITINIB

>  <FDA_approved>  (128) 


>  <Melting points>  (128) 


$$$$
Brivanib Alaninate
     RDKit          2D

 32 35  0  0  0  0  0  0  0  0999 V2000
   -9.8881   -0.0343    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.4562    0.4123    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.2532   -0.4837    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0293    0.3835    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4759    1.8155    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.9758    1.8333    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4590    2.9183    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9956    2.5890    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5490    1.1571    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5659    0.0543    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1193   -1.3777    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0856    0.8278    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6390   -0.6042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1756   -0.9334    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0483   -0.0662    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2513   -0.9622    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7709   -2.3831    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2710   -2.3654    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7458   -3.4681    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2093   -3.1389    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6559   -1.7069    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.6833   -0.5156    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.7860   -1.5324    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2180   -1.0858    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3207   -2.1026    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5472    0.3776    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.9792    0.8242    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0819   -0.1926    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.3084    2.2876    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7404    2.7342    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2057    3.3045    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.0661    1.4337    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  5  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
  9 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 16 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  6
 24 26  1  0
 26 27  1  0
 27 28  2  0
 27 29  1  0
 29 30  1  1
 29 31  1  0
 15 32  1  0
  6  2  1  0
 10  4  1  0
 21 13  2  0
 18 14  1  0
M  END
>  <BrandName>  (129) 
nan

>  <Phase>  (129) 
3.0

>  <Applicants>  (129) 
ZAI Lab

>  <Links>  (129) 
|http://www.chemspider.com/Chemical-Structure.9330033.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL270995|http://pubchem.ncbi.nlm.nih.gov/compound/11154925|http://www.drugbank.ca/drugs/DB11865|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8097|http://zinc15.docking.org/substances/ZINC29134440|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=U2Y5OFN795

>  <LigID>  (129) 
nan

>  <pdbID>  (129) 
nan

>  <Type>  (129) 
nan

>  <RoF>  (129) 
0

>  <MW>  (129) 
441.2

>  <LogP>  (129) 
3.4

>  <TPSA>  (129) 
116.8

>  <HBA>  (129) 
8

>  <HBD>  (129) 
2

>  <NRB>  (129) 
7

>  <Indications>  (129) 
nan

>  <Targets>  (129) 
nan

>  <Kinase families>  (129) 


>  <Canonical_Smiles>  (129) 
Cc1cc2c([nH]1)ccc(c2F)Oc3c4c(c(cn4ncn3)OC[C@@H](C)OC(=O)[C@H](C)N)C

>  <InChiKey>  (129) 
LTEJRLHKIYCEOX-OCCSQVGLSA-N

>  <First_Approval>  (129) 
nan

>  <SC_Patent>  (129) 
None

>  <Chirality>  (129) 
Single Stereoisomer

>  <Synonyms>  (129) 
BMS-582664 | BMS-582664-02 | BRIVANIB ALANINATE | BRIVANIB L-ALANINE ESTER

>  <FDA_approved>  (129) 


>  <Melting points>  (129) 


$$$$
Dinaciclib
     RDKit          2D

 29 32  0  0  0  0  0  0  0  0999 V2000
   -4.2078   -5.0258    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7524   -3.5966    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2870   -3.2764    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1666   -4.2738    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1282   -3.5165    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1920   -2.0510    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6846   -1.9027    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3025   -0.5359    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4277    0.6826    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0650    0.5343    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6828   -0.8325    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1755   -0.9809    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.0502    0.2376    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5429    0.0893    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1607   -1.2776    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6534   -1.4259    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5282   -0.2074    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9103    1.1594    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.4177    1.3078    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7851    2.3779    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0455    2.0495    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1707    3.2680    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7886    4.6348    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2812    4.7832    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1560    3.5647    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5382    2.1978    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4130    0.9793    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9056    1.1277    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.7804   -0.0908    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 18 20  1  0
  9 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  6
 27 28  1  0
 28 29  1  0
  7  3  2  0
 11  6  1  0
 19 14  1  0
 26 21  1  0
M  CHG  2  18   1  20  -1
M  END
>  <BrandName>  (130) 
nan

>  <Phase>  (130) 
3.0

>  <Applicants>  (130) 
Schering-Plough

>  <Links>  (130) 
|http://www.chemspider.com/Chemical-Structure.25027387.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL2103840|http://pubchem.ncbi.nlm.nih.gov/compound/46926350|http://www.drugbank.ca/drugs/DB12021|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7379|http://zinc15.docking.org/substances/ZINC000034894449|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=4V8ECV0NBQ|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50139171

>  <LigID>  (130) 
nan

>  <pdbID>  (130) 
nan

>  <Type>  (130) 
nan

>  <RoF>  (130) 
0

>  <MW>  (130) 
396.2

>  <LogP>  (130) 
2.3

>  <TPSA>  (130) 
92.6

>  <HBA>  (130) 
7

>  <HBD>  (130) 
2

>  <NRB>  (130) 
7

>  <Indications>  (130) 
nan

>  <Targets>  (130) 
CDK4; CDK6; BRDT

>  <Kinase families>  (130) 
(*)<br>CMGC

>  <Canonical_Smiles>  (130) 
CCc1cnn2c1nc(cc2NCc3ccc[n+](c3)[O-])N4CCCC[C@H]4CCO

>  <InChiKey>  (130) 
PIMQWRZWLQKKBJ-SFHVURJKSA-N

>  <First_Approval>  (130) 
nan

>  <SC_Patent>  (130) 
None

>  <Chirality>  (130) 
Single Stereoisomer

>  <Synonyms>  (130) 
DINACICLIB | MK-7965 | SCH-727965

>  <FDA_approved>  (130) 


>  <Melting points>  (130) 


$$$$
Taselisib
     RDKit          2D

 34 38  0  0  0  0  0  0  0  0999 V2000
   -6.6288   -4.9243    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.3787   -3.4453    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0352   -2.7782    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2544   -1.2943    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.7334   -1.0443    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -7.4283   -2.3736    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -7.4005    0.2993    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.8975    0.3934    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5705    1.5487    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1828   -0.2448    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4020    1.2391    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0585    1.9062    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0089    0.8345    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7038   -0.4948    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5167    0.9870    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1704   -0.3464    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6687   -0.4181    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4799    0.8436    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7928    2.1770    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2946    2.2487    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1861    3.6696    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5967    4.1797    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8750    3.3949    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9782    0.7719    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9169    1.9419    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3197    1.4107    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.2480   -0.0876    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.8009   -0.4824    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4180   -1.0262    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4793   -2.1962    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3566    0.1438    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5880   -1.9649    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3601   -3.4475    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.9859   -1.4210    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  5  7  1  0
  7  8  1  0
  7  9  1  0
  4 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 18 24  1  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  1  0
 27 29  1  0
 29 30  1  0
 29 31  1  0
 29 32  1  0
 32 33  2  0
 32 34  1  0
  6  2  2  0
 14 10  1  0
 23 12  1  0
 20 15  1  0
 28 24  2  0
M  END
>  <BrandName>  (131) 
nan

>  <Phase>  (131) 
3.0

>  <Applicants>  (131) 
Hoffmann-La Roche

>  <Links>  (131) 
|http://www.chemspider.com/Chemical-Structure.29315044.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL2387080|http://pubchem.ncbi.nlm.nih.gov/compound/51001932|http://www.drugbank.ca/drugs/DB12108| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=799|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/799|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7794|http://zinc15.docking.org/substances/ZINC000068267049|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=L08J2O299M|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50434806

>  <LigID>  (131) 
'799'

>  <pdbID>  (131) 
5t8f

>  <Type>  (131) 
1

>  <RoF>  (131) 
0

>  <MW>  (131) 
460.2

>  <LogP>  (131) 
3.2

>  <TPSA>  (131) 
118.7

>  <HBA>  (131) 
9

>  <HBD>  (131) 
1

>  <NRB>  (131) 
5

>  <Indications>  (131) 
nan

>  <Targets>  (131) 
PIK3CA; PIK3CD; PIK3CG

>  <Kinase families>  (131) 
Atypical

>  <Canonical_Smiles>  (131) 
Cc1nc(n(n1)C(C)C)c2cn3c(n2)-c4ccc(cc4OCC3)c5cnn(c5)C(C)(C)C(=O)N

>  <InChiKey>  (131) 
BEUQXVWXFDOSAQ-UHFFFAOYSA-N

>  <First_Approval>  (131) 
nan

>  <SC_Patent>  (131) 
None

>  <Chirality>  (131) 
Racemic Mixture

>  <Synonyms>  (131) 
GDC-0032 | RG-7604 | TASELISIB

>  <FDA_approved>  (131) 


>  <Melting points>  (131) 


$$$$
Crenolanib
     RDKit          2D

 33 38  0  0  0  0  0  0  0  0999 V2000
   -8.1628   -1.0900    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.2575    0.4070    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.3522    1.9040    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.8492    1.8093    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -9.7545    0.3123    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.7605    0.5017    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9300   -0.7474    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4330   -0.6527    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6025   -1.9018    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1055   -1.8072    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4390   -0.4634    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2695    0.7857    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7665    0.6911    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3381    1.9616    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0680    1.4392    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0056   -0.0595    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1815   -0.9909    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9628   -2.4748    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1387   -3.4062    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5332   -2.8535    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7090   -3.7849    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1035   -3.2322    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3221   -1.7482    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1463   -0.8169    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7518   -1.3695    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5760   -0.4382    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.3649    0.6671    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.7594    1.2197    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9780    2.7037    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8022    3.6350    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4077    3.0824    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1891    1.5984    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0208    5.1190    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  2  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 24 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 30 33  1  0
  5  2  1  0
 13  8  1  0
 16 11  1  0
 26 17  1  0
 25 20  1  0
 32 27  1  0
M  END
>  <BrandName>  (132) 
nan

>  <Phase>  (132) 
3.0

>  <Applicants>  (132) 
Arog Pharmaceuticals

>  <Links>  (132) 
|http://www.chemspider.com/Chemical-Structure.8541584.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL2105728|http://pubchem.ncbi.nlm.nih.gov/compound/10366136|http://www.drugbank.ca/drugs/DB11832| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=6T2|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/6T2|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7882|http://zinc15.docking.org/substances/ZINC000003820043|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=LQF7I567TQ|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=185149

>  <LigID>  (132) 
'6T2'

>  <pdbID>  (132) 
5lby 6bqp 6joi 6joj

>  <Type>  (132) 
1

>  <RoF>  (132) 
0

>  <MW>  (132) 
443.2

>  <LogP>  (132) 
3.9

>  <TPSA>  (132) 
78.4

>  <HBA>  (132) 
7

>  <HBD>  (132) 
1

>  <NRB>  (132) 
5

>  <Indications>  (132) 
nan

>  <Targets>  (132) 
FLT3; PDGFRA; PDGFRB

>  <Kinase families>  (132) 
Tyr

>  <Canonical_Smiles>  (132) 
CC1(COC1)COc2ccc3c(c2)ncn3c4ccc5cccc(c5n4)N6CCC(CC6)N

>  <InChiKey>  (132) 
DYNHJHQFHQTFTP-UHFFFAOYSA-N

>  <First_Approval>  (132) 
nan

>  <SC_Patent>  (132) 
None

>  <Chirality>  (132) 
Achiral Molecule

>  <Synonyms>  (132) 
ARO 002 | ARO-002 | CP 868596 | CP-868,596 | CP-868596 | CRENOLANIB

>  <FDA_approved>  (132) 


>  <Melting points>  (132) 


$$$$
Radotinib
     RDKit          2D

 39 43  0  0  0  0  0  0  0  0999 V2000
    5.6804   -4.6621    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3180   -4.0345    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0933   -4.9006    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7309   -4.2729    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5932   -2.7793    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8180   -1.9132    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1803   -2.5408    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4051   -1.6748    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.2674   -0.1811    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4921    0.6849    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.3545    2.1786    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9921    2.8062    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7674    1.9402    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9050    0.4465    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.4050    2.5678    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2673    4.0615    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9050    4.6891    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3198    3.8230    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1821    2.3294    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1803    1.7017    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.2308   -2.1516    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9939   -3.0177    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0932   -0.6580    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2692   -0.0303    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4069    1.4633    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7692    2.0909    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9940    1.2249    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8563   -0.2688    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4939   -0.8964    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0810   -1.1348    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1003   -2.6347    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5327   -3.0799    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.3987   -1.8552    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5016   -0.6530    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.0145   -4.5004    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9069    3.5846    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0445    5.0783    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4006    3.4470    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4132    3.7223    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
  5 21  1  0
 21 22  2  0
 21 23  1  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 28 30  1  0
 30 31  1  0
 31 32  2  0
 32 33  1  0
 33 34  2  0
 32 35  1  0
 26 36  1  0
 36 37  1  0
 36 38  1  0
 36 39  1  0
  7  2  1  0
 14  9  1  0
 20 15  1  0
 29 24  1  0
 34 30  1  0
M  END
>  <BrandName>  (133) 
nan

>  <Phase>  (133) 
3.0

>  <Applicants>  (133) 
Il-Yang Pharmaceutical

>  <Links>  (133) 
|http://www.chemspider.com/Chemical-Structure.17222861.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL4297524|http://pubchem.ncbi.nlm.nih.gov/compound/16063245|http://www.drugbank.ca/drugs/DB12323|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7814|http://zinc15.docking.org/substances/ZINC000059749972|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=I284LJY110

>  <LigID>  (133) 
nan

>  <pdbID>  (133) 
nan

>  <Type>  (133) 
nan

>  <RoF>  (133) 
2

>  <MW>  (133) 
530.2

>  <LogP>  (133) 
5.8

>  <TPSA>  (133) 
110.5

>  <HBA>  (133) 
8

>  <HBD>  (133) 
2

>  <NRB>  (133) 
6

>  <Indications>  (133) 
Radotinib is indicated for the treatment of different types of cancer, most notably Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) with resistance or intolerance of other Bcr-Abl tyrosine-kinase inhibitors, such as patients resistant or intolerant to imatinib.

>  <Targets>  (133) 
ABL1; PDGFRB

>  <Kinase families>  (133) 
Tyr

>  <Canonical_Smiles>  (133) 
Cc1ccc(cc1Nc2nccc(n2)c3cnccn3)C(=O)Nc4cc(cc(c4)n5cc(nc5)C)C(F)(F)F

>  <InChiKey>  (133) 
DUPWHXBITIZIKZ-UHFFFAOYSA-N

>  <First_Approval>  (133) 
nan

>  <SC_Patent>  (133) 
None

>  <Chirality>  (133) 
Achiral Molecule

>  <Synonyms>  (133) 
IY5511 | RADOTINIB

>  <FDA_approved>  (133) 


>  <Melting points>  (133) 


$$$$
Linifanib
     RDKit          2D

 28 31  0  0  0  0  0  0  0  0999 V2000
   -9.0600   -0.0141    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.6038    0.3459    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.1875    1.7869    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7313    2.1469    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6915    1.0659    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1078   -0.3752    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5640   -0.7352    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0680   -1.4563    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6118   -1.0963    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1955    0.3448    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5720   -2.1774    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1158   -1.8174    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9241   -2.8984    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3802   -2.5384    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7965   -1.0974    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7567   -0.0163    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3005   -0.3763    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2527   -0.7374    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2925   -1.8184    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7487   -1.4585    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1650   -0.0174    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1252    1.0637    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6690    0.7037    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8767    1.9773    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8431    3.1245    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.2328    2.5598    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.3805    2.0849    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2353    1.4259    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 15 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 24 27  1  0
  5 28  1  0
  7  2  1  0
 17 12  1  0
 23 18  1  0
 26 22  1  0
M  END
>  <BrandName>  (134) 
nan

>  <Phase>  (134) 
3.0

>  <Applicants>  (134) 
Abbott Laboratories

>  <Links>  (134) 
|http://www.chemspider.com/Chemical-Structure.9660475.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL223360|http://pubchem.ncbi.nlm.nih.gov/compound/11485656|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5657|http://zinc15.docking.org/substances/ZINC06718813|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=CO93X137CW|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21079

>  <LigID>  (134) 
nan

>  <pdbID>  (134) 
nan

>  <Type>  (134) 
nan

>  <RoF>  (134) 
0

>  <MW>  (134) 
375.1

>  <LogP>  (134) 
4.9

>  <TPSA>  (134) 
95.8

>  <HBA>  (134) 
3

>  <HBD>  (134) 
4

>  <NRB>  (134) 
3

>  <Indications>  (134) 
nan

>  <Targets>  (134) 
FLT3; CSF1R; KDR

>  <Kinase families>  (134) 
Tyr

>  <Canonical_Smiles>  (134) 
Cc1ccc(c(c1)NC(=O)Nc2ccc(cc2)c3cccc4c3c(n[nH]4)N)F

>  <InChiKey>  (134) 
MPVGZUGXCQEXTM-UHFFFAOYSA-N

>  <First_Approval>  (134) 
nan

>  <SC_Patent>  (134) 
None

>  <Chirality>  (134) 
Achiral Molecule

>  <Synonyms>  (134) 
A-741439 | ABT-869 | AL-39324 | LINIFANIB | RG-3635

>  <FDA_approved>  (134) 


>  <Melting points>  (134) 


$$$$
Motesanib
     RDKit          2D

 28 31  0  0  0  0  0  0  0  0999 V2000
   -7.1065    0.0693    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6142   -0.0833    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6185    1.4167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1932    1.8842    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3081    0.6732    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1864   -0.5428    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5724   -1.9114    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0802   -2.0640    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2019   -0.8480    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8159    0.5206    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2903   -1.0006    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.9043   -2.3692    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0260   -3.5852    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.3965   -2.5218    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0104   -3.8904    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5027   -4.0430    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3809   -2.8269    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7670   -1.4584    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.2747   -1.3058    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6608    0.0628    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.5390    1.2788    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9251    2.6474    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8033    3.8634    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1894    5.2320    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6972    5.3846    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.8189    4.1686    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4329    2.8000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9220   -1.5514    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
  2 28  1  0
  6  2  1  0
 10  5  1  0
 19 14  1  0
 27 22  1  0
M  END
>  <BrandName>  (135) 
nan

>  <Phase>  (135) 
3.0

>  <Applicants>  (135) 
Amgen

>  <Links>  (135) 
|http://www.chemspider.com/Chemical-Structure.9842625.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL572881|http://pubchem.ncbi.nlm.nih.gov/compound/11667893|http://www.drugbank.ca/drugs/DB05575| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=706|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/706|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5660|http://zinc15.docking.org/substances/ZINC18710082|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=U1JK633AYI|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24773

>  <LigID>  (135) 
'706'

>  <pdbID>  (135) 
3efl

>  <Type>  (135) 
2

>  <RoF>  (135) 
0

>  <MW>  (135) 
373.2

>  <LogP>  (135) 
4

>  <TPSA>  (135) 
78.9

>  <HBA>  (135) 
5

>  <HBD>  (135) 
3

>  <NRB>  (135) 
5

>  <Indications>  (135) 
nan

>  <Targets>  (135) 
FLT1; KDR; FLT4; PDGFRA; PDGFRB; KIT; RET

>  <Kinase families>  (135) 
Tyr

>  <Canonical_Smiles>  (135) 
CC1(CNc2c1ccc(c2)NC(=O)c3cccnc3NCc4ccncc4)C

>  <InChiKey>  (135) 
RAHBGWKEPAQNFF-UHFFFAOYSA-N

>  <First_Approval>  (135) 
nan

>  <SC_Patent>  (135) 
None

>  <Chirality>  (135) 
Achiral Molecule

>  <Synonyms>  (135) 
AMG 706 | MOTESANIB

>  <FDA_approved>  (135) 


>  <Melting points>  (135) 


$$$$
Naquotinib
     RDKit          2D

 41 45  0  0  0  0  0  0  0  0999 V2000
    7.0504   -3.4850    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5353   -2.0656    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5484   -0.9359    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0767   -1.2257    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0899   -0.0960    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.5748    1.3234    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0465    1.6132    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0333    0.4835    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.5314    3.0327    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5446    4.1623    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.0031    3.3225    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.5879    2.4531    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.1162    2.1633    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1293    3.2930    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3424    3.0032    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8273    1.5837    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1595    0.4541    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6313    0.7438    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2990    1.2939    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2859    2.4236    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7576    2.1338    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2425    0.7144    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2557   -0.4153    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7839   -0.1255    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.7143    0.4246    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -7.7011    1.5542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.1728    1.2644    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.6577   -0.1550    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -8.6709   -1.2847    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.1992   -0.9949    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -11.1295   -0.4448    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5918   -2.6452    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.1200   -2.9350    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4894   -4.2960    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0002   -4.1168    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7104   -2.6450    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.0205   -1.9146    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6506   -2.0144    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7850   -0.5204    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8773   -2.8778    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2383   -2.2471    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  2  0
  9 11  1  0
  6 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 16 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 22 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 28 31  1  0
  4 32  1  0
 33 32  1  6
 33 34  1  0
 34 35  1  0
 35 36  1  0
 36 37  1  0
 36 38  1  0
 38 39  2  0
 38 40  1  0
 40 41  2  0
  8  3  1  0
 18 13  1  0
 24 19  1  0
 30 25  1  0
 37 33  1  0
M  END
>  <BrandName>  (136) 
nan

>  <Phase>  (136) 
3.0

>  <Applicants>  (136) 
Astellas Pharma

>  <Links>  (136) 
|http://www.chemspider.com/Chemical-Structure.44210447.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3663929|http://pubchem.ncbi.nlm.nih.gov/compound/71667668|http://www.drugbank.ca/drugs/DB12036| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=8RC|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/8RC|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9248|http://zinc15.docking.org/substances/ZINC000205341959|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=47DD4548PB|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=170514

>  <LigID>  (136) 
'8RC'

>  <pdbID>  (136) 
5y9t

>  <Type>  (136) 
nan

>  <RoF>  (136) 
1

>  <MW>  (136) 
562.3

>  <LogP>  (136) 
2.3

>  <TPSA>  (136) 
120.2

>  <HBA>  (136) 
9

>  <HBD>  (136) 
2

>  <NRB>  (136) 
9

>  <Indications>  (136) 
nan

>  <Targets>  (136) 
EGFR

>  <Kinase families>  (136) 
Tyr

>  <Canonical_Smiles>  (136) 
CCc1c(nc(c(n1)C(=O)N)Nc2ccc(cc2)N3CCC(CC3)N4CCN(CC4)C)O[C@@H]5CCN(C5)C(=O)C=C

>  <InChiKey>  (136) 
QKDCLUARMDUUKN-XMMPIXPASA-N

>  <First_Approval>  (136) 
nan

>  <SC_Patent>  (136) 
None

>  <Chirality>  (136) 
Single Stereoisomer

>  <Synonyms>  (136) 
ASP-8273 | ASP8273 | NAQUOTINIB

>  <FDA_approved>  (136) 


>  <Melting points>  (136) 


$$$$
Nazartinib
     RDKit          2D

 35 38  0  0  0  0  0  0  0  0999 V2000
   -9.5074    1.4920    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.0290    1.7457    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.0701    0.5922    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5917    0.8458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0722    2.2530    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0311    3.4065    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.5095    3.1528    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6329   -0.3077    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1524   -1.7148    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1545   -0.0540    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1956   -1.2076    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5652   -2.6613    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2968   -3.4621    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0432   -4.9405    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3640   -5.4600    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5175   -4.5011    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2638   -3.0227    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1433   -2.5032    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6988   -1.1098    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.1020    0.1586    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6934    1.4303    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1950    2.8451    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2219    3.3375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4903    2.5368    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6551    1.0458    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.5922   -0.0126    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0698    0.5474    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3456   -0.9270    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.2089    1.5234    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6237    1.0250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7627    2.0010    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1775    1.5026    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.3165    2.4786    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4532    0.0281    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4174   -2.0639    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  4  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 20 19  1  6
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 25 27  1  0
 27 28  2  0
 27 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
 32 34  1  0
 17 35  1  0
  7  2  1  0
 19 11  1  0
 18 13  1  0
 26 20  1  0
M  END
>  <BrandName>  (137) 
nan

>  <Phase>  (137) 
3.0

>  <Applicants>  (137) 
Novartis

>  <Links>  (137) 
|http://www.chemspider.com/Chemical-Structure.35308229.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3787344|http://pubchem.ncbi.nlm.nih.gov/compound/72703790|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9204|http://zinc15.docking.org/substances/ZINC000210610738|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=KE7K32EME8|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50160870

>  <LigID>  (137) 
nan

>  <pdbID>  (137) 
nan

>  <Type>  (137) 
nan

>  <RoF>  (137) 
0

>  <MW>  (137) 
494.2

>  <LogP>  (137) 
4.3

>  <TPSA>  (137) 
83.4

>  <HBA>  (137) 
6

>  <HBD>  (137) 
1

>  <NRB>  (137) 
6

>  <Indications>  (137) 
nan

>  <Targets>  (137) 
nan

>  <Kinase families>  (137) 


>  <Canonical_Smiles>  (137) 
Cc1cc(ccn1)C(=O)Nc2nc3cccc(c3n2[C@@H]4CCCCN(C4)C(=O)/C=C/CN(C)C)Cl

>  <InChiKey>  (137) 
IOMMMLWIABWRKL-WUTDNEBXSA-N

>  <First_Approval>  (137) 
nan

>  <SC_Patent>  (137) 
None

>  <Chirality>  (137) 
Single Stereoisomer

>  <Synonyms>  (137) 
EGF-816 | EGF816 | NAZARTINIB | NVP-EGF816-NX

>  <FDA_approved>  (137) 


>  <Melting points>  (137) 


$$$$
Losmapimod
     RDKit          2D

 28 30  0  0  0  0  0  0  0  0999 V2000
    1.3558   -3.7790    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1758   -2.5230    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4981   -1.1849    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3181    0.0711    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8159   -0.0110    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4936   -1.3492    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6736   -2.6052    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3513   -3.9434    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    4.6359    1.2450    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9582    2.5832    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.1336    1.1628    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.9537    2.4189    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0358    3.9166    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2918    3.0966    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0004   -1.1027    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6774    0.2355    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1751    0.3176    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9951   -0.9384    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3174   -2.2766    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8197   -2.3587    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4929   -0.8562    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3129   -2.1122    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1706    0.4819    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6684    0.5641    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.3461    1.9023    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.6843    1.2245    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0079    2.5800    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.0238    3.2404    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  5  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
  3 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 18 21  1  0
 21 22  2  0
 21 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 25 27  1  0
 25 28  1  0
  7  2  1  0
 14 12  1  0
 20 15  1  0
M  END
>  <BrandName>  (138) 
nan

>  <Phase>  (138) 
3.0

>  <Applicants>  (138) 
GlaxoSmithKline

>  <Links>  (138) 
|http://www.chemspider.com/Chemical-Structure.9727484.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL1088752|http://pubchem.ncbi.nlm.nih.gov/compound/11552706|http://www.drugbank.ca/drugs/DB12270|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7835|http://zinc15.docking.org/substances/ZINC000035793138|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=F2DQF16BXE|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50418610

>  <LigID>  (138) 
nan

>  <pdbID>  (138) 
nan

>  <Type>  (138) 
nan

>  <RoF>  (138) 
0

>  <MW>  (138) 
383.2

>  <LogP>  (138) 
3.9

>  <TPSA>  (138) 
71.1

>  <HBA>  (138) 
3

>  <HBD>  (138) 
2

>  <NRB>  (138) 
5

>  <Indications>  (138) 
nan

>  <Targets>  (138) 
MAPK14; MAPK11; MAPK13; MAPK12

>  <Kinase families>  (138) 
CMGC

>  <Canonical_Smiles>  (138) 
Cc1c(cc(cc1F)C(=O)NC2CC2)c3ccc(cn3)C(=O)NCC(C)(C)C

>  <InChiKey>  (138) 
KKYABQBFGDZVNQ-UHFFFAOYSA-N

>  <First_Approval>  (138) 
nan

>  <SC_Patent>  (138) 
None

>  <Chirality>  (138) 
Achiral Molecule

>  <Synonyms>  (138) 
GSK-AHAB | GW-856553 | GW-856553X | GW856553X | LOSMAPIMOD

>  <FDA_approved>  (138) 


>  <Melting points>  (138) 


$$$$
Barasertib
     RDKit          2D

 41 44  0  0  0  0  0  0  0  0999 V2000
   11.2660   -3.3224    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7675   -3.2551    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0765   -1.9238    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.5780   -1.8566    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8870   -0.5252    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3885   -0.4580    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6975    0.8734    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.1990    0.9406    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3915   -0.3235    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8931   -0.2563    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2020    1.0751    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0095    2.3392    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5080    2.2720    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3185    3.6706    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1800    3.7378    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9875    2.4737    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2965    1.1423    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1039   -0.1218    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6024   -0.0545    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5376   -1.2273    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9420   -0.7003    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8747    0.7982    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4288    1.1973    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -7.1938   -1.5267    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.5354   -0.8558    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.6252    0.6415    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -9.7872   -1.6822    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  -11.1288   -1.0113    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -11.2186    0.4860    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -12.5602    1.1569    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -13.8120    0.3306    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -13.7222   -1.1668    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -12.3807   -1.8377    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -14.9741   -1.9932    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    9.8840   -0.6597    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3825   -0.7269    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.1900    0.5372    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.6885    0.4700    0.0000 P   0  0  0  0  0  0  0  0  0  0  0  0
   13.7557    1.9685    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.6212   -1.0285    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.1870    0.4027    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 21 24  1  0
 24 25  1  0
 25 26  2  0
 25 27  1  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 32  1  0
 32 33  2  0
 32 34  1  0
  3 35  1  0
 35 36  1  0
 36 37  1  0
 37 38  1  0
 38 39  2  0
 38 40  1  0
 38 41  1  0
 13  8  1  0
 17 11  1  0
 23 19  1  0
 33 28  1  0
M  END
>  <BrandName>  (139) 
nan

>  <Phase>  (139) 
3.0

>  <Applicants>  (139) 
Astrazeneca

>  <Links>  (139) 
|http://www.chemspider.com/Chemical-Structure.9672789.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL415049|http://pubchem.ncbi.nlm.nih.gov/compound/11497983|http://www.drugbank.ca/drugs/DB11747|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7332|http://zinc15.docking.org/substances/ZINC000043129461|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=16XC2U7W8N|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50241089

>  <LigID>  (139) 
nan

>  <pdbID>  (139) 
nan

>  <Type>  (139) 
nan

>  <RoF>  (139) 
1

>  <MW>  (139) 
587.2

>  <LogP>  (139) 
3.6

>  <TPSA>  (139) 
174.8

>  <HBA>  (139) 
9

>  <HBD>  (139) 
5

>  <NRB>  (139) 
15

>  <Indications>  (139) 
nan

>  <Targets>  (139) 
AURKB

>  <Kinase families>  (139) 
Other

>  <Canonical_Smiles>  (139) 
CCN(CCCOc1ccc2c(c1)ncnc2Nc3cc(n[nH]3)CC(=O)Nc4cccc(c4)F)CCOP(=O)(O)O

>  <InChiKey>  (139) 
GBJVVSCPOBPEIT-UHFFFAOYSA-N

>  <First_Approval>  (139) 
nan

>  <SC_Patent>  (139) 
None

>  <Chirality>  (139) 
Achiral Molecule

>  <Synonyms>  (139) 
AZD 1152 | AZD-1152 | AZD1152 | BARASERTIB

>  <FDA_approved>  (139) 


>  <Melting points>  (139) 


$$$$
Sitravatinib
     RDKit          2D

 45 50  0  0  0  0  0  0  0  0999 V2000
  -16.9051    0.2503    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -15.7203   -0.6696    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  -14.3312   -0.1035    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -13.1464   -1.0234    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -11.7574   -0.4573    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  -10.5726   -1.3772    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.1835   -0.8111    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.9792    0.6749    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.5901    1.2410    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4053    0.3211    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6096   -1.1649    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -7.9987   -1.7310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0163    0.8872    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6578    2.3438    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1618    2.4529    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5957    1.0639    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7418    0.0962    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1096    0.8596    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1897    2.0444    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7558    3.4335    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2418    3.6377    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5435   -0.5295    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.9425   -0.7338    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5086   -2.1228    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9947   -2.3271    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9146   -1.1423    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3485    0.2468    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8624    0.4510    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2963    1.8401    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    5.4006   -1.3466    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.9667   -2.7356    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0468   -3.9204    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.4527   -2.9399    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7793   -3.6401    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5096   -4.4388    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9119   -1.5119    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9049   -0.4002    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.3782   -1.1956    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.8374    0.2324    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3037    0.5487    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7629    1.9766    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7558    3.0883    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2896    2.7720    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8304    1.3440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2151    4.5163    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 10 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 16 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 18 22  1  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 26 30  1  0
 30 31  1  0
 31 32  2  0
 31 33  1  0
 33 34  1  0
 34 35  1  0
 33 36  1  0
 36 37  2  0
 36 38  1  0
 38 39  1  0
 39 40  2  0
 40 41  1  0
 41 42  2  0
 42 43  1  0
 43 44  2  0
 42 45  1  0
 12  7  1  0
 17 13  1  0
 21 15  1  0
 28 23  1  0
 35 33  1  0
 44 39  1  0
M  END
>  <BrandName>  (140) 
nan

>  <Phase>  (140) 
3.0

>  <Applicants>  (140) 
Mirati Therapeutics

>  <Links>  (140) 
|http://www.chemspider.com/Chemical-Structure.52083477.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3989926|http://pubchem.ncbi.nlm.nih.gov/compound/25212148|http://www.drugbank.ca/drugs/DB15036|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9920|http://zinc15.docking.org/substances/ZINC000164334830|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=CWG62Q1VTB

>  <LigID>  (140) 
nan

>  <pdbID>  (140) 
nan

>  <Type>  (140) 
nan

>  <RoF>  (140) 
2

>  <MW>  (140) 
629.2

>  <LogP>  (140) 
6.5

>  <TPSA>  (140) 
114.5

>  <HBA>  (140) 
8

>  <HBD>  (140) 
3

>  <NRB>  (140) 
12

>  <Indications>  (140) 
nan

>  <Targets>  (140) 
RET; DDR2; NTRK1; NTRK2; NTRK3

>  <Kinase families>  (140) 
Tyr

>  <Canonical_Smiles>  (140) 
COCCNCc1ccc(nc1)c2cc3c(s2)c(ccn3)Oc4ccc(cc4F)NC(=O)C5(CC5)C(=O)Nc6ccc(cc6)F

>  <InChiKey>  (140) 
WLAVZAAODLTUSW-UHFFFAOYSA-N

>  <First_Approval>  (140) 
nan

>  <SC_Patent>  (140) 
None

>  <Chirality>  (140) 
Achiral Molecule

>  <Synonyms>  (140) 
MG-516 | MG-91516 | MGCD-516 | MGCD516 | SITRAVATINIB

>  <FDA_approved>  (140) 


>  <Melting points>  (140) 


$$$$
Quizartinib
     RDKit          2D

 40 45  0  0  0  0  0  0  0  0999 V2000
  -12.9702    1.7775    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -13.0395    0.2791    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -13.1088   -1.2193    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -14.5379    0.3484    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -11.5411    0.2098    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.7164   -1.0432    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.2699   -0.6461    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.2006    0.8523    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  -10.6043    1.3813    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -8.0984   -1.5828    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.7014   -1.0367    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4759    0.4463    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5299   -1.9735    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1329   -1.4273    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9614   -2.3641    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5643   -1.8180    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3388   -0.3350    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5103    0.6018    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9073    0.0556    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0583    0.2111    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3213   -0.5981    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4812    0.3531    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.9786    0.4408    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0458   -0.6134    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4922   -0.2162    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8715    1.2350    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8044    2.2891    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3579    1.8920    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0949    2.7012    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    1.9350    1.7501    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4376    1.6624    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.3180    1.6322    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.3852    0.5780    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8316    0.9752    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8988   -0.0789    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.5195   -1.5302    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5867   -2.5843    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0331   -2.1872    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.4124   -0.7359    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3453    0.3182    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  2  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  7 10  1  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 17 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  1  0
 30 31  2  0
 26 32  1  0
 32 33  1  0
 33 34  1  0
 34 35  1  0
 35 36  1  0
 36 37  1  0
 37 38  1  0
 38 39  1  0
 39 40  1  0
  9  5  1  0
 19 14  1  0
 31 20  1  0
 30 22  1  0
 28 23  1  0
 40 35  1  0
M  END
>  <BrandName>  (141) 
nan

>  <Phase>  (141) 
3.0

>  <Applicants>  (141) 
Ambit Biosciences

>  <Links>  (141) 
|http://www.chemspider.com/Chemical-Structure.24640357.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL576982|http://pubchem.ncbi.nlm.nih.gov/compound/24889392|http://www.drugbank.ca/drugs/DB12874| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=P30|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/P30|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5658|http://zinc15.docking.org/substances/ZINC43204002|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=7LA4O6Q0D3|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50300690

>  <LigID>  (141) 
'P30'

>  <pdbID>  (141) 
4rt7 4xuf

>  <Type>  (141) 
2

>  <RoF>  (141) 
2

>  <MW>  (141) 
560.2

>  <LogP>  (141) 
5.9

>  <TPSA>  (141) 
106.2

>  <HBA>  (141) 
9

>  <HBD>  (141) 
2

>  <NRB>  (141) 
7

>  <Indications>  (141) 
nan

>  <Targets>  (141) 
FLT3; CSF1R; KIT

>  <Kinase families>  (141) 
Tyr

>  <Canonical_Smiles>  (141) 
CC(C)(C)c1cc(no1)NC(=O)Nc2ccc(cc2)c3cn4c5ccc(cc5sc4n3)OCCN6CCOCC6

>  <InChiKey>  (141) 
CVWXJKQAOSCOAB-UHFFFAOYSA-N

>  <First_Approval>  (141) 
nan

>  <SC_Patent>  (141) 
None

>  <Chirality>  (141) 
Achiral Molecule

>  <Synonyms>  (141) 
AC-010220 | AC-220 | AC010220 | AC220 | ASP-2689 | QUIZARTINIB

>  <FDA_approved>  (141) 


>  <Melting points>  (141) 


$$$$
Semaxanib
     RDKit          2D

 18 20  0  0  0  0  0  0  0  0999 V2000
   -3.0634   -3.0466    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0860   -1.5468    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3127   -0.6835    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8707    0.7499    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3708    0.7725    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8859   -0.6469    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4525   -1.0889    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6470   -0.0686    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1187   -0.3583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8882   -1.6459    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3880   -1.6233    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1184   -0.3131    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3489    0.9745    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8491    0.9519    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8287    2.0514    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.4678    1.4207    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8424    2.1511    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7705    1.9501    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
  4 18  1  0
  6  2  2  0
  8 16  1  0
 14  9  1  0
M  END
>  <BrandName>  (142) 
nan

>  <Phase>  (142) 
3.0

>  <Applicants>  (142) 
Sugen

>  <Links>  (142) 
|http://www.chemspider.com/Chemical-Structure.4486260.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL276711|http://pubchem.ncbi.nlm.nih.gov/compound/5329098|http://www.drugbank.ca/drugs/DB06436| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=X2M|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/X2M|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5056|http://zinc15.docking.org/substances/ZINC12410091|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=71IA9S35AJ|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4810

>  <LigID>  (142) 
'X2M'

>  <pdbID>  (142) 
2x2m

>  <Type>  (142) 
1

>  <RoF>  (142) 
0

>  <MW>  (142) 
238.1

>  <LogP>  (142) 
3.1

>  <TPSA>  (142) 
44.9

>  <HBA>  (142) 
1

>  <HBD>  (142) 
2

>  <NRB>  (142) 
1

>  <Indications>  (142) 
Investigated for use/treatment in colorectal cancer and lung cancer.

>  <Targets>  (142) 
KDR

>  <Kinase families>  (142) 
Tyr

>  <Canonical_Smiles>  (142) 
Cc1cc([nH]c1/C=C\2/c3ccccc3NC2=O)C

>  <InChiKey>  (142) 
WUWDLXZGHZSWQZ-WQLSENKSSA-N

>  <First_Approval>  (142) 
nan

>  <SC_Patent>  (142) 
None

>  <Chirality>  (142) 
Achiral Molecule

>  <Synonyms>  (142) 
NSC-696819 | SEMAXANIB | SEMAXINIB | SU-5416 | SU005416 | SU5416

>  <FDA_approved>  (142) 


>  <Melting points>  (142) 


$$$$
Rigosertib
     RDKit          2D

 31 32  0  0  0  0  0  0  0  0999 V2000
   -7.7742    1.5445    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6079    0.6013    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2079    1.1398    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9742    2.6214    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5742    3.1599    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4079    2.2167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6415    0.7350    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0416    0.1965    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2752   -1.2851    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6753   -1.8236    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9089   -3.3053    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7426   -4.2485    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -7.3090   -3.8438    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0078    2.7552    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1585    1.8119    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    1.1017    2.9783    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7847    0.6456    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.3248    0.8687    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7249    1.4072    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8912    0.4640    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6575   -1.0177    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8238   -1.9609    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2239   -1.4225    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4575    0.0592    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2912    1.0024    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5249    2.4841    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.9249    3.0226    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3902   -2.3657    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.1565   -3.8474    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2575   -1.5562    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.0238   -3.0379    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
  6 14  1  0
 14 15  1  0
 15 16  2  0
 15 17  2  0
 15 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  1  0
 23 28  1  0
 28 29  1  0
 21 30  1  0
 30 31  1  0
  8  3  1  0
 25 20  1  0
M  END
>  <BrandName>  (143) 
nan

>  <Phase>  (143) 
3.0

>  <Applicants>  (143) 
Onconova Therapeutics

>  <Links>  (143) 
|http://www.chemspider.com/Chemical-Structure.5293927.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL1241855|http://pubchem.ncbi.nlm.nih.gov/compound/6918736|http://www.drugbank.ca/drugs/DB12146| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=6FS|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/6FS|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7833|http://zinc15.docking.org/substances/ZINC000003942646|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=67DOW7F9GL|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50060917

>  <LigID>  (143) 
'6FS'

>  <pdbID>  (143) 
5j18 5j2r 5ov7

>  <Type>  (143) 
3

>  <RoF>  (143) 
0

>  <MW>  (143) 
451.1

>  <LogP>  (143) 
2.8

>  <TPSA>  (143) 
120.4

>  <HBA>  (143) 
8

>  <HBD>  (143) 
2

>  <NRB>  (143) 
11

>  <Indications>  (143) 
nan

>  <Targets>  (143) 
PIK3CA; PLK1

>  <Kinase families>  (143) 
Other<br>Atypical

>  <Canonical_Smiles>  (143) 
COc1ccc(cc1NCC(=O)O)CS(=O)(=O)/C=C/c2c(cc(cc2OC)OC)OC

>  <InChiKey>  (143) 
OWBFCJROIKNMGD-BQYQJAHWSA-N

>  <First_Approval>  (143) 
nan

>  <SC_Patent>  (143) 
None

>  <Chirality>  (143) 
Achiral Molecule

>  <Synonyms>  (143) 
ON 01910 | RIGOSERTIB

>  <FDA_approved>  (143) 


>  <Melting points>  (143) 


$$$$
Selpercatinib
     RDKit          2D

 39 44  0  0  0  0  0  0  0  0999 V2000
   -3.8107   -4.9633    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6683   -3.9913    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9388   -2.5159    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3519   -2.0125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6225   -0.5371    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4800    0.4349    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7506    1.9103    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1636    2.4137    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.3061    1.4416    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8931    0.9383    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7506    1.9103    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0212    3.3857    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4342    3.8891    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5767    2.9170    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3376    1.4069    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0670   -0.0684    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6540   -0.5718    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4884    0.4002    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2179    1.8756    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1952    2.3790    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.9015   -0.1031    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0439    0.8689    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4569    0.3656    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7275   -1.1098    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5851   -2.0819    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.5430   -3.5813    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.1040   -4.0046    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2567   -2.7668    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2427   -2.7248    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7421   -2.6827    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.1721   -1.5785    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5994    1.3376    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.0124    0.8342    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1548    1.8063    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1828    2.9487    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1268    0.6638    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2972    2.7783    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0670   -0.0684    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7964   -1.5438    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 11 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 18 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  1  0
 29 30  3  0
 28 31  2  0
 23 32  1  0
 32 33  1  0
 33 34  1  0
 34 35  1  0
 34 36  1  0
 34 37  1  0
  6 38  1  0
 38 39  2  0
 39  3  1  0
 13  8  1  0
 20 15  1  0
 31 21  1  0
 14  9  1  0
 31 25  1  0
M  END
>  <BrandName>  (144) 
nan

>  <Phase>  (144) 
3.0

>  <Applicants>  (144) 
Loxo Oncology

>  <Links>  (144) 
|http://www.chemspider.com/Chemical-Structure.72379991.html|http://pubchem.ncbi.nlm.nih.gov/compound/134436906|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10318|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=296429

>  <LigID>  (144) 
nan

>  <pdbID>  (144) 
nan

>  <Type>  (144) 
nan

>  <RoF>  (144) 
1

>  <MW>  (144) 
525.2

>  <LogP>  (144) 
3.3

>  <TPSA>  (144) 
112

>  <HBA>  (144) 
10

>  <HBD>  (144) 
1

>  <NRB>  (144) 
8

>  <Indications>  (144) 
nan

>  <Targets>  (144) 
nan

>  <Kinase families>  (144) 


>  <Canonical_Smiles>  (144) 
COC1C=CC(CN2C3CN(CC2C3)C2C=CC(=CN=2)C2=CC(=CN3N=CC(C#N)=C32)OCC(C)(C)O)=CN=1

>  <InChiKey>  (144) 
XIIOFHFUYBLOLW-UHFFFAOYSA-N

>  <First_Approval>  (144) 
nan

>  <SC_Patent>  (144) 
nan

>  <Chirality>  (144) 
nan

>  <Synonyms>  (144) 
|WHO 10967|LY3527723|LOXO-292|RETEVMO

>  <FDA_approved>  (144) 


>  <Melting points>  (144) 


$$$$
Futibatinib
     RDKit          2D

 31 34  0  0  0  0  0  0  0  0999 V2000
   -6.1995    4.4880    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.1069    3.2936    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5262    1.9105    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0381    1.7219    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4573    0.3389    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3647   -0.8555    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.8528   -0.6669    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.4335    0.7161    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.7602   -1.8614    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -9.2483   -1.6728    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9693    0.1503    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4812   -0.0383    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0069   -0.2269    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7290   -1.5417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2352   -2.9580    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2148   -4.0939    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.6884   -3.8134    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1823   -2.3971    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.2026   -1.2612    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3912    0.2269    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.0342    0.8661    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.7059    0.9490    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8945    2.4371    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3681    2.7176    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0902    1.4029    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.0629    0.3098    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5783    1.2143    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4857    2.4087    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.1590   -0.1688    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6471   -0.3574    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2384   -3.2385    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  1  0
  5 11  1  0
 11 12  3  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  1  0
 20 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 25 27  1  0
 27 28  2  0
 27 29  1  0
 29 30  2  0
 15 31  1  0
  8  3  1  0
 21 13  2  0
 19 14  1  0
 26 22  1  0
M  END
>  <BrandName>  (145) 
nan

>  <Phase>  (145) 
3.0

>  <Applicants>  (145) 
Taiho Pharmaceutical

>  <Links>  (145) 
|http://www.chemspider.com/Chemical-Structure.58877815.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3701237|http://pubchem.ncbi.nlm.nih.gov/compound/78137072|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=161388

>  <LigID>  (145) 
nan

>  <pdbID>  (145) 
nan

>  <Type>  (145) 
nan

>  <RoF>  (145) 
0

>  <MW>  (145) 
418.2

>  <LogP>  (145) 
1.8

>  <TPSA>  (145) 
108.4

>  <HBA>  (145) 
8

>  <HBD>  (145) 
1

>  <NRB>  (145) 
4

>  <Indications>  (145) 
nan

>  <Targets>  (145) 
nan

>  <Kinase families>  (145) 


>  <Canonical_Smiles>  (145) 
COc1cc(cc(c1)OC)C#Cc2c3c(ncnc3n(n2)C4CCN(C4)C(=O)C=C)N

>  <InChiKey>  (145) 
KEIPNCCJPRMIAX-UHFFFAOYSA-N

>  <First_Approval>  (145) 
nan

>  <SC_Patent>  (145) 
None

>  <Chirality>  (145) 
Unknown

>  <Synonyms>  (145) 
nan

>  <FDA_approved>  (145) 


>  <Melting points>  (145) 


$$$$
Saracatinib
     RDKit          2D

 38 43  0  0  0  0  0  0  0  0999 V2000
   11.0025   -2.1096    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7418   -1.2969    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.4076   -1.9824    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1468   -1.1697    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2203    0.3285    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.5545    1.0140    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8152    0.2013    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9595    1.1413    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6253    0.4558    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3646    1.2685    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.0304    0.5830    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9569   -0.9152    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6227   -1.6007    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6381   -0.7880    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5646    0.7102    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7696    1.3957    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8254    1.5229    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7519    3.0211    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4177    3.7066    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3442    5.2048    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6050    6.0175    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9392    5.3320    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0127    3.8338    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9723   -1.4735    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0457   -2.9717    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7850   -3.7844    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5493   -3.0989    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2330   -0.6608    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5672   -1.3463    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6407   -2.8445    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9749   -3.5299    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.2356   -2.7172    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.1622   -1.2190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8280   -0.5335    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0676    0.9472    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -7.5499    1.1768    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.2264   -0.1620    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3799   -3.6572    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  5  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 15 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 14 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 24 28  1  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 32 33  1  0
 33 34  2  0
 34 35  1  0
 35 36  1  0
 36 37  1  0
 30 38  1  0
  7  2  1  0
 16 11  1  0
 27 13  1  0
 23 18  1  0
 34 29  1  0
 37 33  1  0
M  END
>  <BrandName>  (146) 
nan

>  <Phase>  (146) 
3.0

>  <Applicants>  (146) 
Astrazeneca

>  <Links>  (146) 
|http://www.chemspider.com/Chemical-Structure.8477917.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL217092|http://pubchem.ncbi.nlm.nih.gov/compound/10302451|http://www.drugbank.ca/drugs/DB11805| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=H8H|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/H8H|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7731|http://zinc15.docking.org/substances/ZINC24811973|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=9KD24QGH76|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12255

>  <LigID>  (146) 
'H8H'

>  <pdbID>  (146) 
2h8h 4qmx 5vcx 5vd3

>  <Type>  (146) 
1

>  <RoF>  (146) 
1

>  <MW>  (146) 
541.2

>  <LogP>  (146) 
3.9

>  <TPSA>  (146) 
90.4

>  <HBA>  (146) 
10

>  <HBD>  (146) 
1

>  <NRB>  (146) 
8

>  <Indications>  (146) 
nan

>  <Targets>  (146) 
SRC; ABL1

>  <Kinase families>  (146) 
Tyr

>  <Canonical_Smiles>  (146) 
CN1CCN(CC1)CCOc2cc3c(c(c2)OC4CCOCC4)c(ncn3)Nc5c(ccc6c5OCO6)Cl

>  <InChiKey>  (146) 
OUKYUETWWIPKQR-UHFFFAOYSA-N

>  <First_Approval>  (146) 
nan

>  <SC_Patent>  (146) 
None

>  <Chirality>  (146) 
Achiral Molecule

>  <Synonyms>  (146) 
AZ-10353926 | AZD-0530 | AZD0530 | SARACATINIB

>  <FDA_approved>  (146) 


>  <Melting points>  (146) 


$$$$
Peficitinib
     RDKit          2D

 24 28  0  0  0  0  0  0  0  0999 V2000
   -0.8062   -2.1234    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4706   -3.4682    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9549   -3.2519    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2079   -1.7734    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8799   -1.0759    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8199    0.4229    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0880    1.2242    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4159    0.5267    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4759   -0.9721    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0280    2.7230    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7000    3.4205    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2960    3.5243    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4920    1.1203    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.7761    0.3190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1040    1.0164    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0441   -0.4824    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3121   -1.2837    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9841   -1.9812    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7161   -1.1798    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8987   -0.3555    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7000    0.9126    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6401   -0.5862    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4320    1.7139    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0280    1.6100    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  7 10  1  0
 10 11  2  0
 10 12  1  0
  6 13  1  0
 14 13  1  6
 14 15  1  0
 15 16  1  6
 17 16  1  6
 17 18  1  0
 19 18  1  6
 19 20  1  0
 20 21  1  0
 21 22  1  0
 21 23  1  0
 21 24  1  1
  5  1  1  0
  9  4  1  0
 19 14  1  0
 23 15  1  0
 22 17  1  0
M  END
>  <BrandName>  (147) 
nan

>  <Phase>  (147) 
3.0

>  <Applicants>  (147) 
Astellas Pharma

>  <Links>  (147) 
|http://www.chemspider.com/Chemical-Structure.32742439.html| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=9T6|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/9T6|http://zinc15.docking.org/substances/ZINC000146784326

>  <LigID>  (147) 
'9T6'

>  <pdbID>  (147) 
6aah 6aaj 6aak 6aam

>  <Type>  (147) 
nan

>  <RoF>  (147) 
0

>  <MW>  (147) 
326.2

>  <LogP>  (147) 
2

>  <TPSA>  (147) 
104

>  <HBA>  (147) 
4

>  <HBD>  (147) 
4

>  <NRB>  (147) 
3

>  <Indications>  (147) 
nan

>  <Targets>  (147) 
JAK1; JAK2; JAK3; TYK2

>  <Kinase families>  (147) 
Tyr

>  <Canonical_Smiles>  (147) 
c1c[nH]c2c1c(c(cn2)C(=O)N)N[C@@H]3[C@@H]4C[C@@H]5C[C@H]3C[C@@](C5)(C4)O

>  <InChiKey>  (147) 
DREIJXJRTLTGJC-ZKVNVPQCSA-N

>  <First_Approval>  (147) 
nan

>  <SC_Patent>  (147) 
None

>  <Chirality>  (147) 
Racemic Mixture

>  <Synonyms>  (147) 
|ASP-015K|ASP015K|JNJ-54781532

>  <FDA_approved>  (147) 


>  <Melting points>  (147) 


$$$$
Lestaurtinib
     RDKit          2D

 33 40  0  0  0  0  0  0  0  0999 V2000
   -3.8150   -1.1685    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3157   -1.1224    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7993   -2.5423    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5983   -3.4410    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1516   -2.7418    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6236   -2.4532    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.9918   -1.7709    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.4320   -2.1904    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0839   -3.5413    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5798   -3.6521    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4238   -2.4120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7718   -1.0611    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2759   -0.9503    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3573    0.2355    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9457   -0.2717    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2553    0.6271    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7067    0.2485    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5153    1.5118    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9953    1.7563    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5235    3.1602    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5718    4.3197    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0919    4.0752    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5636    2.6713    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1669    2.1245    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3342    2.6237    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5352    1.7250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7610    2.5894    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1809    2.1058    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.3177    4.0224    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.8178    4.0436    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1609   -1.9129    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3867   -2.7774    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5675   -3.8306    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  6
  2  3  1  0
  3  4  1  0
  5  4  1  1
  5  6  1  0
  5  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 27 29  1  0
 29 30  1  0
  3 31  1  0
 31 32  1  0
  3 33  1  1
  6  2  1  0
 17  2  1  0
 15  7  1  0
 13  8  1  0
 26 14  1  0
 24 16  2  0
 23 18  1  0
 30 25  1  0
M  END
>  <BrandName>  (148) 
nan

>  <Phase>  (148) 
3.0

>  <Applicants>  (148) 
Cephalon

>  <Links>  (148) 
|http://www.chemspider.com/Chemical-Structure.112457.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL603469|http://pubchem.ncbi.nlm.nih.gov/compound/126565|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5672|http://zinc15.docking.org/substances/ZINC03781738|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=DO989GC5D1|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50308060

>  <LigID>  (148) 
nan

>  <pdbID>  (148) 
nan

>  <Type>  (148) 
nan

>  <RoF>  (148) 
0

>  <MW>  (148) 
439.2

>  <LogP>  (148) 
3.5

>  <TPSA>  (148) 
88.7

>  <HBA>  (148) 
6

>  <HBD>  (148) 
3

>  <NRB>  (148) 
1

>  <Indications>  (148) 
nan

>  <Targets>  (148) 
FLT3

>  <Kinase families>  (148) 
Tyr

>  <Canonical_Smiles>  (148) 
C[C@@]12[C@](C[C@@H](O1)n3c4ccccc4c5c3c6n2c7ccccc7c6c8c5C(=O)NC8)(CO)O

>  <InChiKey>  (148) 
UIARLYUEJFELEN-LROUJFHJSA-N

>  <First_Approval>  (148) 
nan

>  <SC_Patent>  (148) 
None

>  <Chirality>  (148) 
Single Stereoisomer

>  <Synonyms>  (148) 
A-154475 | A-154475.0 | CEP-701 | KT-555 | KT5555 | LESTAURTINIB | SP-924 | SP924 | SPM-924

>  <FDA_approved>  (148) 


>  <Melting points>  (148) 


$$$$
Famitinib
     RDKit          2D

 30 33  0  0  0  0  0  0  0  0999 V2000
  -10.0314    0.9734    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.5839    1.3666    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.5196    0.3096    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -7.9029   -1.1406    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.3504   -1.5338    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0720    0.7028    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0078   -0.3543    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5602    0.0389    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1769    1.4891    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7294    1.8823    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6651    0.8253    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0484   -0.6249    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2124   -1.4375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3749   -0.4896    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8326    0.9089    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.8251   -0.8728    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8821    0.1914    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3645   -0.0381    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1857   -1.2933    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6834   -1.2097    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3598    0.1291    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5385    1.3843    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0409    1.3007    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9766    2.3577    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.6424    1.6722    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3036    2.3486    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.5047   -2.4649    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.2961   -2.9352    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4959   -1.0181    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8792   -2.4683    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  3  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 14 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  1  0
 25 26  2  0
 20 27  1  0
 13 28  1  0
 12 29  1  0
 29 30  2  0
 29  8  1  0
 15 11  1  0
 17 25  1  0
 23 18  1  0
M  END
>  <BrandName>  (149) 
nan

>  <Phase>  (149) 
3.0

>  <Applicants>  (149) 
Jiangsu Hengrui Medicine

>  <Links>  (149) 
|http://www.chemspider.com/Chemical-Structure.17595500.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL1278146|http://pubchem.ncbi.nlm.nih.gov/compound/16662431|http://www.drugbank.ca/drugs/DB11741|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7886|http://zinc15.docking.org/substances/ZINC000064453767|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=768FW21J3L|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50331023

>  <LigID>  (149) 
nan

>  <pdbID>  (149) 
nan

>  <Type>  (149) 
nan

>  <RoF>  (149) 
0

>  <MW>  (149) 
410.2

>  <LogP>  (149) 
3.3

>  <TPSA>  (149) 
68.4

>  <HBA>  (149) 
3

>  <HBD>  (149) 
2

>  <NRB>  (149) 
6

>  <Indications>  (149) 
nan

>  <Targets>  (149) 
KIT; KDR; FLT4; PDGFRA; PDGFRB; FLT1; FLT3

>  <Kinase families>  (149) 
Tyr

>  <Canonical_Smiles>  (149) 
CCN(CC)CCN1CCc2c(c(c([nH]2)/C=C\3/c4cc(ccc4NC3=O)F)C)C1=O

>  <InChiKey>  (149) 
GKEYKDOLBLYGRB-LGMDPLHJSA-N

>  <First_Approval>  (149) 
nan

>  <SC_Patent>  (149) 
None

>  <Chirality>  (149) 
Single Stereoisomer

>  <Synonyms>  (149) 
SHR-1020

>  <FDA_approved>  (149) 


>  <Melting points>  (149) 


$$$$
Ripretinib
     RDKit          2D

 33 36  0  0  0  0  0  0  0  0999 V2000
    5.7613   -2.4270    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4439   -0.9609    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0156   -0.5027    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.6983    0.9633    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8093    1.9712    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4919    3.4372    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0636    3.8954    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.9526    2.8876    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2700    1.4215    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1590    0.4137    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4764   -1.0524    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9047   -1.5106    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2220   -2.9766    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.3654   -2.0602    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0629   -1.6020    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1739   -2.6099    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8565   -4.0759    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4282   -4.5341    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6828   -3.5263    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1111   -3.9845    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
   -2.9675   -5.0838    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6022   -2.1517    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9195   -0.6857    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8085    0.3222    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3478   -0.2275    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6652    1.2386    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5542    2.2464    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8715    3.7125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2999    4.1707    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.4108    3.1628    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.0935    1.6968    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6029    4.4451    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.0312    3.9869    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 11 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 17 21  1  0
 16 22  1  0
 22 23  1  0
 23 24  2  0
 23 25  1  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
  6 32  1  0
 32 33  1  0
 12  3  1  0
  9  4  1  0
 19 14  1  0
 31 26  1  0
M  END
>  <BrandName>  (150) 
nan

>  <Phase>  (150) 
3.0

>  <Applicants>  (150) 
Deciphera Pharmaceuticals

>  <Links>  (150) 
|http://www.chemspider.com/Chemical-Structure.67886378.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL4216467|http://pubchem.ncbi.nlm.nih.gov/compound/71584930|http://www.drugbank.ca/drugs/DB14840|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9175|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=9XW757O13D

>  <LigID>  (150) 
nan

>  <pdbID>  (150) 
nan

>  <Type>  (150) 
nan

>  <RoF>  (150) 
2

>  <MW>  (150) 
509.1

>  <LogP>  (150) 
5.7

>  <TPSA>  (150) 
88

>  <HBA>  (150) 
5

>  <HBD>  (150) 
3

>  <NRB>  (150) 
5

>  <Indications>  (150) 
Ripretinib (DCC-2618) is an orally bioavailable, potent pan-KIT and PDGFR&alpha; kinase inhibitor being developed by Dicephera Pharmaceuticals.  It is in clinical development for the treatment of  malignancies that are driven by KIT and/or PDGFR&alpha;, for example gastrointestinal stromal tumors, glioblastoma multiforme and systemic mastocytosis. Ripretinib has activity across a broad range of resistance mutations in its target kinases, that emerge in response to imatinib treatment. Ripretinib binds to the 'switch pocket' of KIT, a domain that regulates the enzyme's catalytic conformation. Compounds that act in this way are often referred to as switch control inhibitors.

>  <Targets>  (150) 
nan

>  <Kinase families>  (150) 


>  <Canonical_Smiles>  (150) 
CCn1c2cc(ncc2cc(c1=O)c3cc(c(cc3Br)F)NC(=O)Nc4ccccc4)NC

>  <InChiKey>  (150) 
CEFJVGZHQAGLHS-UHFFFAOYSA-N

>  <First_Approval>  (150) 
nan

>  <SC_Patent>  (150) 
None

>  <Chirality>  (150) 
Achiral Molecule

>  <Synonyms>  (150) 
DCC-2618 | RIPRETINIB

>  <FDA_approved>  (150) 


>  <Melting points>  (150) 


$$$$
Selumetinib
     RDKit          2D

 27 29  0  0  0  0  0  0  0  0999 V2000
    5.7549   -2.6046    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0068   -1.3044    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.6189    0.0650    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5056    1.0703    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.2055    0.3222    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5152   -1.1455    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3991   -2.1476    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9731   -1.6820    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6634   -0.2143    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7796    0.7878    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4698    2.2555    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7625    0.2513    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0722    1.7190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0439    2.7211    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2658    4.1887    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6917    4.6543    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8079    3.6522    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4982    2.1846    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6143    1.1825    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -2.0015    6.1220    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
   -0.1430   -2.6840    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1667   -4.1517    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5689   -2.2184    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6851   -3.2205    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1110   -2.7549    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2272   -3.7570    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6531   -3.2914    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
  9 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 16 20  1  0
  8 21  1  0
 21 22  2  0
 21 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
  6  2  1  0
 10  5  1  0
 18 13  1  0
M  END
>  <BrandName>  (151) 
nan

>  <Phase>  (151) 
3.0

>  <Applicants>  (151) 
Astrazeneca

>  <Links>  (151) 
|http://www.chemspider.com/Chemical-Structure.8303141.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL1614701|http://pubchem.ncbi.nlm.nih.gov/compound/10127622|http://www.drugbank.ca/drugs/DB11689| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=3EW|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/3EW|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5665|http://zinc15.docking.org/substances/ZINC31773258|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=6UH91I579U|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355497

>  <LigID>  (151) 
'3EW'

>  <pdbID>  (151) 
4u7z

>  <Type>  (151) 
3

>  <RoF>  (151) 
0

>  <MW>  (151) 
456

>  <LogP>  (151) 
3.5

>  <TPSA>  (151) 
88.4

>  <HBA>  (151) 
6

>  <HBD>  (151) 
3

>  <NRB>  (151) 
6

>  <Indications>  (151) 
nan

>  <Targets>  (151) 
MAP2K1; MAP2K2

>  <Kinase families>  (151) 
STE

>  <Canonical_Smiles>  (151) 
Cn1cnc2c1cc(c(c2F)Nc3ccc(cc3Cl)Br)C(=O)NOCCO

>  <InChiKey>  (151) 
CYOHGALHFOKKQC-UHFFFAOYSA-N

>  <First_Approval>  (151) 
nan

>  <SC_Patent>  (151) 
None

>  <Chirality>  (151) 
Achiral Molecule

>  <Synonyms>  (151) 
ARRY-142886 | ARRY-886 | AZD-6244 | AZD6244 | SELUMETINIB

>  <FDA_approved>  (151) 


>  <Melting points>  (151) 


$$$$
Rociletinib
     RDKit          2D

 40 43  0  0  0  0  0  0  0  0999 V2000
  -10.9762    1.5390    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.2200    0.2436    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.9638   -1.0590    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -8.7200    0.2507    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -7.9762    1.5533    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4763    1.5605    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7201    0.2650    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4639   -1.0376    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.9639   -1.0447    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2201    0.2722    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4639   -1.0233    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9639   -1.0161    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2201    0.2865    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9763    1.5819    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4763    1.5748    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2325    2.8845    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9887    4.1800    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2799    0.2936    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.0360   -1.0018    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2922   -2.3044    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.0484   -3.5999    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5484   -3.5927    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2922   -2.2901    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5360   -0.9947    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.7922   -2.2830    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.5360   -0.9804    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0360   -0.9732    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7798    0.3294    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0236    1.6248    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5236    1.6177    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7798    0.3151    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7674    2.9131    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.5112    4.2157    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0112    4.2228    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.7550    5.5112    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4988    6.8137    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3046   -4.8882    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0608   -6.1836    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.0091   -5.6444    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    4.6000   -4.1320    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  7 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 14 16  1  0
 16 17  1  0
 13 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 23 25  1  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 30 32  1  0
 32 33  1  0
 33 34  2  0
 33 35  1  0
 35 36  2  0
 22 37  1  0
 37 38  1  0
 37 39  1  0
 37 40  1  0
  9  4  1  0
 15 10  1  0
 24 19  1  0
 31 26  1  0
M  END
>  <BrandName>  (152) 
nan

>  <Phase>  (152) 
3.0

>  <Applicants>  (152) 
Clovis Oncology

>  <Links>  (152) 
|http://www.chemspider.com/Chemical-Structure.30646712.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3545308|http://pubchem.ncbi.nlm.nih.gov/compound/57335384|http://www.drugbank.ca/drugs/DB11907| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=8JC|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/8JC|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7966|http://zinc15.docking.org/substances/ZINC000098043800|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=72AH61702G|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=149404

>  <LigID>  (152) 
'8JC'

>  <pdbID>  (152) 
5xdk 5xdl

>  <Type>  (152) 
1

>  <RoF>  (152) 
1

>  <MW>  (152) 
555.2

>  <LogP>  (152) 
4.8

>  <TPSA>  (152) 
111.7

>  <HBA>  (152) 
8

>  <HBD>  (152) 
3

>  <NRB>  (152) 
8

>  <Indications>  (152) 
nan

>  <Targets>  (152) 
EGFR

>  <Kinase families>  (152) 
Tyr

>  <Canonical_Smiles>  (152) 
CC(=O)N1CCN(CC1)c2ccc(c(c2)OC)Nc3ncc(c(n3)Nc4cccc(c4)NC(=O)C=C)C(F)(F)F

>  <InChiKey>  (152) 
HUFOZJXAKZVRNJ-UHFFFAOYSA-N

>  <First_Approval>  (152) 
nan

>  <SC_Patent>  (152) 
None

>  <Chirality>  (152) 
Achiral Molecule

>  <Synonyms>  (152) 
AVL-301 | CNX-419 | CO-1686 | CS-1631 | ROCILETINIB

>  <FDA_approved>  (152) 


>  <Melting points>  (152) 


$$$$
Pemigatinib
     RDKit          2D

 35 39  0  0  0  0  0  0  0  0999 V2000
    0.1591   -3.8085    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6192   -2.5262    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1021   -1.2110    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6762    0.0713    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1758    0.0384    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1548   -1.0981    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5382   -0.5182    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4141    0.9767    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9541    1.3207    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2328    2.6358    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7331    2.6687    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0452    1.3864    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5448    1.4193    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3231    0.1370    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.6018   -1.1781    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3801   -2.4604    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.8228    0.1699    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6011   -1.1124    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1007   -1.0795    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8220    0.2357    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0437    1.5180    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5441    1.4851    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7658    2.7674    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    6.7651    2.8331    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.2647    2.8660    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8790   -2.3618    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.3786   -2.3289    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8797   -2.4275    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8205   -1.2965    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.1356   -0.5751    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -7.1685    0.9245    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.4837    1.6459    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.7660    0.8676    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -9.7331   -0.6321    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.4179   -1.3534    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 14 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 21 24  1  0
 24 25  1  0
 19 26  1  0
 26 27  1  0
 18 28  1  0
  7 29  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
 33 34  1  0
 34 35  1  0
 15  3  1  0
 12  4  1  0
  9  5  1  0
 22 17  1  0
 35 30  1  0
M  END
>  <BrandName>  (153) 
nan

>  <Phase>  (153) 
3.0

>  <Applicants>  (153) 
Incyte Corporation

>  <Links>  (153) 
|http://www.chemspider.com/Chemical-Structure.68007304.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL4297522|http://pubchem.ncbi.nlm.nih.gov/compound/86705695|http://www.drugbank.ca/drugs/DB15102|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9767|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=Y6BX7BL23K|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301310

>  <LigID>  (153) 
nan

>  <pdbID>  (153) 
nan

>  <Type>  (153) 
nan

>  <RoF>  (153) 
0

>  <MW>  (153) 
487.2

>  <LogP>  (153) 
3.7

>  <TPSA>  (153) 
83.2

>  <HBA>  (153) 
6

>  <HBD>  (153) 
1

>  <NRB>  (153) 
6

>  <Indications>  (153) 
nan

>  <Targets>  (153) 
nan

>  <Kinase families>  (153) 


>  <Canonical_Smiles>  (153) 
CCN1c2c3cc([nH]c3ncc2CN(C1=O)c4c(c(cc(c4F)OC)OC)F)CN5CCOCC5

>  <InChiKey>  (153) 
HCDMJFOHIXMBOV-UHFFFAOYSA-N

>  <First_Approval>  (153) 
nan

>  <SC_Patent>  (153) 
None

>  <Chirality>  (153) 
Achiral Molecule

>  <Synonyms>  (153) 
INCB054828 | PEMIGATINIB

>  <FDA_approved>  (153) 


>  <Melting points>  (153) 


$$$$
Ruboxistaurin
     RDKit          2D

 35 40  0  0  0  0  0  0  0  0999 V2000
   -2.7478   -7.6916    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4979   -6.2125    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6538   -5.2566    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0920   -5.6895    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8421   -4.2104    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6554   -4.1249    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9676   -3.3982    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8061   -1.6771    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.8567   -0.5158    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6678    0.7460    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1185    0.3645    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2040   -1.1330    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5436   -1.8078    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7978   -0.9850    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7124    0.5126    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3727    1.1873    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6673    1.8636    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2809    2.4363    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2166    2.3508    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5288    1.6241    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3957    0.3999    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0019    1.7720    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8844    2.7725    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1921    4.2406    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6174    4.7081    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7349    3.7076    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4272    2.2395    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6456   -1.0791    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2290   -2.5201    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2285   -3.6377    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.3972    3.9318    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7443    4.9049    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.8555    4.2833    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.6404    3.0051    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1359    2.8887    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  5  4  1  1
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 10 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 21 28  1  0
 28 29  1  0
 29 30  1  0
 18 31  1  0
 31 32  2  0
 31 33  1  0
 33 34  1  0
 34 35  2  0
 30  5  1  0
 12  8  1  0
 16 11  1  0
 34 17  1  0
 23 19  1  0
 27 22  1  0
M  END
>  <BrandName>  (154) 
Arxxant

>  <Phase>  (154) 
3.0

>  <Applicants>  (154) 
Eli Lilly

>  <Links>  (154) 
|http://www.chemspider.com/Chemical-Structure.135727.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL91829|http://pubchem.ncbi.nlm.nih.gov/compound/153999|http://www.drugbank.ca/drugs/DB11829| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=LY4|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/LY4|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5263|http://zinc15.docking.org/substances/ZINC000003812168|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=721809WQCP|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50128281

>  <LigID>  (154) 
'LY4'

>  <pdbID>  (154) 
1uu3 2j2i

>  <Type>  (154) 
nan

>  <RoF>  (154) 
0

>  <MW>  (154) 
468.2

>  <LogP>  (154) 
3.5

>  <TPSA>  (154) 
68.5

>  <HBA>  (154) 
6

>  <HBD>  (154) 
1

>  <NRB>  (154) 
2

>  <Indications>  (154) 
nan

>  <Targets>  (154) 
nan

>  <Kinase families>  (154) 


>  <Canonical_Smiles>  (154) 
CN(C)C[C@@H]1CCn2cc(c3c2cccc3)C4=C(c5cn(c6c5cccc6)CCO1)C(=O)NC4=O

>  <InChiKey>  (154) 
ZCBUQCWBWNUWSU-SFHVURJKSA-N

>  <First_Approval>  (154) 
nan

>  <SC_Patent>  (154) 
None

>  <Chirality>  (154) 
Single Stereoisomer

>  <Synonyms>  (154) 
ARXXANT | LY-333531 | RUBOXISTAURIN

>  <FDA_approved>  (154) 


>  <Melting points>  (154) 


$$$$
Enzastaurin
     RDKit          2D

 39 45  0  0  0  0  0  0  0  0999 V2000
    0.8574   -3.6589    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1018   -2.8214    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.1557   -1.3224    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5981   -0.9104    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4356   -2.1548    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5108   -3.3359    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0713   -4.7273    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5565   -4.9376    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4812   -3.7565    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9207   -2.3652    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1126    0.4986    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2751    1.7430    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1998    2.9241    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7878    4.3664    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.6088    2.4096    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.5549    0.9105    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7359   -0.0142    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.7760    1.7969    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8513    0.6159    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5577    1.1304    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5038    2.6294    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9385    3.0414    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3029    4.4964    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2250    5.5395    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2173    5.1276    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5817    3.6725    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8021    0.2929    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1496    0.9518    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3941    0.1143    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2910   -1.3821    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9435   -2.0411    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6990   -1.2036    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5354   -2.2196    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.8829   -1.5607    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.9860   -0.0642    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.3335    0.5948    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.5779   -0.2427    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.4748   -1.7392    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.1273   -2.3982    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
  4 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  1  0
 16 17  2  0
 12 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 20 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 30 33  1  0
 33 34  1  0
 34 35  2  0
 35 36  1  0
 36 37  2  0
 37 38  1  0
 38 39  2  0
  6  2  1  0
 10  5  1  0
 16 11  1  0
 22 18  1  0
 26 21  1  0
 32 27  1  0
 39 34  1  0
M  END
>  <BrandName>  (155) 
nan

>  <Phase>  (155) 
3.0

>  <Applicants>  (155) 
Eli Lilly

>  <Links>  (155) 
|http://www.chemspider.com/Chemical-Structure.153463.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL300138|http://pubchem.ncbi.nlm.nih.gov/compound/176167|http://www.drugbank.ca/drugs/DB06486|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5693|http://zinc15.docking.org/substances/ZINC000001494900|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=UC96G28EQF|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50128285

>  <LigID>  (155) 
nan

>  <pdbID>  (155) 
nan

>  <Type>  (155) 
nan

>  <RoF>  (155) 
1

>  <MW>  (155) 
515.2

>  <LogP>  (155) 
4.9

>  <TPSA>  (155) 
72.2

>  <HBA>  (155) 
6

>  <HBD>  (155) 
1

>  <NRB>  (155) 
5

>  <Indications>  (155) 
nan

>  <Targets>  (155) 
nan

>  <Kinase families>  (155) 


>  <Canonical_Smiles>  (155) 
Cn1cc(c2c1cccc2)C3=C(C(=O)NC3=O)c4cn(c5c4cccc5)C6CCN(CC6)Cc7ccccn7

>  <InChiKey>  (155) 
AXRCEOKUDYDWLF-UHFFFAOYSA-N

>  <First_Approval>  (155) 
nan

>  <SC_Patent>  (155) 
None

>  <Chirality>  (155) 
Achiral Molecule

>  <Synonyms>  (155) 
ENZASTAURIN | LY-317615 | LY317615

>  <FDA_approved>  (155) 


>  <Melting points>  (155) 


$$$$
Savolitinib
     RDKit          2D

 26 30  0  0  0  0  0  0  0  0999 V2000
   -0.2359   -1.8827    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1426   -0.6877    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6308   -0.8755    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2123   -2.2582    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7005   -2.4459    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6072   -1.2510    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.1020   -1.1252    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -7.4443    0.3352    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1611    1.1120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0257    0.1317    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5375    0.3195    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5611    0.6950    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.8993    1.0373    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0250    2.5320    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3824    3.1704    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.6140    2.3142    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4882    0.8194    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1309    0.1810    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.7198   -0.0368    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1364    0.4562    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0431   -0.7387    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.1869   -1.9703    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.7510   -1.5365    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6799   -3.3869    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3577    3.1135    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3380    1.9781    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  1
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
  2 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 17 19  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  1  0
 22 24  1  0
 14 25  1  0
 25 26  2  0
 11  3  2  0
 10  6  1  0
 26 12  1  0
 18 13  2  0
 23 19  2  0
M  END
>  <BrandName>  (156) 
nan

>  <Phase>  (156) 
3.0

>  <Applicants>  (156) 
Astrazeneca

>  <Links>  (156) 
|http://www.chemspider.com/Chemical-Structure.34501055.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3334567|http://pubchem.ncbi.nlm.nih.gov/compound/68289010|http://www.drugbank.ca/drugs/DB12048| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=V0L|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/V0L|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9918|http://zinc15.docking.org/substances/ZINC000149738712|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=2A2DA6857R|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50023342

>  <LigID>  (156) 
'V0L'

>  <pdbID>  (156) 
5lbw 6sde

>  <Type>  (156) 
nan

>  <RoF>  (156) 
0

>  <MW>  (156) 
345.1

>  <LogP>  (156) 
1.9

>  <TPSA>  (156) 
91.6

>  <HBA>  (156) 
9

>  <HBD>  (156) 
0

>  <NRB>  (156) 
3

>  <Indications>  (156) 
nan

>  <Targets>  (156) 
MET

>  <Kinase families>  (156) 
Tyr

>  <Canonical_Smiles>  (156) 
C[C@@H](c1ccc2nccn2c1)n3c4c(ncc(n4)c5cnn(c5)C)nn3

>  <InChiKey>  (156) 
XYDNMOZJKOGZLS-NSHDSACASA-N

>  <First_Approval>  (156) 
nan

>  <SC_Patent>  (156) 
None

>  <Chirality>  (156) 
Single Stereoisomer

>  <Synonyms>  (156) 
AZD-6094 | AZD6094 | HMPL-504 | SAVOLITINIB | VOLITINIB

>  <FDA_approved>  (156) 


>  <Melting points>  (156) 


$$$$
Tivantinib
     RDKit          2D

 28 33  0  0  0  0  0  0  0  0999 V2000
   -6.1117    0.0870    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.3188    1.5727    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1358    2.4948    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7456    1.9314    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5385    0.4457    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7216   -0.4764    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0616    0.1836    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3559    1.5072    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3967    2.5874    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4056   -1.1653    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0713   -1.4274    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2784   -2.9131    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6021   -3.6188    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0705   -3.5691    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1113   -2.4890    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5969   -2.6961    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.1515   -0.3867    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9444    1.0990    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2933    1.7550    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.3341    0.6748    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6284   -0.6488    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4219   -1.9217    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9210   -1.8711    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6267   -0.5474    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8333    0.7255    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2646    2.1692    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3424    3.3523    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8568    3.1452    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  2  0
  8  9  1  0
 10  7  1  1
 10 11  1  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  2  0
 11 17  1  6
 17 18  2  0
 18 19  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
  6  1  1  0
  9  4  1  0
 15 10  1  0
 21 17  1  0
 28 19  1  0
 25 20  1  0
M  END
>  <BrandName>  (157) 
nan

>  <Phase>  (157) 
3.0

>  <Applicants>  (157) 
Daiichi Sankyo

>  <Links>  (157) 
|http://www.chemspider.com/Chemical-Structure.9669218.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL2103882|http://pubchem.ncbi.nlm.nih.gov/compound/11494412|http://www.drugbank.ca/drugs/DB12200| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=TIV|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/TIV|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7948|http://zinc15.docking.org/substances/ZINC000100016063|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=PJ4H73IL17|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50146168

>  <LigID>  (157) 
'TIV'

>  <pdbID>  (157) 
5cb4

>  <Type>  (157) 
nan

>  <RoF>  (157) 
0

>  <MW>  (157) 
369.1

>  <LogP>  (157) 
3.6

>  <TPSA>  (157) 
66.9

>  <HBA>  (157) 
3

>  <HBD>  (157) 
2

>  <NRB>  (157) 
2

>  <Indications>  (157) 
nan

>  <Targets>  (157) 
MET

>  <Kinase families>  (157) 
Tyr

>  <Canonical_Smiles>  (157) 
c1ccc2c(c1)c(c[nH]2)[C@H]3[C@@H](C(=O)NC3=O)c4cn5c6c4cccc6CCC5

>  <InChiKey>  (157) 
UCEQXRCJXIVODC-PMACEKPBSA-N

>  <First_Approval>  (157) 
nan

>  <SC_Patent>  (157) 
None

>  <Chirality>  (157) 
Single Stereoisomer

>  <Synonyms>  (157) 
ARQ 197 | ARQ-197 | TIVANTINIB

>  <FDA_approved>  (157) 


>  <Melting points>  (157) 


$$$$
Ensartinib
     RDKit          2D

 38 41  0  0  0  0  0  0  0  0999 V2000
  -10.0942   -3.0801    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.6841   -2.5686    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.4221   -1.0917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.0120   -0.5801    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8639   -1.5455    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1260   -3.0224    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.5360   -3.5340    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9779   -3.9878    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.7500    0.8968    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.8980    1.8622    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3399    1.4084    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1918    0.4430    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7818    0.9545    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5197    2.4315    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6678    3.3969    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0779    2.8853    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1097    2.9430    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0384    1.9776    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2236    0.5007    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.4485    2.4892    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5965    1.5238    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0066    2.0354    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2686    3.5123    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1206    4.4777    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.7105    3.9661    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.6787    4.0239    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.1546    1.0700    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.8926   -0.4070    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4825   -0.9185    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0407   -1.3723    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4508   -0.8608    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5988   -1.8262    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3368   -3.3031    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9267   -3.8147    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7787   -2.8493    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3686   -3.3608    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    6.6647   -5.2916    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    7.7128    0.6161    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  6
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  6  8  1  6
  4  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 14 17  1  0
 17 18  1  0
 18 19  2  0
 18 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 23 26  1  0
 22 27  1  0
 27 28  1  0
 28 29  1  1
 28 30  1  0
 30 31  2  0
 31 32  1  0
 32 33  2  0
 33 34  1  0
 34 35  2  0
 35 36  1  0
 34 37  1  0
 31 38  1  0
  7  2  1  0
 16 11  1  0
 25 20  1  0
 35 30  1  0
M  END
>  <BrandName>  (158) 
nan

>  <Phase>  (158) 
3.0

>  <Applicants>  (158) 
Xcovery

>  <Links>  (158) 
|http://www.chemspider.com/Chemical-Structure.58828042.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL4113131|http://pubchem.ncbi.nlm.nih.gov/compound/56960363|http://www.drugbank.ca/drugs/DB14860|http://zinc15.docking.org/substances/ZINC000199407645|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=SMA5ZS5B22|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179297

>  <LigID>  (158) 
nan

>  <pdbID>  (158) 
nan

>  <Type>  (158) 
nan

>  <RoF>  (158) 
1

>  <MW>  (158) 
560.2

>  <LogP>  (158) 
4.7

>  <TPSA>  (158) 
122.5

>  <HBA>  (158) 
7

>  <HBD>  (158) 
3

>  <NRB>  (158) 
6

>  <Indications>  (158) 
nan

>  <Targets>  (158) 
ALK

>  <Kinase families>  (158) 
Tyr

>  <Canonical_Smiles>  (158) 
C[C@@H]1CN(C[C@@H](N1)C)C(=O)c2ccc(cc2)NC(=O)c3cc(c(nn3)N)O[C@H](C)c4c(ccc(c4Cl)F)Cl

>  <InChiKey>  (158) 
GLYMPHUVMRFTFV-QLFBSQMISA-N

>  <First_Approval>  (158) 
nan

>  <SC_Patent>  (158) 
None

>  <Chirality>  (158) 
Single Stereoisomer

>  <Synonyms>  (158) 
ENSARTINIB | X-396

>  <FDA_approved>  (158) 


>  <Melting points>  (158) 


$$$$
Evobrutinib
     RDKit          2D

 32 35  0  0  0  0  0  0  0  0999 V2000
   -8.5569    0.9200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.1885    1.5343    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9723    0.6564    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1245   -0.8359    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6038    1.2707    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4516    2.7629    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0832    3.3772    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8669    2.4992    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0192    1.0070    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3876    0.3927    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4985    3.1135    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7177    2.2356    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.0862    2.8499    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3024    1.9719    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6708    2.5862    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8231    4.0785    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.6069    4.9564    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2384    4.3421    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.8871    1.7082    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.1502    0.4797    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7817   -0.1346    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6295   -1.6269    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8457   -2.5049    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2141   -1.8906    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3664   -0.3983    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6935   -3.9971    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.3250   -4.6114    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1088   -3.7334    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2596   -4.3477    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4119   -5.8400    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1957   -6.7180    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1728   -6.1037    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  8 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 15 19  1  0
 14 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 23 26  1  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 10  5  1  0
 18 13  2  0
 25 20  1  0
 32 27  1  0
M  END
>  <BrandName>  (159) 
nan

>  <Phase>  (159) 
3.0

>  <Applicants>  (159) 
Merck

>  <Links>  (159) 
|http://www.chemspider.com/Chemical-Structure.58827807.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL4072833|http://pubchem.ncbi.nlm.nih.gov/compound/71479709|http://www.drugbank.ca/drugs/DB15170| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=MZJ|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/MZJ|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9752|http://zinc15.docking.org/substances/ZINC000205623965|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=ZA45457L1K|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=291522

>  <LigID>  (159) 
'MZJ'

>  <pdbID>  (159) 
6omu

>  <Type>  (159) 
nan

>  <RoF>  (159) 
0

>  <MW>  (159) 
429.2

>  <LogP>  (159) 
4.4

>  <TPSA>  (159) 
93.4

>  <HBA>  (159) 
6

>  <HBD>  (159) 
2

>  <NRB>  (159) 
7

>  <Indications>  (159) 
nan

>  <Targets>  (159) 
BTK

>  <Kinase families>  (159) 
Tyr

>  <Canonical_Smiles>  (159) 
C=CC(=O)N1CCC(CC1)CNc2c(c(ncn2)N)c3ccc(cc3)Oc4ccccc4

>  <InChiKey>  (159) 
QUIWHXQETADMGN-UHFFFAOYSA-N

>  <First_Approval>  (159) 
nan

>  <SC_Patent>  (159) 
None

>  <Chirality>  (159) 
Achiral Molecule

>  <Synonyms>  (159) 
EVOBRUTINIB | M-2951

>  <FDA_approved>  (159) 


>  <Melting points>  (159) 


$$$$
Surufatinib
     RDKit          2D

 34 37  0  0  0  0  0  0  0  0999 V2000
   -9.8837   -3.9420    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.1556   -2.6306    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.6667   -2.4487    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.3795   -0.9765    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0933   -0.2048    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1184    1.2950    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.4299    2.0231    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.7162    1.2514    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.6910   -0.2484    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.7887   -1.2707    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8322    2.0667    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5207    1.3386    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4955   -0.1611    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1841   -0.8892    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8978   -0.1175    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9230    1.3823    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2345    2.1104    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.3632    2.1540    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.6747    1.4259    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6999   -0.0739    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0113   -0.8020    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2976   -0.0302    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2724    1.4695    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9609    2.1976    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5587    2.2413    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8701    1.5132    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    7.5982    2.8246    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.1420    0.2017    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.1816    0.7851    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.2067   -0.7147    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5182   -1.4428    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5434   -2.9425    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.8548   -3.6706    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2571   -3.7143    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
  6 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 16 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 23 25  1  0
 25 26  1  0
 26 27  2  0
 26 28  2  0
 26 29  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
 32 34  1  0
 10  2  1  0
  9  4  1  0
 17 12  1  0
 24 19  1  0
M  END
>  <BrandName>  (160) 
nan

>  <Phase>  (160) 
3.0

>  <Applicants>  (160) 
Hutchison MediPharma

>  <Links>  (160) 
|http://www.chemspider.com/Chemical-Structure.57583328.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL4297190|http://pubchem.ncbi.nlm.nih.gov/compound/52920501|http://www.drugbank.ca/drugs/DB15106|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9769|http://zinc15.docking.org/substances/ZINC000117218067|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=B2K5L1L8S9

>  <LigID>  (160) 
nan

>  <pdbID>  (160) 
nan

>  <Type>  (160) 
nan

>  <RoF>  (160) 
0

>  <MW>  (160) 
480.2

>  <LogP>  (160) 
3.8

>  <TPSA>  (160) 
112.2

>  <HBA>  (160) 
7

>  <HBD>  (160) 
3

>  <NRB>  (160) 
10

>  <Indications>  (160) 
nan

>  <Targets>  (160) 
nan

>  <Kinase families>  (160) 


>  <Canonical_Smiles>  (160) 
Cc1cc2cc(ccc2[nH]1)Oc3ccnc(n3)Nc4cccc(c4)CS(=O)(=O)NCCN(C)C

>  <InChiKey>  (160) 
TTZSNFLLYPYKIL-UHFFFAOYSA-N

>  <First_Approval>  (160) 
nan

>  <SC_Patent>  (160) 
None

>  <Chirality>  (160) 
Achiral Molecule

>  <Synonyms>  (160) 
HMPL-012 | SULFATINIB | SURUFATINIB

>  <FDA_approved>  (160) 


>  <Melting points>  (160) 


$$$$
Masitinib
     RDKit          2D

 36 40  0  0  0  0  0  0  0  0999 V2000
   -7.7817    1.8752    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.3006    2.1122    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7653    3.5134    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2841    3.7505    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3383    2.5863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8736    1.1850    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3547    0.9480    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8900   -0.4532    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9442   -1.6174    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4464   -1.5365    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9066   -2.9360    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0708   -3.8819    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3301   -3.0669    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4571   -3.3220    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0665   -4.7702    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3830   -5.1561    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4419   -4.0938    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0514   -2.6455    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3981   -2.2596    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8571    2.8233    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9113    1.6591    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4466    0.2578    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.5699    1.8961    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5157    0.7319    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9969    0.9689    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5322    2.3701    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5864    3.5343    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1052    3.2973    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0134    2.6071    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9592    1.4429    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.4239    0.0417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3697   -1.1225    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8509   -0.8855    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.3862    0.5157    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4404    1.6800    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7967   -2.0497    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 11 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
  5 20  1  0
 20 21  1  0
 21 22  2  0
 21 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 26 29  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
 33 34  1  0
 34 35  1  0
 33 36  1  0
  7  2  1  0
 13  9  1  0
 19 14  1  0
 28 23  1  0
 35 30  1  0
M  END
>  <BrandName>  (161) 
Kinavet;Masivet

>  <Phase>  (161) 
3.0

>  <Applicants>  (161) 
AB Science

>  <Links>  (161) 
|http://www.chemspider.com/Chemical-Structure.8250179.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL1908391|http://pubchem.ncbi.nlm.nih.gov/compound/10074640|http://www.drugbank.ca/drugs/DB11526| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=G65|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/G65|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5656|http://zinc15.docking.org/substances/ZINC34177219|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=M59NC4E26P|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355495

>  <LigID>  (161) 
'G65'

>  <pdbID>  (161) 
5mql

>  <Type>  (161) 
nan

>  <RoF>  (161) 
1

>  <MW>  (161) 
498.2

>  <LogP>  (161) 
5.3

>  <TPSA>  (161) 
73.4

>  <HBA>  (161) 
7

>  <HBD>  (161) 
2

>  <NRB>  (161) 
7

>  <Indications>  (161) 
nan

>  <Targets>  (161) 
KIT; PDGFRA; PDGFRB; FGFR1; FGFR2; FGFR3

>  <Kinase families>  (161) 
Tyr

>  <Canonical_Smiles>  (161) 
Cc1ccc(cc1Nc2nc(cs2)c3cccnc3)NC(=O)c4ccc(cc4)CN5CCN(CC5)C

>  <InChiKey>  (161) 
WJEOLQLKVOPQFV-UHFFFAOYSA-N

>  <First_Approval>  (161) 
nan

>  <SC_Patent>  (161) 
None

>  <Chirality>  (161) 
Achiral Molecule

>  <Synonyms>  (161) 
AB-1010 | KINAVET | MASITINIB | MASIVET

>  <FDA_approved>  (161) 


>  <Melting points>  (161) 


$$$$
Lazertinib
     RDKit          2D

 41 45  0  0  0  0  0  0  0  0999 V2000
    8.6793    3.8959    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3647    3.1737    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.0818    3.9511    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3328    1.6740    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0181    0.9518    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6611    1.5908    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6339    0.4977    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.3562   -0.8170    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.8297   -0.5364    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9229   -1.5635    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5799   -3.0238    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6731   -4.0509    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1092   -3.6178    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4521   -2.1575    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3590   -1.1304    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1458    0.6861    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5650    2.0691    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0768    2.2575    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8304    1.0630    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2495   -0.3200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2386   -0.5084    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1568   -1.5145    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6449   -1.3261    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2258    0.0569    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7139    0.2453    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6211   -0.9492    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0403   -2.3322    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5521   -2.5206    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9713   -3.9036    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8785   -5.0981    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.1092   -0.7608    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -7.6901    0.6222    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.1782    0.8106    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.0855   -0.3839    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -9.5046   -1.7669    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.0165   -1.9553    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2948    1.6283    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3875    2.8228    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8994    2.6344    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9684    4.2058    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0611    5.4003    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
  7 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 20 22  1  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  1  0
 26 31  1  0
 31 32  1  0
 32 33  1  0
 33 34  1  0
 34 35  1  0
 35 36  1  0
 25 37  1  0
 37 38  1  0
 38 39  2  0
 38 40  1  0
 40 41  2  0
  9  5  1  0
 15 10  1  0
 21 16  1  0
 28 23  1  0
 36 31  1  0
M  END
>  <BrandName>  (162) 
nan

>  <Phase>  (162) 
3.0

>  <Applicants>  (162) 
Genosco

>  <Links>  (162) 
|http://www.chemspider.com/Chemical-Structure.64835231.html|http://pubchem.ncbi.nlm.nih.gov/compound/121269225|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10136|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=4A2Y23XK11

>  <LigID>  (162) 
nan

>  <pdbID>  (162) 
nan

>  <Type>  (162) 
nan

>  <RoF>  (162) 
1

>  <MW>  (162) 
554.3

>  <LogP>  (162) 
4.1

>  <TPSA>  (162) 
109.7

>  <HBA>  (162) 
10

>  <HBD>  (162) 
2

>  <NRB>  (162) 
10

>  <Indications>  (162) 
Lazertinib (YH-25448, GNS-1480) is an inhibitor of the aberrant activity of EGFR mutant kinases, that was originally developed by Yuhan Corporation for antineoplastic potential in cancers with (acquired) resistance to existing EGFR tyrosine kinase inhibitors, in particular for EGFR mutation positive, advanced non-small cell lung cancer (NSCLC). In addition to predicted efficacy for the treatment of primary lung and extracranial lesions, lazertinib is expected to be beneficial for NSCLC brain metastases as it is able to cross the blood brain barrier.

>  <Targets>  (162) 
nan

>  <Kinase families>  (162) 


>  <Canonical_Smiles>  (162) 
CN(C)Cc1cn(nc1c2ccccc2)c3ccnc(n3)Nc4cc(c(cc4OC)N5CCOCC5)NC(=O)C=C

>  <InChiKey>  (162) 
RRMJMHOQSALEJJ-UHFFFAOYSA-N

>  <First_Approval>  (162) 
nan

>  <SC_Patent>  (162) 
nan

>  <Chirality>  (162) 
nan

>  <Synonyms>  (162) 
nan

>  <FDA_approved>  (162) 


>  <Melting points>  (162) 


$$$$
Simotinib
     RDKit          2D

 35 40  0  0  0  0  0  0  0  0999 V2000
   -2.1964   -3.6811    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7661   -2.2442    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3065   -1.8984    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7228   -2.9895    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1824   -2.6437    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6127   -1.2067    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5834   -0.1156    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1238   -0.4614    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9055    0.6297    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3651    0.2839    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3944    1.3750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8540    1.0292    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4321   -0.3549    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.9271   -0.2327    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.2049   -1.7068    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.3426   -0.7292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.2730    1.2269    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9917    2.0068    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.5542    0.4469    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -9.6919    1.4245    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.1138    2.8086    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.6188    2.6865    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.0723   -0.8609    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1015   -1.9520    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.6712   -3.3890    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2116   -3.7348    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.5026    0.5760    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.9622    0.9219    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9914   -0.1693    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4510    0.1765    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8813    1.6135    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8521    2.7046    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3925    2.3588    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2824    4.1416    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   10.3409    1.9593    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 14 17  1  0
 17 18  1  0
 17 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
  6 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 23 27  1  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 32  1  0
 32 33  2  0
 32 34  1  0
 31 35  1  0
  8  3  1  0
 26  5  1  0
 18 12  1  0
 16 14  1  0
 22 17  1  0
 33 28  1  0
M  END
>  <BrandName>  (163) 
nan

>  <Phase>  (163) 
3.0

>  <Applicants>  (163) 
Advenchen Laboratories

>  <Links>  (163) 
|http://www.chemspider.com/Chemical-Structure.20566604.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3545235|http://pubchem.ncbi.nlm.nih.gov/compound/16735117|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7640|http://zinc15.docking.org/substances/ZINC000137136675|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=58K797D5IK

>  <LigID>  (163) 
nan

>  <pdbID>  (163) 
nan

>  <Type>  (163) 
nan

>  <RoF>  (163) 
1

>  <MW>  (163) 
500.2

>  <LogP>  (163) 
4.4

>  <TPSA>  (163) 
78

>  <HBA>  (163) 
8

>  <HBD>  (163) 
1

>  <NRB>  (163) 
7

>  <Indications>  (163) 
nan

>  <Targets>  (163) 
EGFR

>  <Kinase families>  (163) 
Tyr

>  <Canonical_Smiles>  (163) 
COc1cc2c(cc1OCCN3CC4(CC4)C5(C3)OCCO5)c(ncn2)Nc6ccc(c(c6)Cl)F

>  <InChiKey>  (163) 
OXWUWXCJDBRCCG-UHFFFAOYSA-N

>  <First_Approval>  (163) 
nan

>  <SC_Patent>  (163) 
None

>  <Chirality>  (163) 
Achiral Molecule

>  <Synonyms>  (163) 
SIM-6802 | SIMOTINIB

>  <FDA_approved>  (163) 


>  <Melting points>  (163) 


$$$$
Vatalanib
     RDKit          2D

 25 28  0  0  0  0  0  0  0  0999 V2000
    1.6785   -4.6384    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1942   -4.8554    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7358   -3.6785    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1815   -2.2846    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3027   -2.0677    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2327   -3.2446    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8570   -0.6738    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9270    0.5031    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5572    0.2862    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1115   -1.1077    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5957   -1.3246    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5257   -0.1477    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9715    1.2461    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9014    2.4231    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3857    2.2061    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9399    0.8123    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0099   -0.3646    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.3156    3.3830    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    3.3412   -0.4569    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8955    0.9369    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3797    1.1539    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9339    2.5477    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0040    3.7246    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.5197    3.5077    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9655    2.1139    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 15 18  1  0
  7 19  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
  6  1  1  0
 10  4  1  0
 17 12  1  0
 25 20  1  0
M  END
>  <BrandName>  (164) 
nan

>  <Phase>  (164) 
3.0

>  <Applicants>  (164) 
Novartis

>  <Links>  (164) 
|http://www.chemspider.com/Chemical-Structure.133257.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL101253|http://pubchem.ncbi.nlm.nih.gov/compound/151194|http://www.drugbank.ca/drugs/DB04879|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5705|http://zinc15.docking.org/substances/ZINC00007460|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=5DX9U76296|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4851

>  <LigID>  (164) 
nan

>  <pdbID>  (164) 
nan

>  <Type>  (164) 
nan

>  <RoF>  (164) 
1

>  <MW>  (164) 
346.1

>  <LogP>  (164) 
5

>  <TPSA>  (164) 
50.7

>  <HBA>  (164) 
4

>  <HBD>  (164) 
1

>  <NRB>  (164) 
4

>  <Indications>  (164) 
Used in combination with first- and second-line chemotherapy for the treatment of metastatic colorectal cancer and non-small cell lung cancer (NSCLC).

>  <Targets>  (164) 
FLT1; KDR; FLT4

>  <Kinase families>  (164) 
Tyr

>  <Canonical_Smiles>  (164) 
c1ccc2c(c1)c(nnc2Nc3ccc(cc3)Cl)Cc4ccncc4

>  <InChiKey>  (164) 
YCOYDOIWSSHVCK-UHFFFAOYSA-N

>  <First_Approval>  (164) 
nan

>  <SC_Patent>  (164) 
None

>  <Chirality>  (164) 
Achiral Molecule

>  <Synonyms>  (164) 
BAY-86-5127 | CGP-79787 | K-222584 | NVP-PTK787 | PTK-787 | PTK787 | VATALANIB | ZK-222584

>  <FDA_approved>  (164) 


>  <Melting points>  (164) 


$$$$
Buparlisib
     RDKit          2D

 29 32  0  0  0  0  0  0  0  0999 V2000
    4.5694    1.0558    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1993    0.4452    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9855    1.3263    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1416    2.8182    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5117    3.4289    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.7256    2.5477    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0957    3.1584    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.6154    0.7157    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5985    1.5969    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9686    0.9862    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1247   -0.5057    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9109   -1.3868    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4592   -0.7762    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0670   -2.8787    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4371   -3.4894    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5933   -4.9812    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3794   -5.8624    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0093   -5.2517    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1469   -3.7599    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1825    1.8674    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0263    3.3592    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2402    4.2404    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6102    3.6297    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7664    2.1379    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5525    1.2567    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0432   -1.0467    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8870   -2.5385    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    4.5350   -1.2029    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    1.5513   -0.8905    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  3  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 10 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
  2 26  1  0
 26 27  1  0
 26 28  1  0
 26 29  1  0
  6  1  1  0
 13  8  1  0
 19 14  1  0
 25 20  1  0
M  END
>  <BrandName>  (165) 
nan

>  <Phase>  (165) 
3.0

>  <Applicants>  (165) 
Novartis

>  <Links>  (165) 
|http://www.chemspider.com/Chemical-Structure.17588300.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL2017974|http://pubchem.ncbi.nlm.nih.gov/compound/16654980|http://www.drugbank.ca/drugs/DB11666| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=SD5|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/SD5|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7878|http://zinc15.docking.org/substances/ZINC43154039|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=0ZM2Z182GD|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50380363

>  <LigID>  (165) 
'SD5'

>  <pdbID>  (165) 
3sd5 5m7e

>  <Type>  (165) 
1

>  <RoF>  (165) 
0

>  <MW>  (165) 
410.2

>  <LogP>  (165) 
1.8

>  <TPSA>  (165) 
89.6

>  <HBA>  (165) 
8

>  <HBD>  (165) 
1

>  <NRB>  (165) 
3

>  <Indications>  (165) 
nan

>  <Targets>  (165) 
PIK3CA

>  <Kinase families>  (165) 
Atypical

>  <Canonical_Smiles>  (165) 
c1c(c(cnc1N)c2cc(nc(n2)N3CCOCC3)N4CCOCC4)C(F)(F)F

>  <InChiKey>  (165) 
CWHUFRVAEUJCEF-UHFFFAOYSA-N

>  <First_Approval>  (165) 
nan

>  <SC_Patent>  (165) 
None

>  <Chirality>  (165) 
Achiral Molecule

>  <Synonyms>  (165) 
BKM-120 | BKM-120NX | BKM120-NX | BUPARLISIB | NVP-BKM-120 | NVP-BKM120

>  <FDA_approved>  (165) 


>  <Melting points>  (165) 


$$$$
Filgotinib
     RDKit          2D

 30 34  0  0  0  0  0  0  0  0999 V2000
    3.3409   -4.5122    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8675   -4.2306    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3747   -2.8139    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3552   -1.6787    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.8286   -1.9603    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3214   -3.3770    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5517   -0.6461    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.5252    0.4477    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1678   -0.1905    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.8068    1.9211    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.2235    2.4139    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3587    1.4333    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.5051    3.8872    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0123    5.3039    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4856    5.0224    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0986   -2.5323    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5914   -1.1155    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0648   -0.8340    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0453   -1.9691    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5525   -3.3859    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0791   -3.6674    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5186   -1.6875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0114   -0.2708    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0309    0.8643    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5237    2.2811    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9971    2.5627    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -7.2852    3.3312    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4639    3.9647    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.9776    1.4275    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4848    0.0108    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  5  7  2  0
  7  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  1  0
 14 15  1  0
  3 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 19 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  2  0
 26 28  2  0
 26 29  1  0
 29 30  1  0
  6  1  2  0
  9  4  1  0
 15 13  1  0
 21 16  1  0
 30 23  1  0
M  END
>  <BrandName>  (166) 
nan

>  <Phase>  (166) 
3.0

>  <Applicants>  (166) 
Galapagos

>  <Links>  (166) 
|http://www.chemspider.com/Chemical-Structure.28189566.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3301607|http://pubchem.ncbi.nlm.nih.gov/compound/49831257|http://www.drugbank.ca/drugs/DB14845| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=2HB|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/2HB|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7913|http://zinc15.docking.org/substances/ZINC000096174616|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=3XVL385Q0M|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=103727

>  <LigID>  (166) 
'2HB'

>  <pdbID>  (166) 
4p7e 5ut5

>  <Type>  (166) 
1

>  <RoF>  (166) 
0

>  <MW>  (166) 
425.2

>  <LogP>  (166) 
2

>  <TPSA>  (166) 
96.7

>  <HBA>  (166) 
7

>  <HBD>  (166) 
1

>  <NRB>  (166) 
5

>  <Indications>  (166) 
nan

>  <Targets>  (166) 
JAK1

>  <Kinase families>  (166) 
Tyr

>  <Canonical_Smiles>  (166) 
c1cc(n2c(c1)nc(n2)NC(=O)C3CC3)c4ccc(cc4)CN5CCS(=O)(=O)CC5

>  <InChiKey>  (166) 
RIJLVEAXPNLDTC-UHFFFAOYSA-N

>  <First_Approval>  (166) 
nan

>  <SC_Patent>  (166) 
None

>  <Chirality>  (166) 
Achiral Molecule

>  <Synonyms>  (166) 
FILGOTINIB | G146034 | GLPG-0634 | GLPG0634

>  <FDA_approved>  (166) 


>  <Melting points>  (166) 


$$$$
Alisertib
     RDKit          2D

 37 41  0  0  0  0  0  0  0  0999 V2000
   -5.8907   -4.5708    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1966   -3.2411    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0012   -1.9751    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.4998   -2.0389    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.3044   -0.7729    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.6103    0.5569    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1116    0.6206    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3071   -0.6454    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8084   -0.5816    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1007   -1.9042    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6255   -2.1755    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4936   -1.1912    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8362   -1.8853    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1022   -1.0808    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.0384    0.4179    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7087    1.1120    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5573    0.3074    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7688    1.1920    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2156    0.7963    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2817    1.8515    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9009    3.3024    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4540    3.6980    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3880    2.6428    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9670    4.3576    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    3.3044    1.2224    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.6341    0.5283    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6979   -0.9703    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0276   -1.6644    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2936   -0.8599    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2299    0.6388    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9001    1.3329    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4958    1.4433    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.4321    2.9419    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6234   -1.5540    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8894   -0.7494    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.6871   -3.0526    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4175    1.9504    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 21 24  1  0
 15 25  1  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 30 32  1  0
 32 33  1  0
 29 34  1  0
 34 35  2  0
 34 36  1  0
  7 37  1  0
  8  3  1  0
 19  9  1  0
 17 12  1  0
 23 18  1  0
 31 26  1  0
M  END
>  <BrandName>  (167) 
nan

>  <Phase>  (167) 
3.0

>  <Applicants>  (167) 
Millennium Pharmaceuticals

>  <Links>  (167) 
|http://www.chemspider.com/Chemical-Structure.24700147.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL483158|http://pubchem.ncbi.nlm.nih.gov/compound/24771867|http://www.drugbank.ca/drugs/DB05220| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=A5B|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/A5B|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7790|http://zinc15.docking.org/substances/ZINC40939534|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=T66ES73M18|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50277545

>  <LigID>  (167) 
'A5B'

>  <pdbID>  (167) 
5ia0

>  <Type>  (167) 
1

>  <RoF>  (167) 
2

>  <MW>  (167) 
518.1

>  <LogP>  (167) 
5.7

>  <TPSA>  (167) 
105.9

>  <HBA>  (167) 
7

>  <HBD>  (167) 
2

>  <NRB>  (167) 
6

>  <Indications>  (167) 
For the treatment of various forms of cancer.

>  <Targets>  (167) 
AURKA

>  <Kinase families>  (167) 
Other

>  <Canonical_Smiles>  (167) 
COc1cccc(c1C2=NCc3cnc(nc3-c4c2cc(cc4)Cl)Nc5ccc(c(c5)OC)C(=O)O)F

>  <InChiKey>  (167) 
ZLHFILGSQDJULK-UHFFFAOYSA-N

>  <First_Approval>  (167) 
nan

>  <SC_Patent>  (167) 
None

>  <Chirality>  (167) 
Achiral Molecule

>  <Synonyms>  (167) 
ALISERTIB | MLN 8237 | MLN-8237 | MLN8237

>  <FDA_approved>  (167) 


>  <Melting points>  (167) 


$$$$
Brivanib
     RDKit          2D

 27 30  0  0  0  0  0  0  0  0999 V2000
   -8.2591   -1.0548    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.9184   -0.3821    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5862   -1.0713    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5190   -0.0172    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1917    1.3235    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6747    1.0980    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3670    2.5764    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8696    2.4887    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1968    1.1480    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0215   -0.1049    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3488   -1.4456    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6994    1.0603    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0267   -0.2804    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4708   -0.3681    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5379    0.6860    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8702   -0.0033    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6264   -1.4833    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1435   -1.7088    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.3188   -2.9618    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1786   -2.8740    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8514   -1.5334    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.2109    0.6695    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.4638   -0.1552    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8045    0.5175    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0575   -0.3072    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8923    2.0150    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.3124    2.1689    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  5  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
  9 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 16 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  6
 24 26  1  0
 15 27  1  0
  6  2  1  0
 10  4  1  0
 21 13  2  0
 18 14  1  0
M  END
>  <BrandName>  (168) 
nan

>  <Phase>  (168) 
3.0

>  <Applicants>  (168) 
Bristol Myers Squibb

>  <Links>  (168) 
|http://www.chemspider.com/Chemical-Structure.9409099.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL377300|http://pubchem.ncbi.nlm.nih.gov/compound/11234052|http://www.drugbank.ca/drugs/DB11958|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5671|http://zinc15.docking.org/substances/ZINC13684256|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=DDU33B674I|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50184807

>  <LigID>  (168) 
nan

>  <pdbID>  (168) 
nan

>  <Type>  (168) 
nan

>  <RoF>  (168) 
0

>  <MW>  (168) 
370.1

>  <LogP>  (168) 
3.5

>  <TPSA>  (168) 
84.7

>  <HBA>  (168) 
6

>  <HBD>  (168) 
2

>  <NRB>  (168) 
5

>  <Indications>  (168) 
nan

>  <Targets>  (168) 
KDR

>  <Kinase families>  (168) 
Tyr

>  <Canonical_Smiles>  (168) 
Cc1cc2c([nH]1)ccc(c2F)Oc3c4c(c(cn4ncn3)OC[C@@H](C)O)C

>  <InChiKey>  (168) 
WCWUXEGQKLTGDX-LLVKDONJSA-N

>  <First_Approval>  (168) 
nan

>  <SC_Patent>  (168) 
None

>  <Chirality>  (168) 
Single Stereoisomer

>  <Synonyms>  (168) 
BMS-540215 | BRIVANIB

>  <FDA_approved>  (168) 


>  <Melting points>  (168) 


$$$$
Capmatinib
     RDKit          2D

 31 35  0  0  0  0  0  0  0  0999 V2000
   -9.8107   -1.9666    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.5721   -1.1204    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -7.2200   -1.7700    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.1065   -3.2657    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9815   -0.9239    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0949    0.5718    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8564    1.4180    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5043    0.7684    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3908   -0.7273    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6294   -1.5734    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5159   -3.0691    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2657    1.6145    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3792    3.1102    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1406    3.9564    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.2114    3.3068    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5988    3.8769    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.5698    2.7336    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7825    1.4568    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3249    1.8111    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9137    0.9650    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.3526    0.0694    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8392   -0.1306    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7557    1.0569    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2423    0.8569    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8124   -0.5305    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8959   -1.7180    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4093   -1.5180    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4661   -3.1054    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9527   -3.3054    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8692   -2.1179    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2990   -0.7305    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
  8 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  1  0
 18 21  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 26 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 10  5  1  0
 20 12  2  0
 19 15  1  0
 27 22  1  0
 31 25  1  0
M  END
>  <BrandName>  (169) 
nan

>  <Phase>  (169) 
3.0

>  <Applicants>  (169) 
Novartis

>  <Links>  (169) 
|http://www.chemspider.com/Chemical-Structure.25069712.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3188267|http://pubchem.ncbi.nlm.nih.gov/compound/25145656|http://www.drugbank.ca/drugs/DB11791|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7904|http://zinc15.docking.org/substances/ZINC000043195321|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=TY34L4F9OZ|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50146167

>  <LigID>  (169) 
nan

>  <pdbID>  (169) 
nan

>  <Type>  (169) 
nan

>  <RoF>  (169) 
0

>  <MW>  (169) 
412.1

>  <LogP>  (169) 
3.4

>  <TPSA>  (169) 
85.1

>  <HBA>  (169) 
6

>  <HBD>  (169) 
1

>  <NRB>  (169) 
4

>  <Indications>  (169) 
nan

>  <Targets>  (169) 
MET

>  <Kinase families>  (169) 
Tyr

>  <Canonical_Smiles>  (169) 
CNC(=O)c1ccc(cc1F)c2cnc3ncc(n3n2)Cc4ccc5c(c4)cccn5

>  <InChiKey>  (169) 
LIOLIMKSCNQPLV-UHFFFAOYSA-N

>  <First_Approval>  (169) 
nan

>  <SC_Patent>  (169) 
None

>  <Chirality>  (169) 
Achiral Molecule

>  <Synonyms>  (169) 
CAPMATINIB | INC-280 | INC280 | INCB-28060 | INCB-28060 FREE BASE | NVP-INC280 | NVP-INC280-NX | NYP-INC280-NX

>  <FDA_approved>  (169) 


>  <Melting points>  (169) 


$$$$
Capivasertib
     RDKit          2D

 30 33  0  0  0  0  0  0  0  0999 V2000
    3.1850    1.1141    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5450    2.5703    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9861    2.9866    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0672    1.9467    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7071    0.4906    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2661    0.0743    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9061   -1.3819    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9871   -2.4217    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4282   -2.0054    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5093   -3.0453    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4650   -1.7982    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.3839   -0.7583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7439    0.6978    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0572   -1.1746    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2169    0.3169    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5884    0.9243    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8002    0.0402    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6405   -1.4513    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2689   -2.0587    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1717    0.6476    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3835   -0.2365    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5373   -1.7286    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.0039   -2.0433    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.7565   -0.7458    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.7550    0.3709    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.9147    1.8624    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7030    2.7465    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3314    2.1391    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.6031   -2.5215    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.3461    4.4427    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  6
  8  9  1  0
  9 10  1  0
  7 11  1  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 17 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 14 29  1  0
  3 30  1  0
  6  1  1  0
 19 14  1  0
 28 20  1  0
 25 21  1  0
M  END
>  <BrandName>  (170) 
nan

>  <Phase>  (170) 
3.0

>  <Applicants>  (170) 
Astrazeneca

>  <Links>  (170) 
|http://www.chemspider.com/Chemical-Structure.28189073.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL2325741|http://pubchem.ncbi.nlm.nih.gov/compound/25227436|http://www.drugbank.ca/drugs/DB12218| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=0XZ|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/0XZ|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7709|http://zinc15.docking.org/substances/ZINC000043204023|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=WFR23M21IE|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50427349

>  <LigID>  (170) 
'0XZ'

>  <pdbID>  (170) 
4gv1

>  <Type>  (170) 
nan

>  <RoF>  (170) 
0

>  <MW>  (170) 
428.2

>  <LogP>  (170) 
2.1

>  <TPSA>  (170) 
120.2

>  <HBA>  (170) 
6

>  <HBD>  (170) 
4

>  <NRB>  (170) 
6

>  <Indications>  (170) 
nan

>  <Targets>  (170) 
AKT1

>  <Kinase families>  (170) 
AGC

>  <Canonical_Smiles>  (170) 
c1cc(ccc1[C@H](CCO)NC(=O)C2(CCN(CC2)c3c4cc[nH]c4ncn3)N)Cl

>  <InChiKey>  (170) 
JDUBGYFRJFOXQC-KRWDZBQOSA-N

>  <First_Approval>  (170) 
nan

>  <SC_Patent>  (170) 
None

>  <Chirality>  (170) 
Single Stereoisomer

>  <Synonyms>  (170) 
AZC5363 | AZD 5363 | AZD-5363 | AZD5363 | CAPIVASERTIB

>  <FDA_approved>  (170) 


>  <Melting points>  (170) 


$$$$
Abivertinib
     RDKit          2D

 36 40  0  0  0  0  0  0  0  0999 V2000
    7.7865    2.2220    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2937    2.3694    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.4197    1.1504    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9270    1.2978    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3083    2.6643    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.1823    3.8833    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6750    3.7359    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8155    2.8117    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1968    4.1781    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2959    4.3255    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1700    3.1065    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5513    1.7400    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9415    1.5926    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5602    0.2262    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6627    3.2539    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5367    2.0349    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0295    2.1823    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9035    0.9632    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2848   -0.4032    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.3932   -1.4139    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.6969   -0.6721    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.3943    0.7971    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7921   -0.5506    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9180    0.6684    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1733   -1.9171    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6806   -2.0645    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8066   -0.8455    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6862   -0.9929    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3049   -2.3593    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4308   -3.5784    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0619   -3.4310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0495   -4.9448    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.5423   -5.0922    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4163   -3.8732    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.1610   -6.4587    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6537   -6.6061    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  5  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 11 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 19 23  1  0
 23 24  2  0
 23 25  1  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 30 32  1  0
 32 33  1  0
 33 34  2  0
 33 35  1  0
 35 36  2  0
  7  2  1  0
 13  8  1  0
 24 16  1  0
 22 18  1  0
 31 26  1  0
M  END
>  <BrandName>  (171) 
nan

>  <Phase>  (171) 
3.0

>  <Applicants>  (171) 
ACEA Biosciences

>  <Links>  (171) 
|http://www.chemspider.com/Chemical-Structure.57490375.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL4297865|http://pubchem.ncbi.nlm.nih.gov/compound/72734520|http://www.drugbank.ca/drugs/DB15327|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10044|http://zinc15.docking.org/substances/ZINC000142081723|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=CER0OPG92L|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294480

>  <LigID>  (171) 
nan

>  <pdbID>  (171) 
nan

>  <Type>  (171) 
nan

>  <RoF>  (171) 
0

>  <MW>  (171) 
487.2

>  <LogP>  (171) 
4.5

>  <TPSA>  (171) 
98.4

>  <HBA>  (171) 
7

>  <HBD>  (171) 
3

>  <NRB>  (171) 
7

>  <Indications>  (171) 
AC0010 is an orally active, irreversible EGFR inhibitor that selectively targets mutated EGFRs, and was designed to overcome T790M-induced resistance in tumours [<a href='javascript:callRef("ReferenceDisplayForward?referenceId=35960&displayId=2", 960, 600)' title="2. Xu X, Mao L, Xu W, Tang W, Zhang X, Xi B, Xu R, Fang X, Liu J, Fang C et al.. (2016) Mol. Cancer Ther. 15 (11): 2586-2597">2</a>]. It may also inhibit BTK, thus offering extended clinical utility [<a href='javascript:callRef("ReferenceDisplayForward?referenceId=35961&displayId=3", 960, 600)' title="3. Yan X, Zhou Y, Huang S, Li X, Yu M, Huang J, Wang J, Ma Z, Jin J, Pan J et al.. (2018) J. Cancer Res. Clin. Oncol. 144 (4): 697-706">3</a>]. We show the structure for the free base form of the compound.

>  <Targets>  (171) 
nan

>  <Kinase families>  (171) 


>  <Canonical_Smiles>  (171) 
CN1CCN(CC1)c2ccc(cc2F)Nc3nc4c(cc[nH]4)c(n3)Oc5cccc(c5)NC(=O)C=C

>  <InChiKey>  (171) 
UOFYSRZSLXWIQB-UHFFFAOYSA-N

>  <First_Approval>  (171) 
nan

>  <SC_Patent>  (171) 
None

>  <Chirality>  (171) 
Achiral Molecule

>  <Synonyms>  (171) 
A610 | ABIVERTINIB | AC-0010 | AC0010 | ACEA100610 | EX-ACEA0010

>  <FDA_approved>  (171) 


>  <Melting points>  (171) 


$$$$
Cediranib
     RDKit          2D

 33 37  0  0  0  0  0  0  0  0999 V2000
   10.6913    0.8056    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2389    0.4307    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0819    1.3853    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8165    0.5800    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1914   -0.8724    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6885   -0.9647    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.1210   -1.9233    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6758   -1.5218    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3009   -0.0694    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3712    0.9815    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9963    2.4339    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.8556    0.3321    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.7852   -0.7187    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3400   -0.3172    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0349    1.1352    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4802    1.5367    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5505    0.4858    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1756   -0.9666    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7304   -1.3681    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3555   -2.8205    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.0898   -3.2220    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1601   -2.1711    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9958    0.8873    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0662   -0.1635    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5114    0.2380    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.5818   -0.8129    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.0270   -0.4114    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  -10.2014   -1.3446    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -11.4518   -0.5161    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -11.0503    0.9291    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.5517    0.9939    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8551    2.9891    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7847    4.0400    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  5  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
  9 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 17 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 16 32  1  0
 32 33  1  0
  6  2  1  0
 10  4  1  0
 22 13  2  0
 19 14  1  0
 31 27  1  0
M  END
>  <BrandName>  (172) 
Recentin

>  <Phase>  (172) 
3.0

>  <Applicants>  (172) 
Astrazeneca

>  <Links>  (172) 
|http://www.chemspider.com/Chemical-Structure.8109103.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL491473|http://pubchem.ncbi.nlm.nih.gov/compound/9933475|http://www.drugbank.ca/drugs/DB04849|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5664|http://zinc15.docking.org/substances/ZINC000003948085|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=NQU9IPY4K9|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50331096

>  <LigID>  (172) 
nan

>  <pdbID>  (172) 
nan

>  <Type>  (172) 
nan

>  <RoF>  (172) 
1

>  <MW>  (172) 
450.2

>  <LogP>  (172) 
5.2

>  <TPSA>  (172) 
72.5

>  <HBA>  (172) 
6

>  <HBD>  (172) 
1

>  <NRB>  (172) 
8

>  <Indications>  (172) 
For the treatment of liver cancer, advanced non-small cell lung cancer (NSCLC), advanced colorectal cancer (CRC) and other solid tumors.

>  <Targets>  (172) 
KDR

>  <Kinase families>  (172) 
Tyr

>  <Canonical_Smiles>  (172) 
Cc1cc2c([nH]1)ccc(c2F)Oc3c4cc(c(cc4ncn3)OCCCN5CCCC5)OC

>  <InChiKey>  (172) 
XXJWYDDUDKYVKI-UHFFFAOYSA-N

>  <First_Approval>  (172) 
nan

>  <SC_Patent>  (172) 
None

>  <Chirality>  (172) 
Achiral Molecule

>  <Synonyms>  (172) 
AZD-2171 | AZD2171 | CEDIRANIB | RECENTIN | ZD-2171

>  <FDA_approved>  (172) 


>  <Melting points>  (172) 


$$$$
Tucatinib
     RDKit          2D

 36 41  0  0  0  0  0  0  0  0999 V2000
   -2.7226    4.0612    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1584    2.6713    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6727    2.4651    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1084    1.0752    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0299   -0.1083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5157    0.0980    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0799    1.4878    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5657    1.6941    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4872    0.5105    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9229   -0.8793    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8445   -2.0629    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.3302   -1.8566    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -7.8944   -0.4668    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.9729    0.7168    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.3906   -0.5739    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -9.7511   -2.0300    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.4777   -2.8227    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.3773    0.8690    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.2988    2.0525    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7846    1.8463    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3488    0.4564    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8346    0.2502    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7561    1.4337    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1919    2.8235    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7061    3.0298    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1419    4.4197    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.6561    4.6259    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7346    3.4424    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.3988   -1.1397    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.4773   -2.3232    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8932   -3.7644    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.6510   -4.6053    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4675   -3.6838    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9781   -2.2734    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.6171   -5.7528    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6108   -5.6861    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 13 15  2  0
 15 16  1  0
 16 17  2  0
  4 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 22 29  1  0
 29 30  1  0
 30 31  2  0
 31 32  1  0
 32 33  1  0
 33 34  1  0
 32 35  1  0
 32 36  1  0
  7  2  1  0
 14  9  2  0
 17 12  1  0
 28 19  2  0
 25 20  1  0
 34 30  1  0
M  END
>  <BrandName>  (173) 
nan

>  <Phase>  (173) 
3.0

>  <Applicants>  (173) 
Array BioPharma

>  <Links>  (173) 
|http://www.chemspider.com/Chemical-Structure.34995558.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3989868|http://pubchem.ncbi.nlm.nih.gov/compound/51039094|http://www.drugbank.ca/drugs/DB11652|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9922|http://zinc15.docking.org/substances/ZINC000068250462|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=234248D0HH

>  <LigID>  (173) 
nan

>  <pdbID>  (173) 
nan

>  <Type>  (173) 
nan

>  <RoF>  (173) 
1

>  <MW>  (173) 
480.2

>  <LogP>  (173) 
5.1

>  <TPSA>  (173) 
110.9

>  <HBA>  (173) 
10

>  <HBD>  (173) 
2

>  <NRB>  (173) 
5

>  <Indications>  (173) 
nan

>  <Targets>  (173) 
ERBB2

>  <Kinase families>  (173) 
Tyr

>  <Canonical_Smiles>  (173) 
Cc1cc(ccc1Oc2ccn3c(c2)ncn3)Nc4c5cc(ccc5ncn4)NC6=NC(CO6)(C)C

>  <InChiKey>  (173) 
SDEAXTCZPQIFQM-UHFFFAOYSA-N

>  <First_Approval>  (173) 
nan

>  <SC_Patent>  (173) 
None

>  <Chirality>  (173) 
Achiral Molecule

>  <Synonyms>  (173) 
ARRY-380 | ONT-380 | TUCATINIB

>  <FDA_approved>  (173) 


>  <Melting points>  (173) 
230

$$$$
Orantinib
     RDKit          2D

 23 25  0  0  0  0  0  0  0  0999 V2000
   -1.5412    2.7940    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4754    1.2954    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6491    0.3614    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1235   -1.0435    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6249   -0.9777    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2244    0.4678    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1805    0.9934    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3382    0.0396    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7903    0.4155    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4826    1.7462    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9812    1.8120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7874    0.5471    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0951   -0.7836    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5965   -0.8494    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6427   -2.0070    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.2469   -1.4576    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9820   -2.2639    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9511   -2.2946    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0946    0.7619    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1643   -0.2898    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6098    0.1108    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.9857    1.5629    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -7.6794   -0.9409    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
  4 18  1  0
  3 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  2  0
 21 23  1  0
  6  2  2  0
  8 16  1  0
 14  9  1  0
M  END
>  <BrandName>  (174) 
nan

>  <Phase>  (174) 
3.0

>  <Applicants>  (174) 
Pfizer

>  <Links>  (174) 
|http://www.chemspider.com/Chemical-Structure.4486261.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL274654|http://pubchem.ncbi.nlm.nih.gov/compound/5329099|http://www.drugbank.ca/drugs/DB12072| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=SU6|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/SU6|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7816|http://zinc15.docking.org/substances/ZINC000003834032|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=9RL37ZZ665|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4811

>  <LigID>  (174) 
'SU6'

>  <pdbID>  (174) 
4jlc 5yvc

>  <Type>  (174) 
1

>  <RoF>  (174) 
0

>  <MW>  (174) 
310.1

>  <LogP>  (174) 
3.1

>  <TPSA>  (174) 
82.2

>  <HBA>  (174) 
2

>  <HBD>  (174) 
3

>  <NRB>  (174) 
4

>  <Indications>  (174) 
nan

>  <Targets>  (174) 
KDR; PDGFRB; FGFR1

>  <Kinase families>  (174) 
Tyr

>  <Canonical_Smiles>  (174) 
Cc1c(c([nH]c1/C=C\2/c3ccccc3NC2=O)C)CCC(=O)O

>  <InChiKey>  (174) 
NHFDRBXTEDBWCZ-ZROIWOOFSA-N

>  <First_Approval>  (174) 
nan

>  <SC_Patent>  (174) 
None

>  <Chirality>  (174) 
Achiral Molecule

>  <Synonyms>  (174) 
NSC-702827 | ORANTINIB | SU-6668 | TSU-68

>  <FDA_approved>  (174) 


>  <Melting points>  (174) 


$$$$
Umbralisib
     RDKit          2D

 42 47  0  0  0  0  0  0  0  0999 V2000
    2.6522    2.4495    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7439    1.2558    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3235   -0.1277    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8115   -0.3175    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3911   -1.7010    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8790   -1.8907    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.4828   -2.8947    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0624   -4.2782    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1541   -5.4719    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6662   -5.2821    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0865   -3.8986    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9948   -2.7049    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4152   -1.3214    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.7337   -6.8554    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    4.7198    0.8762    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1401    2.2597    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0485    3.4535    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5364    3.2637    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1160    1.8802    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2077    0.6865    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6040    1.6904    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.2559    1.4455    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4651    2.7609    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9389    2.4815    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1287    0.9936    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7722    0.3533    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4440    0.2725    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7261    1.0511    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0414    0.3300    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0746   -1.1696    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7925   -1.9482    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4772   -1.2271    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8257   -3.4478    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -7.3899   -1.8907    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -8.6720   -1.1122    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.9874   -1.8332    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.6389    0.3875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9177    3.6182    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4227    5.0342    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9489    5.3135    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0298    4.1768    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3914    3.3389    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  1
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
  9 14  1  0
  4 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 19 21  1  0
  2 22  1  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 25 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 31 33  1  0
 30 34  1  0
 34 35  1  0
 35 36  1  0
 35 37  1  0
 24 38  1  0
 38 39  2  0
 39 40  1  0
 40 41  2  0
 38 42  1  0
 13  3  1  0
 12  7  1  0
 20 15  1  0
 26 22  1  0
 41 23  1  0
 32 27  1  0
M  END
>  <BrandName>  (175) 
nan

>  <Phase>  (175) 
3.0

>  <Applicants>  (175) 
TG Therapeutics

>  <Links>  (175) 
|http://www.chemspider.com/Chemical-Structure.34979945.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3948730|http://pubchem.ncbi.nlm.nih.gov/compound/72950888|http://www.drugbank.ca/drugs/DB14989|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8916|http://zinc15.docking.org/substances/ZINC000141831516|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=38073MQB2A|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=184556

>  <LigID>  (175) 
nan

>  <pdbID>  (175) 
nan

>  <Type>  (175) 
nan

>  <RoF>  (175) 
2

>  <MW>  (175) 
571.2

>  <LogP>  (175) 
6.7

>  <TPSA>  (175) 
109.1

>  <HBA>  (175) 
8

>  <HBD>  (175) 
1

>  <NRB>  (175) 
6

>  <Indications>  (175) 
nan

>  <Targets>  (175) 
nan

>  <Kinase families>  (175) 


>  <Canonical_Smiles>  (175) 
C[C@@H](c1c(c(=O)c2cc(ccc2o1)F)c3cccc(c3)F)n4c5c(c(n4)c6ccc(c(c6)F)OC(C)C)c(ncn5)N

>  <InChiKey>  (175) 
IUVCFHHAEHNCFT-INIZCTEOSA-N

>  <First_Approval>  (175) 
nan

>  <SC_Patent>  (175) 
None

>  <Chirality>  (175) 
Single Stereoisomer

>  <Synonyms>  (175) 
RP-5264 | RP5264 | TGR 1202 | TGR-1202 BASE | TGR-1202 FREE BASE | UMBRALISIB

>  <FDA_approved>  (175) 


>  <Melting points>  (175) 


$$$$
Volasertib
     RDKit          2D

 45 50  0  0  0  0  0  0  0  0999 V2000
  -12.0065   -2.2609    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -11.1582   -1.0238    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.6627   -1.1399    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.8144    0.0972    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -7.3189   -0.0188    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4707    1.2183    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9752    1.1022    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3279   -0.2510    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1762   -1.4881    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6717   -1.3720    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.5200   -2.6091    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -9.0155   -2.4931    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.8637   -3.7302    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.8727   -3.9623    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1269    2.3393    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6314    2.2233    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9842    0.8701    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4887    0.7540    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3596    1.9911    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2876    3.3443    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7831    3.4604    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8551    1.8751    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7034    3.1122    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5024    0.5219    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.9979    0.4058    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6451   -0.9473    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1406   -1.0634    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9889    0.1737    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3416    1.5269    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8461    1.6429    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4844    0.0576    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.1316   -1.2955    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6271   -1.4116    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4754   -0.1745    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.8281    1.1787    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3326    1.2947    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9709   -0.2906    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6181   -1.6437    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8552   -2.4920    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.5020   -3.1392    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8324   -0.3670    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1852   -1.7202    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.4617    1.4504    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.6134    2.6875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.9572    1.5665    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  3  2  1  1
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 11 14  1  0
  7 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 19 22  1  0
 22 23  2  0
 22 24  1  0
 25 24  1  6
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 28 31  1  1
 31 32  1  0
 32 33  1  0
 33 34  1  0
 34 35  1  0
 35 36  1  0
 34 37  1  0
 37 38  1  0
 38 39  1  0
 39 40  1  0
 17 41  1  0
 41 42  1  0
  4 43  1  0
 43 44  1  0
 43 45  1  0
 12  3  1  0
 10  5  1  0
 21 16  1  0
 30 25  1  0
 36 31  1  0
 40 38  1  0
M  END
>  <BrandName>  (176) 
nan

>  <Phase>  (176) 
3.0

>  <Applicants>  (176) 
Boehringer Ingelheim

>  <Links>  (176) 
|http://www.chemspider.com/Chemical-Structure.26327706.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL1233528|http://www.drugbank.ca/drugs/DB12062| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=IBI|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/IBI|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7947|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=6EM57086EA|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50402023

>  <LigID>  (176) 
'IBI'

>  <pdbID>  (176) 
3fc2 5v67 5vbr

>  <Type>  (176) 
1

>  <RoF>  (176) 
1

>  <MW>  (176) 
618.4

>  <LogP>  (176) 
4.3

>  <TPSA>  (176) 
106.2

>  <HBA>  (176) 
9

>  <HBD>  (176) 
2

>  <NRB>  (176) 
10

>  <Indications>  (176) 
nan

>  <Targets>  (176) 
PLK1

>  <Kinase families>  (176) 
Other

>  <Canonical_Smiles>  (176) 
CC[C@H]1N(c2nc(ncc2N(C1=O)C)Nc3c(cc(cc3)C(=O)N[C@H]4CC[C@@H](CC4)N5CCN(CC5)CC6CC6)OC)C(C)C

>  <InChiKey>  (176) 
SXNJFOWDRLKDSF-STROYTFGSA-N

>  <First_Approval>  (176) 
nan

>  <SC_Patent>  (176) 
None

>  <Chirality>  (176) 
Single Stereoisomer

>  <Synonyms>  (176) 
BI 6727 | BI-6727 | VOLASERTIB

>  <FDA_approved>  (176) 


>  <Melting points>  (176) 


$$$$
Linsitinib
     RDKit          2D

 32 37  0  0  0  0  0  0  0  0999 V2000
   -5.5026   -5.0677    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7339   -3.5856    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9652   -2.1036    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4831   -1.8723    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2518   -3.3544    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5987   -0.6608    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0590    0.7669    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8435    1.6458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9969    3.1379    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3658    3.7511    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5813    2.8722    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4279    1.3801    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7813    4.0168    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6319    0.7613    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0987   -0.6642    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2043    1.2216    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9081    0.2154    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3358    0.6757    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4482   -0.3305    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.8758    0.1298    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1910    1.5963    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0786    2.6025    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6510    2.1422    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5385    3.1484    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1109    2.6881    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9883   -0.8765    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6731   -2.3430    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7855   -3.3492    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2131   -2.8889    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5283   -1.4224    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4159   -0.4162    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.2160   -3.8169    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  1
  2  3  1  0
  3  4  1  0
  4  5  1  0
  4  6  1  6
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
  9 13  1  0
  8 14  2  0
 14 15  1  0
 14 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 20 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
  2 32  1  0
  5  2  1  0
 15  6  2  0
 12  7  1  0
 25 16  1  0
 23 18  1  0
 31 26  1  0
M  END
>  <BrandName>  (177) 
nan

>  <Phase>  (177) 
3.0

>  <Applicants>  (177) 
Osi Pharmaceuticals

>  <Links>  (177) 
|http://www.chemspider.com/Chemical-Structure.21391708.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL1091644|http://www.drugbank.ca/drugs/DB06075|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7423|http://zinc15.docking.org/substances/ZINC000100071817|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=15A52GPT8T|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50315887

>  <LigID>  (177) 
nan

>  <pdbID>  (177) 
nan

>  <Type>  (177) 
nan

>  <RoF>  (177) 
0

>  <MW>  (177) 
421.2

>  <LogP>  (177) 
4.8

>  <TPSA>  (177) 
89.3

>  <HBA>  (177) 
6

>  <HBD>  (177) 
2

>  <NRB>  (177) 
3

>  <Indications>  (177) 
nan

>  <Targets>  (177) 
IGF1R

>  <Kinase families>  (177) 
Tyr

>  <Canonical_Smiles>  (177) 
C[C@]1(C[C@@H](C1)c2n3c(c(ncc3)N)c(n2)c4cc5nc(ccc5cc4)c6ccccc6)O

>  <InChiKey>  (177) 
PKCDDUHJAFVJJB-VLZXCDOPSA-N

>  <First_Approval>  (177) 
nan

>  <SC_Patent>  (177) 
None

>  <Chirality>  (177) 
Single Stereoisomer

>  <Synonyms>  (177) 
ASP-7487 | LINSITINIB | OSI-906 | OSI-906AA

>  <FDA_approved>  (177) 


>  <Melting points>  (177) 


$$$$
Itacitinib
     RDKit          2D

 40 45  0  0  0  0  0  0  0  0999 V2000
    8.5378   -2.0811    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8755   -2.7598    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9343   -1.6973    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.2510   -0.3620    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7862    1.0393    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.8402    2.2034    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3590    1.9662    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.8239    0.5649    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7699   -0.5992    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3428    0.3277    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6641   -1.0099    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1822   -0.7778    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.9450    0.7033    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.2803    1.3866    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6073    1.3820    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9286    0.0443    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5909    0.7230    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.2696    2.0607    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8349    0.2570    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9513    1.2588    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3771    0.7928    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6864   -0.6750    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5700   -1.6767    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1442   -1.2108    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1122   -1.1409    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4216   -2.6087    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2287   -0.1392    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9193    1.3286    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.0358    2.3304    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.4616    1.8644    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -8.7709    0.3966    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.6545   -0.6051    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.9638   -2.0729    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  -10.1967   -0.0693    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -11.6225   -0.5353    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  -10.6627    1.3565    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -9.7307   -1.4951    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    1.9286    0.0443    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4308   -0.0368    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0029   -0.4779    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 13 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 17 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 22 25  1  0
 25 26  2  0
 25 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 32 33  1  0
 31 34  1  0
 34 35  1  0
 34 36  1  0
 34 37  1  0
 15 38  1  0
 38 39  1  0
 39 40  3  0
  9  1  1  0
  4  9  1  0
 14 10  2  0
 18 15  1  0
 24 19  1  0
 32 27  1  0
M  END
>  <BrandName>  (178) 
nan

>  <Phase>  (178) 
3.0

>  <Applicants>  (178) 
Incyte Corporation

>  <Links>  (178) 
|http://www.chemspider.com/Chemical-Structure.35033258.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3622820|http://pubchem.ncbi.nlm.nih.gov/compound/53380437|http://www.drugbank.ca/drugs/DB12154|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8364|http://zinc15.docking.org/substances/ZINC000118795962|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=19J3781LPM|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246868

>  <LigID>  (178) 
nan

>  <pdbID>  (178) 
nan

>  <Type>  (178) 
nan

>  <RoF>  (178) 
1

>  <MW>  (178) 
553.2

>  <LogP>  (178) 
3.6

>  <TPSA>  (178) 
119.6

>  <HBA>  (178) 
8

>  <HBD>  (178) 
1

>  <NRB>  (178) 
5

>  <Indications>  (178) 
nan

>  <Targets>  (178) 
JAK1

>  <Kinase families>  (178) 
Tyr

>  <Canonical_Smiles>  (178) 
c1cnc-2[nH]cnc(c12)c3cnn(c3)C4(CN(C4)C5CCN(CC5)C(=O)c6ccnc(c6F)C(F)(F)F)CC#N

>  <InChiKey>  (178) 
KTBSXLIQKWEBRB-UHFFFAOYSA-N

>  <First_Approval>  (178) 
nan

>  <SC_Patent>  (178) 
None

>  <Chirality>  (178) 
Achiral Molecule

>  <Synonyms>  (178) 
INCB-039110 | INCB-39110 | INCB039110 | ITACITINIB

>  <FDA_approved>  (178) 


>  <Melting points>  (178) 


$$$$
Alvocidib
     RDKit          2D

 28 31  0  0  0  0  0  0  0  0999 V2000
   -3.8841   -4.9071    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4213   -3.4803    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4255   -2.3661    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9627   -0.9392    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4956   -0.6266    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4914   -1.7409    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9542   -3.1677    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0243   -1.4283    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0328    0.8002    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0371    1.9144    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5743    3.3412    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1072    3.6538    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1029    2.5396    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5658    1.1128    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4385   -0.0014    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.9056    0.3112    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3684    1.7380    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3641    2.8522    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8269    4.2790    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9098   -0.8031    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4470   -2.2299    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4513   -3.3441    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9183   -3.0315    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3811   -1.6047    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3769   -0.4905    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8397    0.9364    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.6444    5.0806    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5041    1.6018    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  6  8  1  6
  5  9  1  6
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 16 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 12 27  1  0
 10 28  1  0
  7  2  1  0
 14  9  1  0
 18 13  1  0
 25 20  1  0
M  END
>  <BrandName>  (179) 
nan

>  <Phase>  (179) 
3.0

>  <Applicants>  (179) 
Sanofi

>  <Links>  (179) 
|http://www.chemspider.com/Chemical-Structure.4450222.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL428690|http://pubchem.ncbi.nlm.nih.gov/compound/5287969|http://www.drugbank.ca/drugs/DB03496| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=CPB|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/CPB|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5680|http://zinc15.docking.org/substances/ZINC000021288966|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=45AD6X575G|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=5655

>  <LigID>  (179) 
'CPB'

>  <pdbID>  (179) 
1c8k 1e1y 3blr 3ebp 4o71

>  <Type>  (179) 
nan

>  <RoF>  (179) 
0

>  <MW>  (179) 
401.1

>  <LogP>  (179) 
3.3

>  <TPSA>  (179) 
94.1

>  <HBA>  (179) 
6

>  <HBD>  (179) 
3

>  <NRB>  (179) 
2

>  <Indications>  (179) 
Investigated for use/treatment in esophageal cancer, leukemia (lymphoid), lung cancer, liver cancer, and lymphoma (unspecified).

>  <Targets>  (179) 
nan

>  <Kinase families>  (179) 


>  <Canonical_Smiles>  (179) 
CN1CC[C@@H]([C@@H](C1)O)c2c(cc(c3c2oc(cc3=O)c4ccccc4Cl)O)O

>  <InChiKey>  (179) 
BIIVYFLTOXDAOV-YVEFUNNKSA-N

>  <First_Approval>  (179) 
nan

>  <SC_Patent>  (179) 
None

>  <Chirality>  (179) 
Single Stereoisomer

>  <Synonyms>  (179) 
ALVOCIDIB | FLAVOPIRIDOL | HL 275 | HMR 1275 | L 86 8275 | L-868275 | MDL-107826A | NSC-649890

>  <FDA_approved>  (179) 


>  <Melting points>  (179) 


$$$$
Abrocitinib
     RDKit          2D

 22 24  0  0  0  0  0  0  0  0999 V2000
   -4.4976    3.3422    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7661    2.0326    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5345    0.7444    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8031   -0.5652    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4935    0.1663    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1126   -1.2967    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0716   -1.8748    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5718   -1.8961    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4961   -0.8506    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5493   -1.9262    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5263   -2.9717    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0492   -1.9476    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.7807   -3.2571    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8176   -0.6593    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0861    0.6502    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6235    0.9829    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4879    2.4768    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8668    3.0674    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.8545    1.9385    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3544    1.9172    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.0858    0.6076    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3174   -0.6806    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  2  0
  4  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 10 12  1  0
 12 13  1  0
 12 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 11  8  1  0
 22 14  1  0
 19 15  1  0
M  END
>  <BrandName>  (180) 
nan

>  <Phase>  (180) 
3.0

>  <Applicants>  (180) 
Pfizer

>  <Links>  (180) 
|http://www.chemspider.com/Chemical-Structure.68006894.html|http://pubchem.ncbi.nlm.nih.gov/compound/78323835

>  <LigID>  (180) 
nan

>  <pdbID>  (180) 
nan

>  <Type>  (180) 
nan

>  <RoF>  (180) 
0

>  <MW>  (180) 
323.1

>  <LogP>  (180) 
1.3

>  <TPSA>  (180) 
91

>  <HBA>  (180) 
5

>  <HBD>  (180) 
2

>  <NRB>  (180) 
6

>  <Indications>  (180) 
nan

>  <Targets>  (180) 
nan

>  <Kinase families>  (180) 


>  <Canonical_Smiles>  (180) 
CCCS(=O)(=O)NC1CC(C1)N(C)c2c3cc[nH]c3ncn2

>  <InChiKey>  (180) 
IUEWXNHSKRWHDY-UHFFFAOYSA-N

>  <First_Approval>  (180) 
nan

>  <SC_Patent>  (180) 
None

>  <Chirality>  (180) 
Single Stereoisomer

>  <Synonyms>  (180) 
|PF-04965842

>  <FDA_approved>  (180) 


>  <Melting points>  (180) 


$$$$
Ipatasertib
     RDKit          2D

 32 35  0  0  0  0  0  0  0  0999 V2000
    2.5973    1.8166    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0442    1.4210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2147    2.3591    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4685    1.5357    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0729    0.0888    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5746    0.0179    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8868   -1.3151    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6973   -2.5772    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.1957   -2.5064    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8834   -1.1733    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.3885   -1.3860    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.5779   -0.1238    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0796   -0.1947    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6082   -1.5277    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.2024   -2.7899    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7007   -2.7190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1065   -1.5986    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7943   -2.9316    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9170   -0.3364    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2293    0.9966    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0398    2.2587    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3520    3.5918    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1626    4.8539    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8537    3.6626    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4154   -0.4073    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2259    0.8548    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.7242    0.7840    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.4120   -0.5491    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6015   -1.8112    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1032   -1.7403    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.9103   -0.6199    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    7.8716    2.0661    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  6
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
  7 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 14 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  1  1
 20 21  1  0
 21 22  1  0
 22 23  1  0
 22 24  1  0
 19 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 28 31  1  0
  4 32  1  1
  6  2  1  0
 10  5  1  0
 16 11  1  0
 30 25  1  0
M  END
>  <BrandName>  (181) 
nan

>  <Phase>  (181) 
3.0

>  <Applicants>  (181) 
Hoffmann-La Roche

>  <Links>  (181) 
|http://www.chemspider.com/Chemical-Structure.28189084.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL2177390|http://pubchem.ncbi.nlm.nih.gov/compound/24788740|http://www.drugbank.ca/drugs/DB11743| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=0RF|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/0RF|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7887|http://zinc15.docking.org/substances/ZINC000068250459|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=524Y3IB4HQ|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50398379

>  <LigID>  (181) 
'0RF'

>  <pdbID>  (181) 
4ekl

>  <Type>  (181) 
1

>  <RoF>  (181) 
0

>  <MW>  (181) 
457.2

>  <LogP>  (181) 
3.1

>  <TPSA>  (181) 
81.6

>  <HBA>  (181) 
6

>  <HBD>  (181) 
2

>  <NRB>  (181) 
6

>  <Indications>  (181) 
nan

>  <Targets>  (181) 
AKT1; AKT2; AKT3

>  <Kinase families>  (181) 
AGC

>  <Canonical_Smiles>  (181) 
C[C@@H]1C[C@H](c2c1c(ncn2)N3CCN(CC3)C(=O)[C@H](CNC(C)C)c4ccc(cc4)Cl)O

>  <InChiKey>  (181) 
GRZXWCHAXNAUHY-NSISKUIASA-N

>  <First_Approval>  (181) 
nan

>  <SC_Patent>  (181) 
None

>  <Chirality>  (181) 
Single Stereoisomer

>  <Synonyms>  (181) 
GDC-0068 | IPATASERTIB | RG-7440 | RG7440

>  <FDA_approved>  (181) 


>  <Melting points>  (181) 


$$$$
Infigratinib
     RDKit          2D

 38 41  0  0  0  0  0  0  0  0999 V2000
  -10.7959   -3.9268    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.3145   -4.1622    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.3700   -2.9969    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -8.9069   -1.5963    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.9623   -0.4310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4809   -0.6664    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9440   -2.0670    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.8886   -3.2323    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5364    0.4989    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0549    0.2635    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1104    1.4288    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6473    2.8294    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1287    3.0647    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0732    1.8995    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7027    3.9946    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2213    3.7593    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6844    2.3587    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7970    2.1233    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7415    3.2885    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.2046    4.6892    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2768    4.9245    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.3339    0.7227    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.3893   -0.4426    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8153    0.4873    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7598    1.6526    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.3522   -0.9133    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.8336   -1.1487    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3705   -2.5493    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8519   -2.7847    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7964   -1.6194    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2595   -0.2188    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7781    0.0166    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2412    1.4172    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    8.2041    0.9465    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.6855    0.7111    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3888   -4.1853    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.8702   -4.4207    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4259   -3.7146    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  6  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 12 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 18 22  1  0
 22 23  1  0
 22 24  1  0
 24 25  2  0
 24 26  1  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 32 33  1  0
 31 34  1  0
 34 35  1  0
 29 36  1  0
 36 37  1  0
 28 38  1  0
  8  3  1  0
 14  9  1  0
 21 16  1  0
 32 27  1  0
M  END
>  <BrandName>  (182) 
nan

>  <Phase>  (182) 
3.0

>  <Applicants>  (182) 
Novartis

>  <Links>  (182) 
|http://www.chemspider.com/Chemical-Structure.26333103.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL1852688|http://pubchem.ncbi.nlm.nih.gov/compound/53235510|http://www.drugbank.ca/drugs/DB11886| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=07J|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/07J|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7877|http://zinc15.docking.org/substances/ZINC000072105034|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=A4055ME1VK|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355393

>  <LigID>  (182) 
'07J'

>  <pdbID>  (182) 
3tt0

>  <Type>  (182) 
1

>  <RoF>  (182) 
2

>  <MW>  (182) 
559.2

>  <LogP>  (182) 
5.4

>  <TPSA>  (182) 
95.1

>  <HBA>  (182) 
8

>  <HBD>  (182) 
2

>  <NRB>  (182) 
8

>  <Indications>  (182) 
nan

>  <Targets>  (182) 
FGFR1; FGFR2; FGFR3

>  <Kinase families>  (182) 
Tyr

>  <Canonical_Smiles>  (182) 
CCN1CCN(CC1)c2ccc(cc2)Nc3cc(ncn3)N(C)C(=O)Nc4c(c(cc(c4Cl)OC)OC)Cl

>  <InChiKey>  (182) 
QADPYRIHXKWUSV-UHFFFAOYSA-N

>  <First_Approval>  (182) 
nan

>  <SC_Patent>  (182) 
None

>  <Chirality>  (182) 
Achiral Molecule

>  <Synonyms>  (182) 
BGJ-398 | BGJ398 | INFIGRATINIB | MVP-BGJ398 | NVP-BGJ398

>  <FDA_approved>  (182) 


>  <Melting points>  (182) 


$$$$
Pralsetinib
     RDKit          2D

 39 43  0  0  0  0  0  0  0  0999 V2000
  -10.4618    3.3494    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.9041    1.9569    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.7029    0.6873    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -9.7422   -0.4647    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -8.3497    0.0929    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.4498    1.5896    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.0801   -0.7058    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7535   -0.0057    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4839   -0.8044    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1573   -0.1042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1004    1.3947    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3700    2.1934    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6966    1.4933    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3131    3.6924    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8876   -0.9030    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9446   -2.4019    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6749   -3.2007    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6516   -2.5005    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7086   -1.0016    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5611   -0.2028    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1108   -3.9285    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.1037   -5.0401    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1377   -2.2963    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7038   -0.9072    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.0576   -3.4811    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.5436   -3.2769    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1097   -1.8878    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5958   -1.6836    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1619   -0.2945    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.2420    0.8903    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7560    0.6861    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1898   -0.7030    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8082    2.2794    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.0172    3.5539    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.9849    4.7000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3739    4.1338    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2647    2.6378    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6484    4.9248    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    5.4635   -4.4617    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  5  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 15 10  1  6
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 18 21  1  1
 21 22  1  0
 18 23  1  0
 23 24  2  0
 23 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 30 33  1  0
 33 34  1  0
 34 35  2  0
 35 36  1  0
 36 37  2  0
 36 38  1  0
 26 39  1  6
  6  2  2  0
 13  8  1  0
 20 15  1  0
 32 27  1  0
 37 33  1  0
M  END
>  <BrandName>  (183) 
nan

>  <Phase>  (183) 
3.0

>  <Applicants>  (183) 
Blueprint Medicines

>  <Links>  (183) 
|http://www.chemspider.com/Chemical-Structure.71060332.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL4297597|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=1WPE73O1WV

>  <LigID>  (183) 
nan

>  <pdbID>  (183) 
nan

>  <Type>  (183) 
nan

>  <RoF>  (183) 
1

>  <MW>  (183) 
533.3

>  <LogP>  (183) 
4.2

>  <TPSA>  (183) 
135.5

>  <HBA>  (183) 
9

>  <HBD>  (183) 
3

>  <NRB>  (183) 
8

>  <Indications>  (183) 
Pralsetinib, also known as BLU-667, is a highly potent, selective, next generation RET inhibitor. BLU-667 is a potent and selective inhibitor of RET mutations, fusions, and predicted resistant mutants. RET fusions are key drivers of multiple cancers, including lung and thyroid cancer, and our research suggests that RET also plays a key role in some colon and breast cancers. By simultaneously targeting the primary driver and predicted resistant mutants that render cancer cells insensitive to treatment with currently approved drugs

>  <Targets>  (183) 
nan

>  <Kinase families>  (183) 


>  <Canonical_Smiles>  (183) 
Cc1[nH]nc(c1)Nc2nc(nc(c2)C)[C@H]3CC[C@@](CC3)(OC)C(=O)N[C@H](c4cnc(cc4)n5ncc(c5)F)C

>  <InChiKey>  (183) 
GBLBJPZSROAGMF-BATDWUPUSA-N

>  <First_Approval>  (183) 
nan

>  <SC_Patent>  (183) 
None

>  <Chirality>  (183) 
Single Stereoisomer

>  <Synonyms>  (183) 
BLU-667 | PRALSETINIB

>  <FDA_approved>  (183) 


>  <Melting points>  (183) 


$$$$
Fruquintinib
     RDKit          2D

 29 32  0  0  0  0  0  0  0  0999 V2000
    6.9609    2.4612    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5887    1.8555    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2721    0.3893    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7798    0.2372    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8943   -0.9735    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4030   -0.8119    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7973    0.5603    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6828    1.7710    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1741    1.6095    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2920    2.6096    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6940    0.7219    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5795   -0.4889    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0708   -0.3273    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6765    1.0450    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1678    1.2065    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0534   -0.0042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4476   -1.3765    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9564   -1.5380    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3506   -2.9103    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8593   -3.0718    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9738   -1.8611    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -7.5446    0.1573    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -8.4302   -1.0534    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7736    2.5788    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8880    3.7895    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2722   -0.7287    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7405   -0.4215    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.8042   -2.1538    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.8043   -3.2717    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
  7 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 16 22  1  0
 22 23  1  0
 15 24  1  0
 24 25  1  0
  3 26  1  0
 26 27  2  0
 26 28  1  0
 28 29  1  0
 10  2  1  0
  9  4  1  0
 21 12  2  0
 18 13  1  0
M  END
>  <BrandName>  (184) 
nan

>  <Phase>  (184) 
3.0

>  <Applicants>  (184) 
Hutchison MediPharma

>  <Links>  (184) 
|http://www.chemspider.com/Chemical-Structure.39625837.html|http://pubchem.ncbi.nlm.nih.gov/compound/44480399|http://www.drugbank.ca/drugs/DB11679|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9428|http://zinc15.docking.org/substances/ZINC000114898570|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=49DXG3M5ZW

>  <LigID>  (184) 
nan

>  <pdbID>  (184) 
nan

>  <Type>  (184) 
nan

>  <RoF>  (184) 
0

>  <MW>  (184) 
393.1

>  <LogP>  (184) 
3.9

>  <TPSA>  (184) 
95.7

>  <HBA>  (184) 
7

>  <HBD>  (184) 
1

>  <NRB>  (184) 
5

>  <Indications>  (184) 
nan

>  <Targets>  (184) 
FLT1; KDR; FLT4

>  <Kinase families>  (184) 
Tyr

>  <Canonical_Smiles>  (184) 
Cc1c(c2ccc(cc2o1)Oc3c4cc(c(cc4ncn3)OC)OC)C(=O)NC

>  <InChiKey>  (184) 
BALLNEJQLSTPIO-UHFFFAOYSA-N

>  <First_Approval>  (184) 
nan

>  <SC_Patent>  (184) 
None

>  <Chirality>  (184) 
Single Stereoisomer

>  <Synonyms>  (184) 
HMPL-013|HMP-013

>  <FDA_approved>  (184) 


>  <Melting points>  (184) 


$$$$
Pyrotinib
     RDKit          2D

 42 46  0  0  0  0  0  0  0  0999 V2000
   -0.0741   -6.2644    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1543   -5.2237    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7930   -3.7678    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8732   -2.7271    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3146   -3.1422    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3948   -2.1014    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0336   -0.6455    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5922   -0.2304    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5120   -1.2712    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0706   -0.8561    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.0096   -1.8969    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6484   -3.3527    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4511   -1.4818    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5312   -2.5226    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9727   -2.1075    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4841   -0.6974    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9832   -0.7480    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3983   -2.1894    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1557   -3.0296    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.1051   -4.5288    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1138    0.3952    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5552   -0.0199    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.9164   -1.4757    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8363   -2.5165    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -7.6354    1.0209    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.7156    2.0617    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7525    1.8511    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3111    2.2662    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2309    1.2254    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7895    1.6405    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4283    3.0963    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5085    4.1371    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9499    3.7220    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1472    5.5930    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    1.0131    3.5114    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.0933    2.4707    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5348    2.8858    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6149    1.8450    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0564    2.2601    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4176    3.7159    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3374    4.7567    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8960    4.3416    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  2  0
 15 14  1  1
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
  7 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 22 25  1  0
 25 26  3  0
 21 27  1  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 32  1  0
 32 33  2  0
 32 34  1  0
 31 35  1  0
 35 36  1  0
 36 37  1  0
 37 38  2  0
 38 39  1  0
 39 40  2  0
 40 41  1  0
 41 42  2  0
  9  4  1  0
 24  6  1  0
 19 15  1  0
 33 28  1  0
 42 37  1  0
M  END
>  <BrandName>  (185) 
nan

>  <Phase>  (185) 
3.0

>  <Applicants>  (185) 
Hengrui Therapeutics

>  <Links>  (185) 
|http://www.chemspider.com/Chemical-Structure.52083721.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3647420|http://pubchem.ncbi.nlm.nih.gov/compound/51039030|http://www.drugbank.ca/drugs/DB14993|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9662|http://zinc15.docking.org/substances/ZINC000068250550|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=CJN36EQM0H|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=139991

>  <LigID>  (185) 
nan

>  <pdbID>  (185) 
nan

>  <Type>  (185) 
nan

>  <RoF>  (185) 
2

>  <MW>  (185) 
582.2

>  <LogP>  (185) 
6.5

>  <TPSA>  (185) 
112.4

>  <HBA>  (185) 
8

>  <HBD>  (185) 
2

>  <NRB>  (185) 
10

>  <Indications>  (185) 
nan

>  <Targets>  (185) 
EGFR; ERBB2

>  <Kinase families>  (185) 
Tyr

>  <Canonical_Smiles>  (185) 
CCOc1cc2c(cc1NC(=O)/C=C/[C@H]3CCCN3C)c(c(cn2)C#N)Nc4ccc(c(c4)Cl)OCc5ccccn5

>  <InChiKey>  (185) 
SADXACCFNXBCFY-IYNHSRRRSA-N

>  <First_Approval>  (185) 
nan

>  <SC_Patent>  (185) 
None

>  <Chirality>  (185) 
Single Stereoisomer

>  <Synonyms>  (185) 
nan

>  <FDA_approved>  (185) 


>  <Melting points>  (185) 


$$$$
Pacritinib
     RDKit          2D

 35 39  0  0  0  0  0  0  0  0999 V2000
   -8.4443   -0.4155    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.0406    1.0291    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5876    1.4018    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5384    0.3298    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9422   -1.1149    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.3951   -1.4875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8044   -2.5320    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8650   -4.0726    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8158   -5.1446    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3628   -4.7719    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9590   -3.3273    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4518   -3.1805    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5061   -2.9546    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.7318   -2.1075    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2385   -2.4347    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4764   -1.5876    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3617   -0.0920    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0091    0.5565    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6053   -0.8881    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8944    2.0521    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2751    3.4183    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.2259    4.4903    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1267    5.1388    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6195    5.2856    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0724    4.9129    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3103    4.0658    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1838    2.8464    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5996    0.7552    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.9521    0.1067    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1900    0.9538    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5426    0.3053    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.8623    1.0184    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9483   -0.0163    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2998   -1.3689    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8130   -1.1701    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 18 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 17 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
 33 34  1  0
 34 35  1  0
  6  1  1  0
 27  3  1  0
 12  7  1  0
 19 14  1  0
 35 31  1  0
M  END
>  <BrandName>  (186) 
nan

>  <Phase>  (186) 
3.0

>  <Applicants>  (186) 
Cell Therapeutics

>  <Links>  (186) 
|http://www.chemspider.com/Chemical-Structure.28518965.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL2035187|http://pubchem.ncbi.nlm.nih.gov/compound/46216796|http://www.drugbank.ca/drugs/DB11697| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=6T3|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/6T3|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7793|http://zinc15.docking.org/substances/ZINC000043153645|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=G22N65IL3O|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50400312

>  <LigID>  (186) 
'6T3'

>  <pdbID>  (186) 
5lbz

>  <Type>  (186) 
nan

>  <RoF>  (186) 
0

>  <MW>  (186) 
472.2

>  <LogP>  (186) 
5

>  <TPSA>  (186) 
68.7

>  <HBA>  (186) 
7

>  <HBD>  (186) 
1

>  <NRB>  (186) 
4

>  <Indications>  (186) 
nan

>  <Targets>  (186) 
JAK2

>  <Kinase families>  (186) 
Tyr

>  <Canonical_Smiles>  (186) 
c1cc2cc(c1)-c3ccnc(n3)Nc4ccc(c(c4)COC/C=C/COC2)OCCN5CCCC5

>  <InChiKey>  (186) 
HWXVIOGONBBTBY-ONEGZZNKSA-N

>  <First_Approval>  (186) 
nan

>  <SC_Patent>  (186) 
None

>  <Chirality>  (186) 
Achiral Molecule

>  <Synonyms>  (186) 
ONX-0803 | PACRITINIB | SB-1518 | SB1518

>  <FDA_approved>  (186) 


>  <Melting points>  (186) 


$$$$
Dovitinib
     RDKit          2D

 29 33  0  0  0  0  0  0  0  0999 V2000
   -9.2698    1.9461    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.9068    1.3197    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6829    2.1869    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3199    1.5605    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1809    0.0669    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4048   -0.8002    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.7678   -0.1738    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8180   -0.5594    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6789   -2.0530    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3160   -2.6794    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0920   -1.8122    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2311   -0.3186    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5940    0.3077    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1464    0.2751    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1368   -0.8515    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3714   -2.1415    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.6303   -0.7125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2567    0.6505    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7502    0.7895    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6174   -0.4344    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1110   -0.2954    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7373    1.0675    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8702    2.2915    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3766    2.1525    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5095    3.3764    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    4.9910   -1.7974    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.4975   -1.9364    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8711   -3.2994    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.3895    1.8744    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  5  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  2  0
 15 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 20 26  1  0
 26 27  1  0
 27 28  2  0
 18 29  1  0
  7  2  1  0
 13  8  1  0
 16 11  1  0
 27 17  1  0
 24 19  1  0
M  END
>  <BrandName>  (187) 
nan

>  <Phase>  (187) 
3.0

>  <Applicants>  (187) 
Novartis

>  <Links>  (187) 
|http://www.chemspider.com/Chemical-Structure.11530944.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL522892|http://pubchem.ncbi.nlm.nih.gov/compound/135398510|http://www.drugbank.ca/drugs/DB05928| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=38O|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/38O|http://zinc15.docking.org/substances/ZINC000003816310|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=I35H55G906|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25118

>  <LigID>  (187) 
'38O'

>  <pdbID>  (187) 
4tyi 5a46 5am6 5am7 5owq

>  <Type>  (187) 
1

>  <RoF>  (187) 
0

>  <MW>  (187) 
392.2

>  <LogP>  (187) 
2.5

>  <TPSA>  (187) 
94

>  <HBA>  (187) 
5

>  <HBD>  (187) 
3

>  <NRB>  (187) 
2

>  <Indications>  (187) 
nan

>  <Targets>  (187) 
FGFR3; VEGFA; FGFR1; PDGFRA; KIT; CSF1R

>  <Kinase families>  (187) 
Tyr<br>(*)

>  <Canonical_Smiles>  (187) 
CN1CCN(CC1)c2ccc3c(c2)[nH]c(n3)c4c(c5c(cccc5F)[nH]c4=O)N

>  <InChiKey>  (187) 
PIQCTGMSNWUMAF-UHFFFAOYSA-N

>  <First_Approval>  (187) 
nan

>  <SC_Patent>  (187) 
None

>  <Chirality>  (187) 
Achiral Molecule

>  <Synonyms>  (187) 
CHIR-258 | DOVITINIB | GFKI-258 | NVP-TKI258 | TKI-258

>  <FDA_approved>  (187) 


>  <Melting points>  (187) 


$$$$
Momelotinib
     RDKit          2D

 31 34  0  0  0  0  0  0  0  0999 V2000
   -4.0114   -2.2227    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5028   -2.0618    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1092   -0.6899    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2242    0.5213    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7329    0.3604    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1265   -1.0115    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6351   -1.1724    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0287   -2.5443    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4626   -2.7052    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3476   -1.4940    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.7412   -0.1221    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7502    0.0388    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.6261    1.0891    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.1175    0.9282    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7239   -0.4437    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2152   -0.6046    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1002    0.6066    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4938    1.9785    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0025    2.1394    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5916    0.4457    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.1979   -0.9262    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6893   -1.0871    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5743    0.1240    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.9679    1.4960    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4765    1.6568    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.6005   -0.5290    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.4855   -1.7402    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -8.2069    0.8429    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -9.6983    1.0038    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.3047    2.3757    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.9111    3.7477    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 17 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
  3 26  1  0
 26 27  2  0
 26 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  3  0
  6  1  1  0
 12  7  1  0
 19 14  1  0
 25 20  1  0
M  END
>  <BrandName>  (188) 
nan

>  <Phase>  (188) 
3.0

>  <Applicants>  (188) 
Ym Biosciences Australia

>  <Links>  (188) 
|http://www.chemspider.com/Chemical-Structure.24676202.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL1078178|http://pubchem.ncbi.nlm.nih.gov/compound/25062766|http://www.drugbank.ca/drugs/DB11763| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=C87|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/C87|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7791|http://zinc15.docking.org/substances/ZINC43199890|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=6O01GMS00P|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50311017

>  <LigID>  (188) 
'C87'

>  <pdbID>  (188) 
6fdz

>  <Type>  (188) 
nan

>  <RoF>  (188) 
0

>  <MW>  (188) 
414.2

>  <LogP>  (188) 
3

>  <TPSA>  (188) 
103.2

>  <HBA>  (188) 
7

>  <HBD>  (188) 
2

>  <NRB>  (188) 
6

>  <Indications>  (188) 
nan

>  <Targets>  (188) 
JAK1; JAK2; JAK3

>  <Kinase families>  (188) 
Tyr

>  <Canonical_Smiles>  (188) 
c1cc(ccc1c2ccnc(n2)Nc3ccc(cc3)N4CCOCC4)C(=O)NCC#N

>  <InChiKey>  (188) 
ZVHNDZWQTBEVRY-UHFFFAOYSA-N

>  <First_Approval>  (188) 
nan

>  <SC_Patent>  (188) 
None

>  <Chirality>  (188) 
Achiral Molecule

>  <Synonyms>  (188) 
CYT-0387 | CYT-11387 | CYT-387 | CYT387 | GS-0387 | MOMELOTINIB

>  <FDA_approved>  (188) 


>  <Melting points>  (188) 


$$$$
Asciminib
     RDKit          2D

 31 34  0  0  0  0  0  0  0  0999 V2000
   -3.7501   -1.0934    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1923   -1.5057    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2705   -0.4629    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9064    0.9923    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4642    1.4046    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3860    0.3617    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9438    0.7740    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8656   -0.2688    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2297   -1.7240    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.5766    0.1434    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6548   -0.8994    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0970   -0.4871    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4610    0.9680    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3829    2.0109    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.9407    1.5986    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9033    1.3803    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.4174    2.7895    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9165    2.7359    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3288    1.2937    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0845    0.4559    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7379    0.7795    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.1752   -1.5300    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6526   -1.2707    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3557   -2.5957    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3129   -3.6738    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.9652   -3.0152    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -7.7127   -0.8752    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -8.7909    0.1677    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.8690    1.2106    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -9.8337   -0.9105    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -7.7480    1.2459    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 13 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 19 21  1  1
 12 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
  3 27  1  0
 27 28  1  0
 28 29  1  0
 28 30  1  0
 28 31  1  0
  6  1  1  0
 15 10  1  0
 20 16  1  0
 26 22  1  0
M  END
>  <BrandName>  (189) 
nan

>  <Phase>  (189) 
3.0

>  <Applicants>  (189) 
Novartis

>  <Links>  (189) 
|http://www.chemspider.com/Chemical-Structure.52085218.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL4208229|http://pubchem.ncbi.nlm.nih.gov/compound/72165228|http://www.drugbank.ca/drugs/DB12597| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=AY7|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/AY7|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8962|http://zinc15.docking.org/substances/ZINC000150275965|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=L1F3R18W77

>  <LigID>  (189) 
'AY7'

>  <pdbID>  (189) 
5mo4

>  <Type>  (189) 
nan

>  <RoF>  (189) 
0

>  <MW>  (189) 
449.1

>  <LogP>  (189) 
3.5

>  <TPSA>  (189) 
103.4

>  <HBA>  (189) 
6

>  <HBD>  (189) 
3

>  <NRB>  (189) 
6

>  <Indications>  (189) 
nan

>  <Targets>  (189) 
nan

>  <Kinase families>  (189) 


>  <Canonical_Smiles>  (189) 
c1cc(ccc1NC(=O)c2cc(c(nc2)N3CC[C@H](C3)O)c4ccn[nH]4)OC(F)(F)Cl

>  <InChiKey>  (189) 
VOVZXURTCKPRDQ-CQSZACIVSA-N

>  <First_Approval>  (189) 
nan

>  <SC_Patent>  (189) 
None

>  <Chirality>  (189) 
Single Stereoisomer

>  <Synonyms>  (189) 
ABL-001 | ABL001 | ABL001-NX | ASCIMINIB | NVP-ABL001

>  <FDA_approved>  (189) 


>  <Melting points>  (189) 


$$$$
Avapritinib
     RDKit          2D

 37 42  0  0  0  0  0  0  0  0999 V2000
    5.4243    3.6324    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1066    2.2966    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7889    0.9608    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9732   -0.2981    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6555   -1.6339    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1536   -1.7109    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9693   -0.4521    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2869    0.8837    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8359   -3.0467    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    4.7708    1.6143    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5120    2.4300    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1761    1.7476    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.0991    0.2496    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3579   -0.5661    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.6938    0.1162    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7633   -0.4327    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4955    0.3830    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8314   -0.2993    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9084   -1.7973    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6495   -2.6130    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6863   -1.9307    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2442   -2.4797    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5030   -1.6639    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7391   -0.1827    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2209    0.0505    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.9006   -1.2867    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8388   -2.3463    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9159   -3.8443    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6570   -4.6600    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3212   -3.9777    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.9032    1.3863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.3850    1.6195    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.6211    3.1008    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -7.2853    3.7831    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2236    2.7235    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.0521    5.2649    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4424    2.9789    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  6
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  6  9  1  0
  2 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 13 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 19 22  1  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 25 31  1  0
 31 32  1  0
 32 33  2  0
 33 34  1  0
 34 35  1  0
 34 36  1  0
  2 37  1  0
  8  3  1  0
 15 10  1  0
 21 16  1  0
 30 22  2  0
 27 23  1  0
 35 31  2  0
M  END
>  <BrandName>  (190) 
nan

>  <Phase>  (190) 
3.0

>  <Applicants>  (190) 
Blueprint Medicines

>  <Links>  (190) 
|http://www.chemspider.com/Chemical-Structure.58828673.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL4204794|http://pubchem.ncbi.nlm.nih.gov/compound/118023034|http://www.drugbank.ca/drugs/DB15233|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10368|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=513P80B4YJ

>  <LigID>  (190) 
nan

>  <pdbID>  (190) 
nan

>  <Type>  (190) 
nan

>  <RoF>  (190) 
0

>  <MW>  (190) 
498.2

>  <LogP>  (190) 
2.6

>  <TPSA>  (190) 
106.3

>  <HBA>  (190) 
10

>  <HBD>  (190) 
1

>  <NRB>  (190) 
5

>  <Indications>  (190) 
nan

>  <Targets>  (190) 
nan

>  <Kinase families>  (190) 


>  <Canonical_Smiles>  (190) 
C[C@](c1ccc(cc1)F)(c2cnc(nc2)N3CCN(CC3)c4c5cc(cn5ncn4)c6cnn(c6)C)N

>  <InChiKey>  (190) 
DWYRIWUZIJHQKQ-SANMLTNESA-N

>  <First_Approval>  (190) 
nan

>  <SC_Patent>  (190) 
None

>  <Chirality>  (190) 
Single Stereoisomer

>  <Synonyms>  (190) 
70C366 | AVAPRITINIB | BLU-285 | C-366 | X-720776 | X720776

>  <FDA_approved>  (190) 


>  <Melting points>  (190) 


$$$$
Tesevatinib
     RDKit          2D

 33 37  0  0  0  0  0  0  0  0999 V2000
   11.2883    0.1438    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7974   -0.0217    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.7873    1.0872    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4205    0.4691    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9515    0.7725    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2090   -0.5309    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2192   -1.6398    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5860   -1.0217    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0550   -1.3251    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7182   -0.6963    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8295    0.5120    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.3386    0.3466    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7365   -1.0272    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7543   -1.1927    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6430    0.0157    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0409    1.3895    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4499    1.5550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0521    2.9288    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5429    3.0943    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1339   -0.1498    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7360   -1.5236    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8473   -2.7320    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3565   -2.5665    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0226    1.0586    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5135    0.8932    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4022    2.1016    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.8930    1.9361    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.4951    0.5623    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.6064   -0.6461    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1156   -0.4807    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2269   -1.6890    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -8.2086   -2.0199    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -9.9860    0.3968    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  4  3  1  6
  4  5  1  0
  5  6  1  0
  6  7  1  0
  8  7  1  6
  8  9  1  0
  6 10  1  6
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 15 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 20 24  1  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 29 32  1  0
 28 33  1  0
  9  2  1  0
  8  4  1  0
 17 12  1  0
 23 14  1  0
 30 25  1  0
M  END
>  <BrandName>  (191) 
nan

>  <Phase>  (191) 
3.0

>  <Applicants>  (191) 
Kadmon Corporation

>  <Links>  (191) 
|http://www.chemspider.com/Chemical-Structure.32699556.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3544983|http://www.drugbank.ca/drugs/DB11973|http://zinc15.docking.org/substances/ZINC000114456300|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=F6XM2TN5A1

>  <LigID>  (191) 
nan

>  <pdbID>  (191) 
nan

>  <Type>  (191) 
nan

>  <RoF>  (191) 
1

>  <MW>  (191) 
490.1

>  <LogP>  (191) 
5.8

>  <TPSA>  (191) 
59.5

>  <HBA>  (191) 
6

>  <HBD>  (191) 
1

>  <NRB>  (191) 
6

>  <Indications>  (191) 
nan

>  <Targets>  (191) 
EGFR; ERBB2; KDR; FLT4; EPHB4

>  <Kinase families>  (191) 
Tyr

>  <Canonical_Smiles>  (191) 
CN1C[C@H]2C[C@H](C[C@H]2C1)COc3cc4c(cc3OC)c(ncn4)Nc5ccc(c(c5F)Cl)Cl

>  <InChiKey>  (191) 
HVXKQKFEHMGHSL-QKDCVEJESA-N

>  <First_Approval>  (191) 
nan

>  <SC_Patent>  (191) 
None

>  <Chirality>  (191) 
Racemic Mixture

>  <Synonyms>  (191) 
EXEL-7647 | KD-019 | KD-020 | KD019 | TESEVATINIB | XL-647 | XL647

>  <FDA_approved>  (191) 


>  <Melting points>  (191) 


$$$$
Canertinib
     RDKit          2D

 34 37  0  0  0  0  0  0  0  0999 V2000
    0.8839    6.2025    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1652    5.1304    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2388    3.6858    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6918    3.3134    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8102    2.6137    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4063    1.1691    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0468    0.7966    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4507   -0.6479    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4017   -1.7201    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0514   -1.3476    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4553    0.0969    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9084    0.4694    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9574   -0.6028    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4104   -0.2303    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4595   -1.3025    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.9125   -0.9300    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -8.3165    0.5146    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.7695    0.8870    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.8186   -0.1851    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  -10.4146   -1.6297    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.9616   -2.0022    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8056   -3.1647    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.2587   -3.5371    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3077   -2.4650    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.9038   -1.0204    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9528    0.0518    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.4058   -0.3207    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8098   -1.7653    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2628   -2.1377    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3119   -1.0656    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9079    0.3790    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4549    0.7515    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9570    1.4511    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    9.7649   -1.4380    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
  9 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 31 33  1  0
 30 34  1  0
 11  6  1  0
 25  8  1  0
 21 16  1  0
 32 27  1  0
M  END
>  <BrandName>  (192) 
nan

>  <Phase>  (192) 
3.0

>  <Applicants>  (192) 
Pfizer

>  <Links>  (192) 
|http://www.chemspider.com/Chemical-Structure.137741.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL31965|http://pubchem.ncbi.nlm.nih.gov/compound/156414|http://www.drugbank.ca/drugs/DB05424|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5675|http://zinc15.docking.org/substances/ZINC27439698|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=C78W1K5ASF|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4779

>  <LigID>  (192) 
nan

>  <pdbID>  (192) 
nan

>  <Type>  (192) 
nan

>  <RoF>  (192) 
0

>  <MW>  (192) 
485.2

>  <LogP>  (192) 
4.4

>  <TPSA>  (192) 
88.6

>  <HBA>  (192) 
7

>  <HBD>  (192) 
2

>  <NRB>  (192) 
9

>  <Indications>  (192) 
Investigated for use/treatment in breast cancer and lung cancer.

>  <Targets>  (192) 
EGFR

>  <Kinase families>  (192) 
Tyr

>  <Canonical_Smiles>  (192) 
C=CC(=O)Nc1cc2c(cc1OCCCN3CCOCC3)ncnc2Nc4ccc(c(c4)Cl)F

>  <InChiKey>  (192) 
OMZCMEYTWSXEPZ-UHFFFAOYSA-N

>  <First_Approval>  (192) 
nan

>  <SC_Patent>  (192) 
None

>  <Chirality>  (192) 
Achiral Molecule

>  <Synonyms>  (192) 
CANERTINIB | CI-1033

>  <FDA_approved>  (192) 


>  <Melting points>  (192) 


$$$$
Tofacitinib
     RDKit          2D

 23 25  0  0  0  0  0  0  0  0999 V2000
    1.2305   -4.2699    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2250   -3.1568    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2417   -3.4711    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2473   -2.3581    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7861   -0.9307    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3194   -0.6164    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6861   -1.7295    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1528   -1.4151    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.1584   -2.5282    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6139    0.0122    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6084    1.1252    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1084    1.1227    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3575    2.5485    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8545    3.4323    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.0695    2.5526    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5362    2.8669    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.5418    1.7539    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0806    0.3265    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7917    0.1823    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3306    1.6097    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2584   -0.1320    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2640    0.9810    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2695    2.0941    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  6
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  6
  8  9  1  0
  8 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
  5 19  1  0
 19 20  2  0
 19 21  1  0
 21 22  1  0
 22 23  3  0
  7  2  1  0
 18 10  1  0
 15 11  1  0
M  END
>  <BrandName>  (193) 
Xeljanz

>  <Phase>  (193) 
4.0

>  <Applicants>  (193) 
Pfizer

>  <Links>  (193) 
|http://www.chemspider.com/Chemical-Structure.8102425.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL221959|http://pubchem.ncbi.nlm.nih.gov/compound/9926791|http://www.drugbank.ca/drugs/DB08895| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=MI1|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/MI1|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5677|http://zinc15.docking.org/substances/ZINC03818808|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=87LA6FU830|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50193995

>  <LigID>  (193) 
'MI1'

>  <pdbID>  (193) 
3eyg 3fup 3lxk 3lxn 4oti

>  <Type>  (193) 
1

>  <RoF>  (193) 
0

>  <MW>  (193) 
312.2

>  <LogP>  (193) 
1.5

>  <TPSA>  (193) 
88.9

>  <HBA>  (193) 
5

>  <HBD>  (193) 
1

>  <NRB>  (193) 
3

>  <Indications>  (193) 
For the treatment of moderate to severe rheumatoid arthritis which is resistant or intolerant to methotrexate therapy. It may also be used as an adjunct to methotrexate therapy, or other non-biologic disease-modifying antirheumatic drugs (DMARDS), when methotrexate alone is not sufficient. Tofacitinib has also been investigated as a preventative therapy for kidney transplant rejections, and as a treatment for psoriasis, ulcerative colitis, and ankylosing spondylitis. It is not to be initiated in patients with a history of chronic or recurrent infections, or in the presence of active infection, even if localized, due to reports of serious and sometimes fatal infections (commonly pneumonia, herpes zoster and urinary tract infections). Use of tofacitinib is also discouraged in those who have been, or are likely to be, exposed to TB. An increased likelihood of exposure may be encountered by traveling to certain areas. In addition, tofacitinib is not to be used in patients with severe hepatic impairment, or low hemoglobin (less than 9g/dL). Cautioned is advised when using tofacitinib in patients at risk of gastrointestinal perforation, and in the elderly who are more susceptible to infection.

>  <Targets>  (193) 
JAK1; JAK2; JAK3; TYK2

>  <Kinase families>  (193) 
Tyr

>  <Canonical_Smiles>  (193) 
C[C@@H]1CCN(C[C@@H]1N(C)c2c3cc[nH]c3ncn2)C(=O)CC#N

>  <InChiKey>  (193) 
UJLAWZDWDVHWOW-YPMHNXCESA-N

>  <First_Approval>  (193) 
2012

>  <SC_Patent>  (193) 
US-6956041-B2

>  <Chirality>  (193) 
Single Stereoisomer

>  <Synonyms>  (193) 
550 | CP 690550 | CP- 690 550 | CP-690 | CP-690,550 | CP-690,550 FREE BASE | CP-690-550 | CP-690550 | CP-690550 FREE BASE | CP690,550 | CP690550 | TASOCITINIB | TOFACITINIB

>  <FDA_approved>  (193) 
Y

>  <Melting points>  (193) 


$$$$
Osimertinib
     RDKit          2D

 37 40  0  0  0  0  0  0  0  0999 V2000
    8.3580   -2.5010    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3024   -1.4353    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.8198   -1.6629    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1451   -0.3232    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2108    0.7324    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5441    0.0451    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8060    0.8560    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7346    2.3543    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4013    3.0417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1394    2.2307    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6647   -0.0815    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1339    1.3214    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6534    1.5631    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7039    0.4018    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.2348   -1.0011    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7152   -1.2427    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.2853   -2.1623    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1951   -1.9206    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7260   -0.5177    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2064   -0.2760    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1559   -1.4372    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6250   -2.8401    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1446   -3.0818    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6137   -4.4847    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5632   -5.6459    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6363   -1.1955    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5858   -2.3568    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1672    0.2074    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.6476    0.4491    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.1785    1.8520    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -9.6589    2.0937    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.2290    3.0132    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7373    1.1269    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7878    2.2881    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3074    2.0464    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3186    3.6910    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3691    4.8523    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
  4 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 15 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  1  0
 21 26  1  0
 26 27  1  0
 26 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 30 32  1  0
 20 33  1  0
 33 34  1  0
 34 35  2  0
 34 36  1  0
 36 37  2  0
  6  2  1  0
 10  5  1  0
 16 11  1  0
 23 18  1  0
M  END
>  <BrandName>  (194) 
Tagrisso

>  <Phase>  (194) 
4.0

>  <Applicants>  (194) 
Astrazeneca

>  <Links>  (194) 
|http://www.chemspider.com/Chemical-Structure.31042598.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3353410|http://pubchem.ncbi.nlm.nih.gov/compound/71496458|http://www.drugbank.ca/drugs/DB09330| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=YY3|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/YY3|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7719|http://zinc15.docking.org/substances/ZINC000098023177|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=3C06JJ0Z2O|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50029668

>  <LigID>  (194) 
'YY3'

>  <pdbID>  (194) 
4zau 6jwl 6jx0 6jx4 6jxt

>  <Type>  (194) 
1

>  <RoF>  (194) 
0

>  <MW>  (194) 
499.3

>  <LogP>  (194) 
4.5

>  <TPSA>  (194) 
87.6

>  <HBA>  (194) 
8

>  <HBD>  (194) 
2

>  <NRB>  (194) 
10

>  <Indications>  (194) 
Osimertinib is indicated for the treatment of patients with metastatic epidermal growth factor receptor (EGFR) T790M mutation-positive non-small cell lung cancer (NSCLC), as detected by an FDA- approved test, who have progressed on or after EGFR-TKI therapy.

>  <Targets>  (194) 
EGFR

>  <Kinase families>  (194) 
Tyr

>  <Canonical_Smiles>  (194) 
Cn1cc(c2c1cccc2)c3ccnc(n3)Nc4cc(c(cc4OC)N(C)CCN(C)C)NC(=O)C=C

>  <InChiKey>  (194) 
DUYJMQONPNNFPI-UHFFFAOYSA-N

>  <First_Approval>  (194) 
2015

>  <SC_Patent>  (194) 
US-8946235-B2

>  <Chirality>  (194) 
Achiral Molecule

>  <Synonyms>  (194) 
AZD-9291 | AZD-9291 FREE BASE | AZD9291 | OSIMERTINIB | TAGRISSO

>  <FDA_approved>  (194) 
Y

>  <Melting points>  (194) 


$$$$
Palbociclib
     RDKit          2D

 33 37  0  0  0  0  0  0  0  0999 V2000
   -3.0248   -3.7842    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3339   -2.3164    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2173   -1.3148    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7916   -1.7810    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3250   -0.7794    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0160    0.6884    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4097    1.1546    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5264    0.1530    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9521    0.6192    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0687   -0.3823    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4944    0.0839    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7596   -1.8502    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8762   -2.8517    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5671   -4.3196    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -7.3019   -2.3855    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2612    2.0870    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6303    2.6997    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4707    4.1912    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0029    4.5003    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2554    3.1999    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1326    1.6900    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.5583    1.2237    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8674   -0.2441    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2931   -0.7103    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4097    0.2913    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1006    1.7591    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6749    2.2253    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.8354   -0.1750    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.1445   -1.6428    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5702   -2.1090    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6868   -1.1074    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.3777    0.3604    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9520    0.8266    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  1  0
 13 14  2  0
 13 15  1  0
  9 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
  6 21  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 25 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
 12  2  2  0
  8  3  1  0
 20 16  1  0
 27 22  1  0
 33 28  1  0
M  END
>  <BrandName>  (195) 
Ibrance

>  <Phase>  (195) 
4.0

>  <Applicants>  (195) 
Pfizer

>  <Links>  (195) 
|http://www.chemspider.com/Chemical-Structure.4487437.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL189963|http://pubchem.ncbi.nlm.nih.gov/compound/5330286|http://www.drugbank.ca/drugs/DB09073| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=LQQ|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/LQQ|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7380|http://zinc15.docking.org/substances/ZINC000003938686|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=G9ZF61LE7G|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6309

>  <LigID>  (195) 
'LQQ'

>  <pdbID>  (195) 
2euf 5l2i

>  <Type>  (195) 
1

>  <RoF>  (195) 
0

>  <MW>  (195) 
447.2

>  <LogP>  (195) 
3

>  <TPSA>  (195) 
105

>  <HBA>  (195) 
9

>  <HBD>  (195) 
2

>  <NRB>  (195) 
5

>  <Indications>  (195) 
Palbociclib is indicated in combination with letrozole for the treatment of postmenopausal women with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer as initial endocrine-based therapy for their metastatic disease. This indication is approved under accelerated approval based on progression-free survival (PFS). Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial.

>  <Targets>  (195) 
CDK4; CDK6

>  <Kinase families>  (195) 
CMGC

>  <Canonical_Smiles>  (195) 
Cc1c2cnc(nc2n(c(=O)c1C(=O)C)C3CCCC3)Nc4ccc(cn4)N5CCNCC5

>  <InChiKey>  (195) 
AHJRHEGDXFFMBM-UHFFFAOYSA-N

>  <First_Approval>  (195) 
2015

>  <SC_Patent>  (195) 
US-6936612-B2

>  <Chirality>  (195) 
Achiral Molecule

>  <Synonyms>  (195) 
IBRANCE | PALBOCICLIB | PD-0332991

>  <FDA_approved>  (195) 
Y

>  <Melting points>  (195) 
263-266 C

$$$$
Pazopanib
     RDKit          2D

 31 34  0  0  0  0  0  0  0  0999 V2000
   -5.8587    3.1697    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1790    1.8325    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6812    1.7526    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0015    0.4154    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8197   -0.8418    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3175   -0.7619    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9972    0.5753    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.4951    0.6553    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -7.5750   -0.8426    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -7.4151    2.1531    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -8.9929    0.7352    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1400   -2.1790    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6421   -2.2590    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9624   -3.5961    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.5354   -3.6761    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3536   -2.4189    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6739   -1.0817    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8239   -1.0018    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.4921    0.1755    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.8124    1.5127    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9900    0.0955    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6697   -1.2417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1675   -1.3216    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9857   -0.0644    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4675    0.1688    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7036    1.6501    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.3677    2.3324    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.3060    1.2728    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8082    1.3527    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0408    2.3298    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5271   -0.8929    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  8 10  2  0
  8 11  1  0
  5 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  1  0
 19 21  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 26 30  1  0
 25 31  1  0
  7  2  1  0
 18 13  1  0
 29 21  2  0
 28 24  1  0
M  END
>  <BrandName>  (196) 
Votrient

>  <Phase>  (196) 
4.0

>  <Applicants>  (196) 
GlaxoSmithKline

>  <Links>  (196) 
|http://www.chemspider.com/Chemical-Structure.8289501.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL477772|http://pubchem.ncbi.nlm.nih.gov/compound/10113978|http://www.drugbank.ca/drugs/DB06589|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5698|http://zinc15.docking.org/substances/ZINC000011617039|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=7RN5DR86CK|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26474

>  <LigID>  (196) 
nan

>  <pdbID>  (196) 
nan

>  <Type>  (196) 
1

>  <RoF>  (196) 
0

>  <MW>  (196) 
437.2

>  <LogP>  (196) 
3.1

>  <TPSA>  (196) 
119

>  <HBA>  (196) 
8

>  <HBD>  (196) 
2

>  <NRB>  (196) 
5

>  <Indications>  (196) 
Treatment of advanced renal cell cancer and advanced soft tissue sarcoma (in patients previously treated with chemotherapy)

>  <Targets>  (196) 
FLT1; KDR; FLT4; PDGFRA; PDGFRB; KIT; FGFR3; ITK; FGFR1

>  <Kinase families>  (196) 
Tyr

>  <Canonical_Smiles>  (196) 
Cc1ccc(cc1S(=O)(=O)N)Nc2nccc(n2)N(C)c3ccc4c(n(nc4c3)C)C

>  <InChiKey>  (196) 
CUIHSIWYWATEQL-UHFFFAOYSA-N

>  <First_Approval>  (196) 
2009

>  <SC_Patent>  (196) 
US-7105530-B2

>  <Chirality>  (196) 
Achiral Molecule

>  <Synonyms>  (196) 
GW786034 | PAZOPANIB | VOTRIENT

>  <FDA_approved>  (196) 
Y

>  <Melting points>  (196) 


$$$$
Pexidartinib
     RDKit          2D

 29 32  0  0  0  0  0  0  0  0999 V2000
    1.5474   -2.4840    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0478   -2.4510    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6735   -1.1358    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1049    0.1465    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.6045    0.1135    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3258   -1.2017    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8254   -1.2347    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6038    0.0475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0240    1.4309    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1605    2.4099    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.4427    1.6315    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0987    0.1715    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1910   -0.8564    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6275   -0.4244    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9715    1.0356    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8791    2.0636    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.7199   -1.4523    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -2.1731   -1.1028    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8944    0.2124    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3940    0.2454    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1153    1.5606    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6149    1.5936    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.3933    0.3113    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6720   -1.0039    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1724   -1.0369    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.8929    0.3443    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.3926    0.3773    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -8.8600    1.8439    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -8.9259   -1.1554    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 14 17  1  0
  3 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 23 26  1  0
 26 27  1  0
 26 28  1  0
 26 29  1  0
  6  1  1  0
 12  8  1  0
 16 11  1  0
 25 20  1  0
M  END
>  <BrandName>  (197) 
Turalio

>  <Phase>  (197) 
4.0

>  <Applicants>  (197) 
Daiichi Sankyo

>  <Links>  (197) 
|http://www.chemspider.com/Chemical-Structure.35308322.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3813873|http://pubchem.ncbi.nlm.nih.gov/compound/25151352|http://www.drugbank.ca/drugs/DB12978| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=P31|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/P31|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8710|http://zinc15.docking.org/substances/ZINC000115705166|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=6783M2LV5X|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50177716

>  <LigID>  (197) 
'P31'

>  <pdbID>  (197) 
4r7h

>  <Type>  (197) 
2

>  <RoF>  (197) 
1

>  <MW>  (197) 
417.1

>  <LogP>  (197) 
5.2

>  <TPSA>  (197) 
66.5

>  <HBA>  (197) 
4

>  <HBD>  (197) 
2

>  <NRB>  (197) 
5

>  <Indications>  (197) 
On august 2019, FDA approved pexidartinib to treat adult patients with symptomatic tenosynovial giant cell tumor

>  <Targets>  (197) 
FLT3; KIT; CSF1R

>  <Kinase families>  (197) 
Tyr

>  <Canonical_Smiles>  (197) 
c1cc(ncc1Cc2c[nH]c3c2cc(cn3)Cl)NCc4ccc(nc4)C(F)(F)F

>  <InChiKey>  (197) 
JGWRKYUXBBNENE-UHFFFAOYSA-N

>  <First_Approval>  (197) 
2019

>  <SC_Patent>  (197) 
None

>  <Chirality>  (197) 
Achiral Molecule

>  <Synonyms>  (197) 
CML-261 | PEXIDARTINIB | PLX-3397 | PLX3397

>  <FDA_approved>  (197) 
Y

>  <Melting points>  (197) 


$$$$
Ponatinib
     RDKit          2D

 39 43  0  0  0  0  0  0  0  0999 V2000
    5.6633   -3.4199    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1859   -3.1607    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2227   -4.3106    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7453   -4.0514    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2310   -2.6423    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1942   -1.4924    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6717   -1.7516    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6349   -0.6017    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5981    0.5482    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5613    1.6981    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1971    3.1532    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4685    3.9492    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.6184    2.9860    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0577    1.5947    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.9822    0.4135    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.4674    0.6235    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0281    2.0148    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1036    3.1960    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2464   -2.3831    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2096   -3.5330    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7606   -0.9740    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2381   -0.7148    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7523    0.6943    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2297    0.9535    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1929   -0.1964    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6787   -1.6055    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2013   -1.8647    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6419   -2.7553    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6051   -3.9052    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4920   -3.7185    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -6.7918   -1.7921    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6704    0.0629    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.1846    1.4720    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2214    2.6218    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.7356    4.0309    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.2131    4.2902    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -9.1763    3.1403    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.6620    1.7312    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.7273    5.6993    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  3  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
  5 19  1  0
 19 20  2  0
 19 21  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 26 28  1  0
 28 29  1  0
 28 30  1  0
 28 31  1  0
 25 32  1  0
 32 33  1  0
 33 34  1  0
 34 35  1  0
 35 36  1  0
 36 37  1  0
 37 38  1  0
 36 39  1  0
  7  2  1  0
 14 10  1  0
 18 13  1  0
 27 22  1  0
 38 33  1  0
M  END
>  <BrandName>  (198) 
Iclusig

>  <Phase>  (198) 
4.0

>  <Applicants>  (198) 
Ariad Pharmaceuticals

>  <Links>  (198) 
|http://www.chemspider.com/Chemical-Structure.24747381.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL1171837|http://pubchem.ncbi.nlm.nih.gov/compound/24826799|http://www.drugbank.ca/drugs/DB08901| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=0LI|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/0LI|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5890|http://zinc15.docking.org/substances/ZINC36701290|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=4340891KFS|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50322535

>  <LigID>  (198) 
'0LI'

>  <pdbID>  (198) 
3ik3 3oxz 3zos 4c8b 4qrc 4tyj 4u0i 4uxq 4v01 4v04 6eg9 6tu9

>  <Type>  (198) 
2

>  <RoF>  (198) 
1

>  <MW>  (198) 
532.2

>  <LogP>  (198) 
4.5

>  <TPSA>  (198) 
65.8

>  <HBA>  (198) 
6

>  <HBD>  (198) 
1

>  <NRB>  (198) 
4

>  <Indications>  (198) 
Ponatinib is indicated for the treatment of adult patients with chronic phase, accelerated phase, or blast phase chronic myeloid leukemia (CML) that is resistant or intolerant to prior tyrosine kinase inhibitor therapy or Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ALL) that is resistant or intolerant to prior tyrosine kinase inhibitor therapy.

>  <Targets>  (198) 
ABL1; BCR; KIT; RET; TEK; FLT3; FGFR1; FGFR2; FGFR3; FGFR4; LCK; SRC; LYN; KDR; PDGFRA

>  <Kinase families>  (198) 
Tyr<br>Atypical

>  <Canonical_Smiles>  (198) 
Cc1ccc(cc1C#Cc2cnc3n2nccc3)C(=O)Nc4ccc(c(c4)C(F)(F)F)CN5CCN(CC5)C

>  <InChiKey>  (198) 
PHXJVRSECIGDHY-UHFFFAOYSA-N

>  <First_Approval>  (198) 
2012

>  <SC_Patent>  (198) 
US-8114874-B2

>  <Chirality>  (198) 
Achiral Molecule

>  <Synonyms>  (198) 
AP24534 | ICLUSIG | PONATINIB

>  <FDA_approved>  (198) 
Y

>  <Melting points>  (198) 


$$$$
Sorafenib
     RDKit          2D

 32 34  0  0  0  0  0  0  0  0999 V2000
  -11.0580   -0.4218    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.5714   -0.2220    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -8.6550   -1.4095    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.2252   -2.7969    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -7.1684   -1.2096    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5982    0.1778    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1115    0.3777    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1951   -0.8098    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7653   -2.1972    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2520   -2.3971    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5413    1.7651    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0547    1.9650    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1383    0.7775    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6517    0.9773    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0815    2.3647    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9979    3.5523    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4845    3.3524    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4052    2.5646    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.3216    1.3771    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7514   -0.0103    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.8082    1.5770    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.7246    0.3895    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1544   -0.9979    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0708   -2.1854    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5574   -1.9855    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1276   -0.5981    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2112    0.5894    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6143   -0.3983    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1009   -0.1984    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    8.4144    1.0884    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    8.8142   -1.8849    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    7.4739   -3.1730    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
  7 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 15 18  1  0
 18 19  1  0
 19 20  2  0
 19 21  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 26 28  1  0
 28 29  1  0
 28 30  1  0
 28 31  1  0
 25 32  1  0
 10  5  1  0
 17 12  1  0
 27 22  1  0
M  END
>  <BrandName>  (199) 
Nexavar

>  <Phase>  (199) 
4.0

>  <Applicants>  (199) 
Bayer

>  <Links>  (199) 
|http://www.chemspider.com/Chemical-Structure.187440.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL1336|http://pubchem.ncbi.nlm.nih.gov/compound/216239|http://www.drugbank.ca/drugs/DB07438| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=BAX|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/BAX|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5711|http://zinc15.docking.org/substances/ZINC01493878|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=9ZOQ3TZI87|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16673

>  <LigID>  (199) 
'BAX'

>  <pdbID>  (199) 
1uwh 1uwj 3gcs 3heg 3rgf 3wze 4asd 5hi2

>  <Type>  (199) 
2

>  <RoF>  (199) 
1

>  <MW>  (199) 
464.1

>  <LogP>  (199) 
5.5

>  <TPSA>  (199) 
92.3

>  <HBA>  (199) 
4

>  <HBD>  (199) 
3

>  <NRB>  (199) 
5

>  <Indications>  (199) 
Sorafenib is indicated for the treatment of unresectable hepatocellular carcinoma and advanced renal cell carcinoma.

>  <Targets>  (199) 
BRAF; RAF1; FLT4; KDR; FLT3; PDGFRB; KIT; FGFR1; RET; FLT1

>  <Kinase families>  (199) 
Tyr<br>TKL

>  <Canonical_Smiles>  (199) 
CNC(=O)c1cc(ccn1)Oc2ccc(cc2)NC(=O)Nc3ccc(c(c3)C(F)(F)F)Cl

>  <InChiKey>  (199) 
MLDQJTXFUGDVEO-UHFFFAOYSA-N

>  <First_Approval>  (199) 
2005

>  <SC_Patent>  (199) 
US-7235576-B1

>  <Chirality>  (199) 
Achiral Molecule

>  <Synonyms>  (199) 
BAY 43-9006 | NEXAVAR | SORAFENIB

>  <FDA_approved>  (199) 
Y

>  <Melting points>  (199) 
205.6 C

$$$$
Ruxolitinib
     RDKit          2D

 23 26  0  0  0  0  0  0  0  0999 V2000
    3.7938   -1.8866    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2306   -2.3176    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0845   -1.0844    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.1756    0.1088    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7599   -0.3869    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6227    0.5912    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9012    2.0651    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.3169    2.5609    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4541    1.5827    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.2070    0.0955    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7759   -1.3412    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7237   -1.3752    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2195    0.0405    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0262    0.9494    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6562    0.4716    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0012    1.9313    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4380    2.3624    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8747    2.7935    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7479   -0.5571    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5573   -2.0450    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9135   -2.6860    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9422   -1.5943    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2218   -0.2786    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  6 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 13 15  1  0
 15 16  1  1
 16 17  1  0
 17 18  3  0
 15 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
  5  1  1  0
  9  4  1  0
 14 10  2  0
 23 19  1  0
M  END
>  <BrandName>  (200) 
Jakafi;Jakavi

>  <Phase>  (200) 
4.0

>  <Applicants>  (200) 
Incyte Corporation

>  <Links>  (200) 
|http://www.chemspider.com/Chemical-Structure.25027389.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL1789941|http://pubchem.ncbi.nlm.nih.gov/compound/25126798|http://www.drugbank.ca/drugs/DB08877| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=RXT|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/RXT|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5688|http://zinc15.docking.org/substances/ZINC43207851|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=82S8X8XX8H|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355501

>  <LigID>  (200) 
'RXT'

>  <pdbID>  (200) 
4u5j

>  <Type>  (200) 
1

>  <RoF>  (200) 
0

>  <MW>  (200) 
306.2

>  <LogP>  (200) 
3.5

>  <TPSA>  (200) 
83.2

>  <HBA>  (200) 
5

>  <HBD>  (200) 
1

>  <NRB>  (200) 
4

>  <Indications>  (200) 
Treatment of intermediate or high-risk myelofibrosis, including primary myelofibrosis, post-polycythemia vera (post-PV) myelofibrosis and post-essential thrombocythemia (post-ET) myelofibrosis. [Lexicomp] Myeolofibrosis is the proliferation of abnormal bone marrow stem cells which cause fibrosis (the excessive formation of connective tissue).

>  <Targets>  (200) 
JAK1; JAK2

>  <Kinase families>  (200) 
Tyr

>  <Canonical_Smiles>  (200) 
c1c[nH]c2c1c(ncn2)c3cnn(c3)[C@H](CC#N)C4CCCC4

>  <InChiKey>  (200) 
HFNKQEVNSGCOJV-OAHLLOKOSA-N

>  <First_Approval>  (200) 
2011

>  <SC_Patent>  (200) 
US-7598257-B2

>  <Chirality>  (200) 
Single Stereoisomer

>  <Synonyms>  (200) 
INC-424 | INC424 | INCB-018424 | INCB-18424 | INCB018424 | JAKAVI | RUXOLITINIB

>  <FDA_approved>  (200) 
Y

>  <Melting points>  (200) 


$$$$
Sunitinib
     RDKit          2D

 29 31  0  0  0  0  0  0  0  0999 V2000
  -10.2315    0.8288    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.8053    1.2934    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.6898    0.2905    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -8.0006   -1.1769    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.4268   -1.6415    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2635    0.7551    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1481   -0.2477    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7218    0.2168    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6064   -0.7860    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9171   -2.2535    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1801   -0.3214    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0341   -1.2022    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2469   -0.3196    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7823    1.1066    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7177    1.1055    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6003    2.3184    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6738   -0.7821    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7878    0.2225    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2553   -0.0883    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0062   -1.3868    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5062   -1.3856    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2553   -0.0860    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5043    1.2124    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0043    1.2113    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9998    2.3253    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.6299    1.7141    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3303    2.4632    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.2572   -2.6841    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0352   -2.7022    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  3  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 13 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  1  0
 26 27  2  0
 21 28  1  0
 12 29  1  0
 15 11  2  0
 18 26  1  0
 24 19  1  0
M  END
>  <BrandName>  (201) 
Sutent

>  <Phase>  (201) 
4.0

>  <Applicants>  (201) 
Cp Pharmaceuticals

>  <Links>  (201) 
|http://www.chemspider.com/Chemical-Structure.4486264.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL535|http://pubchem.ncbi.nlm.nih.gov/compound/5329102|http://www.drugbank.ca/drugs/DB07417| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=B49|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/B49|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5713|http://zinc15.docking.org/substances/ZINC000003964325|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=V99T50803M|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4814

>  <LigID>  (201) 
'B49'

>  <pdbID>  (201) 
2y7j 3g0e 3g0f 3miy 3ti1 4agd 4ks8 4qmz 6jok 6nfy 6nfz 6ng0 6v0x

>  <Type>  (201) 
1

>  <RoF>  (201) 
0

>  <MW>  (201) 
398.2

>  <LogP>  (201) 
3.3

>  <TPSA>  (201) 
77.2

>  <HBA>  (201) 
3

>  <HBD>  (201) 
3

>  <NRB>  (201) 
7

>  <Indications>  (201) 
For the treatment of advanced renal cell carcinoma as well as the treatment of gastrointestinal stromal tumor after disease progression on or intolerance to imatinib mesylate.

>  <Targets>  (201) 
PDGFRB; FLT1; KIT; KDR; FLT4; FLT3; CSF1R; PDGFRA

>  <Kinase families>  (201) 
Tyr

>  <Canonical_Smiles>  (201) 
CCN(CC)CCNC(=O)c1c(c([nH]c1C)/C=C\2/c3cc(ccc3NC2=O)F)C

>  <InChiKey>  (201) 
WINHZLLDWRZWRT-ATVHPVEESA-N

>  <First_Approval>  (201) 
2006

>  <SC_Patent>  (201) 
US-6573293-B2

>  <Chirality>  (201) 
Achiral Molecule

>  <Synonyms>  (201) 
SU-011248 | SU-11248 | SU011248 | SUNITINIB | SUTENT

>  <FDA_approved>  (201) 
Y

>  <Melting points>  (201) 


$$$$
Tivozanib
     RDKit          2D

 32 35  0  0  0  0  0  0  0  0999 V2000
  -11.2699    1.0431    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.7776    0.8912    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.0234   -0.4054    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.5572   -0.0887    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.4053    1.4035    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -8.7776    2.0092    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4392   -1.0888    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0142   -0.6206    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7071    0.8476    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8962   -1.6207    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4711   -1.1525    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3531   -2.1526    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0719   -1.6844    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3790   -0.2162    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7390    0.7839    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1640    0.3157    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2820    1.3158    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    1.8041    0.2520    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9221   -0.7480    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6150   -2.2163    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7330   -3.2163    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1580   -2.7482    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.4651   -1.2799    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3471   -0.2799    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6542    1.1884    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0793    1.6565    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1973    0.6565    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8902   -0.8118    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6223    1.1246    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.7403    0.1246    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3864    3.1248    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.8114    3.5929    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  4  7  1  0
  7  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 14 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 27 29  1  0
 29 30  1  0
 26 31  1  0
 31 32  1  0
  6  2  1  0
 16 11  1  0
 24 19  1  0
 28 23  1  0
M  END
>  <BrandName>  (202) 
Fotivda

>  <Phase>  (202) 
4.0

>  <Applicants>  (202) 
Aveo Pharmaceuticals

>  <Links>  (202) 
|http://www.chemspider.com/Chemical-Structure.8087481.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL1289494|http://pubchem.ncbi.nlm.nih.gov/compound/9911830|http://www.drugbank.ca/drugs/DB11800| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=AV9|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/AV9|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6058|http://zinc15.docking.org/substances/ZINC01489430|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=172030934T|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50331095

>  <LigID>  (202) 
'AV9'

>  <pdbID>  (202) 
4ase

>  <Type>  (202) 
2

>  <RoF>  (202) 
1

>  <MW>  (202) 
454.1

>  <LogP>  (202) 
5.6

>  <TPSA>  (202) 
107.7

>  <HBA>  (202) 
7

>  <HBD>  (202) 
2

>  <NRB>  (202) 
6

>  <Indications>  (202) 
Tivozanib is an oral VEGF receptor tyrosine kinase inhibitor.

>  <Targets>  (202) 
FLT1; KDR; FLT4

>  <Kinase families>  (202) 
Tyr

>  <Canonical_Smiles>  (202) 
Cc1cc(no1)NC(=O)Nc2ccc(cc2Cl)Oc3ccnc4c3cc(c(c4)OC)OC

>  <InChiKey>  (202) 
SPMVMDHWKHCIDT-UHFFFAOYSA-N

>  <First_Approval>  (202) 
nan

>  <SC_Patent>  (202) 
None

>  <Chirality>  (202) 
Achiral Molecule

>  <Synonyms>  (202) 
ASP-4130 | AV-951 | FOTIVDA | KIL-8951 | KIL8951 | KRN-951 | TIVOZANIB

>  <FDA_approved>  (202) 
N

>  <Melting points>  (202) 


$$$$
Nintedanib
     RDKit          2D

 40 44  0  0  0  0  0  0  0  0999 V2000
   -9.4367   -4.6012    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.7902   -3.2477    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -9.6391   -2.0110    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.9925   -0.6575    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.4971   -0.5407    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6482   -1.7774    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.2947   -3.1309    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.8505    0.8128    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3551    0.9296    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5062   -0.3071    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7086    2.2831    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5574    3.5198    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2131    2.3999    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3642    1.1633    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8688    1.2801    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2222    2.6336    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0711    3.8703    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5666    3.7534    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2732    2.7504    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.1221    1.5137    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6176    1.6306    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5911    0.4894    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3944   -0.9977    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5839   -1.9115    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9701   -1.3383    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1667    0.1488    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9772    1.0626    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8604    2.5581    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.4020    2.9091    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8288    4.2952    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.1596   -2.2521    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5457   -1.6789    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.9629   -3.7392    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.1524   -4.6530    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4756    0.1602    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0199    0.0434    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6664   -1.3101    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1825   -2.5468    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6779   -2.4300    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3245   -1.0764    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  5  8  1  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  1  0
 11 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 16 19  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  1  0
 29 30  2  0
 25 31  1  0
 31 32  2  0
 31 33  1  0
 33 34  1  0
 20 35  1  0
 35 36  2  0
 36 37  1  0
 37 38  2  0
 38 39  1  0
 39 40  2  0
  7  2  1  0
 18 13  1  0
 21 29  1  0
 27 22  1  0
 40 35  1  0
M  END
>  <BrandName>  (203) 
Ofev;Vargatef

>  <Phase>  (203) 
4.0

>  <Applicants>  (203) 
Boehringer Ingelheim

>  <Links>  (203) 
|http://www.chemspider.com/Chemical-Structure.7985471.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL502835|http://pubchem.ncbi.nlm.nih.gov/compound/9809715|http://www.drugbank.ca/drugs/DB09079| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=XIN|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/XIN|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5936|http://zinc15.docking.org/substances/ZINC000100014909|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=G6HRD2P839|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50026612

>  <LigID>  (203) 
'XIN'

>  <pdbID>  (203) 
3c7q 5maf 5te0 6nec

>  <Type>  (203) 
1

>  <RoF>  (203) 
1

>  <MW>  (203) 
539.3

>  <LogP>  (203) 
3.6

>  <TPSA>  (203) 
94.2

>  <HBA>  (203) 
7

>  <HBD>  (203) 
2

>  <NRB>  (203) 
7

>  <Indications>  (203) 
Nintedanib is indicated for the treatment of idiopathic pulmonary fibrosis (IPF).

>  <Targets>  (203) 
FLT1; KDR; FLT4; FGFR1; FGFR2; FGFR3; FLT3; LCK; LYN; SRC

>  <Kinase families>  (203) 
Tyr

>  <Canonical_Smiles>  (203) 
CN1CCN(CC1)CC(=O)N(C)c2ccc(cc2)N/C(=C\3/c4ccc(cc4NC3=O)C(=O)OC)/c5ccccc5

>  <InChiKey>  (203) 
XZXHXSATPCNXJR-ZIADKAODSA-N

>  <First_Approval>  (203) 
2014

>  <SC_Patent>  (203) 
US-6762180-B1

>  <Chirality>  (203) 
Achiral Molecule

>  <Synonyms>  (203) 
BIBF 1120 | BIBF-1120 | BIBF1120 | INTEDANIB | NINTEDANIB | OFEV | VARGATEF

>  <FDA_approved>  (203) 
Y

>  <Melting points>  (203) 


$$$$
Trametinib
     RDKit          2D

 37 41  0  0  0  0  0  0  0  0999 V2000
   -2.2821   -1.6501    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8739   -1.1334    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6172    0.3445    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7910    0.8612    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9425   -0.1000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6859   -1.5779    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.2777   -2.0946    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0211   -3.5724    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.8375   -2.5391    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3507    0.4167    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.5023   -0.5445    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2457   -2.0224    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3972   -2.9835    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8054   -2.4669    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0621   -0.9890    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9105   -0.0278    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1671    1.4501    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    7.9570   -3.4280    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0
    1.0476    2.3391    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4558    2.8558    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1040    3.3003    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5122    2.7836    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6637    3.7448    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7688    1.3057    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1770    0.7890    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3286    1.7502    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7368    1.2335    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9934   -0.2444    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8418   -1.2056    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4336   -0.6889    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0985   -2.6835    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5067   -3.2001    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.6582   -2.2390    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.7633   -4.6780    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1527    4.7782    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3640    6.1864    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1138    5.9297    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  6  9  1  0
  5 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 14 18  1  0
  4 19  1  0
 19 20  2  0
 19 21  1  0
 21 22  1  0
 22 23  2  0
 22 24  1  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 29 31  1  0
 31 32  1  0
 32 33  2  0
 32 34  1  0
 21 35  1  0
 35 36  1  0
 36 37  1  0
  7  2  1  0
 24  3  1  0
 16 11  1  0
 30 25  1  0
 37 35  1  0
M  END
>  <BrandName>  (204) 
Mekinist

>  <Phase>  (204) 
4.0

>  <Applicants>  (204) 
GlaxoSmithKline

>  <Links>  (204) 
|http://www.chemspider.com/Chemical-Structure.9881833.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL2103875|http://pubchem.ncbi.nlm.nih.gov/compound/11707110|http://www.drugbank.ca/drugs/DB08911|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6495|http://zinc15.docking.org/substances/ZINC43100709|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=33E86K87QN

>  <LigID>  (204) 
nan

>  <pdbID>  (204) 
nan

>  <Type>  (204) 
3

>  <RoF>  (204) 
1

>  <MW>  (204) 
615.1

>  <LogP>  (204) 
3.9

>  <TPSA>  (204) 
107.1

>  <HBA>  (204) 
8

>  <HBD>  (204) 
2

>  <NRB>  (204) 
5

>  <Indications>  (204) 
Trametinib is indicated for the treatment of unresectable or metastatic melanoma with BRAF V600E or V600K mutations, as detected by an FDA-approved test.

>  <Targets>  (204) 
BRAF; MAP2K1; MAP2K2

>  <Kinase families>  (204) 
STE<br>TKL

>  <Canonical_Smiles>  (204) 
Cc1c2c(c(n(c1=O)C)Nc3ccc(cc3F)I)c(=O)n(c(=O)n2c4cccc(c4)NC(=O)C)C5CC5

>  <InChiKey>  (204) 
LIRYPHYGHXZJBZ-UHFFFAOYSA-N

>  <First_Approval>  (204) 
2013

>  <SC_Patent>  (204) 
None

>  <Chirality>  (204) 
Achiral Molecule

>  <Synonyms>  (204) 
GSK-1120212 | GSK1120212 | JTP 74057 | JTP-74057 | MEKINIST | TRAMETINIB

>  <FDA_approved>  (204) 
Y

>  <Melting points>  (204) 
293-303

$$$$
Regorafenib
     RDKit          2D

 33 35  0  0  0  0  0  0  0  0999 V2000
  -11.0440   -0.5921    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.5577   -0.3895    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -8.6391   -1.5753    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.2067   -2.9637    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -7.1529   -1.3726    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5852    0.0158    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0990    0.2185    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1804   -0.9673    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7480   -2.3558    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2342   -2.5584    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5314    1.6070    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0451    1.8096    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1265    0.6238    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6403    0.8265    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0726    2.2149    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9913    3.4007    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4775    3.1981    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4236    4.7892    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    1.4136    2.4176    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.3322    1.2318    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7646   -0.1567    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.8185    1.4344    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.7371    0.2486    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1695   -1.1398    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0881   -2.3256    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5744   -2.1230    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1420   -0.7345    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2234    0.4513    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6282   -0.5319    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1145   -0.3292    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    8.4256    0.9544    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    8.8309   -2.0181    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    7.4930   -3.3088    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
  7 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 16 18  1  0
 15 19  1  0
 19 20  1  0
 20 21  2  0
 20 22  1  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 27 29  1  0
 29 30  1  0
 29 31  1  0
 29 32  1  0
 26 33  1  0
 10  5  1  0
 17 12  1  0
 28 23  1  0
M  END
>  <BrandName>  (205) 
Stivarga

>  <Phase>  (205) 
4.0

>  <Applicants>  (205) 
Bayer

>  <Links>  (205) 
|http://www.chemspider.com/Chemical-Structure.9342697.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL1946170|http://pubchem.ncbi.nlm.nih.gov/compound/11167602|http://www.drugbank.ca/drugs/DB08896|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5891|http://zinc15.docking.org/substances/ZINC06745272|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=24T2A1DOYB|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50363397

>  <LigID>  (205) 
nan

>  <pdbID>  (205) 
nan

>  <Type>  (205) 
2

>  <RoF>  (205) 
1

>  <MW>  (205) 
482.1

>  <LogP>  (205) 
5.7

>  <TPSA>  (205) 
92.3

>  <HBA>  (205) 
4

>  <HBD>  (205) 
3

>  <NRB>  (205) 
5

>  <Indications>  (205) 
Regorafenib is indicated for the treatment of patients with metastatic colorectal cancer (CRC) who have been previously treated with fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy, an anti-VEGF therapy, and, if KRAS wild type, an anti-EGFR therapy. Regorafenib is also indicated for the treatment of patients with locally advanced, unresectable or metastatic gastrointestinal stromal tumor (GIST) who have been previously treated with imatinib mesylate and sunitinib malate.

>  <Targets>  (205) 
FLT1; KDR; FLT4; KIT; PDGFRA; PDGFRB; FGFR1; FGFR2; TEK; DDR2; NTRK1; EPHA2; RAF1; BRAF; MAPK11; FRK; ABL1; RET

>  <Kinase families>  (205) 
Tyr<br>CMGC<br>TKL

>  <Canonical_Smiles>  (205) 
CNC(=O)c1cc(ccn1)Oc2ccc(c(c2)F)NC(=O)Nc3ccc(c(c3)C(F)(F)F)Cl

>  <InChiKey>  (205) 
FNHKPVJBJVTLMP-UHFFFAOYSA-N

>  <First_Approval>  (205) 
2012

>  <SC_Patent>  (205) 
US-7351834-B1

>  <Chirality>  (205) 
Achiral Molecule

>  <Synonyms>  (205) 
BAY 73-4506 | BAY 73-4506 MONOHYDRATE | BAY-734506 | REGORAFENIB | STIVARGA

>  <FDA_approved>  (205) 
Y

>  <Melting points>  (205) 


$$$$
Zanubrutinib
     RDKit          2D

 35 39  0  0  0  0  0  0  0  0999 V2000
   -7.3301    5.3998    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4261    4.2029    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.0106    2.8215    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.4993    2.6370    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1066    1.6245    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6180    1.8090    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7139    0.6120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2985   -0.7694    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7871   -0.9539    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6912    0.2431    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3945   -1.9664    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9790   -3.3478    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0750   -4.5447    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5864   -4.3603    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0018   -2.9789    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9059   -1.7819    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0468   -0.5522    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.3881   -0.9892    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4159   -2.4890    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6456   -3.3480    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5165   -4.8424    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.0044   -2.7126    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.5851   -0.0852    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9665   -0.6698    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1634    0.2343    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9790    1.7229    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5976    2.3075    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4006    1.4034    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1759    2.6269    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.5573    2.0424    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7418    0.5538    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1232   -0.0308    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3201    0.8732    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1357    2.3618    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7543    2.9464    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  8 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  1  0
 20 21  2  0
 20 22  1  0
 18 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 26 29  1  0
 29 30  1  0
 30 31  2  0
 31 32  1  0
 32 33  2  0
 33 34  1  0
 34 35  2  0
 10  5  1  0
 16 11  1  0
 19 15  2  0
 28 23  1  0
 35 30  1  0
M  END
>  <BrandName>  (206) 
nan

>  <Phase>  (206) 
4.0

>  <Applicants>  (206) 
BeiGene

>  <Links>  (206) 
|http://www.chemspider.com/Chemical-Structure.60600294.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3973435|http://pubchem.ncbi.nlm.nih.gov/compound/135905454|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=249900

>  <LigID>  (206) 
nan

>  <pdbID>  (206) 
nan

>  <Type>  (206) 
nan

>  <RoF>  (206) 
0

>  <MW>  (206) 
471.2

>  <LogP>  (206) 
4.2

>  <TPSA>  (206) 
102.5

>  <HBA>  (206) 
6

>  <HBD>  (206) 
2

>  <NRB>  (206) 
6

>  <Indications>  (206) 
Zanubrutinib (BGB-3111) is a potent, selective and and irreversible BTK inhibitor that is being investigated for clinical utility in the treatment of hematological cancers, such as non-Hodgkin's lymphoma and chronic lymphocytic leukemia (CLL) [<a href='javascript:callRef("ReferenceDisplayForward?referenceId=34570,34571&displayId=1,2", 960, 600)' title="1. Robak P, Robak T. (2017) Expert Opin Investig Drugs. 26 (11): 1249-1265; 2. Thompson PA, Burger JA. (2018) Expert Opin Investig Drugs. 27 (1): 31-42">1-2</a>].

>  <Targets>  (206) 
nan

>  <Kinase families>  (206) 


>  <Canonical_Smiles>  (206) 
C=CC(=O)N1CCC(CC1)C2CCNc3n2nc(c3C(=O)N)c4ccc(cc4)Oc5ccccc5

>  <InChiKey>  (206) 
RNOAOAWBMHREKO-UHFFFAOYSA-N

>  <First_Approval>  (206) 
2019

>  <SC_Patent>  (206) 
None

>  <Chirality>  (206) 
Single Stereoisomer

>  <Synonyms>  (206) 
nan

>  <FDA_approved>  (206) 
Y

>  <Melting points>  (206) 


$$$$
Lenvatinib
     RDKit          2D

 30 33  0  0  0  0  0  0  0  0999 V2000
    8.5254   -0.5212    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5041    0.5774    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.0420    0.2421    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6013   -1.1916    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1392   -1.5269    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1179   -0.4283    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5586    1.0055    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0207    1.3407    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4614    2.7745    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4400    3.8731    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.9234    3.1097    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.6558   -0.7635    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2151   -2.1973    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2364   -3.2959    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6985   -2.9607    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.6345    0.3351    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8276   -0.0001    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8489    1.0984    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3110    0.7632    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7517   -0.6706    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7304   -1.7692    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2683   -1.4339    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1711   -3.2029    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -5.2138   -1.0058    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2351    0.0928    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7944    1.5266    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -7.6972   -0.2424    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -8.7185    0.8561    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.1523    1.2969    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.0537    2.3182    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
  6 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 12 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 21 23  1  0
 20 24  1  0
 24 25  1  0
 25 26  2  0
 25 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
  8  3  1  0
 15  5  1  0
 22 17  1  0
 30 28  1  0
M  END
>  <BrandName>  (207) 
Kisplyx;Lenvima

>  <Phase>  (207) 
4.0

>  <Applicants>  (207) 
Eisai

>  <Links>  (207) 
|http://www.chemspider.com/Chemical-Structure.7999567.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL1289601|http://pubchem.ncbi.nlm.nih.gov/compound/9823820|http://www.drugbank.ca/drugs/DB09078| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=LEV|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/LEV|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7426|http://zinc15.docking.org/substances/ZINC03816292|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=EE083865G2|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50331094

>  <LigID>  (207) 
'LEV'

>  <pdbID>  (207) 
3wzd 5zv2

>  <Type>  (207) 
1.5

>  <RoF>  (207) 
0

>  <MW>  (207) 
426.1

>  <LogP>  (207) 
4.1

>  <TPSA>  (207) 
115.6

>  <HBA>  (207) 
5

>  <HBD>  (207) 
3

>  <NRB>  (207) 
6

>  <Indications>  (207) 
Lenvatinib is indicated for the treatment of patients with locally recurrent or metastatic, progressive, radioactive iodine-refractory differentiated thyroid cancer.

>  <Targets>  (207) 
FLT1; KDR; FLT4; FGFR1; FGFR2; FGFR3; FGFR4; KIT

>  <Kinase families>  (207) 
Tyr

>  <Canonical_Smiles>  (207) 
COc1cc2c(cc1C(=O)N)c(ccn2)Oc3ccc(c(c3)Cl)NC(=O)NC4CC4

>  <InChiKey>  (207) 
WOSKHXYHFSIKNG-UHFFFAOYSA-N

>  <First_Approval>  (207) 
2015

>  <SC_Patent>  (207) 
US-7253286-B2

>  <Chirality>  (207) 
Achiral Molecule

>  <Synonyms>  (207) 
E-7080 | ER-203492-00 | KISPLYX | LENVATINIB | LENVIMA

>  <FDA_approved>  (207) 
Y

>  <Melting points>  (207) 


$$$$
Netarsudil
     RDKit          2D

 34 37  0  0  0  0  0  0  0  0999 V2000
   -8.1992    4.8387    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.5923    3.4670    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1008    3.3068    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4939    1.9351    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.3783    0.7235    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.8697    0.8837    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.4767    2.2555    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.7542   -0.3278    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7713   -0.6482    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6558   -1.8597    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2799   -0.8084    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6730   -2.1801    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1815   -2.3403    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5746   -3.7120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0831   -3.8722    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8013   -2.6607    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1943   -1.2890    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2971   -1.1288    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2927   -2.8209    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8997   -4.1926    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0153   -5.4041    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.1772   -1.6094    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5702   -0.2376    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.6686   -1.7696    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.5530   -0.5580    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0445   -0.7182    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9289    0.4933    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3219    1.8650    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2064    3.0765    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5994    4.4482    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.1080    4.6084    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2235    3.3969    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8305    2.0252    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9461    0.8137    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  5  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 16 19  1  0
 19 20  1  6
 20 21  1  0
 19 22  1  0
 22 23  2  0
 22 24  1  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 32 33  1  0
 33 34  2  0
  7  2  1  0
 18 13  1  0
 34 25  1  0
 33 28  1  0
M  END
>  <BrandName>  (208) 
Rhopressa

>  <Phase>  (208) 
4.0

>  <Applicants>  (208) 
Aerie Pharmaceutical

>  <Links>  (208) 
|http://www.chemspider.com/Chemical-Structure.34980598.html|http://pubchem.ncbi.nlm.nih.gov/compound/66599893|http://www.drugbank.ca/drugs/DB13931|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9322|http://zinc15.docking.org/substances/ZINC000113149554|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=W6I5QDT7QI

>  <LigID>  (208) 
nan

>  <pdbID>  (208) 
nan

>  <Type>  (208) 
nan

>  <RoF>  (208) 
0

>  <MW>  (208) 
453.2

>  <LogP>  (208) 
4.9

>  <TPSA>  (208) 
94.3

>  <HBA>  (208) 
5

>  <HBD>  (208) 
2

>  <NRB>  (208) 
7

>  <Indications>  (208) 
On december 18, 2017, the FDA approved netarsudil to treat glaucoma or ocular hypertension

>  <Targets>  (208) 
nan

>  <Kinase families>  (208) 


>  <Canonical_Smiles>  (208) 
Cc1ccc(c(c1)C)C(=O)OCc2ccc(cc2)[C@@H](CN)C(=O)Nc3ccc4cnccc4c3

>  <InChiKey>  (208) 
OURRXQUGYQRVML-AREMUKBSSA-N

>  <First_Approval>  (208) 
2017

>  <SC_Patent>  (208) 
US-8394826-B2

>  <Chirality>  (208) 
Racemic Mixture

>  <Synonyms>  (208) 
AR-13324|AR-11324 FREE BASE

>  <FDA_approved>  (208) 
Y

>  <Melting points>  (208) 


$$$$
Neratinib
     RDKit          2D

 40 43  0  0  0  0  0  0  0  0999 V2000
    0.1440   -6.2854    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9188   -5.2269    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5335   -3.7772    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5963   -2.7187    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0444   -3.1098    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1072   -2.0513    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7219   -0.6016    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2738   -0.2105    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2110   -1.2690    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2371   -0.8779    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.2999   -1.9364    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9146   -3.3861    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.7480   -1.5453    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8108   -2.6038    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2589   -2.2126    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3217   -3.2712    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.7698   -2.8800    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9364   -4.7208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7847    0.4569    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2328    0.0658    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6181   -1.3839    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5553   -2.4424    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -7.2956    1.1243    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.3584    2.1828    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3994    1.9066    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9513    2.2977    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8885    1.2392    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4404    1.6303    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0550    3.0800    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1178    4.1385    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5659    3.7474    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7325    5.5882    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    1.3931    3.4711    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4559    2.4126    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9040    2.8037    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9667    1.7452    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4149    2.1364    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8002    3.5860    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7374    4.6446    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2893    4.2534    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 16 18  1  0
  7 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 20 23  1  0
 23 24  3  0
 19 25  1  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 30 32  1  0
 29 33  1  0
 33 34  1  0
 34 35  1  0
 35 36  2  0
 36 37  1  0
 37 38  2  0
 38 39  1  0
 39 40  2  0
  9  4  1  0
 22  6  1  0
 31 26  1  0
 40 35  1  0
M  END
>  <BrandName>  (209) 
Nerlynx

>  <Phase>  (209) 
4.0

>  <Applicants>  (209) 
Puma Biotechnology

>  <Links>  (209) 
|http://www.chemspider.com/Chemical-Structure.8091392.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL180022|http://pubchem.ncbi.nlm.nih.gov/compound/9915743|http://www.drugbank.ca/drugs/DB11828|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5686|http://zinc15.docking.org/substances/ZINC000003916214|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=JJH94R3PWB|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50161957

>  <LigID>  (209) 
nan

>  <pdbID>  (209) 
nan

>  <Type>  (209) 
nan

>  <RoF>  (209) 
2

>  <MW>  (209) 
556.2

>  <LogP>  (209) 
5.9

>  <TPSA>  (209) 
112.4

>  <HBA>  (209) 
8

>  <HBD>  (209) 
2

>  <NRB>  (209) 
11

>  <Indications>  (209) 
For use as an extended adjuvant treatment in adult patients with early stage HER2-overexpressed/amplified breast cancer, to follow adjuvant trastuzumab-based therapy

>  <Targets>  (209) 
ERBB2; EGFR

>  <Kinase families>  (209) 
Tyr

>  <Canonical_Smiles>  (209) 
CCOc1cc2c(cc1NC(=O)/C=C/CN(C)C)c(c(cn2)C#N)Nc3ccc(c(c3)Cl)OCc4ccccn4

>  <InChiKey>  (209) 
JWNPDZNEKVCWMY-VQHVLOKHSA-N

>  <First_Approval>  (209) 
2017

>  <SC_Patent>  (209) 
US-6288082-B1

>  <Chirality>  (209) 
Achiral Molecule

>  <Synonyms>  (209) 
CDP-820 | HKI-272 | NERATINIB | WAY-179272

>  <FDA_approved>  (209) 
Y

>  <Melting points>  (209) 


$$$$
Midostaurin
     RDKit          2D

 43 51  0  0  0  0  0  0  0  0999 V2000
    1.0953   -2.7367    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2511   -1.4969    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7547   -1.5053    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6004   -0.2665    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9504    1.0854    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4547    1.1983    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0019   -0.1983    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9784    1.6413    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3982    3.0814    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6089    4.3569    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3190    5.6783    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8183    5.7240    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6075    4.4485    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8975    3.1271    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4043    1.7154    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2183    0.7971    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3313   -0.6987    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2323   -1.7196    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8636   -3.0802    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2749   -4.4599    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1753   -5.6595    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6645   -5.4796    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2532   -4.0999    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3528   -2.9003    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6418   -1.4284    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8692   -0.4304    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7562    1.0653    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1438    1.6350    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4986    3.0924    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -7.1144    0.4913    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.3266   -0.7852    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0962   -0.3794    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.7462   -1.7313    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9419    0.8594    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2919    2.2112    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.4376    0.7464    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0877   -0.6054    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5834   -0.7184    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4291    0.5205    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7791    1.8723    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2833    1.9853    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4048   -2.8572    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.5590   -4.0960    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  6
  2  3  1  0
  3  4  1  0
  4  5  1  0
  6  5  1  1
  6  7  1  0
  6  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 28 30  1  0
 30 31  1  0
  4 32  1  1
 32 33  1  0
 32 34  1  0
 34 35  2  0
 34 36  1  0
 36 37  2  0
 37 38  1  0
 38 39  2  0
 39 40  1  0
 40 41  2  0
  3 42  1  1
 42 43  1  0
  7  2  1  0
 18  2  1  0
 16  8  1  0
 14  9  1  0
 27 15  1  0
 25 17  2  0
 24 19  1  0
 31 26  1  0
 41 36  1  0
M  END
>  <BrandName>  (210) 
Rydapt

>  <Phase>  (210) 
4.0

>  <Applicants>  (210) 
Novartis Pharmaceuticals Corp

>  <Links>  (210) 
|http://www.chemspider.com/Chemical-Structure.8005258.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL608533|http://pubchem.ncbi.nlm.nih.gov/compound/9829523|http://www.drugbank.ca/drugs/DB06595| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=2K2|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/2K2|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5702|http://zinc15.docking.org/substances/ZINC000100013130|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=ID912S5VON|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50326053

>  <LigID>  (210) 
'2K2'

>  <pdbID>  (210) 
4nct

>  <Type>  (210) 
nan

>  <RoF>  (210) 
2

>  <MW>  (210) 
570.2

>  <LogP>  (210) 
5.9

>  <TPSA>  (210) 
77.7

>  <HBA>  (210) 
6

>  <HBD>  (210) 
1

>  <NRB>  (210) 
3

>  <Indications>  (210) 
On april 28 , 2017, the FDA approved midostaurin to  treat acute myeloid leukemia

>  <Targets>  (210) 
nan

>  <Kinase families>  (210) 


>  <Canonical_Smiles>  (210) 
C[C@@]12[C@@H]([C@@H](C[C@@H](O1)n3c4ccccc4c5c3c6n2c7ccccc7c6c8c5C(=O)NC8)N(C)C(=O)c9ccccc9)OC

>  <InChiKey>  (210) 
BMGQWWVMWDBQGC-IIFHNQTCSA-N

>  <First_Approval>  (210) 
2017

>  <SC_Patent>  (210) 
US-7973031-B2

>  <Chirality>  (210) 
Single Stereoisomer

>  <Synonyms>  (210) 
CGP 41251 | MIDOSTAURIN | NVP-PKC412 | PKC 412 | PKC-412 | RYDAPT

>  <FDA_approved>  (210) 
Y

>  <Melting points>  (210) 
235-260

$$$$
Lorlatinib
     RDKit          2D

 30 33  0  0  0  0  0  0  0  0999 V2000
    3.4946   -2.8833    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3844   -1.8746    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0713   -0.5411    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4048   -1.2281    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6664   -0.4167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5946    1.0816    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2611    1.7685    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9995    0.9571    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1881    2.2188    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1967    3.3290    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.8546    2.9057    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6436    2.8338    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9053    2.0225    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5922    0.6890    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0727    0.9302    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3007    2.4128    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9612    3.0878    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6342    3.0997    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1380   -0.1257    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2034   -1.1816    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5203   -0.8093    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7090   -2.0709    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3755   -2.7578    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6060   -3.6665    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0718   -3.3481    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5290   -1.9195    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1488   -5.0952    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1228   -2.6860    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.1730    4.3715    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9999   -1.1036    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  1
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  1  0
 16 18  1  0
 15 19  1  0
 19 20  3  0
 14 21  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 24 27  1  0
 23 28  1  0
 11 29  1  0
  5 30  1  0
 28  2  1  0
  8  3  1  0
 17 13  2  0
 26 21  2  0
M  END
>  <BrandName>  (211) 
Lorbrena

>  <Phase>  (211) 
4.0

>  <Applicants>  (211) 
Pfizer

>  <Links>  (211) 
|http://www.chemspider.com/Chemical-Structure.32813339.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3286830|http://pubchem.ncbi.nlm.nih.gov/compound/71731823|http://www.drugbank.ca/drugs/DB12130| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=5P8|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/5P8|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7476|http://zinc15.docking.org/substances/ZINC000098208524|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=OSP71S83EU|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50018830

>  <LigID>  (211) 
'5P8'

>  <pdbID>  (211) 
4cli 4clj 4uxl 5a9u 5aa8 5aa9

>  <Type>  (211) 
1

>  <RoF>  (211) 
0

>  <MW>  (211) 
406.2

>  <LogP>  (211) 
2.8

>  <TPSA>  (211) 
110.1

>  <HBA>  (211) 
7

>  <HBD>  (211) 
1

>  <NRB>  (211) 
0

>  <Indications>  (211) 
On november 2, 2018, the FDA approved lorlatinib to treat patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer

>  <Targets>  (211) 
ALK; ROS1

>  <Kinase families>  (211) 
Tyr

>  <Canonical_Smiles>  (211) 
C[C@@H]1c2cc(ccc2C(=O)N(Cc3c(c(n(n3)C)C#N)-c4cc(c(nc4)N)O1)C)F

>  <InChiKey>  (211) 
IIXWYSCJSQVBQM-LLVKDONJSA-N

>  <First_Approval>  (211) 
2018

>  <SC_Patent>  (211) 
US-8680111-B2

>  <Chirality>  (211) 
Single Stereoisomer

>  <Synonyms>  (211) 
LORBRENA | LORLATINIB | PF-06463922

>  <FDA_approved>  (211) 
Y

>  <Melting points>  (211) 


$$$$
Ibrutinib
     RDKit          2D

 33 37  0  0  0  0  0  0  0  0999 V2000
    6.5906    5.7184    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5339    4.2194    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2074    3.5191    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9376    4.3176    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.1507    2.0201    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.4205    1.2216    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3638   -0.2773    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0373   -0.9777    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7676   -0.1792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8243    1.3198    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4411   -0.8795    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.2280   -2.3643    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7501   -2.6205    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0497   -1.2940    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0948   -0.2181    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4351   -1.0810    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9930    0.3114    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4777    0.5245    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4047   -0.6549    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8468   -2.0473    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3620   -2.2603    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8894   -0.4418    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4473    0.9506    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5204    2.1299    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0783    3.5223    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.5631    3.7354    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.4900    2.5561    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.9321    1.1637    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2330   -4.0285    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1938   -5.1804    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.6718   -4.9242    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1889   -3.5162    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2450   -4.2847    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  9 11  1  1
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 14 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 19 22  1  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 13 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 29 33  1  0
 10  5  1  0
 15 11  1  0
 32 12  1  0
 21 16  1  0
 28 23  1  0
M  END
>  <BrandName>  (212) 
Imbruvica

>  <Phase>  (212) 
4.0

>  <Applicants>  (212) 
Pharmacyclics

>  <Links>  (212) 
|http://www.chemspider.com/Chemical-Structure.26637187.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL1873475|http://pubchem.ncbi.nlm.nih.gov/compound/24821094|http://www.drugbank.ca/drugs/DB09053| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=1E8|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/1E8|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6912|http://zinc15.docking.org/substances/ZINC35328014|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=1X70OSD4VX|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50357312

>  <LigID>  (212) 
'1E8'

>  <pdbID>  (212) 
4ifg 4rz7 5p9i 5yu9

>  <Type>  (212) 
1.5

>  <RoF>  (212) 
0

>  <MW>  (212) 
440.2

>  <LogP>  (212) 
4.2

>  <TPSA>  (212) 
99.2

>  <HBA>  (212) 
7

>  <HBD>  (212) 
1

>  <NRB>  (212) 
5

>  <Indications>  (212) 
Ibrutinib was approved by the FDA for the treatment of mantle cell lymphoma, and later in February 2014 for the treatment of chronic lymphocytic leukemia

>  <Targets>  (212) 
BTK

>  <Kinase families>  (212) 
Tyr

>  <Canonical_Smiles>  (212) 
C=CC(=O)N1CCC[C@H](C1)n2c3c(c(n2)c4ccc(cc4)Oc5ccccc5)c(ncn3)N

>  <InChiKey>  (212) 
XYFPWWZEPKGCCK-GOSISDBHSA-N

>  <First_Approval>  (212) 
2013

>  <SC_Patent>  (212) 
US-7514444-B2

>  <Chirality>  (212) 
Single Stereoisomer

>  <Synonyms>  (212) 
CRA-032765 | IBRUTINIB | IMBRUVICA | PC-32765 | PCI 32765 | PCI-32765 | PCI-32765-00

>  <FDA_approved>  (212) 
Y

>  <Melting points>  (212) 
149-158C

$$$$
Larotrectinib
     RDKit          2D

 31 35  0  0  0  0  0  0  0  0999 V2000
    6.6807    1.5444    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1368    0.1154    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1274   -0.9941    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6618   -0.6747    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2056    0.7543    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2151    1.8638    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7589    3.2928    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    3.6524   -1.7842    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9567   -3.2530    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6538   -3.9963    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5442   -2.9869    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1614   -1.6197    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.4181   -0.3168    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1748    0.9783    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4315    2.2812    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0684    2.2890    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8251    0.9938    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0819   -0.3091    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2907    1.3133    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4398    2.8058    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0664    3.4088    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4106    0.3153    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8348    0.7862    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1391    2.2550    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9547   -0.2117    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8056   -1.7043    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.1790   -2.3073    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.1770   -1.1874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.4203    0.1077    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.6695   -1.3365    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.5836   -2.4231    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  8  4  1  1
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 17 19  2  0
 19 20  1  0
 20 21  2  0
 19 22  1  0
 22 23  1  0
 23 24  2  0
 23 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 28 30  1  6
  3 31  1  0
  6  1  1  0
 12  8  1  0
 18 13  2  0
 21 16  1  0
 29 25  1  0
M  END
>  <BrandName>  (213) 
Vitrakvi

>  <Phase>  (213) 
4.0

>  <Applicants>  (213) 
Array BioPharma

>  <Links>  (213) 
|http://www.chemspider.com/Chemical-Structure.44210503.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3889654|http://pubchem.ncbi.nlm.nih.gov/compound/46188928|http://www.drugbank.ca/drugs/DB14723|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8909|http://zinc15.docking.org/substances/ZINC000118399834|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=PF9462I9HX|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=136597

>  <LigID>  (213) 
nan

>  <pdbID>  (213) 
nan

>  <Type>  (213) 
nan

>  <RoF>  (213) 
0

>  <MW>  (213) 
428.2

>  <LogP>  (213) 
2.9

>  <TPSA>  (213) 
86

>  <HBA>  (213) 
6

>  <HBD>  (213) 
2

>  <NRB>  (213) 
3

>  <Indications>  (213) 
On november 26, 2018, the FDA approved larotrectinib to treat patients whose cancers have a specific genetic feature (biomarker)

>  <Targets>  (213) 
NTRK1; NTRK2; NTRK3

>  <Kinase families>  (213) 
Tyr

>  <Canonical_Smiles>  (213) 
c1cc(c(cc1F)[C@H]2CCCN2c3ccn4c(n3)c(cn4)NC(=O)N5CC[C@@H](C5)O)F

>  <InChiKey>  (213) 
NYNZQNWKBKUAII-KBXCAEBGSA-N

>  <First_Approval>  (213) 
2018

>  <SC_Patent>  (213) 
US-8513263-B2

>  <Chirality>  (213) 
Single Stereoisomer

>  <Synonyms>  (213) 
ARRY-470 | LAROTRECTINIB | LOXO-101

>  <FDA_approved>  (213) 
Y

>  <Melting points>  (213) 


$$$$
Lapatinib
     RDKit          2D

 40 44  0  0  0  0  0  0  0  0999 V2000
   -6.4375    7.6486    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0015    6.2134    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -7.4367    5.7774    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5663    6.6494    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5655    4.7782    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5904    3.6830    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1544    2.2477    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -7.1794    1.1525    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.7434   -0.2827    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.6482   -1.4791    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.7901   -2.7093    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3548   -2.2733    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3260   -0.7736    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1585   -3.1782    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3439   -4.6667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1476   -5.5715    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7658   -4.9879    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5803   -3.4994    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7767   -2.5945    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1985   -2.9158    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9978   -3.8206    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.8123   -5.3091    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5695   -5.8927    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0131   -1.4273    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.3687   -0.8436    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5650   -1.7485    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9468   -1.1648    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1323    0.3236    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9360    1.2285    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5542    0.6449    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1214    2.7170    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    5.5141    0.9073    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.7104    0.0024    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0922    0.5861    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2886   -0.3188    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6704    0.2648    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8558    1.7533    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6595    2.6582    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2777    2.0746    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8449    4.1467    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  2  0
  2  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 12 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 18 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 20 24  1  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 29 31  1  0
 28 32  1  0
 32 33  1  0
 33 34  1  0
 34 35  2  0
 35 36  1  0
 36 37  2  0
 37 38  1  0
 38 39  2  0
 38 40  1  0
 13  9  1  0
 19 14  1  0
 23 17  1  0
 30 25  1  0
 39 34  1  0
M  END
>  <BrandName>  (214) 
Tykerb;Tyverb

>  <Phase>  (214) 
4.0

>  <Applicants>  (214) 
GlaxoSmithKline

>  <Links>  (214) 
|http://www.chemspider.com/Chemical-Structure.181006.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL554|http://pubchem.ncbi.nlm.nih.gov/compound/208908|http://www.drugbank.ca/drugs/DB02584| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=FMM|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/FMM|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5692|http://zinc15.docking.org/substances/ZINC000001550477|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=0VUA21238F|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=5445

>  <LigID>  (214) 
'FMM'

>  <pdbID>  (214) 
1xkk 3bbt

>  <Type>  (214) 
1.5

>  <RoF>  (214) 
2

>  <MW>  (214) 
580.1

>  <LogP>  (214) 
6.1

>  <TPSA>  (214) 
106.4

>  <HBA>  (214) 
8

>  <HBD>  (214) 
2

>  <NRB>  (214) 
11

>  <Indications>  (214) 
Indicated in combination with capecitabine for the treatment of patients with advanced or metastatic breast cancer whose tumors overexpress the human epidermal receptor type 2 (HER2) protein and who have received prior therapy including an anthracycline, a taxane, and trastuzuma.

>  <Targets>  (214) 
EGFR; ERBB2

>  <Kinase families>  (214) 
Tyr

>  <Canonical_Smiles>  (214) 
CS(=O)(=O)CCNCc1ccc(o1)c2ccc3c(c2)c(ncn3)Nc4ccc(c(c4)Cl)OCc5cccc(c5)F

>  <InChiKey>  (214) 
BCFGMOOMADDAQU-UHFFFAOYSA-N

>  <First_Approval>  (214) 
2007

>  <SC_Patent>  (214) 
US-6713485-B2

>  <Chirality>  (214) 
Achiral Molecule

>  <Synonyms>  (214) 
GSK-572016 | GW-2016 | GW-572016 | GW-572016X | GW572016 | LAPATINIB | TYVERB

>  <FDA_approved>  (214) 
Y

>  <Melting points>  (214) 


$$$$
Imatinib
     RDKit          2D

 37 41  0  0  0  0  0  0  0  0999 V2000
   -7.7450    1.8017    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2611    2.0209    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7090    3.4156    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2251    3.6347    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2933    2.4592    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8455    1.0645    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3294    0.8454    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8815   -0.5493    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9497   -1.7248    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5019   -3.1195    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5701   -4.2950    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0862   -4.0758    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5341   -2.6811    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4658   -1.5056    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0502   -2.4620    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1184   -3.6375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3655   -3.4183    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9176   -2.0236    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9859   -0.8481    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4980   -1.0673    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8094    2.6784    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8777    1.5029    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4298    0.1082    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.6062    1.7221    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5380    0.5466    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0219    0.7658    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5740    2.1604    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6423    3.3360    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1584    3.1168    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0579    2.3796    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9897    1.2041    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.4376   -0.1906    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3693   -1.3661    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8532   -1.1469    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.4054    0.2478    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4736    1.4233    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7850   -2.3224    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
  5 21  1  0
 21 22  1  0
 22 23  2  0
 22 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 27 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
 33 34  1  0
 34 35  1  0
 35 36  1  0
 34 37  1  0
  7  2  1  0
 14  9  1  0
 20 15  1  0
 29 24  1  0
 36 31  1  0
M  END
>  <BrandName>  (215) 
Gleevec

>  <Phase>  (215) 
4.0

>  <Applicants>  (215) 
Novartis

>  <Links>  (215) 
|http://www.chemspider.com/Chemical-Structure.5101.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL941|http://pubchem.ncbi.nlm.nih.gov/compound/5291|http://www.drugbank.ca/drugs/DB03261| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=STI|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/STI|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5687|http://zinc15.docking.org/substances/ZINC19632618|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=BKJ8M8G5HI|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13530

>  <LigID>  (215) 
'STI'

>  <pdbID>  (215) 
1iep 1opj 1t46 1xbb 2hyy 2oiq 2pl0 3fw1 3gvu 3hec 3k5v 3ms9 3mss 3oez 3pyy 4bkj 4csv 4r7i 5mqt 6hd4 6hd6 6jol 6ktn 6npe 6npu 6npv 6vxh

>  <Type>  (215) 
2

>  <RoF>  (215) 
0

>  <MW>  (215) 
493.3

>  <LogP>  (215) 
4.6

>  <TPSA>  (215) 
86.3

>  <HBA>  (215) 
7

>  <HBD>  (215) 
2

>  <NRB>  (215) 
7

>  <Indications>  (215) 
For the treatment of Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML), Ph+ acute lymphoblastic leukaemia, myelodysplastic/myeloproliferative diseases, aggressive systemic mastocytosis, hypereosinophilic syndrome and/or chronic eosinophilic leukemia (CEL), dermatofibrosarcoma protuberans, and malignant gastrointestinal stromal tumors (GIST).

>  <Targets>  (215) 
KIT; RET; NTRK1; CSF1R; PDGFRA; DDR1; ABL1; PDGFRB

>  <Kinase families>  (215) 
Tyr

>  <Canonical_Smiles>  (215) 
Cc1ccc(cc1Nc2nccc(n2)c3cccnc3)NC(=O)c4ccc(cc4)CN5CCN(CC5)C

>  <InChiKey>  (215) 
KTUFNOKKBVMGRW-UHFFFAOYSA-N

>  <First_Approval>  (215) 
2001

>  <SC_Patent>  (215) 
US-6894051-B1

>  <Chirality>  (215) 
Achiral Molecule

>  <Synonyms>  (215) 
GLEEVEC | IMATINIB | STI-571

>  <FDA_approved>  (215) 
Y

>  <Melting points>  (215) 
226C (mesylate salt)

$$$$
Idelalisib
     RDKit          2D

 31 35  0  0  0  0  0  0  0  0999 V2000
   -2.3225    2.1148    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9021    1.6326    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6095    0.1615    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8109   -0.3207    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1035   -1.7919    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.5239   -2.2741    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8166   -3.7452    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2369   -4.2274    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3647   -3.2384    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0721   -1.7672    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6517   -1.2851    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3591    0.1861    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4868    1.1751    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.9387    0.6683    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.6461    2.1395    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7738    3.1285    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4812    4.5997    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0608    5.0818    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0670    4.0928    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2257    2.6216    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1999   -0.7782    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7372   -0.8276    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1576   -0.3454    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2854   -1.3344    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7058   -0.8522    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6033   -2.0541    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7376   -3.2791    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3050   -2.8343    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9984    0.6190    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8707    1.6080    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4503    1.1258    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  3  2  1  1
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 10 21  1  0
  3 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  1  0
 27 28  2  0
 25 29  1  0
 29 30  2  0
 30 31  1  0
 14  4  1  0
 11  6  1  0
 20 15  1  0
 31 23  2  0
 28 24  1  0
M  END
>  <BrandName>  (216) 
Zydelig

>  <Phase>  (216) 
4.0

>  <Applicants>  (216) 
Gilead Sciences

>  <Links>  (216) 
|http://www.chemspider.com/Chemical-Structure.9800565.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL2216870|http://pubchem.ncbi.nlm.nih.gov/compound/11625818|http://www.drugbank.ca/drugs/DB09054| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=40L|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/40L|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6741|http://zinc15.docking.org/substances/ZINC13986658|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=YG57I8T5M0|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50403068

>  <LigID>  (216) 
'40L'

>  <pdbID>  (216) 
4xe0

>  <Type>  (216) 
1

>  <RoF>  (216) 
0

>  <MW>  (216) 
415.2

>  <LogP>  (216) 
3.8

>  <TPSA>  (216) 
101.4

>  <HBA>  (216) 
7

>  <HBD>  (216) 
2

>  <NRB>  (216) 
5

>  <Indications>  (216) 
Idelalisib is indicated in the treatment of chronic lymphocytic leukemia (CLL), relapsed follicular B-cell non-Hodgkin lymphoma (FL), and relapsed small lymphocytic lymphoma (SLL). For the treatment of relapsed CLL, it is currently indicated as a second-line agent in combination with rituximab in patients for whom rituximab alone would be considered appropriate therapy due to other co-morbidities, while in the treatment of FL and SLL it is intended to be used in patients who have received at least two prior systemic therapies.

>  <Targets>  (216) 
PIK3CD

>  <Kinase families>  (216) 
Atypical

>  <Canonical_Smiles>  (216) 
CC[C@@H](c1nc2cccc(c2c(=O)n1c3ccccc3)F)Nc4c5c([nH]cn5)ncn4

>  <InChiKey>  (216) 
IFSDAJWBUCMOAH-HNNXBMFYSA-N

>  <First_Approval>  (216) 
2014

>  <SC_Patent>  (216) 
US-6800620-B2

>  <Chirality>  (216) 
Single Stereoisomer

>  <Synonyms>  (216) 
CAL-101 | GS-1101 | GS-11CAL-101 | IDELALISIB | ZYDELIG

>  <FDA_approved>  (216) 
Y

>  <Melting points>  (216) 


$$$$
Icotinib
     RDKit          2D

 29 32  0  0  0  0  0  0  0  0999 V2000
   -8.3777   -1.7918    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.3938   -0.6596    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4099    0.4726    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.8984    1.8908    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9145    3.0230    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4420    2.7370    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9534    1.3188    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9374    0.1866    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4810    1.0328    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9924   -0.3855    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5199   -0.6715    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4640    0.4607    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9365    0.1747    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4250   -1.2435    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4411   -2.3757    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0314   -2.0897    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0153   -3.2219    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4878   -2.9359    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9763   -1.5177    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.5572   -2.2274    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.0297   -2.5134    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4479   -2.0249    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4319   -0.8927    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.7179    0.5798    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2293    1.9980    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0971    2.9819    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.6246    3.2679    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2064    2.7794    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2225    1.6472    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  3  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 14 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
  8  3  1  0
 19 10  2  0
 16 11  1  0
 29 13  1  0
M  END
>  <BrandName>  (217) 
nan

>  <Phase>  (217) 
4.0

>  <Applicants>  (217) 
Zhejiang Beta Pharma

>  <Links>  (217) 
|http://www.chemspider.com/Chemical-Structure.10762174.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL2087361|http://pubchem.ncbi.nlm.nih.gov/compound/22024915|http://www.drugbank.ca/drugs/DB11737|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7641|http://zinc15.docking.org/substances/ZINC000043207566|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=9G6U5L461Q|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50391089

>  <LigID>  (217) 
nan

>  <pdbID>  (217) 
nan

>  <Type>  (217) 
nan

>  <RoF>  (217) 
0

>  <MW>  (217) 
391.2

>  <LogP>  (217) 
3.2

>  <TPSA>  (217) 
74.7

>  <HBA>  (217) 
7

>  <HBD>  (217) 
1

>  <NRB>  (217) 
2

>  <Indications>  (217) 
Icotinib hydrochloride is a novel epidermal growth factor receptor (EGFR)tyrosine kinase inhibitor, exhibits encouraging efficacy and tolerability in patients with advanced non-small-cell lung cancer (NSCLC) who failed previous chemotherapy.

>  <Targets>  (217) 
EGFR

>  <Kinase families>  (217) 
Tyr

>  <Canonical_Smiles>  (217) 
C#Cc1cccc(c1)Nc2c3cc4c(cc3ncn2)OCCOCCOCCO4

>  <InChiKey>  (217) 
QQLKULDARVNMAL-UHFFFAOYSA-N

>  <First_Approval>  (217) 
2011

>  <SC_Patent>  (217) 
None

>  <Chirality>  (217) 
Achiral Molecule

>  <Synonyms>  (217) 
BPI-2009H | ICOTINIB

>  <FDA_approved>  (217) 
N

>  <Melting points>  (217) 


$$$$
Gilteritinib
     RDKit          2D

 40 44  0  0  0  0  0  0  0  0999 V2000
    6.9789   -3.4293    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4421   -2.0026    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4382   -0.8881    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9711   -1.2002    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9672   -0.0857    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.4304    1.3410    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8976    1.6532    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9015    0.5386    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.3609    3.0798    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3570    4.1944    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.8280    3.3920    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.4265    2.4555    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.9594    2.1434    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9555    3.2579    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5117    2.9458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9750    1.5191    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0289    0.4046    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4961    0.7167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4343   -1.0221    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9015   -1.3342    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4421    1.2070    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4460    2.3215    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9132    2.0094    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3765    0.5827    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3725   -0.5318    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9054   -0.2197    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.8436    0.2706    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -7.8475    1.3851    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.3147    1.0730    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.7779   -0.3537    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -8.7740   -1.4682    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.3069   -1.1561    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -11.2451   -0.6659    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5078   -2.6269    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.0406   -2.9390    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0367   -1.8245    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5696   -2.1366    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1063   -3.5633    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.1102   -4.6778    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5774   -4.3657    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  2  0
  9 11  1  0
  6 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  1  0
 16 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 24 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 30 33  1  0
  4 34  1  0
 34 35  1  0
 35 36  1  0
 36 37  1  0
 37 38  1  0
 38 39  1  0
 39 40  1  0
  8  3  1  0
 18 13  1  0
 26 21  1  0
 32 27  1  0
 40 35  1  0
M  END
>  <BrandName>  (218) 
Xospata

>  <Phase>  (218) 
4.0

>  <Applicants>  (218) 
Astellas Pharma

>  <Links>  (218) 
|http://www.chemspider.com/Chemical-Structure.32055842.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3301622|http://pubchem.ncbi.nlm.nih.gov/compound/49803313|http://www.drugbank.ca/drugs/DB12141| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=C6F|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/C6F|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8708|http://zinc15.docking.org/substances/ZINC000113476229|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=66D92MGC8M|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=144315

>  <LigID>  (218) 
'C6F'

>  <pdbID>  (218) 
6jqr

>  <Type>  (218) 
nan

>  <RoF>  (218) 
1

>  <MW>  (218) 
552.4

>  <LogP>  (218) 
2.7

>  <TPSA>  (218) 
121.1

>  <HBA>  (218) 
10

>  <HBD>  (218) 
3

>  <NRB>  (218) 
9

>  <Indications>  (218) 
On november 28, 2018, the FDA approved gilteritinib to treat patients who have relapsed or refractory acute myeloid leukemia (AML)

>  <Targets>  (218) 
FLT3; AXL; ALK

>  <Kinase families>  (218) 
Tyr

>  <Canonical_Smiles>  (218) 
CCc1c(nc(c(n1)C(=O)N)Nc2ccc(c(c2)OC)N3CCC(CC3)N4CCN(CC4)C)NC5CCOCC5

>  <InChiKey>  (218) 
GYQYAJJFPNQOOW-UHFFFAOYSA-N

>  <First_Approval>  (218) 
2018

>  <SC_Patent>  (218) 
US-8969336-B2

>  <Chirality>  (218) 
Achiral Molecule

>  <Synonyms>  (218) 
ASP-2215 | ASP2215 | GILTERITINIB

>  <FDA_approved>  (218) 
Y

>  <Melting points>  (218) 


$$$$
Ribociclib
     RDKit          2D

 32 36  0  0  0  0  0  0  0  0999 V2000
   -8.3251   -1.2153    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.8748   -0.8324    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4813    0.6151    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8181   -1.8969    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2116   -3.3444    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3678   -1.5140    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2055   -2.4623    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9445   -1.6500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4971   -2.0435    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5675   -0.9867    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.1846    0.4636    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2629    0.8571    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3274   -0.1997    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8251   -0.1157    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6374    1.1453    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1351    1.2294    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5180    2.6797    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2570    3.4920    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0947    2.5437    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2491    1.5203    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.6966    1.1268    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0795   -0.3235    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5269   -0.7171    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5915    0.3397    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2086    1.7900    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7611    2.1835    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.0389   -0.0539    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.4218   -1.5042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8693   -1.8977    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9338   -0.8410    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.5509    0.6093    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1035    1.0029    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 11 20  1  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 24 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 14  6  1  0
 13  8  1  0
 19 15  1  0
 26 21  1  0
 32 27  1  0
M  END
>  <BrandName>  (219) 
Kisqali

>  <Phase>  (219) 
4.0

>  <Applicants>  (219) 
Novartis

>  <Links>  (219) 
|http://www.chemspider.com/Chemical-Structure.30798107.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3545110|http://pubchem.ncbi.nlm.nih.gov/compound/44631912|http://www.drugbank.ca/drugs/DB11730| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=6ZZ|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/6ZZ|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7383|http://zinc15.docking.org/substances/ZINC000072316335|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=TK8ERE8P56|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=148264

>  <LigID>  (219) 
'6ZZ'

>  <pdbID>  (219) 
5l2t

>  <Type>  (219) 
1

>  <RoF>  (219) 
0

>  <MW>  (219) 
434.3

>  <LogP>  (219) 
2.8

>  <TPSA>  (219) 
91.2

>  <HBA>  (219) 
8

>  <HBD>  (219) 
2

>  <NRB>  (219) 
5

>  <Indications>  (219) 
Kisqali (ribociclib) is a selective cyclin-dependent kinase inhibitor, a class of drugs that help slow the progression of cancer by inhibiting two proteins called cyclin-dependent kinase 4 and 6 (CDK4/6). These proteins, when over-activated, can enable cancer cells to grow and divide too quickly. Targeting CDK4/6 with enhanced precision may play a role in ensuring that cancer cells do not continue to replicate uncontrollably.

>  <Targets>  (219) 
CDK4; CDK6

>  <Kinase families>  (219) 
CMGC

>  <Canonical_Smiles>  (219) 
CN(C)C(=O)c1cc2cnc(nc2n1C3CCCC3)Nc4ccc(cn4)N5CCNCC5

>  <InChiKey>  (219) 
RHXHGRAEPCAFML-UHFFFAOYSA-N

>  <First_Approval>  (219) 
2017

>  <SC_Patent>  (219) 
US-8324225-B2

>  <Chirality>  (219) 
Achiral Molecule

>  <Synonyms>  (219) 
LEE-011 | LEE-011A | LEE011 | NVP-LEE011 | RIBOCICLIB

>  <FDA_approved>  (219) 
Y

>  <Melting points>  (219) 


$$$$
Entrectinib
     RDKit          2D

 41 46  0  0  0  0  0  0  0  0999 V2000
   -7.4763   -5.6972    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4270   -4.6253    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.8307   -3.1806    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7814   -2.1087    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3285   -2.4814    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9248   -3.9261    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9740   -4.9980    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2792   -1.4095    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8262   -1.7822    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7770   -0.7102    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1807    0.7344    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6336    1.1071    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6829    0.0352    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0373    2.5518    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4903    2.9245    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8940    4.3692    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.3469    4.7419    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.3962    3.6699    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.9925    2.2253    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5395    1.8526    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1314    1.8063    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5351    3.2510    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.3215    1.4336    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.3708    2.5056    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8548    2.2868    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6851    1.0376    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1821    1.1321    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8488    2.4758    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0184    3.7250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5214    3.6305    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4495    4.6797    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.1203    3.9845    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.0125   -0.1171    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3458   -1.4609    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8488   -1.5554    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1822   -2.8991    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0125   -4.1483    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5095   -4.0538    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1762   -2.7101    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3399   -5.3030    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.6851   -2.9936    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  5  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 11 21  1  0
 21 22  2  0
 21 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  1  0
 27 33  1  0
 33 34  1  0
 34 35  2  0
 35 36  1  0
 36 37  2  0
 37 38  1  0
 38 39  2  0
 38 40  1  0
 36 41  1  0
  7  2  1  0
 13  8  1  0
 20 15  1  0
 32 24  2  0
 30 25  1  0
 39 34  1  0
M  END
>  <BrandName>  (220) 
Rozlytrek

>  <Phase>  (220) 
4.0

>  <Applicants>  (220) 
Ignyta

>  <Links>  (220) 
|http://www.chemspider.com/Chemical-Structure.24808589.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL1983268|http://pubchem.ncbi.nlm.nih.gov/compound/25141092|http://www.drugbank.ca/drugs/DB11986| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=YMX|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/YMX|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8290|http://zinc15.docking.org/substances/ZINC000043204146|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=L5ORF0AN1I|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=158154

>  <LigID>  (220) 
'YMX'

>  <pdbID>  (220) 
5fto 5kvt

>  <Type>  (220) 
1

>  <RoF>  (220) 
2

>  <MW>  (220) 
560.3

>  <LogP>  (220) 
5

>  <TPSA>  (220) 
85.5

>  <HBA>  (220) 
6

>  <HBD>  (220) 
3

>  <NRB>  (220) 
7

>  <Indications>  (220) 
On august 2019, FDA approved entrectinib to treat adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are ROS1-positive and to treat adult and pediatric patients 12 years of age and older with solid tumors

>  <Targets>  (220) 
NTRK1; NTRK2; NTRK3; ROS1; ALK

>  <Kinase families>  (220) 
Tyr

>  <Canonical_Smiles>  (220) 
CN1CCN(CC1)c2ccc(c(c2)NC3CCOCC3)C(=O)Nc4c5cc(ccc5[nH]n4)Cc6cc(cc(c6)F)F

>  <InChiKey>  (220) 
HAYYBYPASCDWEQ-UHFFFAOYSA-N

>  <First_Approval>  (220) 
2019

>  <SC_Patent>  (220) 
None

>  <Chirality>  (220) 
Achiral Molecule

>  <Synonyms>  (220) 
ENTRECTINIB | NMS-E628 | RXDX-101

>  <FDA_approved>  (220) 
Y

>  <Melting points>  (220) 


$$$$
Nilotinib
     RDKit          2D

 39 43  0  0  0  0  0  0  0  0999 V2000
    5.6804   -4.6621    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3180   -4.0345    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0933   -4.9006    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7309   -4.2729    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5932   -2.7793    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8180   -1.9132    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1803   -2.5408    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4051   -1.6748    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.2674   -0.1811    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4921    0.6849    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.3545    2.1786    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9921    2.8062    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7674    1.9402    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9050    0.4465    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.4050    2.5678    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2673    4.0615    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9050    4.6891    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3198    3.8230    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1821    2.3294    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1803    1.7017    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2308   -2.1516    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9939   -3.0177    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0932   -0.6580    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2692   -0.0303    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4069    1.4633    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7692    2.0909    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9940    1.2249    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8563   -0.2688    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4939   -0.8964    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0810   -1.1348    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1003   -2.6347    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5327   -3.0799    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.3987   -1.8552    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5016   -0.6530    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.0145   -4.5004    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9069    3.5846    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0445    5.0783    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4006    3.4470    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4132    3.7223    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
  5 21  1  0
 21 22  2  0
 21 23  1  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 28 30  1  0
 30 31  1  0
 31 32  2  0
 32 33  1  0
 33 34  2  0
 32 35  1  0
 26 36  1  0
 36 37  1  0
 36 38  1  0
 36 39  1  0
  7  2  1  0
 14  9  1  0
 20 15  1  0
 29 24  1  0
 34 30  1  0
M  END
>  <BrandName>  (221) 
Tasigna

>  <Phase>  (221) 
4.0

>  <Applicants>  (221) 
Novartis

>  <Links>  (221) 
|http://www.chemspider.com/Chemical-Structure.559260.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL255863|http://pubchem.ncbi.nlm.nih.gov/compound/644241|http://www.drugbank.ca/drugs/DB04868| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=NIL|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/NIL|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5697|http://zinc15.docking.org/substances/ZINC06716957|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=F41401512X|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50237710

>  <LigID>  (221) 
'NIL'

>  <pdbID>  (221) 
3cs9 3gp0 5mo4

>  <Type>  (221) 
2

>  <RoF>  (221) 
2

>  <MW>  (221) 
529.2

>  <LogP>  (221) 
6.4

>  <TPSA>  (221) 
97.6

>  <HBA>  (221) 
7

>  <HBD>  (221) 
2

>  <NRB>  (221) 
6

>  <Indications>  (221) 
For the potential treatment of various leukemias, including chronic myeloid leukemia (CML).

>  <Targets>  (221) 
ABL1; KIT

>  <Kinase families>  (221) 
Tyr

>  <Canonical_Smiles>  (221) 
Cc1ccc(cc1Nc2nccc(n2)c3cccnc3)C(=O)Nc4cc(cc(c4)n5cc(nc5)C)C(F)(F)F

>  <InChiKey>  (221) 
HHZIURLSWUIHRB-UHFFFAOYSA-N

>  <First_Approval>  (221) 
2007

>  <SC_Patent>  (221) 
US-7169791-B2

>  <Chirality>  (221) 
Achiral Molecule

>  <Synonyms>  (221) 
AMN 107 | AMN107 | NILOTINIB | TASIGNA

>  <FDA_approved>  (221) 
Y

>  <Melting points>  (221) 


$$$$
Gefitinib
     RDKit          2D

 31 34  0  0  0  0  0  0  0  0999 V2000
   -1.3428    6.3344    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6883    4.8748    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5969    3.8457    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8399    4.2764    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9313    3.2473    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5858    1.7876    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1489    1.3570    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9424    2.3861    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3793    1.9554    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7248    0.4958    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1616    0.0651    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5071   -1.3945    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9440   -1.8252    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -7.0353   -0.7961    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.4722   -1.2268    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.8177   -2.6864    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -7.7263   -3.7155    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2895   -3.2848    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6772    0.7586    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1140    1.1892    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.4595    2.6489    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3682    3.6779    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.3317   -0.7011    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.4230   -1.7301    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0775   -3.1898    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1689   -4.2188    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6058   -3.7882    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9513   -2.3285    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8599   -1.2995    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3881   -1.8979    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    6.6971   -4.8172    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
  6 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 19 23  1  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 28 30  1  0
 27 31  1  0
  8  3  1  0
 22  5  1  0
 18 13  1  0
 29 24  1  0
M  END
>  <BrandName>  (222) 
Iressa

>  <Phase>  (222) 
4.0

>  <Applicants>  (222) 
Astrazeneca

>  <Links>  (222) 
|http://www.chemspider.com/Chemical-Structure.110217.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL939|http://pubchem.ncbi.nlm.nih.gov/compound/123631|http://www.drugbank.ca/drugs/DB07998| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=IRE|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/IRE|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4941|http://zinc15.docking.org/substances/ZINC19632614|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=S65743JHBS|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=5447

>  <LigID>  (222) 
'IRE'

>  <pdbID>  (222) 
2ito 2ity 2itz 3ug2 4i22 4wkq 5y7z 5y80

>  <Type>  (222) 
1.5

>  <RoF>  (222) 
0

>  <MW>  (222) 
446.2

>  <LogP>  (222) 
4.3

>  <TPSA>  (222) 
68.7

>  <HBA>  (222) 
7

>  <HBD>  (222) 
1

>  <NRB>  (222) 
8

>  <Indications>  (222) 
For the continued treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of either platinum-based or docetaxel chemotherapies.

>  <Targets>  (222) 
EGFR

>  <Kinase families>  (222) 
Tyr

>  <Canonical_Smiles>  (222) 
COc1cc2c(cc1OCCCN3CCOCC3)c(ncn2)Nc4ccc(c(c4)Cl)F

>  <InChiKey>  (222) 
XGALLCVXEZPNRQ-UHFFFAOYSA-N

>  <First_Approval>  (222) 
2003

>  <SC_Patent>  (222) 
None

>  <Chirality>  (222) 
Achiral Molecule

>  <Synonyms>  (222) 
GEFITINIB | IRESSA | ZD1839

>  <FDA_approved>  (222) 
Y

>  <Melting points>  (222) 


$$$$
Apatinib
     RDKit          2D

 30 33  0  0  0  0  0  0  0  0999 V2000
   -5.6805   -2.6420    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5900   -1.1448    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4995    0.3525    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.9980    0.2860    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.5243    1.6906    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.3511    2.6252    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0997    1.7982    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0199    0.1060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4935   -1.2986    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0139   -1.5451    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0607   -0.3870    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5870    1.0176    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0666    1.2641    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4190   -0.6335    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.9453   -2.0381    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0080   -3.1963    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4249   -2.2846    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9512   -3.6893    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4308   -3.9358    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3841   -2.7776    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8578   -1.3730    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.3782   -1.1265    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8518    0.2781    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.8051    1.4363    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2847    1.1898    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2380    2.3479    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.7117    3.7525    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2321    3.9990    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2788    2.8409    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7992    3.0874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  3  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  3  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 11 14  1  0
 14 15  1  0
 15 16  2  0
 15 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
  7  3  1  0
 13  8  1  0
 22 17  1  0
 29 24  1  0
M  END
>  <BrandName>  (223) 
nan

>  <Phase>  (223) 
4.0

>  <Applicants>  (223) 
Bukwang Pharmaceutical

>  <Links>  (223) 
|http://www.chemspider.com/Chemical-Structure.34980756.html|http://pubchem.ncbi.nlm.nih.gov/compound/66577012|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7648|http://zinc15.docking.org/substances/ZINC000083291412

>  <LigID>  (223) 
nan

>  <pdbID>  (223) 
nan

>  <Type>  (223) 
nan

>  <RoF>  (223) 
1

>  <MW>  (223) 
397.2

>  <LogP>  (223) 
5.1

>  <TPSA>  (223) 
90.7

>  <HBA>  (223) 
5

>  <HBD>  (223) 
2

>  <NRB>  (223) 
5

>  <Indications>  (223) 
Apatinib mesylate is an orally bioavailable, small-molecule receptor tyrosine kinase inhibitor with potential antiangiogenic and antineoplastic activities. The free-base form is also known as Rivoceranib. Apatinib selectively binds to and inhibits vascular endothelial growth factor receptor 2, which may inhibit VEGF-stimulated endothelial cell migration and proliferation and decrease tumor microvessel density. In addition, this agent mildly inhibits c-Kit and c-SRC tyrosine kinases.

>  <Targets>  (223) 
KDR

>  <Kinase families>  (223) 
Tyr

>  <Canonical_Smiles>  (223) 
N#CC1(CCCC1)c1ccc(cc1)NC(=O)c1cccnc1Nc1cnccc1C

>  <InChiKey>  (223) 
MGZNERAVOCFMCU-UHFFFAOYSA-N

>  <First_Approval>  (223) 
2014

>  <SC_Patent>  (223) 
nan

>  <Chirality>  (223) 
nan

>  <Synonyms>  (223) 
|ALBUMIN PACLITAXEL|H20140103|PACLITAXOL|APATINIB|PLATINU|OXALIPLATIN|EGAFUR|APATINIB 500MG|YN968D1,(AITAN|APATINIB 750MG|YN968D1|PEMETREXED|YEW|EMOZOLOMIDE|SHR-1210|ARM A|SPA|APATINIB GROUP|CRYOABLATION|NO.|EMOZOLOMIDETMZ|S-1|5-FLUOROURACIL|CAPECITABINE|STUDY DRUG|ARGET THERAPY|AITAN|APATINIB MESYLATE|REATMENT GROUP|AI TAN|ATAN|DOCETAXEL|ESYLATE APATINIB|APATINIB TABLETS|CARBOPLATIN|NAVELBINE+AITAN|VP-16|S1|XELOX

>  <FDA_approved>  (223) 
N

>  <Melting points>  (223) 


$$$$
Fostamatinib
     RDKit          2D

 40 43  0  0  0  0  0  0  0  0999 V2000
   -7.5685   -3.7323    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.2302   -2.2710    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.4121   -0.7821    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.7924   -0.1951    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2135    0.1199    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8331   -0.4670    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6513   -1.9560    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2709   -2.5429    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0724   -1.6409    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2542   -0.1520    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6346    0.4350    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0557    0.7500    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.3247    0.1630    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5066   -1.3259    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8869   -1.9128    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0855   -1.0108    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.9036    0.4781    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5232    1.0650    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.1021    1.3801    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.4825    0.7931    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6644   -0.6958    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0448   -1.2828    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2433   -0.3808    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0614    1.1082    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6810    1.6951    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2599    2.0101    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.0780    3.4991    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6237   -0.9677    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.8222   -0.0657    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2266   -2.7717    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.0281   -3.6737    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6920   -2.2279    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8498   -2.8579    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.3954    1.6088    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1969    2.5108    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3788    3.9998    0.0000 P   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8899    4.1817    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.8677    3.8179    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5607    5.4887    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -8.7281   -2.1916    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 24 26  1  0
 26 27  1  0
 23 28  1  0
 28 29  1  0
 22 30  1  0
 30 31  1  0
 14 32  1  0
  7 33  1  0
  5 34  1  0
 34 35  1  0
 35 36  1  0
 36 37  2  0
 36 38  1  0
 36 39  1  0
  2 40  1  0
 33  2  1  0
 11  6  1  0
 18 13  1  0
 25 20  1  0
M  END
>  <BrandName>  (224) 
Tavalisse

>  <Phase>  (224) 
4.0

>  <Applicants>  (224) 
Rigel Pharmaceuticals

>  <Links>  (224) 
|http://www.chemspider.com/Chemical-Structure.9846198.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL2103830|http://pubchem.ncbi.nlm.nih.gov/compound/11671467|http://www.drugbank.ca/drugs/DB12010| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=2RC|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/2RC|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7796|http://zinc15.docking.org/substances/ZINC000043131420|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=SQ8A3S5101|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50431381

>  <LigID>  (224) 
'2RC'

>  <pdbID>  (224) 
4o75

>  <Type>  (224) 
nan

>  <RoF>  (224) 
2

>  <MW>  (224) 
580.1

>  <LogP>  (224) 
3.1

>  <TPSA>  (224) 
186.7

>  <HBA>  (224) 
12

>  <HBD>  (224) 
4

>  <NRB>  (224) 
10

>  <Indications>  (224) 
Indicated for the treatment of chronic immune thrombocytopenia (ITP) in adult patients who have had an insufficient response to a previous treatment

>  <Targets>  (224) 
SYK

>  <Kinase families>  (224) 
Tyr

>  <Canonical_Smiles>  (224) 
CC1(C(=O)N(c2c(ccc(n2)Nc3c(cnc(n3)Nc4cc(c(c(c4)OC)OC)OC)F)O1)COP(=O)(O)O)C

>  <InChiKey>  (224) 
GKDRMWXFWHEQQT-UHFFFAOYSA-N

>  <First_Approval>  (224) 
2018

>  <SC_Patent>  (224) 
US-7449458-B2

>  <Chirality>  (224) 
Achiral Molecule

>  <Synonyms>  (224) 
FOSTAMATINIB | R-788 | R-935788 | R788 FREE ACID | R935788 FREE ACID

>  <FDA_approved>  (224) 
Y

>  <Melting points>  (224) 


$$$$
Upadacitinib
     RDKit          2D

 27 30  0  0  0  0  0  0  0  0999 V2000
    0.6514    3.0309    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1685    1.6228    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2077    0.4710    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2889    0.5712    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8468   -0.8212    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6949   -1.7820    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5748   -0.9834    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9673   -1.5413    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3344   -2.9957    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8310   -3.0959    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.3889   -1.7035    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2370   -0.7427    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.4932    0.7353    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5662    1.9146    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4014    3.1606    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8445    2.7513    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.9012    1.2524    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0531    0.2916    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.7969   -1.1864    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3012   -1.1883    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7104   -2.6314    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3463   -0.1123    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8007   -0.4795    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.8458    0.5965    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.8909    1.6725    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -7.9218   -0.4486    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7698    1.6416    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  3  2  1  1
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  1
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
  5 20  1  0
 20 21  2  0
 20 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 24 26  1  0
 24 27  1  0
  7  3  1  0
 12  8  1  0
 19 11  1  0
 17 13  2  0
M  END
>  <BrandName>  (225) 
Rinvoq

>  <Phase>  (225) 
4.0

>  <Applicants>  (225) 
Abbvie

>  <Links>  (225) 
|http://www.chemspider.com/Chemical-Structure.44210449.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3622821|http://pubchem.ncbi.nlm.nih.gov/compound/58557659|http://www.drugbank.ca/drugs/DB15091|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9246|http://zinc15.docking.org/substances/ZINC000147180128|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=4RA0KN46E0

>  <LigID>  (225) 
nan

>  <pdbID>  (225) 
nan

>  <Type>  (225) 
nan

>  <RoF>  (225) 
0

>  <MW>  (225) 
380.2

>  <LogP>  (225) 
2.9

>  <TPSA>  (225) 
78.3

>  <HBA>  (225) 
4

>  <HBD>  (225) 
2

>  <NRB>  (225) 
3

>  <Indications>  (225) 
On august 2019, FDA approved fedratinib to treat adults with moderately to severely active rheumatoid arthritis

>  <Targets>  (225) 
JAK1

>  <Kinase families>  (225) 
Tyr

>  <Canonical_Smiles>  (225) 
CC[C@@H]1CN(C[C@@H]1c2cnc3n2c4cc[nH]c4nc3)C(=O)NCC(F)(F)F

>  <InChiKey>  (225) 
WYQFJHHDOKWSHR-MNOVXSKESA-N

>  <First_Approval>  (225) 
2019

>  <SC_Patent>  (225) 
None

>  <Chirality>  (225) 
Single Stereoisomer

>  <Synonyms>  (225) 
ABT-494 | UPADACITINIB

>  <FDA_approved>  (225) 
Y

>  <Melting points>  (225) 
16-19

$$$$
Fedratinib
     RDKit          2D

 37 40  0  0  0  0  0  0  0  0999 V2000
    3.6403   -5.6667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7459   -4.4625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2558   -4.6350    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3615   -3.4308    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.9571   -2.0541    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4472   -1.8817    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.3416   -3.0858    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8316   -2.9134    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.4273   -1.5367    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9173   -1.3643    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5130    0.0124    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6186    1.2166    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1286    1.0441    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5329   -0.3325    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2342    2.2483    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    5.4384    3.1427    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.0300    1.3539    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.3398    3.4525    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.9354    4.8292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5588    5.4248    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3121    4.2335    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5311    6.2058    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0627   -0.8499    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4273   -1.0224    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0230   -2.3991    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5130   -2.5715    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4074   -1.3673    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8118    0.0093    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3217    0.1818    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8975   -1.5398    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.7919   -0.3356    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.2819   -0.5081    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.1763    0.6961    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -8.7278    2.1275    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.9505    2.9964    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -11.1547    2.1020    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.6762    0.6803    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  2  0
 15 17  2  0
 15 18  1  0
 18 19  1  0
 19 20  1  0
 19 21  1  0
 19 22  1  0
  5 23  1  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 27 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
 33 34  1  0
 34 35  1  0
 35 36  1  0
 36 37  1  0
  7  2  1  0
 14  9  1  0
 29 24  1  0
 37 33  1  0
M  END
>  <BrandName>  (226) 
Inrebic

>  <Phase>  (226) 
4.0

>  <Applicants>  (226) 
Sanofi

>  <Links>  (226) 
|http://www.chemspider.com/Chemical-Structure.17626393.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL1287853|http://pubchem.ncbi.nlm.nih.gov/compound/16722836|http://www.drugbank.ca/drugs/DB12500| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=2TA|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/2TA|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5716|http://zinc15.docking.org/substances/ZINC000019862646|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=6L1XP550I6|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50332294

>  <LigID>  (226) 
'2TA'

>  <pdbID>  (226) 
4ogj 4ps5

>  <Type>  (226) 
nan

>  <RoF>  (226) 
1

>  <MW>  (226) 
524.3

>  <LogP>  (226) 
4.8

>  <TPSA>  (226) 
108.5

>  <HBA>  (226) 
8

>  <HBD>  (226) 
3

>  <NRB>  (226) 
10

>  <Indications>  (226) 
On august 2019, FDA approved fedratinib to treat adult patients with intermediate-2 or high-risk primary or secondary myelofibrosis

>  <Targets>  (226) 
JAK2; FLT3; BRD4

>  <Kinase families>  (226) 
Tyr<br>(*)

>  <Canonical_Smiles>  (226) 
Cc1cnc(nc1Nc2cccc(c2)S(=O)(=O)NC(C)(C)C)Nc3ccc(cc3)OCCN4CCCC4

>  <InChiKey>  (226) 
JOOXLOJCABQBSG-UHFFFAOYSA-N

>  <First_Approval>  (226) 
2019

>  <SC_Patent>  (226) 
None

>  <Chirality>  (226) 
Achiral Molecule

>  <Synonyms>  (226) 
FEDRATINIB | SAR-302503 | SAR302503 | TG-101348 | TG101348

>  <FDA_approved>  (226) 
Y

>  <Melting points>  (226) 


$$$$
Abemaciclib
     RDKit          2D

 37 41  0  0  0  0  0  0  0  0999 V2000
   -3.0503    5.7123    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4857    5.2767    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8262    3.8159    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7313    2.7906    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0718    1.3297    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5071    0.8942    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6020    1.9195    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2615    3.3803    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8476   -0.5666    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7528   -1.5919    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0932   -3.0528    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9984   -4.0781    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5630   -3.6425    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2225   -2.1817    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3174   -1.1564    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4681   -4.6678    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0327   -4.2323    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0622   -5.2576    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.4975   -4.8220    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8380   -3.3612    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7431   -2.3359    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3078   -2.7714    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.0836   -0.8750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5190   -0.4395    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8595    1.0213    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7646    2.0466    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3292    1.6111    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9887    0.1503    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2343    2.6364    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    3.4014    3.4048    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.8898    3.2188    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1729    1.7458    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.5311    1.1090    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6587   -0.3855    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7616    1.9668    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9151    4.3137    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2734   -2.9256    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  6  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 13 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 21 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 27 29  1  0
 26 30  1  0
 30 31  2  0
 31 32  1  0
 32 33  1  0
 33 34  1  0
 33 35  1  0
 31 36  1  0
 20 37  1  0
  8  3  1  0
 15 10  1  0
 22 17  1  0
 28 23  1  0
 32 25  1  0
M  END
>  <BrandName>  (227) 
Verzenio;Verzenios

>  <Phase>  (227) 
4.0

>  <Applicants>  (227) 
Eli Lilly

>  <Links>  (227) 
|http://www.chemspider.com/Chemical-Structure.29340700.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3301610|http://pubchem.ncbi.nlm.nih.gov/compound/46220502|http://www.drugbank.ca/drugs/DB12001| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=6ZV|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/6ZV|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7382|http://zinc15.docking.org/substances/ZINC000072318121|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=60UAB198HK|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50110183

>  <LigID>  (227) 
'6ZV'

>  <pdbID>  (227) 
5l2s

>  <Type>  (227) 
1

>  <RoF>  (227) 
1

>  <MW>  (227) 
506.3

>  <LogP>  (227) 
4.9

>  <TPSA>  (227) 
75

>  <HBA>  (227) 
8

>  <HBD>  (227) 
1

>  <NRB>  (227) 
7

>  <Indications>  (227) 
On September 28, 2017, the Food and Drug Administration approved abemaciclib (VERZENIO, Eli Lilly and Company) in combination with fulvestrant for women with HR-positive, HER2-negative advanced or metastatic breast cancer with disease progression following endocrine therapy. In addition, abemaciclib was approved as monotherapy for  women and men with HR-positive, HER2-negative advanced or metastatic breast cancer with disease progression following endocrine therapy and prior chemotherapy in the metastatic setting.

>  <Targets>  (227) 
CDK4; CDK6

>  <Kinase families>  (227) 
CMGC

>  <Canonical_Smiles>  (227) 
CCN1CCN(CC1)Cc2ccc(nc2)Nc3ncc(c(n3)c4cc5c(c(c4)F)nc(n5C(C)C)C)F

>  <InChiKey>  (227) 
UZWDCWONPYILKI-UHFFFAOYSA-N

>  <First_Approval>  (227) 
2017

>  <SC_Patent>  (227) 
US-7855211-B2

>  <Chirality>  (227) 
Achiral Molecule

>  <Synonyms>  (227) 
ABEMACICLIB | LY-2835219 | LY2835219 | VERZENIO | VERZENIOS

>  <FDA_approved>  (227) 
Y

>  <Melting points>  (227) 


$$$$
Vandetanib
     RDKit          2D

 30 33  0  0  0  0  0  0  0  0999 V2000
   10.1222    0.1160    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6352   -0.0807    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.0620   -1.4669    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5750   -1.6636    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6611   -0.4741    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2342    0.9121    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7213    1.1088    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1740   -0.6708    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2601    0.5186    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.7731    0.3219    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1999   -1.0643    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2871   -1.2610    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2010   -0.0715    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6278    1.3147    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8592    1.5114    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4324    2.8976    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9194    3.0943    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6880   -0.2682    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2612   -1.6544    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3473   -2.8439    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8603   -2.6472    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6019    0.9212    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0890    0.7245    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0029    1.9140    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.4899    1.7172    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.0631    0.3311    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.1492   -0.8584    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6621   -0.6617    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7482   -1.8511    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -9.5501    0.1344    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  5  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  1  0
 13 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 18 22  1  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 26 30  1  0
  7  2  1  0
 15 10  1  0
 21 12  1  0
 28 23  1  0
M  END
>  <BrandName>  (228) 
Caprelsa;Zactima

>  <Phase>  (228) 
4.0

>  <Applicants>  (228) 
Ipr Pharmaceuticals

>  <Links>  (228) 
|http://www.chemspider.com/Chemical-Structure.2338979.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL24828|http://pubchem.ncbi.nlm.nih.gov/compound/3081361|http://www.drugbank.ca/drugs/DB08764| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=ZD6|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/ZD6|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5717|http://zinc15.docking.org/substances/ZINC000053683345|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=YO460OQ37K|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21

>  <LigID>  (228) 
'ZD6'

>  <pdbID>  (228) 
2ivu

>  <Type>  (228) 
1.5

>  <RoF>  (228) 
1

>  <MW>  (228) 
474.1

>  <LogP>  (228) 
5

>  <TPSA>  (228) 
59.5

>  <HBA>  (228) 
6

>  <HBD>  (228) 
1

>  <NRB>  (228) 
6

>  <Indications>  (228) 
Vandetanib is currently approved as an alternative to local therapies for both unresectable and disseminated disease. Because Vandetanib can prolong the Q-T interval, it is contraindicated for use in patients with serious cardiac complications such as congenital long QT syndrome and uncompensated heart failure.

>  <Targets>  (228) 
VEGFA; EGFR; PTK6; TEK; RET

>  <Kinase families>  (228) 
Tyr<br>(*)

>  <Canonical_Smiles>  (228) 
CN1CCC(CC1)COc2cc3c(cc2OC)c(ncn3)Nc4ccc(cc4F)Br

>  <InChiKey>  (228) 
UHTHHESEBZOYNR-UHFFFAOYSA-N

>  <First_Approval>  (228) 
2011

>  <SC_Patent>  (228) 
US-7173038-B1

>  <Chirality>  (228) 
Achiral Molecule

>  <Synonyms>  (228) 
CAPRELSA | GNF-PF-2188 | VANDETANIB | ZACTIMA | ZD-64 | ZD6474

>  <FDA_approved>  (228) 
Y

>  <Melting points>  (228) 


$$$$
Flumatinib
     RDKit          2D

 41 45  0  0  0  0  0  0  0  0999 V2000
   -4.4877   -5.2701    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3225   -4.3254    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5580   -2.8440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3929   -1.8993    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9922   -2.4360    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7567   -3.9174    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9218   -4.8621    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.1730   -1.4913    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.5736   -2.0281    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8092   -3.5094    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.7388   -1.0834    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1395   -1.6201    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3046   -0.6754    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0691    0.8060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6684    1.3427    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5033    0.3980    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4329    2.8241    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1973    4.3055    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    1.9515    2.5885    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    4.9143    3.0596    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    6.2343    1.7507    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6350    1.2139    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.8705   -0.2675    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2712   -0.8042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4363    0.1405    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.2008    1.6219    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8001    2.1586    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8370   -0.3962    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9587   -2.3073    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1943   -0.8259    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0291    0.1188    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2647    1.6002    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6653    2.1369    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.8305    1.1922    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5950   -0.2892    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -8.2312    1.7289    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.4667    3.2103    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.8674    3.7470    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -11.0326    2.8024    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.7970    1.3210    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -9.3963    0.7843    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  5  8  1  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 15 17  1  0
 17 18  1  0
 17 19  1  0
 17 20  1  0
 14 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 25 28  1  0
  3 29  1  0
 29 30  1  0
 30 31  2  0
 31 32  1  0
 32 33  2  0
 33 34  1  0
 34 35  2  0
 34 36  1  0
 36 37  2  0
 37 38  1  0
 38 39  2  0
 39 40  1  0
 40 41  2  0
  7  2  1  0
 16 11  1  0
 27 22  1  0
 35 30  1  0
 41 36  1  0
M  END
>  <BrandName>  (229) 
nan

>  <Phase>  (229) 
4.0

>  <Applicants>  (229) 
Jiangsu Hengrui Medicine

>  <Links>  (229) 
|http://www.chemspider.com/Chemical-Structure.25069687.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3545413|http://pubchem.ncbi.nlm.nih.gov/compound/46848036|http://www.drugbank.ca/drugs/DB11904|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9913|http://zinc15.docking.org/substances/ZINC000068244727|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=R4009Y24AI

>  <LigID>  (229) 
nan

>  <pdbID>  (229) 
nan

>  <Type>  (229) 
nan

>  <RoF>  (229) 
2

>  <MW>  (229) 
562.2

>  <LogP>  (229) 
5

>  <TPSA>  (229) 
99.2

>  <HBA>  (229) 
8

>  <HBD>  (229) 
2

>  <NRB>  (229) 
7

>  <Indications>  (229) 
nan

>  <Targets>  (229) 
BCR; ABL1; PDGFRB; KIT

>  <Kinase families>  (229) 
Tyr<br>Atypical

>  <Canonical_Smiles>  (229) 
Cc1c(cc(cn1)NC(=O)c2ccc(c(c2)C(F)(F)F)CN3CCN(CC3)C)Nc4nccc(n4)c5cccnc5

>  <InChiKey>  (229) 
BJCJYEYYYGBROF-UHFFFAOYSA-N

>  <First_Approval>  (229) 
nan

>  <SC_Patent>  (229) 
None

>  <Chirality>  (229) 
Achiral Molecule

>  <Synonyms>  (229) 
FLUMATINIB | HH-GV678 | HHGV-678

>  <FDA_approved>  (229) 
N

>  <Melting points>  (229) 


$$$$
Fasudil
     RDKit          2D

 20 22  0  0  0  0  0  0  0  0999 V2000
    2.7967   -2.7203    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8432   -1.6457    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4359   -0.2021    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4825    0.8725    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0751    2.3161    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.6213    2.6852    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5747    1.6106    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9820    0.1670    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9355   -0.9076    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3428   -2.3512    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5184   -0.5385    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8875   -1.9924    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1494    0.9154    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9723   -0.1695    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9357   -1.3192    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4352   -1.2829    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3418   -0.0879    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9727    1.3660    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6059    1.9839    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2706    1.3006    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  2  0
 11 13  2  0
 11 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 10  1  1  0
  8  3  1  0
 20 14  1  0
M  END
>  <BrandName>  (230) 
nan

>  <Phase>  (230) 
4.0

>  <Applicants>  (230) 
Asahi Kasei Pharma Corp

>  <Links>  (230) 
|http://www.chemspider.com/Chemical-Structure.3426.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL38380|http://pubchem.ncbi.nlm.nih.gov/compound/3547|http://www.drugbank.ca/drugs/DB08162| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=M77|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/M77|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5181|http://zinc15.docking.org/substances/ZINC000000006486|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=Q0CH43PGXS|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=14027

>  <LigID>  (230) 
'M77'

>  <pdbID>  (230) 
1q8w 2esm 2f2u 2gni 3tku 5lcp 5nw8 5o0e 5ok3 5vef 6em2 6emb 6ers 6erw 6i2a 6i2c

>  <Type>  (230) 
nan

>  <RoF>  (230) 
0

>  <MW>  (230) 
291.1

>  <LogP>  (230) 
1.2

>  <TPSA>  (230) 
62.3

>  <HBA>  (230) 
4

>  <HBD>  (230) 
1

>  <NRB>  (230) 
2

>  <Indications>  (230) 
Fasudil is a potent inhibitor of the Rho-kinases ROCK1 and ROCK2.

>  <Targets>  (230) 
nan

>  <Kinase families>  (230) 


>  <Canonical_Smiles>  (230) 
c1cc2cnccc2c(c1)S(=O)(=O)N3CCCNCC3

>  <InChiKey>  (230) 
NGOGFTYYXHNFQH-UHFFFAOYSA-N

>  <First_Approval>  (230) 
nan

>  <SC_Patent>  (230) 
None

>  <Chirality>  (230) 
Achiral Molecule

>  <Synonyms>  (230) 
AT 877 | AT-877 | FASUDIL | HA 1077 | HA-1077 | ZK-258594

>  <FDA_approved>  (230) 
N

>  <Melting points>  (230) 


$$$$
Erlotinib
     RDKit          2D

 29 31  0  0  0  0  0  0  0  0999 V2000
   -1.2256    7.2656    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8069    5.8253    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8450    4.7425    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4263    3.3021    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4644    2.2193    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0457    0.7789    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5890    0.4213    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1703   -1.0191    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2083   -2.1018    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6651   -1.7442    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0838   -0.3038    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5405    0.0538    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5786   -1.0290    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.0353   -0.6714    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.0734   -1.7542    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -9.5302   -1.3966    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7897   -3.5422    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.6671   -3.8998    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7052   -2.8171    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.2865   -1.3767    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3245   -0.2939    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.7813   -0.6515    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2000   -2.0919    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6567   -2.4495    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6948   -1.3667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2761    0.0737    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8194    0.4313    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3142    1.1565    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3523    2.2392    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
  9 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 26 28  1  0
 28 29  3  0
 11  6  1  0
 20  8  1  0
 27 22  1  0
M  END
>  <BrandName>  (231) 
Tarceva

>  <Phase>  (231) 
4.0

>  <Applicants>  (231) 
Osi Pharmaceuticals

>  <Links>  (231) 
|http://www.chemspider.com/Chemical-Structure.154044.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL553|http://pubchem.ncbi.nlm.nih.gov/compound/176870|http://www.drugbank.ca/drugs/DB00530| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=AQ4|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/AQ4|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4920|http://zinc15.docking.org/substances/ZINC01546066|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=J4T82NDH7E|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=5446

>  <LigID>  (231) 
'AQ4'

>  <pdbID>  (231) 
1m17 4hjo 6dwn

>  <Type>  (231) 
1.5

>  <RoF>  (231) 
0

>  <MW>  (231) 
393.2

>  <LogP>  (231) 
3.4

>  <TPSA>  (231) 
74.7

>  <HBA>  (231) 
7

>  <HBD>  (231) 
1

>  <NRB>  (231) 
10

>  <Indications>  (231) 
For the treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of at least one prior chemotherapy regimen. Also for use, in combination with gemcitabine, as the first-line treatment of patients with locally advanced, unresectable or metastatic pancreatic cancer.

>  <Targets>  (231) 
EGFR; NR1I2

>  <Kinase families>  (231) 
Tyr<br>(*)

>  <Canonical_Smiles>  (231) 
COCCOc1cc2c(cc1OCCOC)ncnc2Nc3cccc(c3)C#C

>  <InChiKey>  (231) 
AAKJLRGGTJKAMG-UHFFFAOYSA-N

>  <First_Approval>  (231) 
2004

>  <SC_Patent>  (231) 
US-6900221-B1

>  <Chirality>  (231) 
Achiral Molecule

>  <Synonyms>  (231) 
CP-358,774 | CP-358774 | CP-35877401 | ERLOTINIB | OSI-774 | R-1415 | RG-1415 | RO-508231 | TARCEVA

>  <FDA_approved>  (231) 
Y

>  <Melting points>  (231) 


$$$$
Erdafitinib
     RDKit          2D

 33 36  0  0  0  0  0  0  0  0999 V2000
   -4.3196    6.0890    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2763    4.5897    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5532    3.8025    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9562    3.8774    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9130    2.3780    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5929    1.6658    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5497    0.1664    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2296   -0.5459    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1864   -2.0452    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1338   -2.7575    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4106   -1.9704    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3674   -0.4710    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0473    0.2413    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6443    0.3161    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.9644   -0.3961    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0076   -1.8955    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7307   -2.6826    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.2413    0.3910    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3551    1.8867    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8127    2.2407    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.5998    0.9638    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.6286   -0.1794    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0955    0.8500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8266   -0.6207    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1467    0.0915    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4236   -0.6956    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3804   -2.1950    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0602   -2.9072    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7834   -2.1201    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0170   -4.4066    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2939   -5.1937    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.7437    0.0167    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.7869    1.5161    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 15 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  1  0
 21 23  1  0
  7 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 28 30  1  0
 30 31  1  0
 26 32  1  0
 32 33  1  0
 13  8  1  0
 17 11  1  0
 22 18  2  0
 29 24  1  0
M  END
>  <BrandName>  (232) 
Balversa

>  <Phase>  (232) 
4.0

>  <Applicants>  (232) 
Janssen

>  <Links>  (232) 
|http://www.chemspider.com/Chemical-Structure.35308353.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3545376|http://pubchem.ncbi.nlm.nih.gov/compound/67462786|http://www.drugbank.ca/drugs/DB12147| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=5SF|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/5SF|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9039|http://zinc15.docking.org/substances/ZINC000168520308|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=890E37NHMV

>  <LigID>  (232) 
'5SF'

>  <pdbID>  (232) 
5ew8

>  <Type>  (232) 
1

>  <RoF>  (232) 
0

>  <MW>  (232) 
446.2

>  <LogP>  (232) 
4.2

>  <TPSA>  (232) 
77.3

>  <HBA>  (232) 
8

>  <HBD>  (232) 
1

>  <NRB>  (232) 
9

>  <Indications>  (232) 
On april 2019, FDA approved erdafitinib to treat adult patients with locally advanced or metastatic bladder cancer

>  <Targets>  (232) 
FGFR1

>  <Kinase families>  (232) 
Tyr

>  <Canonical_Smiles>  (232) 
CC(C)NCCN(c1ccc2c(c1)nc(cn2)c3cnn(c3)C)c4cc(cc(c4)OC)OC

>  <InChiKey>  (232) 
OLAHOMJCDNXHFI-UHFFFAOYSA-N

>  <First_Approval>  (232) 
2019

>  <SC_Patent>  (232) 
US-8895601-B2

>  <Chirality>  (232) 
Achiral Molecule

>  <Synonyms>  (232) 
BALVERSA | ERDAFITINIB | JNJ-42756493

>  <FDA_approved>  (232) 
Y

>  <Melting points>  (232) 


$$$$
Encorafenib
     RDKit          2D

 36 38  0  0  0  0  0  0  0  0999 V2000
   -5.9184    3.4437    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7118    2.5525    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3368    3.1519    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1302    2.2607    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7552    2.8600    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5867    4.3506    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.7884    4.9499    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9950    4.0587    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8265    2.5682    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4514    1.9689    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.0331    1.6771    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4632    2.1294    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3354    0.9090    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.4442   -0.2976    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.0213    0.1771    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8009   -0.6950    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4354   -0.0742    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7850   -0.9463    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6399   -2.4393    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7256   -3.0601    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9460   -2.1880    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3115   -2.8088    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.8707   -4.5531    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3497   -5.4252    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2219   -4.2048    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.5224   -6.6456    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5701   -6.2974    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1505   -0.3255    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    6.8353    0.8972    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5751   -0.4077    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5955    2.1903    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8803    1.0620    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2554    0.4627    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.4620    1.3538    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4239   -1.0278    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -7.7989   -1.6272    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  1
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 20 23  1  0
 23 24  1  0
 24 25  2  0
 24 26  2  0
 24 27  1  0
 18 28  1  0
 13 29  1  0
 29 30  1  0
 29 31  1  0
  2 32  1  0
 32 33  1  0
 33 34  2  0
 33 35  1  0
 35 36  1  0
 10  5  1  0
 15 11  1  0
 21 16  1  0
M  END
>  <BrandName>  (233) 
Braftovi

>  <Phase>  (233) 
4.0

>  <Applicants>  (233) 
Novartis

>  <Links>  (233) 
|http://www.chemspider.com/Chemical-Structure.28536139.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3301612|http://pubchem.ncbi.nlm.nih.gov/compound/50922675|http://www.drugbank.ca/drugs/DB11718|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7908|http://zinc15.docking.org/substances/ZINC000068249103|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=8L7891MRB6|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221688

>  <LigID>  (233) 
nan

>  <pdbID>  (233) 
nan

>  <Type>  (233) 
nan

>  <RoF>  (233) 
1

>  <MW>  (233) 
539.2

>  <LogP>  (233) 
3.9

>  <TPSA>  (233) 
140.1

>  <HBA>  (233) 
9

>  <HBD>  (233) 
3

>  <NRB>  (233) 
9

>  <Indications>  (233) 
On June 27, 2018, the Food and Drug Administration approved encorafenib and binimetinib in combination patients with unresectable or metastatic melanoma with a BRAF V600E or V600K mutation, as detected by an FDA-approved test.

>  <Targets>  (233) 
BRAF

>  <Kinase families>  (233) 
TKL

>  <Canonical_Smiles>  (233) 
C[C@@H](CNc1nccc(n1)c2cn(nc2c3cc(cc(c3F)NS(=O)(=O)C)Cl)C(C)C)NC(=O)OC

>  <InChiKey>  (233) 
CMJCXYNUCSMDBY-ZDUSSCGKSA-N

>  <First_Approval>  (233) 
2018

>  <SC_Patent>  (233) 
US-8501758-B2

>  <Chirality>  (233) 
Single Stereoisomer

>  <Synonyms>  (233) 
BRAFTOVI | ENCORAFENIB | LGX-818 | NVP-LGX-818-NXA | NVP-LGX818 | NVP-LGX818-NXA

>  <FDA_approved>  (233) 
Y

>  <Melting points>  (233) 


$$$$
Duvelisib
     RDKit          2D

 30 34  0  0  0  0  0  0  0  0999 V2000
   -0.9446    1.7228    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6820    0.2459    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7282   -0.2651    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9908   -1.7420    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4011   -2.2530    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6636   -3.7298    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0739   -4.2409    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2216   -3.2751    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9590   -1.7982    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5488   -1.2872    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2862    0.1896    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4339    1.1555    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.8759    0.7007    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.6134    2.1775    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7611    3.1433    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4985    4.6202    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0883    5.1312    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0594    4.1654    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2031    2.6886    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1067   -0.8324    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -1.8297   -0.7199    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2400   -0.2089    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3877   -1.1747    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7980   -0.6636    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.7198   -1.8470    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8792   -3.0893    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4379   -2.6738    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0605    0.8132    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9128    1.7790    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5025    1.2680    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  1
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
  9 20  1  0
  2 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  1  0
 26 27  2  0
 24 28  1  0
 28 29  2  0
 29 30  1  0
 13  3  1  0
 10  5  1  0
 19 14  1  0
 30 22  2  0
 27 23  1  0
M  END
>  <BrandName>  (234) 
Copiktra

>  <Phase>  (234) 
4.0

>  <Applicants>  (234) 
Infinity Pharmacueticals

>  <Links>  (234) 
|http://www.chemspider.com/Chemical-Structure.28637766.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3039502|http://pubchem.ncbi.nlm.nih.gov/compound/50905713|http://www.drugbank.ca/drugs/DB11952|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7795|http://zinc15.docking.org/substances/ZINC000088346058|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=610V23S0JI|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50193013

>  <LigID>  (234) 
nan

>  <pdbID>  (234) 
nan

>  <Type>  (234) 
nan

>  <RoF>  (234) 
0

>  <MW>  (234) 
416.1

>  <LogP>  (234) 
4.5

>  <TPSA>  (234) 
88.5

>  <HBA>  (234) 
6

>  <HBD>  (234) 
2

>  <NRB>  (234) 
4

>  <Indications>  (234) 
On october 27, 2018, the FDA approved duvelisib to treat relapsed or refractory chronic lymphocytic leukemia, small lymphocytic lymphoma and follicular lymphoma

>  <Targets>  (234) 
PIK3CD; PIK3CG

>  <Kinase families>  (234) 
Atypical

>  <Canonical_Smiles>  (234) 
C[C@@H](c1cc2cccc(c2c(=O)n1c3ccccc3)Cl)Nc4c5c([nH]cn5)ncn4

>  <InChiKey>  (234) 
SJVQHLPISAIATJ-ZDUSSCGKSA-N

>  <First_Approval>  (234) 
2018

>  <SC_Patent>  (234) 
US-8193182-B2

>  <Chirality>  (234) 
Single Stereoisomer

>  <Synonyms>  (234) 
COPIKTRA | DUVELISIB | INK-1147 | INK-1197 | IPI-145

>  <FDA_approved>  (234) 
Y

>  <Melting points>  (234) 
>190 C

$$$$
Dasatinib
     RDKit          2D

 33 36  0  0  0  0  0  0  0  0999 V2000
   -2.3701   -1.7411    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6146   -0.9038    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9621   -1.5628    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2066   -0.7255    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1037    0.7710    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7562    1.4301    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5117    0.5927    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1643    1.2518    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0613    2.7483    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3059    3.5856    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7139    3.4074    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4551    4.8849    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0301    5.0953    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.6891    3.7479    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6113    2.7047    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    3.1667    3.4891    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.6813    2.0801    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7184    0.9300    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2331   -0.4790    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7106   -0.7378    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.6734    0.4124    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1588    1.8214    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.1509    0.1536    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2702   -1.6291    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.7927   -1.3704    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1702   -2.5205    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3445   -3.9295    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.8220   -4.1883    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7848   -3.0381    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6184   -5.0796    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1038   -6.4886    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0667   -7.6388    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6533    2.9265    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 14 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 21 23  1  0
 19 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 27 30  1  0
 30 31  1  0
 31 32  1  0
  6 33  1  0
  7  2  1  0
 15 11  1  0
 22 17  1  0
 29 24  1  0
M  END
>  <BrandName>  (235) 
Dasatinib;Sprycel

>  <Phase>  (235) 
4.0

>  <Applicants>  (235) 
Bristol Myers Squibb

>  <Links>  (235) 
|http://www.chemspider.com/Chemical-Structure.2323020.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL1421|http://pubchem.ncbi.nlm.nih.gov/compound/3062316|http://www.drugbank.ca/drugs/DB01254| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=1N1|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/1N1|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5678|http://zinc15.docking.org/substances/ZINC21982951|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=X78UG0A0RN|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13216

>  <LigID>  (235) 
'1N1'

>  <pdbID>  (235) 
2gqg 2y6o 2zva 3g5d 3k54 3lfa 3oct 3oht 3qlg 3sxr 4qms 4xey 4xli 5bvw 5h2u 5i9y 5owr 5vcv 6bsd 6fnm

>  <Type>  (235) 
1

>  <RoF>  (235) 
0

>  <MW>  (235) 
487.2

>  <LogP>  (235) 
3.3

>  <TPSA>  (235) 
106.5

>  <HBA>  (235) 
9

>  <HBD>  (235) 
3

>  <NRB>  (235) 
7

>  <Indications>  (235) 
For the treatment of adults with chronic, accelerated, or myeloid or lymphoid blast phase chronic myeloid leukemia with resistance or intolerance to prior therapy. Also indicated for the treatment of adults with Philadelphia chromosome-positive acute lymphoblastic leukemia with resistance or intolerance to prior therapy.

>  <Targets>  (235) 
ABL1; SRC; EPHA2; LCK; YES1; KIT; PDGFRB; ABL2; FYN

>  <Kinase families>  (235) 
Tyr

>  <Canonical_Smiles>  (235) 
Cc1cccc(c1NC(=O)c2cnc(s2)Nc3cc(nc(n3)C)N4CCN(CC4)CCO)Cl

>  <InChiKey>  (235) 
ZBNZXTGUTAYRHI-UHFFFAOYSA-N

>  <First_Approval>  (235) 
2006

>  <SC_Patent>  (235) 
US-6596746-B1

>  <Chirality>  (235) 
Achiral Molecule

>  <Synonyms>  (235) 
BMS-354825 | BMS-354825 HYDRATE | BMS-354825-03 | DASATINIB | DASATINIB HYDRATE | DASATINIB MONOHYDRATE | SPRYCEL

>  <FDA_approved>  (235) 
Y

>  <Melting points>  (235) 
280-286 C

$$$$
Dacomitinib
     RDKit          2D

 33 36  0  0  0  0  0  0  0  0999 V2000
   -2.4626    3.7377    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1170    2.2781    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6802    1.8475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4111    2.8767    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8480    2.4461    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1936    0.9865    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1023   -0.0426    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3346    0.3879    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4259   -0.6412    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8627   -0.2107    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2083    1.2490    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9540   -1.2398    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3909   -0.8093    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4822   -1.8384    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.9191   -1.4079    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -8.2647    0.0518    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.7016    0.4823    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.7929   -0.5468    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.4473   -2.0065    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.0104   -2.4370    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6305    0.5560    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7218    1.5851    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.3762    3.0447    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9393    3.4752    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.9761   -0.9037    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.4130   -1.3342    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7586   -2.7939    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1955   -3.2244    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2868   -2.1953    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9412   -0.7356    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5043   -0.3051    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0325    0.2935    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    9.7237   -2.6258    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
  6 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 21 25  1  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 30 32  1  0
 29 33  1  0
  8  3  1  0
 24  5  1  0
 20 15  1  0
 31 26  1  0
M  END
>  <BrandName>  (236) 
Vizimpro

>  <Phase>  (236) 
4.0

>  <Applicants>  (236) 
Pfizer

>  <Links>  (236) 
|http://www.chemspider.com/Chemical-Structure.9685914.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL2110732|http://pubchem.ncbi.nlm.nih.gov/compound/11511120|http://www.drugbank.ca/drugs/DB11963| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=1C9|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/1C9|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7422|http://zinc15.docking.org/substances/ZINC000072266312|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=2XJX250C20|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=112499

>  <LigID>  (236) 
'1C9'

>  <pdbID>  (236) 
4i23 4i24

>  <Type>  (236) 
1

>  <RoF>  (236) 
1

>  <MW>  (236) 
469.2

>  <LogP>  (236) 
5.2

>  <TPSA>  (236) 
79.4

>  <HBA>  (236) 
6

>  <HBD>  (236) 
2

>  <NRB>  (236) 
7

>  <Indications>  (236) 
On october 27, 2018, the FDA approved dacomitinib to treat metastatic non-small-cell lung cancer

>  <Targets>  (236) 
EGFR

>  <Kinase families>  (236) 
Tyr

>  <Canonical_Smiles>  (236) 
COc1cc2c(cc1NC(=O)/C=C/CN3CCCCC3)c(ncn2)Nc4ccc(c(c4)Cl)F

>  <InChiKey>  (236) 
LVXJQMNHJWSHET-AATRIKPKSA-N

>  <First_Approval>  (236) 
2018

>  <SC_Patent>  (236) 
US-7772243-B2

>  <Chirality>  (236) 
Achiral Molecule

>  <Synonyms>  (236) 
DACOMITINIB | DACOMITINIB HYDRATE | PF-00299804

>  <FDA_approved>  (236) 
Y

>  <Melting points>  (236) 
184-187 C

$$$$
Dabrafenib
     RDKit          2D

 35 38  0  0  0  0  0  0  0  0999 V2000
   -6.2980    2.8387    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0085    3.6050    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7190    4.3713    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7748    4.8945    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2422    2.3155    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7486    2.1775    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4183    0.7143    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7078   -0.0520    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8350    0.9376    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8458   -1.5456    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6213   -2.4120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7593   -3.9056    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1219   -4.5329    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3464   -3.6666    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2084   -2.1729    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.7089   -4.2939    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0404    0.1214    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8649   -1.3682    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5130   -1.9611    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7154   -1.0642    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5398    0.4255    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1619    1.0183    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0136    2.5080    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.7422    1.3224    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.1200    0.7295    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    3.5272   -0.6484    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.7129    2.1074    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.4979    0.1367    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6735   -1.3530    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0513   -1.9458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2537   -1.0489    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0781    0.4407    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7003    1.0336    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5247    2.5233    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    4.4711   -2.2499    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  2  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  8 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 14 16  1  0
  7 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 21 24  1  0
 24 25  1  0
 25 26  2  0
 25 27  2  0
 25 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 32  1  0
 32 33  2  0
 33 34  1  0
 29 35  1  0
  9  5  1  0
 15 10  1  0
 22 17  1  0
 33 28  1  0
M  END
>  <BrandName>  (237) 
Tafinlar

>  <Phase>  (237) 
4.0

>  <Applicants>  (237) 
GlaxoSmithKline

>  <Links>  (237) 
|http://www.chemspider.com/Chemical-Structure.25948204.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL2028663|http://pubchem.ncbi.nlm.nih.gov/compound/44462760|http://www.drugbank.ca/drugs/DB08912| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=P06|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/P06|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6494|http://zinc15.docking.org/substances/ZINC000068153186|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=QGP4HA4G1B|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50428286

>  <LigID>  (237) 
'P06'

>  <pdbID>  (237) 
4xv2 5csw 5hie 6hj2

>  <Type>  (237) 
1.5

>  <RoF>  (237) 
2

>  <MW>  (237) 
519.1

>  <LogP>  (237) 
5.4

>  <TPSA>  (237) 
110.9

>  <HBA>  (237) 
7

>  <HBD>  (237) 
2

>  <NRB>  (237) 
5

>  <Indications>  (237) 
Dabrafenib is indicated for the treatment of patients with unresectable or metastatic melanoma with BRAF V600E mutation as detected by an FDA-approved test.

>  <Targets>  (237) 
BRAF; RAF1; SIK1; NEK11; LIMK1

>  <Kinase families>  (237) 
CAMK<br>NEK<br>TKL

>  <Canonical_Smiles>  (237) 
CC(C)(C)c1nc(c(s1)c2ccnc(n2)N)c3cccc(c3F)NS(=O)(=O)c4c(cccc4F)F

>  <InChiKey>  (237) 
BFSMGDJOXZAERB-UHFFFAOYSA-N

>  <First_Approval>  (237) 
2013

>  <SC_Patent>  (237) 
US-7994185-B2

>  <Chirality>  (237) 
Achiral Molecule

>  <Synonyms>  (237) 
DABRAFENIB | GSK-2118436 | GSK-2118436A | GSK2118436 | GSK2118436A | TAFINLAR

>  <FDA_approved>  (237) 
Y

>  <Melting points>  (237) 


$$$$
Crizotinib
     RDKit          2D

 30 33  0  0  0  0  0  0  0  0999 V2000
    1.1739    0.6682    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5352    0.0383    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7614    0.9022    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1227    0.2723    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3490    1.1362    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2139    2.6301    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8526    3.2601    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6263    2.3961    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2650    3.0261    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    4.7175    4.7540    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    5.2578   -1.2216    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    2.6703   -1.4556    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.4441   -2.3196    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0828   -1.6896    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1434   -2.5535    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0083   -4.0474    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3530   -4.6774    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.5792   -3.8135    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9405   -4.4434    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5047   -1.9236    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8145   -2.6546    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9145   -1.6348    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2846   -0.2735    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7952   -0.4520    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0156    1.0363    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2468    2.3243    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9778    3.6341    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4777    3.6559    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -7.2465    2.3679    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5155    1.0581    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  6
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  7 10  1  0
  4 11  1  0
  2 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 15 20  1  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  1  0
 23 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
  8  3  1  0
 18 13  1  0
 24 20  2  0
 30 25  1  0
M  END
>  <BrandName>  (238) 
Xalkori

>  <Phase>  (238) 
4.0

>  <Applicants>  (238) 
Pfizer

>  <Links>  (238) 
|http://www.chemspider.com/Chemical-Structure.9801307.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL601719|http://pubchem.ncbi.nlm.nih.gov/compound/11626560|http://www.drugbank.ca/drugs/DB08865| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=VGH|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/VGH|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4903|http://zinc15.docking.org/substances/ZINC000035902489|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=53AH36668S|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50306682

>  <LigID>  (238) 
'VGH'

>  <pdbID>  (238) 
2wgj 2xp2 2yfx 3zbf 4anq 4ans 4c9w 5aaa 5aab 5aac 6imz

>  <Type>  (238) 
1

>  <RoF>  (238) 
1

>  <MW>  (238) 
449.1

>  <LogP>  (238) 
5

>  <TPSA>  (238) 
78

>  <HBA>  (238) 
6

>  <HBD>  (238) 
2

>  <NRB>  (238) 
5

>  <Indications>  (238) 
Crizotinib is used for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) that is anaplastic-lymphoma kinase (ALK)-positive as detected by a FDA-approved test.

>  <Targets>  (238) 
ALK; MET

>  <Kinase families>  (238) 
Tyr

>  <Canonical_Smiles>  (238) 
C[C@H](c1c(ccc(c1Cl)F)Cl)Oc2cc(cnc2N)c3cnn(c3)C4CCNCC4

>  <InChiKey>  (238) 
KTEIFNKAUNYNJU-GFCCVEGCSA-N

>  <First_Approval>  (238) 
2011

>  <SC_Patent>  (238) 
US-7230098-B2

>  <Chirality>  (238) 
Single Stereoisomer

>  <Synonyms>  (238) 
CRIZOTINIB | PF-02341066 | PF-2341066 | XALKORI

>  <FDA_approved>  (238) 
Y

>  <Melting points>  (238) 


$$$$
Cobimetinib
     RDKit          2D

 30 33  0  0  0  0  0  0  0  0999 V2000
   -6.1573    0.1522    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6426    1.5715    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6561    2.7015    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1843    2.4121    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6990    0.9928    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6855   -0.1371    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2271    0.7035    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7418   -0.7159    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7283   -1.8458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2430   -3.2651    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7712   -3.5545    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2153   -2.4245    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2700   -1.0052    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7165    0.1247    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2312    1.5441    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.1883   -0.1646    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.0245   -1.4100    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2698   -0.5738    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4337    0.6715    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1059   -1.8192    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.5152    0.2623    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8619   -0.3981    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.1073    0.4380    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0058    1.9346    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6591    2.5950    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4137    1.7589    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2295   -4.3951    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2002   -1.5565    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1978    3.5421    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -8.1145    1.8609    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 14 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 18 20  1  0
 21 18  1  6
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 10 27  1  0
  9 28  1  0
  4 29  1  0
  2 30  1  0
  6  1  1  0
 13  8  1  0
 19 16  1  0
 26 21  1  0
M  END
>  <BrandName>  (239) 
Cotellic

>  <Phase>  (239) 
4.0

>  <Applicants>  (239) 
Hoffmann-La Roche

>  <Links>  (239) 
|http://www.chemspider.com/Chemical-Structure.17349374.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL2146883|http://pubchem.ncbi.nlm.nih.gov/compound/16222096|http://www.drugbank.ca/drugs/DB05239| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=EUI|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/EUI|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7626|http://zinc15.docking.org/substances/ZINC000060325170|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=ER29L26N1X|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50391802

>  <LigID>  (239) 
'EUI'

>  <pdbID>  (239) 
4an2 4lmn

>  <Type>  (239) 
3

>  <RoF>  (239) 
1

>  <MW>  (239) 
531.1

>  <LogP>  (239) 
3.8

>  <TPSA>  (239) 
64.6

>  <HBA>  (239) 
4

>  <HBD>  (239) 
3

>  <NRB>  (239) 
4

>  <Indications>  (239) 
For the treatment of patients with unresectable or metastatic melanoma with a BRAF V600E or V600K mutation. Cobimetinib is used in combination with vemurafenib, a BRAF inhibitor.

>  <Targets>  (239) 
MAP2K1

>  <Kinase families>  (239) 
STE

>  <Canonical_Smiles>  (239) 
c1c(cc(c(c1)Nc2c(c(ccc2C(=O)N3C[C@@](C3)(O)[C@H]4NCCCC4)F)F)F)I

>  <InChiKey>  (239) 
BSMCAPRUBJMWDF-KRWDZBQOSA-N

>  <First_Approval>  (239) 
2015

>  <SC_Patent>  (239) 
US-7803839-B2

>  <Chirality>  (239) 
Single Stereoisomer

>  <Synonyms>  (239) 
COBIMETINIB | COTELLIC | GDC-0973 | RG 7420 | RG-7421 | XL-518

>  <FDA_approved>  (239) 
Y

>  <Melting points>  (239) 


$$$$
Ceritinib
     RDKit          2D

 38 41  0  0  0  0  0  0  0  0999 V2000
    5.7267   -3.2197    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7768   -2.0588    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2965   -2.3010    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3465   -1.1402    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8769    0.2629    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3572    0.5052    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3071   -0.6557    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7874   -0.4134    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7374   -1.5743    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2177   -1.3321    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7481    0.0711    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.7981    1.2319    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3178    0.9897    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9269    1.4238    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4573    2.8269    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5074    3.9878    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9376    3.0692    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8662   -1.3824    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0837   -0.2215    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4466    1.1816    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5033    2.3424    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9836    2.1002    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5140    0.6971    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5641   -0.4638    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9943    0.4548    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5247   -0.9483    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5747   -2.1091    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1051   -3.5122    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5854   -3.7545    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5353   -2.5936    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0050   -1.1905    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.9549   -0.0297    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7941    0.9203    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -8.1158   -0.9796    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -7.9049    1.1312    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.3852    0.8890    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.3745    2.5343    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9336    3.2611    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
  5 14  1  0
 14 15  1  0
 15 16  1  0
 15 17  1  0
  4 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 23 25  1  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 32  1  0
 32 33  2  0
 32 34  2  0
 32 35  1  0
 35 36  1  0
 35 37  1  0
 22 38  1  0
  7  2  1  0
 13  8  1  0
 24 19  1  0
 31 26  1  0
M  END
>  <BrandName>  (240) 
Zykadia

>  <Phase>  (240) 
4.0

>  <Applicants>  (240) 
Novartis

>  <Links>  (240) 
|http://www.chemspider.com/Chemical-Structure.29315053.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL2403108|http://pubchem.ncbi.nlm.nih.gov/compound/57379345|http://www.drugbank.ca/drugs/DB09063| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=4MK|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/4MK|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7397|http://zinc15.docking.org/substances/ZINC000096272772|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=K418KG2GET|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50436850

>  <LigID>  (240) 
'4MK'

>  <pdbID>  (240) 
4mkc

>  <Type>  (240) 
1

>  <RoF>  (240) 
2

>  <MW>  (240) 
557.2

>  <LogP>  (240) 
6.4

>  <TPSA>  (240) 
105.2

>  <HBA>  (240) 
8

>  <HBD>  (240) 
3

>  <NRB>  (240) 
9

>  <Indications>  (240) 
Ceritinib is a kinase inhibitor indicated for the treatment of patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) who have progressed on or are intolerant to crizotinib. This indication is approved under accelerated approval based on tumor response rate and duration of response. An improvement in survival or disease-related symptoms has not been established. Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trials.

>  <Targets>  (240) 
ALK

>  <Kinase families>  (240) 
Tyr

>  <Canonical_Smiles>  (240) 
Cc1cc(c(cc1C2CCNCC2)OC(C)C)Nc3ncc(c(n3)Nc4ccccc4S(=O)(=O)C(C)C)Cl

>  <InChiKey>  (240) 
VERWOWGGCGHDQE-UHFFFAOYSA-N

>  <First_Approval>  (240) 
2014

>  <SC_Patent>  (240) 
US-7153964-B2

>  <Chirality>  (240) 
Achiral Molecule

>  <Synonyms>  (240) 
CERITINIB | LDK-378 | LDK378 | NVP-LDK-378-NX | NVP-LDK378-NX | ZYKADIA

>  <FDA_approved>  (240) 
Y

>  <Melting points>  (240) 


$$$$
Cabozantinib
     RDKit          2D

 37 41  0  0  0  0  0  0  0  0999 V2000
   -9.8401   -1.8981    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.3423   -1.9781    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -7.5240   -0.7209    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0262   -0.8009    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2079    0.4563    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7101    0.3763    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8918    1.6334    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5715    2.9706    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0693    3.0506    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8876    1.7935    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.3854    1.8735    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.2037    0.6163    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.7015    0.6963    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  -10.3812    2.0335    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0304   -0.9609    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5326   -1.0410    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8529   -2.3782    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6449   -2.4582    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4632   -1.2010    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7835    0.1362    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7143    0.2162    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9610   -1.2810    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.6407   -2.6182    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8224   -3.8754    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.1385   -2.6982    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5187   -3.2857    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3198   -4.1872    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4774   -1.2370    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3814   -0.2129    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.9123   -0.7999    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.2512    0.6613    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6861    1.0984    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0250    2.5596    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9290    3.5837    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4941    3.1466    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1552    1.6854    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2679    5.0449    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
  6 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 19 22  1  0
 22 23  1  0
 23 24  2  0
 23 25  1  0
 25 26  1  0
 26 27  1  0
 25 28  1  0
 28 29  2  0
 28 30  1  0
 30 31  1  0
 31 32  2  0
 32 33  1  0
 33 34  2  0
 34 35  1  0
 35 36  2  0
 34 37  1  0
 12  3  1  0
 10  5  1  0
 21 16  1  0
 27 25  1  0
 36 31  1  0
M  END
>  <BrandName>  (241) 
Cabometyx;Cometriq

>  <Phase>  (241) 
4.0

>  <Applicants>  (241) 
Exelixis

>  <Links>  (241) 
|http://www.chemspider.com/Chemical-Structure.25948202.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL2105717|http://pubchem.ncbi.nlm.nih.gov/compound/25102847|http://www.drugbank.ca/drugs/DB08875|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5887|http://zinc15.docking.org/substances/ZINC000070466416|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=1C39JW444G|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50021574

>  <LigID>  (241) 
nan

>  <pdbID>  (241) 
nan

>  <Type>  (241) 
2

>  <RoF>  (241) 
2

>  <MW>  (241) 
501.2

>  <LogP>  (241) 
5.5

>  <TPSA>  (241) 
98.8

>  <HBA>  (241) 
6

>  <HBD>  (241) 
2

>  <NRB>  (241) 
8

>  <Indications>  (241) 
For the treatment of metastatic medullary thyroid cancer and for the treatment of patients with advanced renal cell carcinoma (RCC) who have received prior anti-angiogenic therapy.

>  <Targets>  (241) 
MET; KDR; RET

>  <Kinase families>  (241) 
Tyr

>  <Canonical_Smiles>  (241) 
COc1cc2c(ccnc2cc1OC)Oc3ccc(cc3)NC(=O)C4(CC4)C(=O)Nc5ccc(cc5)F

>  <InChiKey>  (241) 
ONIQOQHATWINJY-UHFFFAOYSA-N

>  <First_Approval>  (241) 
2012

>  <SC_Patent>  (241) 
US-7579473-B2

>  <Chirality>  (241) 
Achiral Molecule

>  <Synonyms>  (241) 
BMS-907351 | CABOMETYX | CABOZANTINIB | COMETRIQ | XL-184 FREE BASE | XL184

>  <FDA_approved>  (241) 
Y

>  <Melting points>  (241) 


$$$$
Brigatinib
     RDKit          2D

 40 44  0  0  0  0  0  0  0  0999 V2000
  -13.2331   -0.7910    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -11.7428   -0.6209    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  -11.1449    0.7548    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.6546    0.9248    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.7622   -0.2808    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -9.3600   -1.6565    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.8504   -1.8266    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.2718   -0.1107    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.3794   -1.3164    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8891   -1.1463    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2912    0.2294    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1836    1.4350    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6740    1.2650    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8009    0.3995    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9084   -0.8061    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4181   -0.6361    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1798    0.7396    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7126    1.9453    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2030    1.7752    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1148    3.3209    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0072    4.5266    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6701    0.9097    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.5626   -0.2959    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9647   -1.6716    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.8571   -2.8773    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3475   -2.7072    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9454   -1.3315    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0529   -0.1259    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.4357   -1.1614    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.0336    0.2143    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1411    1.4199    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7390    2.7956    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2293    2.9657    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1218    1.7601    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5239    0.3844    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4163   -0.8213    0.0000 P   0  0  0  0  0  0  0  0  0  0  0  0
   10.3088   -2.0269    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.2107   -1.7137    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6220    0.0712    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2399   -3.9128    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  5  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 11 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 18 20  1  0
 20 21  1  0
 17 22  1  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 27 29  1  0
 29 30  1  0
 30 31  2  0
 31 32  1  0
 32 33  2  0
 33 34  1  0
 34 35  2  0
 35 36  1  0
 36 37  2  0
 36 38  1  0
 36 39  1  0
 26 40  1  0
  7  2  1  0
 13  8  1  0
 19 14  1  0
 28 23  1  0
 35 30  1  0
M  END
>  <BrandName>  (242) 
Alunbrig

>  <Phase>  (242) 
4.0

>  <Applicants>  (242) 
Ariad Pharmaceuticals

>  <Links>  (242) 
|http://www.chemspider.com/Chemical-Structure.34982928.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3545311|http://pubchem.ncbi.nlm.nih.gov/compound/68165256|http://www.drugbank.ca/drugs/DB12267| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=6GY|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/6GY|http://zinc15.docking.org/substances/ZINC000148723177|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=HYW8DB273J|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50185140

>  <LigID>  (242) 
'6GY'

>  <pdbID>  (242) 
6mx8

>  <Type>  (242) 
1

>  <RoF>  (242) 
2

>  <MW>  (242) 
583.3

>  <LogP>  (242) 
5.1

>  <TPSA>  (242) 
85.9

>  <HBA>  (242) 
9

>  <HBD>  (242) 
2

>  <NRB>  (242) 
8

>  <Indications>  (242) 
The anaplastic lymphoma kinase positive, metastatic non-small cell lung cancer (ALK+ NSCLC), represents only 3-5% of the NSCLC cancer cases, but the ALK mutation, overexpression and presence in several oncogenic fusion proteins in solid and hematologic tumors have pointed out the importance as well as its potential as a cancer therapy target. The ALK-related cases of NSCLC are associated with the presence of the fusion gene EML4-ALK which fused the ALK protein with the echinoderm microtubule-associated protein like-4 whose original function is the correct formation of microtubules. The presence of the aberrant fusion protein results in abnormal signaling that provokes increased cell growth, proliferation and survival. Crizotinib is indicated for the treatment of such cases but the presence of ALK kinase domain mutations confer resistance to the treatment. Thus, brigatinib is indicated for the treatment of patients with ALK+ NSCLC with intolerance to Crizotinib.

>  <Targets>  (242) 
ALK; EGFR

>  <Kinase families>  (242) 
Tyr

>  <Canonical_Smiles>  (242) 
CN1CCN(CC1)C2CCN(CC2)c3ccc(c(c3)OC)Nc4ncc(c(n4)Nc5ccccc5P(=O)(C)C)Cl

>  <InChiKey>  (242) 
AILRADAXUVEEIR-UHFFFAOYSA-N

>  <First_Approval>  (242) 
2017

>  <SC_Patent>  (242) 
US-9012462-B2

>  <Chirality>  (242) 
Achiral Molecule

>  <Synonyms>  (242) 
ALUNBRIG | AP-26113 | AP26113 | BRIGATINIB

>  <FDA_approved>  (242) 
Y

>  <Melting points>  (242) 


$$$$
Bosutinib
     RDKit          2D

 36 39  0  0  0  0  0  0  0  0999 V2000
  -12.5897   -0.0020    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -11.1128   -0.2640    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  -10.1474    0.8841    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.6705    0.6220    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.1589   -0.7880    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -9.1243   -1.9361    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.6013   -1.6741    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6820   -1.0501    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7166    0.0980    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2397   -0.1640    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2743    0.9840    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7973    0.7220    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2858   -0.6881    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1911   -0.9501    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1565    0.1979    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6450    1.6080    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8320    1.8700    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3435    3.2801    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3781    4.4282    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6335   -0.0641    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1450   -1.4742    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1796   -2.6222    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7027   -2.3602    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.6219   -1.7362    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0989   -1.9982    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.5989    1.0840    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.0758    0.8219    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5873   -0.5881    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0643   -0.8502    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0297    0.2979    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5181    1.7080    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0412    1.9700    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5296    3.3801    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    9.5066    0.0359    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    7.5758   -2.2602    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.0528   -2.5223    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  5  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 15 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 21 24  1  0
 24 25  3  0
 20 26  1  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 32 33  1  0
 30 34  1  0
 29 35  1  0
 35 36  1  0
  7  2  1  0
 17 12  1  0
 23 14  1  0
 32 27  1  0
M  END
>  <BrandName>  (243) 
Bosulif

>  <Phase>  (243) 
4.0

>  <Applicants>  (243) 
Wyeth

>  <Links>  (243) 
|http://www.chemspider.com/Chemical-Structure.4486102.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL288441|http://pubchem.ncbi.nlm.nih.gov/compound/5328940|http://www.drugbank.ca/drugs/DB06616| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=DB8|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/DB8|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5710|http://zinc15.docking.org/substances/ZINC000022448983|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=5018V4AEZ0|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4552

>  <LigID>  (243) 
'DB8'

>  <pdbID>  (243) 
3soa 3ue4 4mxo 4mxx 4mxy 4mxz 4qmn 5ajq 5i9x 5vc3 5vcy 6fdy 6op9

>  <Type>  (243) 
1

>  <RoF>  (243) 
2

>  <MW>  (243) 
529.2

>  <LogP>  (243) 
5.2

>  <TPSA>  (243) 
82.9

>  <HBA>  (243) 
8

>  <HBD>  (243) 
1

>  <NRB>  (243) 
9

>  <Indications>  (243) 
Treatment of chronic, accelerated, or blast phase Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia (CML) with resistance or intolerance to prior therapy in adult patients.

>  <Targets>  (243) 
BCR; ABL1; LYN; HCK; SRC; CDK2; MAP2K1; MAP2K2; MAP3K2; CAMK2G

>  <Kinase families>  (243) 
CAMK<br>Atypical<br>Tyr<br>STE<br>CMGC

>  <Canonical_Smiles>  (243) 
CN1CCN(CC1)CCCOc2cc3c(cc2OC)c(c(cn3)C#N)Nc4cc(c(cc4Cl)Cl)OC

>  <InChiKey>  (243) 
UBPYILGKFZZVDX-UHFFFAOYSA-N

>  <First_Approval>  (243) 
2012

>  <SC_Patent>  (243) 
US-7417148-B2

>  <Chirality>  (243) 
Achiral Molecule

>  <Synonyms>  (243) 
BOSULIF | BOSUTINIB | BOSUTINIB MONOHYDRATE | SK-606 | SKI-606

>  <FDA_approved>  (243) 
Y

>  <Melting points>  (243) 


$$$$
Binimetinib
     RDKit          2D

 27 29  0  0  0  0  0  0  0  0999 V2000
    5.7549   -2.6046    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0068   -1.3044    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.6189    0.0650    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5056    1.0703    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.2055    0.3222    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5152   -1.1455    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3991   -2.1476    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9731   -1.6820    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6634   -0.2143    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7796    0.7878    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4698    2.2555    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7625    0.2513    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0722    1.7190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0439    2.7211    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2658    4.1887    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6917    4.6543    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8079    3.6522    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4982    2.1846    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6143    1.1825    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0015    6.1220    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
   -0.1430   -2.6840    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1667   -4.1517    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5689   -2.2184    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6851   -3.2205    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1110   -2.7549    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2272   -3.7570    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6531   -3.2914    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
  9 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 16 20  1  0
  8 21  1  0
 21 22  2  0
 21 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
  6  2  1  0
 10  5  1  0
 18 13  1  0
M  END
>  <BrandName>  (244) 
Mektovi

>  <Phase>  (244) 
4.0

>  <Applicants>  (244) 
Novartis

>  <Links>  (244) 
|http://www.chemspider.com/Chemical-Structure.8463660.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3187723|http://pubchem.ncbi.nlm.nih.gov/compound/10288191|http://www.drugbank.ca/drugs/DB11967|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7921|http://zinc15.docking.org/substances/ZINC000038460704|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=181R97MR71

>  <LigID>  (244) 
nan

>  <pdbID>  (244) 
nan

>  <Type>  (244) 
nan

>  <RoF>  (244) 
0

>  <MW>  (244) 
440

>  <LogP>  (244) 
3

>  <TPSA>  (244) 
88.4

>  <HBA>  (244) 
6

>  <HBD>  (244) 
3

>  <NRB>  (244) 
6

>  <Indications>  (244) 
On June 27, 2018, the Food and Drug Administration approved encorafenib and binimetinib in combination patients with unresectable or metastatic melanoma with a BRAF V600E or V600K mutation, as detected by an FDA-approved test.

>  <Targets>  (244) 
MAP2K1

>  <Kinase families>  (244) 
STE

>  <Canonical_Smiles>  (244) 
Cn1cnc2c1cc(c(c2F)Nc3ccc(cc3F)Br)C(=O)NOCCO

>  <InChiKey>  (244) 
ACWZRVQXLIRSDF-UHFFFAOYSA-N

>  <First_Approval>  (244) 
2018

>  <SC_Patent>  (244) 
US-7777050-B2

>  <Chirality>  (244) 
Achiral Molecule

>  <Synonyms>  (244) 
ARRY 438162 | ARRY-162 | ARRY-438162 | BINIMETINIB | MEK-162 | MEK162 | MEKTOVI | NVP-MEK162

>  <FDA_approved>  (244) 
Y

>  <Melting points>  (244) 


$$$$
Baricitinib
     RDKit          2D

 26 29  0  0  0  0  0  0  0  0999 V2000
    7.0516    1.1972    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4880   -0.1929    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0023   -0.3998    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    4.7954    1.0859    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.2092   -1.8854    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.5166   -0.6066    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.3198    0.2976    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4156   -0.8992    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6124   -1.8035    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3198    0.2976    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8084    0.1129    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2975    0.2939    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.2188    0.0050    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2162   -0.4317    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0750    0.7981    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1708    1.9949    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2469    1.5048    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5748    0.8262    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3490   -0.4586    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9122   -1.8936    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1420   -2.7524    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.3388   -1.8482    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8487   -0.4305    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5743    0.8823    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8001    2.1671    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3003    2.1390    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  2  0
  3  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  8 10  1  0
 10 11  1  0
 11 12  3  0
  8 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 15 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
  9  6  1  0
 17 13  1  0
 26 18  1  0
 23 19  1  0
M  END
>  <BrandName>  (245) 
Olumiant

>  <Phase>  (245) 
4.0

>  <Applicants>  (245) 
Eli Lilly

>  <Links>  (245) 
|http://www.chemspider.com/Chemical-Structure.26373084.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL2105759|http://pubchem.ncbi.nlm.nih.gov/compound/44205240|http://www.drugbank.ca/drugs/DB11817| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=3JW|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/3JW|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7792|http://zinc15.docking.org/substances/ZINC000073069247|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=ISP4442I3Y|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50021656

>  <LigID>  (245) 
'3JW'

>  <pdbID>  (245) 
4w9x

>  <Type>  (245) 
1

>  <RoF>  (245) 
0

>  <MW>  (245) 
371.1

>  <LogP>  (245) 
1.1

>  <TPSA>  (245) 
120.6

>  <HBA>  (245) 
7

>  <HBD>  (245) 
1

>  <NRB>  (245) 
5

>  <Indications>  (245) 
Indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying anti-rheumatic drugs as monotherapy or in combination with methotrexate.

>  <Targets>  (245) 
JAK1; JAK2

>  <Kinase families>  (245) 
Tyr

>  <Canonical_Smiles>  (245) 
CCS(=O)(=O)N1CC(C1)(CC#N)n2cc(cn2)c3c4cc[nH]c4ncn3

>  <InChiKey>  (245) 
XUZMWHLSFXCVMG-UHFFFAOYSA-N

>  <First_Approval>  (245) 
2017

>  <SC_Patent>  (245) 
US-8158616-B2

>  <Chirality>  (245) 
Achiral Molecule

>  <Synonyms>  (245) 
BARICITINIB | INCB-28050 | INCB028050 | LY-3009104 | OLUMIANT

>  <FDA_approved>  (245) 
Y

>  <Melting points>  (245) 


$$$$
Axitinib
     RDKit          2D

 28 31  0  0  0  0  0  0  0  0999 V2000
   -8.0028   -3.1808    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.5451   -1.7524    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0792   -1.4345    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0710   -2.5451    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6215   -0.0061    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6297    1.1046    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1720    2.5330    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7061    2.8509    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6978    1.7403    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1555    0.3118    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1473   -0.7988    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6814   -0.4810    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6731   -1.5916    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7928   -1.2737    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2505    0.1547    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2423    1.2653    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2237    0.9475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9870    2.5674    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.4554    2.2616    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.6183    0.7704    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9204    0.0257    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2164    0.7810    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5185    0.0363    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5246   -1.4637    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8267   -2.2084    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1226   -1.4531    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1165    0.0469    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8144    0.7916    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 16 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 10  5  1  0
 17 12  1  0
 20 15  1  0
 28 23  1  0
M  END
>  <BrandName>  (246) 
Inlyta

>  <Phase>  (246) 
4.0

>  <Applicants>  (246) 
Pfizer

>  <Links>  (246) 
|http://www.chemspider.com/Chemical-Structure.4953153.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL1289926|http://pubchem.ncbi.nlm.nih.gov/compound/6450551|http://www.drugbank.ca/drugs/DB06626| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=AXI|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/AXI|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5659|http://zinc15.docking.org/substances/ZINC03816287|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=C9LVQ0YUXG|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25117

>  <LigID>  (246) 
'AXI'

>  <pdbID>  (246) 
4ag8 4agc 4twp 4wa9

>  <Type>  (246) 
2

>  <RoF>  (246) 
0

>  <MW>  (246) 
386.1

>  <LogP>  (246) 
4.6

>  <TPSA>  (246) 
70.7

>  <HBA>  (246) 
4

>  <HBD>  (246) 
2

>  <NRB>  (246) 
5

>  <Indications>  (246) 
Used in kidney cell cancer and investigated for use/treatment in pancreatic and thyroid cancer.

>  <Targets>  (246) 
FLT1; KDR; FLT4

>  <Kinase families>  (246) 
Tyr

>  <Canonical_Smiles>  (246) 
CNC(=O)c1ccccc1Sc2ccc3c(c2)[nH]nc3/C=C/c4ccccn4

>  <InChiKey>  (246) 
RITAVMQDGBJQJZ-FMIVXFBMSA-N

>  <First_Approval>  (246) 
2012

>  <SC_Patent>  (246) 
US-6534524-B1

>  <Chirality>  (246) 
Achiral Molecule

>  <Synonyms>  (246) 
AG-013736 | AG-13736 | AXITINIB | INLYTA

>  <FDA_approved>  (246) 
Y

>  <Melting points>  (246) 


$$$$
Anlotinib
     RDKit          2D

 30 34  0  0  0  0  0  0  0  0999 V2000
   -9.5022    1.0614    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.0623    0.6413    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.8760    1.5593    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6363    0.7148    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0564   -0.7251    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.5558   -0.7706    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0194   -1.8090    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5623   -1.4528    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1422   -0.0128    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1792    1.0710    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7591    2.5109    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6851    0.3433    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6481   -0.7405    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0682   -2.1804    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0312   -3.2643    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4259   -2.9081    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.8460   -1.4681    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8090   -0.3843    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2291    1.0557    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6862    1.4118    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7232    0.3280    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3031   -1.1120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1803    0.6842    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.2173   -0.3996    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6744   -0.0435    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1654   -0.2072    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2782   -1.4166    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5767    1.4533    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.1063    2.8518    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.5634    3.2079    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  5  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
  9 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 21 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 25 28  1  0
 20 29  1  0
 29 30  1  0
  6  2  1  0
 10  4  1  0
 18 13  1  0
 22 17  1  0
 27 25  1  0
M  END
>  <BrandName>  (247) 
nan

>  <Phase>  (247) 
4.0

>  <Applicants>  (247) 
Advenchen Laboratories

>  <Links>  (247) 
|http://www.chemspider.com/Chemical-Structure.45743493.html|http://pubchem.ncbi.nlm.nih.gov/compound/25017411|http://www.drugbank.ca/drugs/DB11885|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9601|http://zinc15.docking.org/substances/ZINC000117924202|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=GKF8S4C432

>  <LigID>  (247) 
nan

>  <pdbID>  (247) 
nan

>  <Type>  (247) 
nan

>  <RoF>  (247) 
0

>  <MW>  (247) 
407.2

>  <LogP>  (247) 
4.8

>  <TPSA>  (247) 
82.4

>  <HBA>  (247) 
5

>  <HBD>  (247) 
2

>  <NRB>  (247) 
6

>  <Indications>  (247) 
Anlotinib (AL3818) is a non-selective inhibitor of multiple receptor tyrosine kinases, including vascular endothelial growth factor receptor type 2 (VEGFR-2, FLT1) and type 3 (VEGFR-3, FLT4). It is being investigated for antineoplastic and anti-angiogenic potential. The dihydrochloride has PubChem CID: 57380530. Preparation and crystallisation of AL3818 is described in patent WO2016179123.

>  <Targets>  (247) 
KDR; FLT4

>  <Kinase families>  (247) 
Tyr

>  <Canonical_Smiles>  (247) 
Cc1cc2c([nH]1)ccc(c2F)Oc3ccnc4c3cc(c(c4)OCC5(CC5)N)OC

>  <InChiKey>  (247) 
KSMZEXLVHXZPEF-UHFFFAOYSA-N

>  <First_Approval>  (247) 
nan

>  <SC_Patent>  (247) 
None

>  <Chirality>  (247) 
Single Stereoisomer

>  <Synonyms>  (247) 
AL 3818|APCII|AL3818|ATCII|ANLOTINIB|FU KE WEI|ALTN|AL-3818|APC I|ATC I

>  <FDA_approved>  (247) 
N

>  <Melting points>  (247) 


$$$$
Alpelisib
     RDKit          2D

 30 32  0  0  0  0  0  0  0  0999 V2000
    1.1304   -5.0113    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2568   -3.7919    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7299   -2.3684    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4777   -1.4787    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6971   -2.3522    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2431   -3.7819    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1206   -1.8792    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4226   -0.4099    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3012    0.5863    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8461    0.0632    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0655   -0.8104    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.2731    0.0794    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.8000    1.5028    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3001    1.4928    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4103    2.7004    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9196    2.5336    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0112    4.0748    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.1595   -1.9145    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2675   -2.9256    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6972   -2.4716    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0188   -1.0065    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.9109    0.0046    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4812   -0.4494    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2325    1.4697    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7674    1.7914    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6976    1.1480    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5542    2.9348    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8759    4.3999    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    3.0891    3.2565    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    6.0193    2.6131    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  1
 15 16  2  0
 15 17  1  0
  3 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 22 24  1  0
 24 25  1  0
 24 26  1  0
 24 27  1  0
 27 28  1  0
 27 29  1  0
 27 30  1  0
  6  2  1  0
 14 10  1  0
 23 18  1  0
M  END
>  <BrandName>  (248) 
Piqray

>  <Phase>  (248) 
4.0

>  <Applicants>  (248) 
Novartis

>  <Links>  (248) 
|http://www.chemspider.com/Chemical-Structure.28424123.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL2396661|http://pubchem.ncbi.nlm.nih.gov/compound/56649450|http://www.drugbank.ca/drugs/DB12015| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=1LT|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/1LT|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7955|http://zinc15.docking.org/substances/ZINC000068198368|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=08W5N2C97Q|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50436459

>  <LigID>  (248) 
'1LT'

>  <pdbID>  (248) 
4jps

>  <Type>  (248) 
nan

>  <RoF>  (248) 
0

>  <MW>  (248) 
441.1

>  <LogP>  (248) 
3.8

>  <TPSA>  (248) 
101.2

>  <HBA>  (248) 
5

>  <HBD>  (248) 
2

>  <NRB>  (248) 
4

>  <Indications>  (248) 
On may 2019, FDA approved alpelisib to treat breast cancer

>  <Targets>  (248) 
PIK3CA

>  <Kinase families>  (248) 
Atypical

>  <Canonical_Smiles>  (248) 
Cc1c(sc(n1)NC(=O)N2CCC[C@H]2C(=O)N)c3ccnc(c3)C(C)(C)C(F)(F)F

>  <InChiKey>  (248) 
STUWGJZDJHPWGZ-LBPRGKRZSA-N

>  <First_Approval>  (248) 
2019

>  <SC_Patent>  (248) 
US-8227462-B2

>  <Chirality>  (248) 
Single Stereoisomer

>  <Synonyms>  (248) 
ALPELISIB | BYL-719 | NVP-BYL719 | PIQRAY

>  <FDA_approved>  (248) 
Y

>  <Melting points>  (248) 


$$$$
Alectinib
     RDKit          2D

 36 41  0  0  0  0  0  0  0  0999 V2000
   -3.4743   -2.8643    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0023   -3.1529    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0165   -2.0223    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4555   -2.3109    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4414   -1.1803    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9552    0.2387    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5168    0.5272    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5026   -0.6033    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9746   -0.3148    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4607    1.1043    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9327    1.3928    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9186    0.2622    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4325   -1.1568    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9605   -1.4453    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.3906    0.5508    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -7.8767    1.9698    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.3487    2.2583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.3346    1.1278    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -9.8484   -0.2913    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.3764   -0.5798    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9411    1.3692    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4131    1.0807    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8992   -0.3383    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3990   -0.3145    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4203   -1.4131    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8824   -1.0780    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3232    0.3558    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3019    1.4544    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8398    1.1193    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6124    1.9816    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.7853    0.6909    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2474    1.0261    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.9134   -1.4688    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3995   -2.8879    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4808    2.7688    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6566    2.1438    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 12 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
  6 21  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 27 31  1  0
 31 32  3  0
 23 33  1  0
 33 34  2  0
 21 35  1  0
 21 36  1  0
  8  3  1  0
 33  5  1  0
 14  9  1  0
 20 15  1  0
 30 22  1  0
 29 24  1  0
M  END
>  <BrandName>  (249) 
Alecensa

>  <Phase>  (249) 
4.0

>  <Applicants>  (249) 
Hoffmann-La Roche

>  <Links>  (249) 
|http://www.chemspider.com/Chemical-Structure.26326738.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL1738797|http://pubchem.ncbi.nlm.nih.gov/compound/49806720|http://www.drugbank.ca/drugs/DB11363| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=EMH|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/EMH|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7739|http://zinc15.docking.org/substances/ZINC000066166864|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=LIJ4CT1Z3Y|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50362781

>  <LigID>  (249) 
'EMH'

>  <pdbID>  (249) 
3aox 5xv7

>  <Type>  (249) 
1

>  <RoF>  (249) 
0

>  <MW>  (249) 
482.3

>  <LogP>  (249) 
4.8

>  <TPSA>  (249) 
72.4

>  <HBA>  (249) 
5

>  <HBD>  (249) 
1

>  <NRB>  (249) 
3

>  <Indications>  (249) 
Alectinib is a kinase inhibitor indicated for the treatment of patients with anaplastic lymphoma kinase (ALK)-positive, metastatic non-small cell lung cancer (NSCLC) who have progressed on or are intolerant to crizotinib. This indication is approved under accelerated approval based on tumor response rate and duration of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trials.

>  <Targets>  (249) 
ALK

>  <Kinase families>  (249) 
Tyr

>  <Canonical_Smiles>  (249) 
CCc1cc2c(cc1N3CCC(CC3)N4CCOCC4)C(c5c(c6ccc(cc6[nH]5)C#N)C2=O)(C)C

>  <InChiKey>  (249) 
KDGFLJKFZUIJMX-UHFFFAOYSA-N

>  <First_Approval>  (249) 
2015

>  <SC_Patent>  (249) 
US-9126931-B2

>  <Chirality>  (249) 
Achiral Molecule

>  <Synonyms>  (249) 
AF802 | ALECENSA | ALECTINIB | CH5424802 | RO-5424802 | RO5424802

>  <FDA_approved>  (249) 
Y

>  <Melting points>  (249) 


$$$$
Afatinib
     RDKit          2D

 34 37  0  0  0  0  0  0  0  0999 V2000
   -0.8173    9.1747    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3575    7.7469    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1089    7.4313    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3640    6.6348    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9042    5.2070    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9108    4.0949    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4509    2.6671    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0155    2.3515    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4575    1.5550    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9977    0.1273    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5313   -0.1884    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0714   -1.6162    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0780   -2.7283    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5444   -2.4126    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0042   -0.9849    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4706   -0.6692    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4772   -1.7813    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1691   -3.2494    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4701   -3.9960    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.5822   -2.9894    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.9686   -1.6207    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6181   -4.1561    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.8483   -4.4717    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8548   -3.3596    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.3950   -1.9318    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4016   -0.8197    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.8680   -1.1354    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3278   -2.5631    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7942   -2.8788    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8008   -1.7667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3410   -0.3389    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8746   -0.0232    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3475    0.7732    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    8.2672   -2.0823    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 17 16  1  1
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 13 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 31 33  1  0
 30 34  1  0
 15 10  1  0
 25 12  1  0
 21 17  1  0
 32 27  1  0
M  END
>  <BrandName>  (250) 
Gilotrif;Giotrif

>  <Phase>  (250) 
4.0

>  <Applicants>  (250) 
Boehringer Ingelheim

>  <Links>  (250) 
|http://www.chemspider.com/Chemical-Structure.8360155.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL1173655|http://pubchem.ncbi.nlm.nih.gov/compound/10184653|http://www.drugbank.ca/drugs/DB08916| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=0WM|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/0WM|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5667|http://zinc15.docking.org/substances/ZINC03976838|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=41UD74L59M|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50322823

>  <LigID>  (250) 
'0WM'

>  <pdbID>  (250) 
4g5j

>  <Type>  (250) 
1

>  <RoF>  (250) 
0

>  <MW>  (250) 
485.2

>  <LogP>  (250) 
4.4

>  <TPSA>  (250) 
88.6

>  <HBA>  (250) 
7

>  <HBD>  (250) 
2

>  <NRB>  (250) 
8

>  <Indications>  (250) 
Afatinib is a kinase inhibitor indicated for the first-line treatment of patient with metastatic non-small cell lung cancer (NSCLC) whose tumours have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L858R) substitution mutations as detected by an FDA-approved test.

>  <Targets>  (250) 
EGFR; ERBB2; ERBB4

>  <Kinase families>  (250) 
Tyr

>  <Canonical_Smiles>  (250) 
CN(C)C/C=C/C(=O)Nc1cc2c(cc1O[C@H]3CCOC3)ncnc2Nc4ccc(c(c4)Cl)F

>  <InChiKey>  (250) 
ULXXDDBFHOBEHA-CWDCEQMOSA-N

>  <First_Approval>  (250) 
2013

>  <SC_Patent>  (250) 
US-RE43431-E1

>  <Chirality>  (250) 
Single Stereoisomer

>  <Synonyms>  (250) 
AFATINIB | BIBW2992 | GILOTRIF | GIOTRIF

>  <FDA_approved>  (250) 
Y

>  <Melting points>  (250) 


$$$$
Acalabrutinib
     RDKit          2D

 35 39  0  0  0  0  0  0  0  0999 V2000
    6.3038   -6.4041    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7158   -5.0242    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1277   -3.6443    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5396   -2.2644    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0505   -2.0837    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.4406   -1.0652    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.9404   -1.0892    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4267    0.3298    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2275    1.2308    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0000    0.3687    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5810    0.8550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3535   -0.0071    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1543    0.8938    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6406    2.3128    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1404    2.2888    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.9111    3.5757    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1820    4.8866    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6822    4.9106    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.9115    3.6237    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5883    3.6477    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2796    0.4532    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3781    1.4746    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8119    1.0340    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1472   -0.4280    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0487   -1.4494    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6149   -1.0088    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5810   -0.8686    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9164   -2.3307    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6795    0.1528    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -7.1134   -0.2878    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.2119    0.7336    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.6457    0.2930    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.9810   -1.1691    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.8825   -2.1905    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.4487   -1.7499    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  3  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  6
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 13 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 24 27  1  0
 27 28  2  0
 27 29  1  0
 29 30  1  0
 30 31  2  0
 31 32  1  0
 32 33  2  0
 33 34  1  0
 34 35  2  0
 10  6  1  0
 15 11  1  0
 19 14  1  0
 26 21  1  0
 35 30  1  0
M  END
>  <BrandName>  (251) 
Calquence

>  <Phase>  (251) 
4.0

>  <Applicants>  (251) 
Astrazeneca

>  <Links>  (251) 
|http://www.chemspider.com/Chemical-Structure.36764951.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3707348|http://pubchem.ncbi.nlm.nih.gov/compound/71226662|http://www.drugbank.ca/drugs/DB11703|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8912|http://zinc15.docking.org/substances/ZINC000208774715|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=I42748ELQW|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50175583

>  <LigID>  (251) 
nan

>  <pdbID>  (251) 
nan

>  <Type>  (251) 
nan

>  <RoF>  (251) 
0

>  <MW>  (251) 
465.2

>  <LogP>  (251) 
3.3

>  <TPSA>  (251) 
118.5

>  <HBA>  (251) 
7

>  <HBD>  (251) 
2

>  <NRB>  (251) 
4

>  <Indications>  (251) 
Acalabrutinib is currently indicated for the treatment of adult patients with Mantle Cell Lymphoma (MCL) who have received at least one prior therapy

>  <Targets>  (251) 
BTK

>  <Kinase families>  (251) 
Tyr

>  <Canonical_Smiles>  (251) 
CC#CC(=O)N1CCC[C@H]1c2nc(c3n2ccnc3N)c4ccc(cc4)C(=O)Nc5ccccn5

>  <InChiKey>  (251) 
WDENQIQQYWYTPO-IBGZPJMESA-N

>  <First_Approval>  (251) 
2017

>  <SC_Patent>  (251) 
US-7459554-B2

>  <Chirality>  (251) 
Single Stereoisomer

>  <Synonyms>  (251) 
ACALABRUTINIB | ACP-196 | CALQUENCE

>  <FDA_approved>  (251) 
Y

>  <Melting points>  (251) 


$$$$
Vemurafenib
     RDKit          2D

 33 36  0  0  0  0  0  0  0  0999 V2000
  -10.0263   -0.0831    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.5337   -0.2316    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.9160   -1.5985    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4234   -1.7470    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2749   -0.2544    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5719   -3.2397    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9308   -1.8955    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0558   -0.6772    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6735    0.6898    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7986    1.9082    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3059    1.7596    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6883    0.3927    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5632   -0.8257    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9455   -2.1926    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1956    0.2442    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4221   -1.1227    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.6793    1.4626    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2079    2.8866    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4165    3.7750    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.6349    2.9000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1793    1.4709    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1891    0.3618    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6546    0.6817    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1102    2.1109    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1004    3.2200    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.6645   -0.4274    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2089   -1.8565    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2187   -2.9657    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6842   -2.6457    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1398   -1.2165    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1299   -0.1074    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6941   -3.7548    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -1.4310    2.9780    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  2  0
  4  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 12 15  1  0
 15 16  2  0
 15 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 23 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 29 32  1  0
 11 33  1  0
 13  8  1  0
 21 17  1  0
 25 20  1  0
 31 26  1  0
M  END
>  <BrandName>  (252) 
Zelboraf

>  <Phase>  (252) 
4.0

>  <Applicants>  (252) 
Hoffmann-La Roche

>  <Links>  (252) 
|http://www.chemspider.com/Chemical-Structure.24747352.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL1229517|http://pubchem.ncbi.nlm.nih.gov/compound/42611257|http://www.drugbank.ca/drugs/DB08881| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=032|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/032|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5893|http://zinc15.docking.org/substances/ZINC000052509366|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=207SMY3FQT|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50396483

>  <LigID>  (252) 
'032'

>  <pdbID>  (252) 
3og7 4rzv 5hes

>  <Type>  (252) 
1.5

>  <RoF>  (252) 
1

>  <MW>  (252) 
489.1

>  <LogP>  (252) 
5.5

>  <TPSA>  (252) 
91.9

>  <HBA>  (252) 
4

>  <HBD>  (252) 
2

>  <NRB>  (252) 
7

>  <Indications>  (252) 
Vemurafenib is approved since 2011 for the treatment of metastatic melanoma with a mutation on BRAF in the valine located in the exon 15 at codon 600, this mutation is denominated as V600E.

>  <Targets>  (252) 
BRAF

>  <Kinase families>  (252) 
TKL

>  <Canonical_Smiles>  (252) 
CCCS(=O)(=O)Nc1ccc(c(c1F)C(=O)c2c[nH]c3c2cc(cn3)c4ccc(cc4)Cl)F

>  <InChiKey>  (252) 
GPXBXXGIAQBQNI-UHFFFAOYSA-N

>  <First_Approval>  (252) 
2011

>  <SC_Patent>  (252) 
US-7504509-B2

>  <Chirality>  (252) 
Achiral Molecule

>  <Synonyms>  (252) 
PLX-4032 | PLX4032 | RG 7204 | RO 5185426 | RO-51-85426 | VEMURAFENIB | ZELBORAF

>  <FDA_approved>  (252) 
Y

>  <Melting points>  (252) 
272C

$$$$
Copanlisib
     RDKit          2D

 35 39  0  0  0  0  0  0  0  0999 V2000
    1.7522    2.2553    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5259    1.3914    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.6609   -0.1025    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0222   -0.7326    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1572   -2.2265    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9309   -3.0903    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4304   -2.4603    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5653   -0.9664    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9266   -0.3363    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1529   -1.2002    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0179   -2.6941    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6566   -3.3241    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8352   -4.8135    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3068   -5.1039    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0378   -3.7940    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5141   -0.5701    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6491    0.9238    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4228    1.7877    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0104    1.5539    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1454    3.0478    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.5066    3.6778    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -8.7329    2.8140    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.5979    1.3201    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -7.2367    0.6900    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.0942    3.4441    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.2485    0.1313    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.6097   -0.4988    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8360    0.3651    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1973   -0.2650    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4235    0.5989    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.7848   -0.0312    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0111    0.8327    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8761    2.3266    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.5148    2.9566    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2886    2.0928    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 10 16  1  0
 16 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 22 25  1  0
  4 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
 33 34  1  0
 34 35  1  0
  8  3  1  0
 12  7  1  0
 15 11  1  0
 24 19  1  0
 35 30  1  0
M  END
>  <BrandName>  (253) 
Aliqopa

>  <Phase>  (253) 
4.0

>  <Applicants>  (253) 
Bayer

>  <Links>  (253) 
|http://www.chemspider.com/Chemical-Structure.25069683.html|https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3218576|http://pubchem.ncbi.nlm.nih.gov/compound/24989044|http://www.drugbank.ca/drugs/DB12483| http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=6E2|http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/6E2|http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7875|http://zinc15.docking.org/substances/ZINC000068247389|http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=fdasrs&actionHandle=default&nextPage=jsp/srs/ResultScreen.jsp&TXTSUPERLISTID=WI6V529FZ9|http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50204093

>  <LigID>  (253) 
'6E2'

>  <pdbID>  (253) 
5g2n

>  <Type>  (253) 
1

>  <RoF>  (253) 
1

>  <MW>  (253) 
480.2

>  <LogP>  (253) 
0.7

>  <TPSA>  (253) 
139.8

>  <HBA>  (253) 
11

>  <HBD>  (253) 
2

>  <NRB>  (253) 
7

>  <Indications>  (253) 
Indicated for the treatment of adult patients with relapsed follicular lymphoma (FL) who have received at least two prior systemic therapies.

>  <Targets>  (253) 
PIK3CA; PIK3CB

>  <Kinase families>  (253) 
Atypical

>  <Canonical_Smiles>  (253) 
COc1c(ccc2c1N=C(N3C2=NCC3)NC(=O)c4cnc(nc4)N)OCCCN5CCOCC5

>  <InChiKey>  (253) 
PZBCKZWLPGJMAO-UHFFFAOYSA-N

>  <First_Approval>  (253) 
2017

>  <SC_Patent>  (253) 
US-7511041-B2

>  <Chirality>  (253) 
Achiral Molecule

>  <Synonyms>  (253) 
BAY 80-6946 | BAY-80-6946 | BAY80-6946 | COPANLISIB

>  <FDA_approved>  (253) 
Y

>  <Melting points>  (253) 


$$$$
